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Sources warn the global HIV/AIDS epidemic will not be halted without significant 
reductions in Intimate partner violence (IPV). South African women have been 
hardest hit by the HIV-IPV link, suffering deleterious health outcomes as 
sequelae of significant barriers to HIV care. Extant literature focuses on HIV 
prevention, and there is a paucity of effective methods for mitigating IPV-related 
barriers among women living with HIV. 
 
This study was a Phase II trial testing the effectiveness and safety of the HIV IPV 
	   
ix 
Risk and Safety (HIRS) protocol administered to women experiencing IPV and 
testing HIV+ during mobile HIV Counseling and Testing (HCT). Research 
questions compared experiences between a Standard of Care and an 
Experimental group with two dosage levels. All participants (N=255) were black 
South African females residing in Gauteng province and aged about 33 years 
(M=33). Two psychometric instruments were created for this study: the Danger 
Indicator and the HIRS scale with the latter having good reliability (Cronbach 
alpha .882) but both needing refinement in validity.  
 
The protocol was shown to be effective in mitigating violence upon partner 
notification of serostatus (X2(1) = 7.83, p=.005) and promoting linkage to care, 
with participants aged 33-43 years trending towards significant (X2(1) = 3.57, 
p=.059). The protocol was found to be feasible to implement, having impressive 
retention, brevity in administration, and high usage of safety strategies with 
minimal risks resulting from participation. Satisfaction was confirmed through 
positive participant ratings and safety through both non-significant group 
differences on the HIRS scale (t(1, 237)= -1.09; p= .278) and the perceived 
benefits of study participation far outweighing harms. 
 
Women receiving the protocol displayed notable self-determination towards self-
protection and suffered significantly less re-assault upon partner notification. The 
number of participants utilizing certain safety strategies suggests this brief 
intervention was effective in galvanizing South African women to reclaim power 
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and act towards the betterment of their health. 
 
Findings herald the promise of a protocol that effectively mitigates IPV to improve 
HIV outcomes. The effectiveness of the HIRS protocol, in facilitating safe partner 
notification of serostatus, could be a significant contribution to the knowledge 
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CHAPTER 1  
INTRODUCTION: THE HIV-IPV INTERSECTION 
 
 
The story of the human immunodeficiency virus (HIV) epidemic in South 
Africa is one of widespread devastation and yet also great hope. Although the 
country has been hardest hit by the HIV epidemic (UNAIDS, 2012), South Africa 
has one of the strongest national campaigns for HIV/AIDS relief (UNAIDS, 
2015b). Additionally, countries worldwide have become allies to tackle the 
epidemic in sub-Saharan Africa, with greatest force in South Africa. From these 
efforts have abounded stories and statistics of life-saving programs and 
initiatives. Yet, for many, HIV continues to claim their lives at an alarming rate, 
and the number of those impacted in South Africa remains formidable (Mall, 
Middlekoop, Mark, Wood & Bekker, 2013). Despite the rollout of more testing and 
treatment services, many individuals continue to be unaware of their status, and 
the majority of individuals who have been tested are not utilizing available 
treatment (Mall et al; UNAIDS, 2000). Given the investment in curbing the 
disease in South Africa, the need for evidence-based programs that provide 
preventative measures and halt disease progression is ever increasing, and 
there is a particular urgency for the development of interventions that effectively 
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reach those who do not access services offered in traditional mediums (Krazner 
et al., 2010). 
The HIV care continuum (Figure 1.1) is a model that illustrates the stages 
of care needed in order for a person with HIV to receive the most long-term 
health benefits (AIDS.gov, 2015). Approaches like HIV Counseling and Testing 
(HCT) initiate the care process by informing individuals of their HIV diagnosis. 
HCT is an important technique used during the diagnostic stage because it has 
been associated with reductions in risky behaviors (Painter, 2001), and, 
consequently, lowered transmission rates (Beer et al., 2012). Further, it can be 
instrumental in encouraging individuals to successfully engage in the subsequent 
steps in the care continuum.  
 
Figure 1.1 HIV Care Continuum 
 
Figure 1.1 HIV Care Continuum AIDS.gov (2015). HIV care continuum. Retrieved on February 6, 
2016 from https://www.aids.gov/federal-resources/policies/care-continuum/ 
 
Thus, the effectiveness of HCT can determine if an individual begins the 
care continuum or falls off the treatment cascade, either delaying or abstaining 
from linking to care. Linkage to care is the next important stage in the continuum 
because the care a person receives helps assess disease progression: eligibility 
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for antiretroviral therapy (ART) is based on CD4 cell count and often linking to 
some form of care is the only way to receive these results. Unfortunately, a vast 
number of individuals delay ART initiation and suffer health consequences such 
as opportunistic infections and consequently death (Van Zyl, Brown & Pahl, 
2015).  
 Past research has helped refine HCT methods so that programs more 
effectively encourage a greater number of individuals to link to care and at a 
faster pace. Although it is difficult to find an average linkage rate in the literature 
due to variations in collection periods and classifications of “successful” linkage 
periods, rates ranged from only 10% (Bassett, Regan et al., 2014) to 47% 
(Losina et al., 2010), 53.4% (Krazner et al., 2010) and 51% in a large sample of 
South African youth (Van Zyl et al., 2015). While most of these numbers indicate 
mobile HCT can be effective in assisting many, the demand for more 
improvements with HCT is underscored. Additional research is required to 
identify and reduce barriers to timely linkage to care. Notably, the improvement 
and expansion of services like HCT has been recognized as vital to AIDS 
eradication (Centers for Disease Control & Prevention (CDCa, 2015, pg. 1). 
 
1.1 The intersection of HIV and IPV 
Global strategies to end the HIV epidemic have also identified various 
societal injustices that contribute to disease transmission and progression and 
act as barriers to available services such as HCT and ART. Successful 
eradication of the epidemic hinges on advances of an array of human rights’ 
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issues (UNAIDS, 2015a), and one issue that is a fulcrum of the HIV epidemic is 
that of gender inequality (UNAIDS, 2012). Almost 60% of HIV cases worldwide 
are among women in sub-Saharan Africa (UNAIDS, 2012), and the disease is the 
primary cause of death among those of reproductive age (AVERT, 2015). In 
South Africa alone, there are more than 3.5 million women living with HIV. Young 
women (aged 20-24) are four times more likely to become HIV infected than their 
male counterparts, and women (aged 30-34) experience the highest prevalence 
rate of 42.6% (UNAIDS, 2012).  
It is believed that women suffer disparately from the HIV epidemic, in large 
part, due to gender inequalities. One mechanism to keep women in their place is 
gender-based violence (GBV). The elimination of GBV was listed as a top ten 
goal for the 2015 plan to eradicate HIV (UNAIDS, 2013b); thus, the connection 
between HIV and GBV has already been made. This elimination plan is 
paramount for the health and well-being of South African women considering the 
country has simultaneously been ravaged by the epidemic of gender-based 
violence and the highest documented rate of femicide in the world (Wong, 
Huang, DiGangi, Thompson & Smith, 2008). While GBV may be perpetrated in 
many different ways by all sorts of men who encounter women publically and 
privately, the private form of GBV—intimate partner violence (IPV)—is the most 
pervasive globally (Maman, Mwambo, Hogan, Kilonzo, & Sweat, 2002) and is 
used as a proxy for GBV (UNAIDS, 2015a).  
IPV afflicts women gravely in HIV prevalent areas such as South Africa. 
Definitions vary, but a basic description of IPV includes “physical, sexual or 
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psychological harm by a current or former partner or spouse” (CDCb, 2015, para. 
1). Prevalence rates also vary; one in four women (Bendall, 2010), or up to 55% 
(Dunkle et al. as cited in Adams et al., 2011) of women in South Africa reportedly 
have experienced IPV at some point in their lives. The prevalence is thought to 
be higher in actuality with these rates being non-reflective of the gross 
underreporting of IPV that occurs (Boonzaier & Gordon, 2015). Many view IPV as 
a private matter, with some women opting, for myriad reasons, to not discuss 
what they have endured (Bendall, 2010). Others contextualize IPV in South 
Africa as a cultural matter—both a vestige of post-apartheid culture, where IPV 
stems from the general overuse of violence as a common resolution tactic 
(Jewkes, Levin & Penn-Kekana, 2002) and an ideology of gender-based violence 
propagated as a normal, acceptable or even desired mechanism for maintaining 
traditional masculinity (Jewkes et al. as cited in Boonzaier & Gordon, 2015). 
Hence, resulting from cultural norms steeped in gender-based violence, a certain 
level of IPV is seen as acceptable (Jewkes et al., 2002). 
In addition to the baseline gender-based violence commonly endured in 
South Africa, women living with HIV experience increased IPV through a number 
of different mechanisms. It is important to note that often an HIV diagnosis does 
not alone create violence in a relationship (although some violence has been 
reported as occurring after an HIV diagnosis only, and this is reviewed in Chapter 
Five). Rather, many women with HIV diagnoses have already been experiencing 
IPV in their relationship. Thus, the pathway between HIV and IPV is 
multidirectional (see figure 1.2); IPV increases the risk for HIV transmission, and 
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living with HIV increases the risk for [further] IPV in various forms (Ball, 2013; 
Dunkle et al. 2004; Hale & Vazquez, 2011; Jewkes, Sikweyiya, Morrell, & Dunkle, 
2011; Maman, Yamanis, Kouyoumdjian, Watt, & Mbwambo, 2010; Prowse, 
Logue, Fantasia, & Sutherland, 2013; CDC, 2014; Ramachandran, Yonas, 
Silvestre, & Burke, 2010; Ball, 2013; Shi, Kouyoumdjian, & Dushoff, 2013). 
Women who are HIV+, compared with their HIV- counterparts, are more likely to 
report a history of IPV—physical, sexual, a combination of both, (Maman et al., 
2002) or psychological (controlling partners) (Dunkle et al., 2004; Hale & 
Vazquez, 2011). One theory is that men who batter are more likely to be infected 
with HIV and transmit infections through forced sexual activity (Dunkle et al.). 
Physical or sexual IPV can lead to HIV transmission by compromising a person’s 
immune system (Shai, Jewkes, Nduna, & Dunkle, 2012) or through direct contact 
if a woman’s genitalia are damaged in a sexual assault (UNAIDS, 2013b). Other 
studies have shown a correlation between HIV transmission and other risk 
factors related to IPV (Shai et al.). For example, coercion in a relationship can 
reduce a woman’s ability to protect herself (Maman et al.; Shi et al.; Dunkle & 
Decker, 2012; Prowse et al., 2013), or negotiate safer sex (Shi et al.; UNAIDS, 













Figure 1.2 Pathways from Gender Inequality to Increased HIV Risk among 
Survivors of Violence  
 
Figure 1.2 “Pathways from gender inequality…to increased HIV risk among survivors of violence.” 
Dunkle, K.L. & Decker, M.R. (2012). Gender-Based violence and HIV: reviewing the evidence for 
links and causal pathways in the general population and higher-risk groups. American Journal of 
Reproductive Immunology, 69(1), 21. 
 
Regardless of the mode of transmission, women living with HIV are more 
likely to already be experiencing IPV and the diagnosis has been shown to 
foment further aggression (Prowse et al., 2013). Cultural and structural violence 
is experienced by women living with HIV, where women are often blamed for the 
IPV and then pressured by family and society to stay in the relationship. Financial 
constraints additionally prevent women from having the means to flee the 
relationship (Hale & Vazquez, 2011). Personal violence also occurs related to the 
general cycle of escalating violence in certain types of IPV relationships (Gielen, 
McDonnell, Burke, & O’Campo, 2000; WHO, 2012), and upon disclosure of an 
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HIV+ serostatus to one’s partner (Prowse et al., 2013; Mkandawire-Vahlmu, 
Stevens, Kako & Dressel, 2013), often due to the social stigma of the diagnosis 
(Myer, Rebe & Morroni, 2007). An exploratory study in sub-Saharan Africa cited 
that IPV against women with HIV frequently follows the scenario of a man coming 
home drunk and becoming enraged when either the woman notifies him of her 
seropositive status or she refuses to have sex with him (Murray et al. as cited in 
Hale & Vazquez, 2011). Another study in the area found that 19% of women 
reportedly experienced IPV “because of their HIV status,” and slightly higher 
rates were found in the United States, specifically linking physical violence as a 
result of a woman’s serostatus (Nilo as cited in Hale & Vazquez, 2011, pg. 18). 
Other women have reported experiencing abandonment or blame by their partner 
also as a result of serostatus notification (Mkandawire-Vahlmu et al., 2013). 
The social stigma of an HIV diagnosis plays a nefarious role in increasing 
IPV among women living with HIV. Stigma is a form of “labeling or ‘othering’ of 
persons or a group of people” (Goffman as cited in Abdool Karim et al., 2013, pg. 
352). When someone is diagnosed as HIV+ they often experience a great deal of 
stigma from their community and in other social realms, and generally this stigma 
acts as a force that reinforces gender inequalities by reproducing dynamics of 
power and control (Abdool Karim et al., 2013). HIV-stigma-related abuse is “often 
aimed at rejecting, dehumanizing, and isolating” people living with HIV (Dlamini 
et al., 2008, pg. 395). 
Some examples of stigma-related verbal abuse towards people living with 
HIV in African countries are name-calling, the shouting of insults and blame, 
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being labeled as an other, and partners seeking retribution or revenge (Dlamini et 
al., 2008). More, physical abuse has been shown to be related to partner 
notification of serostatus with partners reacting violently to the shock of the news 
or becoming enraged at the partner for possibly exposing them to the disease 
(Dlamini et al., 2008). See figure 1.3 for a description of the model of HIV/AIDS 
related stigma experienced in many African cultures. In addition to these types of 
stigma people living with HIV experience, in general, women with IPV are at an 
increased risk for stigma-related abuse by their partners, and this places a 
significant hindrance on their ability to engage in HIV-related services, from 
testing to treatment (UNAIDS, 2013b). 
 
Figure 1.3 Model of the Dynamics of HIV/AIDS Stigma 
 
Figure 1.3 Model of the Dynamics of HIV/AIDS Stigma. Dlamini, P.S., Kohi, T.W., Uys, L.R., 
Phetlhu, R.D., Chirwa, M.L., Naidoo, J.R., Holzemer, W.L., Greef, M., Makoae, L.N. (2008). 
Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African 




1.2 IPV as a Barrier to HIV Care & Health-related Implications 
South African women affected by the HIV-IPV link face insidious barriers 
to receiving care, and access to HIV testing and treatment remains insufficient 
among this group (AVERT, 2015). The majority of individuals who receive HIV 
testing either face subsequent delays to entry to care or are lost to follow-up at 
some point in the HIV treatment continuum (Christopulous et al, 2013). A portion 
of this attrition is attributed to the HIV-IPV link (Abramsky et al., 2012; Adams et 
al., 2011; CDC, 2014; Mkandawire-Vahlmu et al. 2013; Prowse, Logue, Fantasia, 
& Sutherland 2013; WHO, n.d), as women with both HIV and IPV face one of the 
heaviest burdens of care (Hale & Vazquez, 2011). One study found 16-51% of 
individuals reported fear of IPV as a substantial barrier to HIV disclosure 
(Medley, Garcia-Moreno, McGill & Maman, 2004; WHO, n.d.). For these reasons, 
and others, some women may choose to avoid HIV testing from the onset (CDC, 
2014, Abramsky et al.), or refrain from linking to care or adhering to treatment 
once diagnosed (Snyder et al., 2014; Mkandawire-Vahlmu et al.).  
 Hence, the effects of the HIV-IPV link on South African women’s health 
have been immense with those already HIV+ being at risk of worse health 
outcomes and conditions (Shafer et al., 2012). Women living with HIV and IPV 
have been shown to have lower CD4 cell counts (Shafer et al.) and often miss 
doses of ART when the abuse thwarts their ability to access or adhere to 
treatments. With the latter case, these women frequently experience blame from 
healthcare workers for the poor adherence (Human Rights Watch as cited in 
Hale & Vazquez, 2011). See Figure 1.4 for the causes and consequences of 
	   
11 
violence against women living with HIV. 
 
Figure 1.4 Causes & Consequences of Violence Against Women Living with HIV 
 
Figure 1.4 Causes and Consequences of Violence Against Women Living with HIV Hale, F. & 
Vazquez, M. (2011). Violence against women living with HIV/AIDS: A background paper. 
Development Connections. USA, 16. 
 
1.3 Rationale for Current Study  
The conjoined epidemics of HIV and IPV have ravaged the lives of South 
African women at a disproportionate magnitude, and the need for effective 
interventions with a joint target has gained increasing recognition (Abramsky et 
al., 2012). Much of extant initiatives and research targeting the HIV-IPV 
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intersection have focused on addressing IPV as a means for preventing HIV, and 
this has led to a gap in knowledge as well as supportive services for those who 
are already living with HIV and experiencing IPV. Unfortunately, there has been 
little effort globally to mitigate IPV among women with HIV: there is a paucity of 
empirical support for services effective in diverse settings and populations and a 
general dearth “of systematic research on this issue” with past research failing to 
recognize IPV as a consequence of an HIV diagnosis (Hale & Vazquez, 2011, 
pg. 4).  
This gap emphasizes the great need for initiatives and research that 
concentrate on women living with HIV and IPV, especially bearing the 
pervasiveness of IPV among those who attend for social services (Lindhorst, 
Nurius & Macy, 2005) and the potential for identifying those “at risk for abuse 
after an HIV-positive diagnosis” (Gielen, McDonnell, Burke & O’Campo, 2000, 
pg. 11). It is, therefore, crucial that providers of HIV testing incorporate IPV 
assessment into HIV post-test counseling (Gielen et al., 2000) with those 
identified being offered contextualized safety planning (Lindhorst et al., 2005) 
with referrals to community services such as counseling and legal assistance 
(Kouyoumdjian et al., 2013). 
Given that IPV is said to be responsible for a portion of the loss to follow-
up in the HIV treatment cascade (Mkandawire-Valhmu et al., 2013), incorporating 
an IPV component into any stage of the care continuum could assist in reducing 
barriers to care related to IPV. WHO (n.d.) recognizes HCT, in particular, as a 
critical entry point for IPV detection and response, and suggests that by training 
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HIV counselors to assist IPV survivors both HIV and GBV epidemics may be 
greatly reduced. On the one hand, IPV screening during HCT has been 
connected with reductions in IPV (Christofides & Jewkes, 2010), and the 
literature calls for a scale-up of IPV screening in health care and HIV services 
(Ahmad et al., 2009; Baig, Ryan & Rodriguez, 2009; Thackeray, Stelzner, Downs 
& Miller, 2007). Yet, on the other hand, because self-protective techniques 
learned during HCT can “trigger violence” (Christofides & Jewkes, 2010, pg. 
279), supportive services are essential to safe implementation of IPV screening 
(Matseke, Peltzer & Habil, 2013). However, research is needed to develop and 
test interventions that help reduce risks of future violence among those reporting 
IPV during routine screening in healthcare settings (Jewkes, 2013). 
Notwithstanding the charge to create more services jointly targeting IPV 
and HIV (Abramsky et al., 2012; Matseke et al., 2013; Mkandawire-Valhmu, 
2013; WHO, 2001), research on effective programs for this purpose remains 
scant. A review of the literature found that research is needed to: 1. Assist with a 
basic understanding of the HIV-IPV intersection and its social, economic and 
behavioral dimensions (Pronyk et al., 2006); 2. Develop and test IPV detection 
methods in resource-limited countries (Baig et al., 2012; Mkandawire-Valhmu et 
al., 2013); 3. Underscore the breadth of the HIV-IPV phenomenon as well as its 
causes and consequences among varying populations; 4. Test the effectiveness 
of HIV-IPV interventions (WHO, 2001) using rigorous methodology and 
prioritizing effectiveness in resource-limited countries in sub-Saharan Africa 
(Jewkes et al., 2006); and 5. Explore strategies for effective safety planning for 
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women with HIV who are also IPV victims (Mkandawire-Vahlmu et al., 2013), 
with a particular need for developing safe partner notification strategies 
(Kennedy, Haberlen, Amin, Baggaley & Narasimhan, 2015). 
In order for more interventions to effectively target the HIV-IPV 
intersection, there is a precursory need for the refinement of effective IPV 
screening techniques aimed at reducing retributional violence. Nonetheless, 
experts have cautioned that providers must move beyond simply offering IPV 
screening (Jewkes, 2013), and so while research should test IPV screening 
protocols for their validity and reliability during the HIV screening process, 
supportive interventions should be offered in conjunction with screenings. 
Globally, knowledge is required on the acceptability and feasibility of IPV 
screenings and interventions (Baig et al., 2009). In particular, there is a call for: 1. 
Effective responses to victims identified during screening (Decker et al., 2012); 2. 
Best practices with implementing and monitoring screenings and results; and 3. 
Ways to sensitively conduct IPV screenings without causing discomfort or 
unnecessary difficulties for victims during the process or once they return home 
(Thackeray et al., 2007). 
As stated, much of the extant literature on the HIV-IPV link focuses on IPV 
as a risk factor for HIV and fails to pay proper attention to IPV among women 
who are already living with HIV. Interventions, for women with HIV, are equally 
important, as they can lead to improvements in health and safety. By exploring 
and circumventing IPV-related barriers to care (Mkandawire-Valhmu et al., 2013), 
women may more readily access HIV care and experience the long-term benefits 
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of suppressed viral loads and reductions in reinfections, effectively contributing to 
HIV prevention through lowered transmission rates (Jones, Beach, Forehand & 
The Family Healthy Project Research Group, 2001). Simply, the HIV/AIDS 
epidemic in southern Africa will not be halted without a deeper understanding of 
the experiences of women living with HIV, their continued vulnerability to 
reinfection and reasons for loss to follow-up along the treatment cascade 
(Mkandawire-Valhmu et al., 2013); all of which relate directly to the effects of 
gender inequalities such as IPV.  
Finally, there is a dearth of information on how IPV specifically contributes 
to attrition along the treatment cascade. Despite the great volume of individuals 
lost to follow-up along the continuum, effective programs for linkage to care, 
retention and adherence are lacking (Treatment Action group, 2013). Sources 
urge future research to identify trends associated with delays in linkage to care 
(Rosen & Fox, 2011; Reed et al., 2009; Van Zyl et al., 2015) so that programs 
may be refined to better overcome physical and emotional barriers (Treatment 
Action Group, 2013; Snyder et al., 2014). This need is greatest among young 
females (aged <23 years) because they have been shown to have high HIV 
prevalence (UNAIDS, 2012) and the worst linkage rates (Van Zyl et al., 2015).  
1.4 Purpose of Study 
The purpose of this study was to develop and test a risk assessment and 
safety planning protocol that would mitigate IPV-related barriers to HIV care for 
South African women testing HIV+ during mobile HCT. To test the intervention, 
data were compared between the standard of care and two experimental groups 
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receiving the dosage levels of 1. Danger Indicator + an initial safety plan, and 2. 
Danger Indicator + initial safety plan + follow-up safety plan. The protocol 
implemented assessed for danger levels relevant to the HIV-IPV intersection and 
conducted safety planning as a means to mitigate the impact of IPV on HIV 
outcomes immediately following an HIV+ diagnosis. The protocol was not 
developed to be an IPV intervention but instead to use psychoeducation on the 
dynamics of IPV to facilitate safe linkage to care and other HIV-related help-
seeking behavior. The concept was to first alter participant’s subjective norms on 
IPV, leading to heightened awareness of IPV in their relationship, and then use 
the heightened awareness in conjunction with the safety plan to not only catalyze 
HIV linkage to care but do so in the safest manner. Because this protocol added 
the new IPV components to a pre-existing evidence-based practice, this study 
included questions over feasibility and acceptability of the IPV components and 
was an experimental study exploring the use of two dosage levels.  
To date, no interventions have been found that specifically test the 
efficacy and dosage levels of an IPV risk assessment and safety protocol 
administered alongside mobile HCT in South Africa, nor that consider the impact 
of IPV on linkage to care for women recently testing HIV+. No standardized tool 
could be found for assessing danger associated with the HIV-IPV link, and this 
study sought to validate such a psychometric instrument. Finally, because no 
standardized safety planning protocol could be found that addressed the HIV-IPV 
intersection, the study also aimed to test the acceptability and feasibility of using 
specific safety-planning strategies.  
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The results of this study will inform future research about the effectiveness 
and required dosage levels of an IPV risk assessment and safety planning 
protocol during mobile HCT, provide a valid and reliable tool for measuring 
participant risk and safety related to the HIV-IPV intersection, and provide trends 
in links to care for those who are HIV+ and experiencing IPV. Successful 
components of this protocol can be used to assist women who might not have 
received other formal IPV assistance or who may be at risk of delaying linkage to 
HIV care due to IPV-related barriers. IPV resources are limited in South Africa, 
and literature cites that many victims are more likely to show up for health-related 
services than seek out formal IPV services (Campbell, 2004; Lindhorst et al., 
2005). Thus, refining health-related services, like mobile HCT, to include a risk 
assessment and safety planning protocol could mitigate the effects of IPV and 
improve health and safety of recently diagnosed individuals. 
The study’s overall aim was to refine the IPV components, retain 
participants, avoid contamination, and test effectiveness of the intervention 
related to participant risk and safety and linkage to care. The main Independent 
variable for this study was the risk assessment and safety planning intervention, 
which had two levels. Dependent variables for this study included the primary 
areas of risk and safety scores and successful linkage to care, and the 
secondary areas of feasibility, acceptability and satisfaction.  
The study was administered in two phases. The aims of Phase I were to: 
1). Refine study instrumentation, via focus interviews, to improve cultural 
sensitivity of instruments as well as feasibility of use (readability, problems with 
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wording, etc.), and 2). Refine program components via focus interviews to 
improve cultural sensitivity of proposed safety plan (phrasing/wording). The aims 
of Phase II of the study were to: 1). Determine feasibility of the protocol a). by 
successfully implementing it with 75% of eligible participants B). and successfully 
retaining 75% of participants at one month follow-up; 2). Determine acceptability 
of the protocol A). by receiving a positive rating from at least 80% of participants, 
and B). analyzing any significant variations in participant acceptability between 
the Experimental groups (between dosage levels) and the Standard of Care 
group. 3). Test the effectiveness of strategies used to avoid contamination of the 
sample between the Standard of Care and experimental groups with successful 
avoidance of contamination determined by a low contamination percentage of 
<10%. 4). Determine effectiveness of intervention related to A). participant risk 
and safety scores, and B). successful linkage to care. 
1.5 Research Questions 
Primary Research Questions and Results 
Research Question 1A 
What is the difference in participant risk and safety scores between the combined 
Experimental groups and the Standard of Care group?  
Hypothesis: Participants in the combined Experimental group (receiving any level 
of the intervention) will have improved scores on the HIV IPV Risk and Safety 
scale (HIRS) as compared to participants receiving only the standard of care.  
Research Question 1B 
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What is the difference in participant risk and safety scores between dosage 
levels of those who receive 1. danger indicator score + initial safety plan, and 2. 
danger indicator score + initial safety plan + follow-up safety plan? Analysis was 
done on pre & post difference scores. 
Hypothesis: Participants with the highest level of dosage will have the highest 
amount of increased perceived safety as measured by the HIRS. 
Research Question 2 
What is the difference in participant linkage success between the combined 
Experimental groups and the Standard of Care group? Successful linkage (within 
30 days) and number of days linked were used as indicators. 
Hypothesis: Participants in the combined Experimental groups (receiving any 
level of the intervention) will have increased rates of linkage (more links at a 
faster rate). 
Secondary Research Questions:  
Research Question 3A 
What is the difference in participant satisfaction scores between the combined  
Experimental groups and the Standard of Care group? 
Hypothesis: Participants in the Experimental group (receiving any level of the 
intervention) will have higher satisfaction scores as compared to participants 
receiving only the Standard of Care.  
Research Question 3B 
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What is the difference in participant satisfaction, feasibility and acceptability 
scores between dosage levels of those who receive 1. danger indicator + initial 
safety plan, and 2. danger indicator + initial safety plan + follow-up safety plan?  
Hypothesis: The possible impact of higher dosage intervention on satisfaction, 
acceptability and feasibility is uncertain.   
1.6 Summary & What to Expect 
The current study was designed to build on the strengths of contemporary 
evidence-based practices of HCT by incorporating a risk and safety protocol as a 
method for mitigating IPV immediately following an HIV+ diagnosis. The need for 
such an approach has been underscored in this chapter, and the results of this 
study will improve researchers’ understanding of women’s experience with IPV 
immediately following a diagnosis and help refine HCT services so that practice 
initiatives may better address the HIV-IPV intersection. It is urgent that more 
research focus on mitigating the effects of IPV on HIV outcomes (Shafer et al., 
2012), and this protocol is a first attempt at doing so for women in South Africa 
who have recently tested HIV+ during mobile HCT. Study results will contribute 
significantly to both the HIV and IPV knowledge base as there is a great need for 
information on effective safety planning techniques for IPV, in general, and 
specific to the HIV-IPV intersection, especially among those recently testing 
HIV+. Findings shed light on the experiences of women in IPV relationships in 
the first 30 days after testing HIV+ and reveal trends associated with linkage to 
care for women who currently have IPV in their relationship.  
Chapter Two explicates each component of the independent and 
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dependent variables. These components are deconstructed and analyzed from a 
theoretical perspective with empirical support provided for the inclusion of each 
element. Evidence is provided for best measurement methods for the dependent 
variables. This explication provides clarity of protocol components, their 
theoretical foundations, and the mechanisms by which they operate, while also 
demonstrating the ethics and objectives of the study. 
Chapter Three describes the study’s methodology. The chapter further 
explains the study’s aims, design, analysis methods, operational definitions of the 
protocol variables, instruments and program components, support for the 
inclusion of items, study procedures including participant recruitment, staff 
training and data collection, and ethical considerations. 
Chapter Four provides study results. This chapter describes the sample 
demographics, methods of data cleaning and incorporates a consort diagram for 
clarity. It then includes results on the reliability and validity of the study’s 
psychometric instruments, and operationalization of the dependent variables. 
Finally, the heart of the chapter discusses findings first from Phase I of the study, 
and then Phase II, beginning with an outline of how the study measured up to its 
aims, and ending with tables, figures and discussions over primary and 
secondary research questions as well as additional relevant findings.  
Finally, Chapter Five discusses the practical significance of the study’s 
findings and is outlined predominately by research question. Then the study’s 
strengths and limitations are discussed as well as the implications for future 
practice and research.
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CHAPTER 2  
LITERATURE REVIEW & THEORETICAL BACKGROUND 
 
 
Chapter One provided an introduction of the study’s topic, underscored 
the need for the current study, and briefly introduced the independent and 
dependent variables. This chapter provides a deeper explication of each variable 
by presenting empirical support and theoretical underpinnings of each 
component of the HIRS protocol. Discussion begins with the independent 
variable, explaining each component of the HIRS protocol, and ends with a 
review of best practice evaluation measurements for each Dependent variable: 
linkage to care, safety, feasibility, acceptability and satisfaction.  
 
The HIV IPV Risk & Safety (HIRS) Protocol 
 The Independent variable for this study is the HIRS protocol (HIV IPV Risk 
and Safety), or intervention, which was implemented in two dosage levels. A 
greater description of this protocol may be found in Chapter Three. However, a 
brief description of the protocol’s three components follows. The first component 
was the standard of care service, which included mobile HIV Counseling and 
Testing (HCT) utilizing an evidence-based edutainment 
	   23 
approach and a Links to Care call centre program. All participants in the study 
received this portion of the protocol approximately one day after testing HIV+ 
during mobile HCT. The second component was the risk assessment, as 
measured by the Danger Indicator. While all participants were issued the Danger 
Indicator, only the Experimental groups were informed of their danger levels as 
an intervention component. The final component was a safety plan, which was 
administered in two dosage levels. Both Experimental groups received the initial 
safety plan, administered during the initial phone call, immediately following the 
danger indicator score. Only Dosage Level 2 group received a follow-up safety 
plan, administered approximately two weeks after the initial phone call and 
approximately two weeks before the post-test. All individuals received a post-test 
approximately one month after their HIV testing date. 
 An important note about the HIRS protocol is that it was not administered 
as an intimate partner violence (IPV) intervention but, instead, as an HIV 
intervention that works towards reducing barriers to care associated with the HIV-
IPV intersection. Therefore, the protocol recruited participants from an HIV 
testing program and its main focus was on facilitating linkage to HIV care—post 
HIV diagnosis—in a safe and satisfactory manner. To adequately explain this 
protocol, the HIV testing approach will first be explained. This will be followed by 
a theoretical explanation of how IPV impacts help-seeking behavior and the 
mechanisms by which this protocol attempted to attenuate impairments in help 
seeking or barriers associated with the HIV-IPV intersection. 
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2.1 Empirical Support for the Standard of Care 
Component One of the Standard of Care: Mobile HCT 
Mobile HCT, sometimes referred to as community-based HIV Counseling 
and Testing, is a service that counsels individuals on HIV testing options, tests 
results, and HIV prevention techniques; this is seen as the pre-test, post-test and 
follow-up counseling trifecta. The counseling provides education so that 
individuals can make informed and voluntary decisions about HIV testing uptake. 
Services are offered in a safe and confidential space and results are followed by 
emotional support. Individuals testing HIV+ are evaluated for their risk for HIV 
transmission and encouraged to link to further HIV care. Because individuals 
testing HIV+ may go on to experience stigmatization with many negative 
consequences, VCT endorses only voluntary counseling (UNAIDS, 2000). 
Although the phrase has been dropped from the newer acronym, HCT also 
endorses only voluntary testing and is used as synonymous with VCT. In 
summary, VCT acts as both an HIV preventative measure and entry-point for HIV 
care (UNAIDS, 2000). 
Although HCT has been linked with reduced transmission rates, uptake is 
often cited as poor (Mall et al., 2013; UNAIDS, 2000), and innovative approaches 
are needed to reduce barriers to VCT. One way to reduce barriers is to make 
services more accessible or population-tailored; some examples are those that 
are more physically convenient (as with hours of operation and/or location, etc.), 
or those that help reduce psychological barriers by offering services that 
challenge stigma (UNAIDS, 2000). 
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Because HCT has traditionally been offered in a clinic-based setting 
(Khumalo-Sakutukwa et al., 2008), mobile HCT is an innovative alternative that 
enables services to be more physically accessible. Mobile HCT is offered as a 
roving pop-up service, enabling provision boundlessly, and impervious to 
physical limitations. Also known for being a safe testing method, mobile HCT 
services are anonymous, confidential, rapid, and free. Its accessibility has been 
shown to increase testing uptake, alter perceptions about testing and spread 
community awareness about HIV (Khumalo-Sakutukwa et al.). Historically, South 
Africans have branded HIV as a private matter of individual pathology, but the 
ensuing need for community responsibility and response has been documented 
(Lippman et al., 2013). Following the 2010 South African government campaign 
to increase HIV testing in nonmedical and mobile forums (Bassett, Govindasamy, 
et al., 2014), mobile HCT has increased in popularity and facilitated a needed 
shift in HIV testing norms (Khumalo-Sakutukwa et al., 2008).  
Component Two of the Standard of Care: The Edutainment Approach 
 Another component of the specific mobile HCT service provided as the 
standard of care in this study was an empirically supported edutainment 
approach. This particular edutainment approach combines HCT with technology 
and health messaging. Potential testers view a celebrity-based HIV prevention 
video before deciding if they will engage in testing. These videos contained 
health messaging from hip local South African celebrities on HIV risk reduction 
methods (safe sex, HIV testing, etc). The video was shown to de-stigmatize HIV 
testing, and results show it was effective in improving HCT uptake among young 
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black participants (with the celebrities also being black) (Van Zyl & Barney, 
2014). Further, this approach was also found to increase HIV knowledge and 
reduce fears associated with testing (Van Zyl, Barney & Pahl, 2014). 
Component Three of the Standard of Care: Links to Care Call Centre program 
 The final component to the mobile HCT utilized in the standard of care 
service in this study was the Links to Care call centre program. This program 
also has empirical support for its use among South Africans (Van Zyl et al., 
2015). While offering HCT through the mobile medium has assisted with testing 
uptake, most individuals living with HIV remain without needed medical care 
because they delay linkage to care (Lawn et al, 2006; Losina et al., 2010; Bassett 
et al., 2010; Kayigamba, Bakker, Fikse, Mugisha, & Asiimwe, 2012). The Links to 
Care call centre program utilizes a call centre to make daily contact with 
individuals who have recently tested HIV+. Mobile phone contact has been 
shown to be an effective way for healthcare providers to stay connected with 
youth for test results (Van der Kop et al., 2013) and appointment reminders 
(Jewkes et al., 2006; Zhang & Chen 2013), and this program has been used to 
encourage linkage to care after HIV testing and diagnosis, with an average 
linkage to care rate of 51% within 31 days (Van Zyl et al.). 
2.1.1. Theoretical Background of the Standard of Care 
 Several theoretical frameworks collectively support the effectiveness of 
the standard of care service. Applicable models and theories are the Health 
Belief Model, the Theory of Action/Planned Behavior, Social Ecological Model, 
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Social Movement Theory, Diffusion of Innovations Theory, and Entertainment 
Education Theory. 
 As the most basic explanation, the health belief model demonstrates that 
individuals will act to avoid poor health. Individuals must first perceive 
themselves to be at risk and then discern the possibility for risk high enough that 
action should be taken to avoid harm. One criticism of this model is that it does 
not consider the role of social pressure or even external forces in the 
continuation of risky behaviors despite perceived risk of harm and desire to avoid 
illness (NAM AIDSmap, 2016). However, the Theory of Planned Behavior 
suggests that congruency in intentionality, attitude and subjective norms 
increases one’s sense of self-efficacy to achieve a desired behavior and leads to 
a greater likelihood of action towards such self-protective behavior, despite any 
dissonant external forces (Ajzen, 2006). Thus, the premise of HCT is to effect 
changes in attitudes and subjective norms as a means for buttressing 
intentionality and catalyzing congruent action.  
 Although these models help explain, generally, why someone would be 
motivated to engage in HIV testing, it is the combination of Social Ecological 
model and Social Movement Theory that elucidate how HIV testing in non-clinical 
settings has become an available and effective approach. Social Ecological 
model first illustrates that individuals and their environment are inextricably 
connected; people are influenced by the environment, and the environment is 
influenced by people (Chimphamba Gombachika et al., 2012). Social Movement 
Theory provides a framework for how and why communities begin to mobilize 
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around an issue (Lippman et al., 2013). For example, community-based HCT 
appeared when traditional HIV testing services failed to appeal to certain high-
risk populations, and community members subsequently championed efforts to 
increase testing uptake among those groups. Once these services appeared, a 
norm around HIV testing was shifted. The pop up mobile tents created a milieu 
where testing was seen as quotidian. Stigma associated with HIV testing was 
attenuated, increasing the acceptability of services and, ultimately, uptake.  
 The final theories applicable to the standard of care service offered in this 
study are Diffusion of Innovations Theory and Entertainment Education Theory. 
The celebrity video approach utilized during this mobile HCT was guided by both 
of these theories. Entertainment Education Theory blends education into the 
entertainment forum to increase palatability of subject matter and improve 
knowledge on an issue, as well as attitudes and behaviors (Vaughn, Rogers, 
Singhal, and Swalehe, 2000). This theory has particularly been used in the 
creation of HIV/AIDS preventative interventions in South Africa and within the 
international context (Cardey, Garforth, Govender, & Dyll-Myklebust, 2013). In 
addition to blending education with entertainment to increase health-messaging 
appeal, the edutainment approach was guided by a concept within the diffusions 
of innovations theory, which has been used to construct HIV/AIDS preventative 
strategies previously. The theory, in general, seeks to explain how innovations 
are diffused or spread throughout a social system (Rogers, 1997), but the 
concept of homophily posits, “ideas are most often transferred between 
individuals who are alike” (Rogers as cited in Van Zyl & Barney, 2014). Literature 
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supports that individuals are more likely to find HIV/AIDS messaging credible 
when it is delivered by someone of a shared race (Herek et al. as cited in Van Zyl 
& Barney, 2014). This demonstrates, in part, how the edutainment approach has 
been effective in improving testing uptake among individuals who identify as 
black. 
Incorporating an IPV component into HCT 
Chapter One described how linkage to care after HCT has remained low, 
and IPV was identified as a significant barrier to engagement of care at various 
points of the HIV care continuum. Literature both underscores the need for 
services that address the HIV-IPV intersection and offers suggestions for 
effective joint approaches. The World Health Organization (n.d.) identifies HCT is 
a crucial gateway for IPV detection and support and recommends cross-training 
HIV counselors to address IPV during HCT services. More, IPV screening is 
seen as a vital service for those who are newly diagnosed as HIV+ and 
experiencing IPV (Mkandawire-Vahlmu et al., 2013).  
HCT has been associated with the reduction of sexual risk behaviors 
(Jewkes et al., 2006) as well the reduction of IPV when routine screenings are 
conducted (Christofides & Jewkes, 2010). IPV screening, in general, has been 
found to be a low risk and inexpensive approach with the potential to reduce 
revictimization when administered by healthcare providers who display a genuine 
sense of concern and when referrals are made to increase financial and social 
support (Ahmad et al., 2009). Because HIV diagnosis and partner notification of 
HIV+ status have been associated with increased risks for IPV (Mkandawire-
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Vahlmu et al., 2013), IPV screenings during HCT could lead to identifying and 
assisting those vulnerable to the HIV-IPV link.  
Generally, the literature calls for a scale-up of IPV screening in health care 
and HIV services (Thackeray et al., 2007; Ahmad et al., 2009; Baig et al., 2009). 
Sources in the U.S. state that screening for IPV in healthcare settings has been 
shown effective and is now endorsed by the National Association of Social 
Workers, the American Psychological Association, the American Medical 
Association and several other large governing bodies; yet, routine screening is 
infrequently offered (Thackeray et al., 2007). Moreover, self-protective behaviors 
promoted during HCT (condom use, HIV status disclosure, etc.) can “trigger 
violence” (Christofides & Jewkes, 2010, pg. 279), and, therefore, efforts 
addressing the HIV-IPV link should move beyond routine IPV screening (Matseke 
et al., 2013) and work towards developing and testing more interventions that 
effectively reduce risks among those screened (Jewkes, 2013). 
 
2.2 Empirical Support for Experimental Components of HIRS Protocol 
Conceptual Definition of Intimate Partner Violence 
Several theoretical frameworks guided the conceptual definition of intimate 
partner violence used within the IPV component of this protocol. While some of 
these frameworks diverge at times, this study takes an integrative approach to 
conceptualizing IPV. First, an explanation of the nomenclature employed will 
provide baseline clarity. The term intimate partner violence has been used rather 
than domestic violence because this study focuses on violence occurring in 
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romantic relationships (spouse, ex-spouse, current or past partner) rather that 
perpetrated by any person within a person’s domestic realm. The term partner is 
used to reference a romantic partner (boyfriend, girlfriend, spouse, etc.) as an 
effort to be inclusive of all relationship types (heterosexual, same sex, etc.). 
It is also necessary to provide an illustration of how physical, emotional or 
sexual abuse manifests in South Africa. Commonly, physical violence appears as 
slapping, pushing, hitting with a fist or stick, threats of physical harm, or stabbing 
or shooting. Examples of typical emotional abuse are tactics to control or belittle 
a partner, flaunting other relationships in a shared home, forcing women and 
their children out of the home, or denial of essential financial support (when it is 
available). Like the other forms, sexual abuse occurs on a continuum of severity 
ranging from persuading a partner to have sex, forcing sex without a condom, or 
perpetrating violent rape (Jewkes et al., 2002). 
The two main theories that have generally been used to explain the 
dynamics of intimate partner violence, not specific to the South African context, 
are Feminist Theory and Family Violence Theory (Kurz as cited in Carlson & 
Jones, 2010). Feminist theory conceptualizes that IPV is “rooted in patriarchal 
traditions of male dominance in heterosexual relationships” (Johnson & Leone, 
2005, pg. 323). From this perspective, violence is seen as escalating and largely 
maintained through tactics of power and control perpetrated systematically by 
men against women (Home of the Duluth Model, 2011). Evidence supporting this 
approach largely grew from phenomenological studies of women attending to 
medical facilities, shelters or legal services for domestic violence (Carlson & 
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Jones, 2010). Family Violence Theory, appearing around the same time as 
Feminist Theory, posits that IPV is rooted in family conflict, which inherently 
occurs in all social groups, and results from “the methods by which conflicts are 
resolved” (Straus as cited in Carlson & Jones, 2010, pg. 250). Whereas both 
perspectives hold that IPV is a form of gender-based violence, Feminist Theory 
places sexism “at the center of the analysis,” and Family violence theory views 
sexism “as only one causal structural factor among many” (Lawson, 2012, pg. 
583). The other operative difference in these approaches is that Feminist Theory 
views IPV as a manifestation of systematic power and control, and Family 
Violence Theory views IPV as the product of actions taken to address family 
conflict. 
Johnson (2008) argues that framing all IPV as the result of power and 
control is myopic because the phenomenon is more complex and, conversely, 
contains varying IPV typologies. According to this theory, the major IPV 
typologies that still explain male violence against women are Situational Couple 
Violence and Intimate Terrorism (Johnson & Leone, 2005). Intimate Terrorism is 
the typology ordinarily illustrated in the literature on domestic and intimate 
partner violence, derived from samples of abused women. This form of IPV is 
rooted in power and control and its victims experience more severe, frequent and 
persistent violence (Johnson & Leone). Situational Couple Violence, on the other 
hand, is more often a typology of gender parity where violence erupts as male or 
female partners attempt to resolve conflict. In this typology, there may be some 
efforts to control another person, but there is no general or pervasive pattern of 
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control as an exertion of power. While not seen as a typically escalating or 
systematic form of violence, Situational Couple Violence can be just as violent or 
fatal. Most of the IPV found in general survey populations is that of Situational 
Couple Violence (Johnson & Leone).  
The HIRS protocol is based on an integrative approach, including Feminist 
Theory, Family Violence Theory and some integrative theories that help expand 
the explanation of IPV such as that of Anderson (1997) and Heise (1998) 
(Lawson, 2012). Anderson argues that gender and ecology are relevant to 
understanding IPV, and Heise discusses the need to explore multiple causal 
factors of IPV. Heise posits that feminist theory “fails to explain why some men 
beat and rape women when others do not” although all men are exposed to 
patriarchy (Heise, 1998, pg. 263).  
Heise, instead, offers a more holistic and somewhat universal explanation 
positing that IPV results from many intermingling ecological factors. Her theory 
describes IPV on a broader level and helps allow the conceptualized causation of 
IPV to move beyond the limits of individual pathology pitted against socio-cultural 
power play (1998). Through her theory, IPV is seen as the result of a matrix of 
causal factors rising from the confluence of individual, microsystem (family), 
exosystem (institutions and social structures), and macrosystem (cultural norms 
and attitudes) factors. 
To some extent, this theory helps explain the higher occurrence of IPV 
against women with HIV—i.e. when the culture of gender-based violence in 
South Africa (microsystem and exosystem) and a stigma-laden HIV status 
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(macrosystem) are coupled with individual and family factors such as pre-existing 
IPV or childhood abuse (Jewkes et al., 2002). According to Heise’s theory, these 
factors intermingle in a concentric circle, sharing the same axis so that one factor 
feeds into another factor. However, Jewkes et al. (2002) assert that Heise’s 
theory, while involving some international consideration, is reflective of North 
American ideology; the theory is beneficial and relevant to the South African 
context but it is also incomplete. Instead, the etiology and consequences of 
gender-based violence in South Africa are more complex than what can be 
explained by the ecological framework she proposes. 
Although the etiology of IPV has been connected to larger South African 
cultural norms such as “conservative ideas about the position of women” 
(Sugarman & Frankel as cited in Jewkes et al., 2002, pg. 1613), mediators of IPV 
also shed light on country-specific underlying causes. For example, two different 
studies found that having some post-school education is protective against 
lifetime occurrence of IPV (Straus, Gelles, & Steinmetz as cited in Jewkes et al., 
2002). Jewkes et al. hypothesize that the mediator is actually women’s social 
empowerment experienced as a result of their higher education, as augmented 
social empowerment enables a woman to utilize available resources and 
consequently increase her agency while decreasing isolation (pg. 1612). Further, 
the major problem with strictly using the ecological framework to explain IPV in 
South Africa is that factors such as poverty can be characterized as a larger 
cultural or societal issue or as an individual factor (as the example above 
illustrated). While a solid framework for understanding IPV etiology in South 
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Africa is still evolving, two fixed factors are “the unequal position of women and 
the acceptance of certain forms of interpersonal violence” (pg. 1614). 
Component One of the HIRS Protocol: The Danger Indicator 
Understanding IPV within its appropriate context is integral to the creation 
or use of a valid IPV risk assessment tool (Thackeray et al., 2007). First, a 
conceptual definition of IPV risk assessment tools provides clarity for the larger 
explanation of the HIRS risk assessment tool creation. 
Generally, IPV risk assessment tools function exactly as the name 
suggests. These tools rely on reports of past assault to estimate the amount of 
relative risk each person has for IPV-related re-assault or lethality by a domestic 
or intimate partner. Assessments are conducted as a collaborative dialogic 
process with a victim, perpetrator or both. The point of the assessment is not 
merely to ascertain knowledge on the likelihood of re-assault but to explicitly use 
the information procured to assist in the creation of a personalized safety plan 
that addresses each person’s specific risks. Essentially, the risk assessment is 
the means to the safety plan’s end, and an effective safety plan hinges on an 
effective and thorough risk assessment (Ending Violence Association of BC, 
2013).  
IPV risk assessments fall into several general categories: clinical, 
actuarial, structured and unstructured clinical professional judgment approaches 
(Bowen, 2011; Department of Justice, 2015) and victim’s risk-assessing scales 
(Department of Justice). The clinical risk assessment is utilized most commonly 
and relies on practitioners’ clinical judgment of a person’s risk. This type of tool 
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has been criticized for poor validity and reliability and its propensity for 
practitioner bias (Bowen). The actuarial risk assessment uses statistics to predict 
violent behavior as occurring within a certain amount of time. While some 
sources claim this approach to have stronger reliability, others disagree and, 
ultimately, more research is needed to verify each approach’s robustness in 
varying contexts (Bowen). Less research has been conducted on victim risk 
assessing scales, and, therefore, less is known about the validity and reliability of 
these scales (Department of Justice).  
IPV risk assessments require an iterative process to gauge on-going risks. 
While current literature does not provide a consistent operationalization for a 
general IPV risk definition (Kropp as cited in Bowen, 2011), it is important to note 
that IPV risk factors should be considered within the context for which they are 
being used for violence prediction (Bowen). Risk assessment is strengthened by 
not merely considering past or possible future acts of violence, but by, instead, 
examining the contexts of the violence (frequency, severity and type) and 
situations that may impact its occurrence (Douglas & Kropp as cited in Bowen).  
One of the more empirically supported risk assessment tools is the 
Danger Assessment (DA). The DA is an actuarial tool “as it draws upon a 
retrospective empirical evidence base concerning the risk factors for either 
intimate partner homicide or severe IPV” (Bowen, 2011, pg. 221). It has been 
shown to reliably measure potential IPV lethality (Campbell et al., n.d.) and was 
created to help women appraise personalized risk levels so that practitioners 
could better assist them in developing a plan for safety (Glass, Eden, Bloom & 
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Perrin, 2010). Most other IPV risk assessment tools measure risk for re-assault 
rather than femicide and normally also rely on collateral information-gathering 
(police records, perpetrators, etc.) rather than just reports from a victim (Messing 
& Thaller, 2013). Although sources conflict about which IPV risk assessment 
approach is best, Campbell (2004), a creator of the DA, explains that many 
women have the most accurate assessment of their own risk for fatality, with one 
study showing that approximately half of the women were accurate (Campbell, 
2004). Heckert & Gondolf (2004) found that using the combination of obtained 
risk markers, based on a woman’s perception, in conjunction with the Danger 
Assessment was the best prediction of re-assault. 
Component Two of the HIRS protocol: Safety Planning 
Once the risk assessment information has been procured, it is then used 
to create a person-specific safety plan. Safety planning is considered the 
benchmark intervention for addressing IPV (Campbell, Webster & Glass, 2009; 
Bloom et al., 2014; Glass et al., 2010) and is suggested as a tool to be used 
following IPV screenings (Thackeray et al., 2007). The information gathered 
during risk assessment is contextualized, with each person’s particular 
circumstances, and synthesized into a plan to help mitigate future harm 
(Thackeray et al., 2007). This plan considers personal interpretation of the 
violence (Dienemann, Campbell, Landenberger & Curry, 2002), levels of danger, 
resources, priorities and goals (Davies, Lyon, & Monti-Catania as cited in Bloom 
et al., 2014, pg. 243; Mkandawire-Vahlmu et al., 2013). 
Although safety planning is critical to improving a person’s safety, most 
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victims do not seek formal services for IPV (Lindhorst et al., 2005) and never 
receive such assistance. Some individuals are not aware of the existence of 
formal IPV services or how to access them. Others may be distrusting of 
providers, fear the loss of privacy, be too fearful or ashamed, or even worry 
about shaming their partners (Bloom et al., 2014). Considering that IPV is 
occurring at epidemic rates throughout the world (WHO, n.d.) and victims are 
more likely to show up for other types of social services, more IPV risk 
assessment and safety-planning protocols should be conducted “in all contexts 
by generalist practitioners” (Lindhorst et al., 2005, pg. 331).  
Sources repeatedly laud the effectiveness and necessity of safety 
planning; yet, there is a dearth of information on effective strategies, and the 
literature that does exist is still in its nascent stages. Parker & Gielen (2014) 
highlight that “little is known about the duration of use of safety strategies, the 
strategies actually discussed with women during safety planning, or whether 
women use multiple strategies at the same time…” (pg. 591). Therefore, while 
we know that safety planning, in general, is effective, and we know some specific 
strategies are shown to reduce and others increase revictimization, more 
research is needed to define reliable components of safety planning and explore 
risks and benefits of specific safety strategies (Parker & Gielen, 2014). 
 Based on the systematic review of literature on IPV safety techniques, 
Parker & Gielen (2014) assert that IPV safety planning generally falls into 6 
domains. Each domain includes a strategy victims report using. The first three 
domains cover victim engagement with support systems and resources. The final 
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three domains cover strategies victims either use or avoid for optimal safety. 
Domain one considers victim engagement with formal networks such as medical 
services, clergy, counselors and IPV-specific services. Domain two considers 
victim engagement with informal networks such as friends and family. Domain 
three considers victim engagement with legal services. Domain four involves the 
use of placating strategies such as “trying to avoid the abuser at certain times, 
doing whatever the abuser wants, and trying to keep things quiet from the 
abuser” (pg. 590). Domain five involves the use of resistance strategies such as 
“fighting back physically, putting a weapon where she could get it to protect 
herself, trying to end the relationship, and running and hiding” (pg. 590). Finally, 
Domain six involves the use of general safety planning techniques like “trying to 
avoid the abuser at certain times, doing whatever the abuser wants, and trying to 
keep things quiet from the abuser” […] “hiding money or keeping important 
phone numbers to use” (pg. 590). 
 These enumerated strategies highlight safety planning techniques ground 
in standard IPV practice, but research is needed to show safety planning’s 
efficacy in the context of HIV. Strategies should always be contextualized to each 
woman’s self-perceived threats, options and abilities as a means to help her 
identify personalized risks and protective factors in her situation (Lindhorst et al., 
2005). In addition to a victim’s perception being key to the appropriation of each 
of these strategies, the safety plan would also need to address the nuances of 
the HIV-IPV intersection.  
Areas relevant to safety planning, with those living with both HIV and IPV, 
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are outlined by the National Network to End Domestic Violence (NNEDV) (2014). 
HIV-IPV specific safety planning addresses many of the standard areas found in 
the IPV power and control wheel, with the additional area of Medical Abuse. 
However, each spoke of the power and control wheel, representing tactics used 
by abusers, is formulated in the HIV/AIDS Power and Control Wheel to reflect 
how abusers specifically harm individuals living with both HIV and IPV (figure 
2.1). Although safety planning strategies specific to the HIV-IPV intersection have 
yet to be adequately tested, an effective HIV-IPV safety plan would logically work 
to mitigate the tactics found within the HIV-IPV Power and Control Wheel and 
address any other forms of abuse found to be commonly used against those 
living with HIV (CDC, 2014). Some of these areas include educating victims on 
healthy relationships, altering norms around abuse (CDC), creating plans for 
safely getting to medical appointments, taking medication (NNEDV, 2014), and 
safe partner notification (Ramachandran et al., 2010). 
Take partner notification (or disclosure) of serostatus as an example: 
UNAIDS (2000) stresses that although it is important to disclose one’s serostatus 
to one’s partner to initiate practices of safer sex, this may not be possible for 
women experiencing IPV “who face abuse or abandonment if known to be 
seropositive” (pg. 5). Consequently, strategies to facilitate non-violence upon 
partner notification are vitally needed for women affected by both HIV and IPV 
(Kennedy et al., 2015; Maman, Mbwambo, Hogan, Kilonzo & Sweat, 2001). In 
the process of planning safe disclosure strategies, individuals should be 
empowered to make their own decision as to whether or not they will disclose to 
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their partners, given that each situation is unique and each person must 
determine if it is safe for her to disclose (A le Roux-Kemp, 2013). 
 
Figure 2.1 HIV/AIDS Power and Control Wheel 
 
Figure 2.1 HIV/AIDS Power and Control Wheel. National Network to End Domestic Violence. 
(2014). Positively Safe: The intersection of domestic violence and HIV/AIDS. HIV/AIDS Power 
and Control Wheel. Alabama Coalition Against Domestic Violence & Motgomery AIDS Outreach. 
Based on the Power and Control Wheel developed by the Domestic Abuse Intervention Project, 
Duluth, MN. © July 2014. 
 
 
Finally, because thorough IPV risk assessment is said to rely on an 
iterative process, safety planning may also require more than one contact for 
thoroughness. The Ending Violence Association of BC (2013) describes risk 
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assessment and safety planning as dynamic processes so that when conducting 
them providers must expect changes in victim’s circumstances and the possibility 
for needed revisions. Hence, revising safety plans over time can be beneficial for 
survivors to anticipate changing needs. 
 
2.2.1 Theoretical Background of the HIRS Protocol 
The theoretical models relevant to the HIRS protocol are Crisis Theory, 
Stress and Coping Theory, Lindenberger’s Theory of Entrapment and Recovery, 
the Transtheoretical model, Empowerment Theory, and Theory of Action/Planned 
Behavior. 
Crisis Theory was used to guide the stages and some content of the 
study’s intervention. Crisis Theory may be applied both as a conceptual theory, 
explaining the crisis phenomenon, and as an intervention theory, directing 
interventions to effectively mitigate crises. Conceptually, Crisis Theory emerged 
in the 1940’s from the work of theorists Erich Lindemann and Gerald Caplan and 
was used to explain and predict responses to traumatic events. A crisis is defined 
“as the perception or experience of an event (genuine harm, the threat of harm, 
or a challenge) as an intolerable difficulty” for which a person’s typical coping 
mechanisms cannot sufficiently manage the event (Walsh, 2013, pg. 306). The 
formal modality of crisis intervention was created in the 1960’s and focuses on 
attempts to help an individual either return to pre-crisis functioning levels or to 
grow despite catastrophe.  
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Some major concepts of Crisis Theory are stress and crisis. Stress is 
defined basically as demand exceeding resource. Crisis occurs in three stages: 
first the person abruptly experiences a rise in tension. Next, the person attempts 
to manage the stress but fails to adequately do so; the person then becomes 
overwhelmed by the inability to cope and is more open to receiving assistance. 
Finally, the person returns to pre-crisis levels (Walsh, 2013, pg. 309-310). The 
return to pre-crisis levels regularly occurs about four weeks later and the person 
experiences resolution either through adaptive or maladaptive coping 
mechanisms (Walsh).  
The main concepts of crisis stages, stress, and coping help inform the 
final relevant areas of crisis theory: assessment and intervention. Coping, as 
referenced above, is a person’s attempt to manage the difficulties of the stressor 
and a person may cope biologically, psychologically or through the help of social 
supports (Folkman as cited in Walsh, 2013). Crisis intervention requires an 
ordered response to individuals in crisis, beginning with assessment and ending 
with planning and referral. According to the theory, all people should: 1. 
Experience a supportive worker/client relationship; 2. Be encouraged to express 
their feelings about the challenge at hand; 3. Receive an assessment to identify 
precipitating factors and resources such as internal and external coping 
mechanism—capacity to function adaptively and available social supports, 
respectively; 4. Be given time for processing the meaning of the assessment; 5. 
Help develop an intervention plan based on meaning making of the assessment; 
6. Receive “referral and linkage” (pg. 314) with resources; and 7. Receive a 
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formal termination or follow-up discussion as a time to meditate on means for 
averting future crises (Walsh, 2013). 
Situational crisis is most germane to the intersection of HIV and IPV as it 
is defined as “uncommon, extraordinary events that a person has no way of 
forecasting or controlling” (Walsh, pg. 310). An individual already experiencing 
IPV and receiving an HIV diagnosis is likely to be experiencing multiple crises, 
but most acutely the HIV diagnosis will likely spur a new crisis at some point 
following a diagnosis. Each person experiences a unique response to the 
diagnosis, but those already experiencing IPV encounter increased difficulties 
due to the dynamics of the relationship (Davis, 2012). It cannot be assumed that 
an individual will experience a sharp crisis immediately following an HIV 
diagnosis, but it is a working assumption that a crisis ensues at some point 
following the diagnosis and is related to the intersection of it (HIV) and IPV (see 
Chapter One). The HIRS protocol follows the 7 steps outlined for crisis 
intervention and does all of which within the timeframe of four weeks. Greater 
detail is provided in Chapter Three, but the steps most applicable to this 
theoretical discussion are assessment and planning. Risk assessment is the first 
action in the sequence from which safety planning is crafted.  
The risk assessment component of this study is also informed by Stress 
and Coping Theory, which is rooted in Stress Theory. Krohne (2002) explains 
that theories of stress consider either the physiological or psychological response 
to “external demands (stressors) and bodily processes (stress)” (pg. 2). 
Fundamental concepts of Stress Theory are appraisal and coping. Appraisal is a 
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person’s assessment of how an event impacts their welfare, and coping is the 
person’s cognitive and behavioral responses as they attempt to withstand that 
impact (Lazarus as cited in Krohne, 2002, pg. 3). The Lazarus Theory considers 
the psychological responses to these stressors, in which stress is viewed as a 
“transaction’ between individuals and their environment” (Krohne, 2002, pg. 3).  
From this, Stress and Coping Theory grew and is described as focusing 
on a person’s assessment, or meaning making, of a situation and their evaluation 
of the best way to cope with the situation based on their available resources 
(Lindhorst et al. 2005). Stress Theories inform the IPV risk assessment process 
so that it includes assessing each person’s unique risks for danger and potential 
protective factors (Lindhorst et al., 2005) as a means to inform the most 
appropriate safety plan in response to the risks identified. 
Theories pertinent to enacting a safety plan are Lindenberger’s Theory of 
Entrapment and Recovery, the Theory of Action/Planned Behavior, 
Transtheoretical model and the Empowerment model. Lindenberger’s theory 
posits that a woman’s decision-making in an abusive relationship is influenced by 
the “social context and the need to balance care for others and herself” 
(Dienemann et al., 2002, pg. 221). Through this theory, it can be said that a 
woman will only “decide” she is ready to end an abusive relationship, or take 
action that could decrease the abuse, once she begins to believe she is not to 
blame for the abuse (Landenberger, 1989). Employing this theory alone could 
dangerously begin to shape the hypothesis that a woman is responsible for 
preventing the abuse or that it is in her control to end the relationship. However, 
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the enriching component of this theory is that it emphasizes the need to help a 
victim break the cycle of power and control that has entrapped her in the belief 
that that she is responsible. Hence, this theory explains how educating a woman 
about victim-blaming as a component of abuse may be instrumental in her 
process of recovery from the abuse, which according to the theory is said to be a 
non-linear process of moving on. 
Receiving psychoeducation on the dynamics of IPV assists a survivor not 
only with the ability to recognize the presence of abuse but also may provide a 
shift in the cultural and subjective norms associated with abuse. As stated before 
under the Conceptual Definition of IPV section, in the South African context, 
abuse is perpetuated not only by gender inequalities but also by the acceptance 
of gender-based violence as a normative. Therefore, the Theory of 
Action/Planned Behavior is again applicable to this component of the protocol in 
that the idea is to impact changes in a survivor’s subjective norms as a means to 
galvanize change or increase change-directed behavior that is congruent with a 
new subjective norm. Considering this protocol does not attempt to be an IPV 
intervention but an HIV intervention that works towards reducing barriers to care 
associated with the HIV-IPV intersection, it is paramount to underscore that 
change is used in this discussion to indicate action towards health-related help 
seeking behavior or, specifically, linkage to HIV care. Change here does not 
indicate an end goal of women leaving abusive partners or taking action towards 
breaking subservient roles with partners. Instead, the process of change focuses 
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on influencing women to take action towards healthiness (theory of 
action/planned behavior) despite the influences of external forces.  
There is evidence that women in abusive relationships who are 
considering making a change go through a similar readiness to change process 
as seen with other change processes. According to the Transtheoretical Model 
(TTM), one must be ready, willing and able to make a change (Miller & Rollnick, 
2002). Although Motivational Interviewing was not used as an intervention nor 
was TTM as a predominate approach in this protocol, the work of Miller & 
Rollnick explains how change occurs on a theoretical level. More, TTM has been 
used particularly in sub-Saharan Africa to understand stages of readiness to 
change among women in IPV relationships (Wagman et al., 2013).  
An exploratory study of TTM with abused women showed that those in 
early stages of change engage in the cognitive processes of consciousness-
raising, self-reevaluation, dramatic relief, environmental reevaluation and social 
liberation (Burke, Denison, Gielen, MacDonnell, & O’Campo, 2004). Women 
reported that the psychoeducation they received on abuse assisted them in 
moving from precontemplation to contemplation by way of consciousness-raising. 
Through these processes, women reported being able to remain in the 
relationship while more effectively avoiding violence. Burke et al. explain that 
while Prochaska’s theory of stimulus control has typically been used to explain 
how individuals can change their own behavior, the tactic of stimulus control was 
used among the sample as a means for reducing triggers for violence when 
women altered their own responses during precipitating events.  
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If the Theory of Action/Planned Behavior explains the shift in motivation or 
readiness for change (altered subjective norms increases willingness to change), 
then the final impetus for change may hinge on actual or perceived ability to 
change. IPV interventions using TTM work towards affecting large, community-
level change as a means for supporting a community member’s ability to change 
(changes in community subjective norms increase person’s ability to change). 
Because this is not an IPV intervention, change was not attempted on a 
community level but builds on the work of an HIV intervention that has already 
targeted change at the community level. Smaller scale changes were sought for 
the IPV component of the study as a means for catalyzing health-related help 
seeking behaviors. Thus, the protocol attempted to impact shifts in perceived 
ability to change.  
 When a person perceives they possess the ability to take action towards 
goal attainment, it is referred to as self-efficacy, and this is a key concept in the 
mechanism by which methods of empowerment work. Individuals are 
empowered to take action when they are supplied “with requisite knowledge, 
skills, and resilient self-beliefs of efficacy to alter aspects of their lives over which 
they can exercise some control” (Ozer & Bandura, 1990, pg. 472). Ozer & 
Bandura avow that the use of self-empowerment as a means to protect one’s self 
from sexual and physical violence is important given that 80% of sexual 
assailants attack without the use of weapons but through other forms of physical 
force, coercion or intimidation. In sum, the role of self-efficacy could be 
instrumental in a woman’s ability to protect herself when violence arises. This 
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source points out the important and implicit caveat that women are not solely 
responsible for the outcome of these transgressions. Instead, such acts are seen 
as societal problems that should be tackled by advances in issues related to 
gender inequalities. In their study investigating the role of perceived coping and 
self-efficacy in response to physical violence, two mediators were shown to 
jointly impact behavior, a person’s perception of their vulnerability for risk and 
their sense of self-efficacy. This suggests that perceptions of risk coupled with a 
belief in one’s ability to protect one’s self may increase protective behaviors, and 
ultimately, safety. 
Two components that enable someone to implement a safety plan are 
sense of empowerment (sometimes referred to as agency) and the deployment 
of social supports. By empowering individuals, providers help each person 
uncover the resource available to them (internal and external) with the objective 
of raising “the person’s “awareness of oppressive tensions and conflicts in their 
lives, [and] to help them find ways to be free of these constraints” (Pinderhughes 
as cited in Dass-Brailsford, 2007, pg. 72). Services using an empowerment 
model typically use a collaborative approach to focus on improving the well-being 
of those who have been oppressed or marginalized, and hold the assumptions 
that people are key players in their own change process, have inherent strengths 
and capabilities and are interconnected with their environment (Dass-Brailsford, 
2007). When applying the empowerment model to a crisis intervention, 
assumptions are that crises are different for everyone and responses should be 
tailored to meet each person’s needs. Because people are the experts on their 
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own lives, services should focus on uncovering each person’s individual 
strengths and connecting them to resources (Walsh, 2013). 
Applying the empowerment model to the etiology of IPV, abuse is seen as 
something that occurs because of an abusive person’s propensity to exert power 
and control over their partner and not because of any personal attribute (class, 
race, etc.) of the victim (Payne & Wermeling, 2009). IPV services operating from 
an empowerment model hold that all victims reserve the right to  
have access to information, education, and other necessary social and 
economic support to make informed decisions that best reflect their 
interests and needs. Rather than attempting to eliminate the violence, 
which is not controlled by victims, the empowerment approach uses 
knowledge dissemination, training, and counseling to create a set of 
services that victims control, such as post-victimization assistance and risk 
minimization (Ofstehage, Gandhi, Sholk, Radday & Stanzler, 2011, pg. 3). 
An example of how these theories culminate to explain the intention 
behind the protocol would be (see Figure 2.2): A person initiates HIV testing 
(reasons discussed under theoretical underpinnings of HCT component of 
protocol), learns of their diagnosis, an acute crisis ensues (at some point 
typically) and they begin an attempt to cope with the crisis. Those with IPV would 
theoretically have an impaired ability to employ adaptive coping methods and 
would be in a state where their acceptance of help would be heightened. 
Although at this stage they may not be aware of the role of IPV in their 
relationship, through the risk assessment and safety plan they are informed of 
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the danger levels present in their relationship and asked to reflect on this 
(meaning making). From here, the safety plan is developed and largely involves 
the deployment of social supports as the primary coping strategy as aligned with 
crisis intervention. The follow-up safety plan is offered as a means to test if 
additional psychoeducation on IPV is a necessary reinforcement to stimulate 
health-related help-seeking behaviors (take action according to the Theory of 
Action/Planned Behavior).  
 
Figure 2.2 Contextualized Assessment for Strategic Safety Planning with 
Battered Women 
 
Figure 2.2 Contextualized Assessment for Strategic Safety Planning…with Battered Women. 
Lindhorst, T., Nurius, P., Macy, R.J. (2005). Contextualized assessment with battered women: 




2.3 Evaluating the Intervention & the Implementation Process 
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The development of an ethical and effective intervention relies on the 
foundation of strong theoretical and empirical support. Chapter One and the 
beginning of Chapter Two laid out the foundation for the development of the 
intervention as well as theoretical explanations to describe the processes by 
which the intervention operated. This latter half of Chapter Two concentrates on 
describing the dependent variables of linkage to care, perceived safety, and the 
evaluation components of feasibility, acceptability and satisfaction used for 
measuring the impact of the protocol. The rationale for the inclusion of each 
variable will be provided as well as best practices for measuring the component. 
 The development and implementation of the intervention was informed by 
the principles of implementation science, as the intervention was built from an 
inter-disciplinary integration of several theories and sought to understand and 
design an effective means for implementing the intervention (May, 2013, pg.1). 
Yet, implementation theory, focusing on uncovering relevant components of the 
implementation process as well as outcomes (May, 2013), influenced which 
outcomes were included as dependent variables. 
The main aims of implementation theory are to 1. Describe the protocol 
process so that research and practice are clearly synthesized, 2. Use theory to 
explain how outcomes are influenced, and 3. Evaluate the intervention or the 
actual process of implementation (Nilsen, 2015). The discussion on the 
dependent variables will touch on all of these aims but will largely focus on 
providing a rationale for chosen outcome and evaluation variables. Literature in 
the respective areas of HIV and IPV were exhausted to uncover the standard 
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benchmarks used in each discipline. These best practice measurement sticks 
were integrated into the protocol, as a means for procuring data that would most 
saliently compare findings with extant knowledge.  
Measuring Linkage to Care 
Definitions of the term linkage to care vary widely among current literature. 
Universally, sources use this term to mean that a person with HIV has linked to 
some type of medical care, but variations exist in both components of the 
phrase—linkage (when and where) and care (the nature of what is being 
received). Furthermore, delays in linkage are defined differently depending on 
study follow-up periods. This section will describe how other sources have 
defined this term, and comparisons of findings will be presented in Chapter Five.  
Definitions of delays in care range from more conservative estimations of 
linkage as >30 days to broader timeframes such as >6 months. For example, 
whereas Elul et al. (2014) used the marker of 30 days as the endpoint for linkage 
to care, Losina et al. (2010) defined a loss to follow-up as not linking to care 
within 8 weeks of a diagnosis. Bassett, Regan et al. (2014) defined linkage to 
care as either retrieving CD4 cell results or completing an ART literacy training 
within 90 days from an HIV diagnosis, and Reed et al. (2009) defined delays in 
linkage for those after 3 months. Another source followed participants for 6 
months but this also included observation of ART initiation and death 
(MacPherson et al. 2012). An alternative but common practice is using CD4 cell 
stratum to guide and gauge linkage rates so that those with lower CD4 cell 
counts are advised to link to care sooner given the urgency of their need for care 
	   54 
(Krazner et al., 2012; Govindassamy et al., 2013). Linkage to care may refer to 
going to a clinic for CD4 cell results (Losina et al. 2010) or may indicate linking to 
further medical care after CD4 cell results have been received. The latter is more 
often the case in studies using point of care CD4 testing, in which an individual 
receives both an HIV+ diagnosis and CD4 cell results in the same visit (Wynberg, 
Cooke, Shroufi, Reid & Ford, 2014).  
The importance of timely linkage to care has been cited by many sources. 
Delayed entry to care has been connected to lower CD4 cell counts (Mugglin et 
al., 2012; Patten et al., 2013; Van Zyl et al., 2015) and premature death 
Kayigamba et al., 2012; Larson et al., 2010; Van Zyl et al.). However, linkage to 
care earlier in the disease cycle has been shown to improve health outcomes 
(Bassett, Govindasamy et al., 2014) with the timeliness of linkage to care being 
critical to patients reaping the maximum benefits from ART (Losina et al. 2010) 
and an important aspect of reducing secondary infections (Jenness et al., 2012). 
Regrettably, a large number of individuals delay entry to care and initiate ART 
“with far too advanced immunodeficiency” (Lawn et al., 2006, pg. 770). 
Therefore, improving linkage to care is essential to actualizing the potential 
health benefits of ART (Mayer, 2011), but research on the pre-ART period (post 
diagnosis) remains scant (Mugglin et al., 2012). 
Measuring safety 
Stopping violence, by way of ending an abusive relationship, has been the 
touchstone evaluation for many initiatives addressing IPV, but this type of 
benchmark is problematic because it 1. Perpetuates victim-blaming by assuming 
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victims are responsible for perpetrators’ behavior (Dienemman et al., 2002), 2. 
Assumes abuse will end if the relationship ends, and 3. Presumes women want 
to leave their partners (Dienemman et al., 2002).  
Arguments against victims being responsible for perpetrators’ behavior 
have already been presented above in the theoretical explanation of the 
mechanics of IPV. The assumption that abuse will stop if someone leaves his/her 
partner is counter to the perilous truth that the most dangerous time in a violent 
relationship is when a victim attempts to leave (Halket, Gormley, Mello, 
Rosenthal, & Mirkin, 2014). In actuality, more than half (70%) of all violence 
happens after a woman has left her partner (Halket et al., 2014), and the generic 
prescription of an exit plan for the relationship could lead to re-assault (Lindhorst 
et al., 2005). Contrary to the aforementioned false assumptions, many women do 
not want to end their relationship and those who do commonly leave many times 
before they leave for good, with each time being more dangerous than the last 
(Heckert & Gondolf, 2004). 
In light of these dynamics, in can be presumed that measures of safety 
often are not rendered from black and white assessments with equifinality but 
rather are more complex processes. Because safety plans should be informed by 
each woman’s personalized goals, extracted from her subjective interpretation of 
the abuse (Dienemann et al., 2002, pg. 221), each person’s end goal for safety 
will be different. Safety, instead, may be viewed as a subjective construct with 
multifarious endpoints.  
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Yet, for the purpose of quantifying this intricate concept, best practices in 
IPV service were reviewed and two thematic approaches were discovered for 
gauging changes in safety before and after receipt of services: victims’ reports of 
using the strategies (coupled with finding them helpful) and re-assault 
experienced. A third potential category would be changes in perception of 
danger, but victims’ perception of danger may not be an accurate indicator of 
safety because it can fluctuate with the person’s mental health at the time of the 
assessment. For example, abuse survivors with posttraumatic stress disorder 
may have a heightened response to questions triggering an arousal of traumatic 
memories and responses may be influenced by intrusive thoughts of past events 
(Cattaneo, Bell, Goodman & Dutton, 2007). Further, those with worse IPV 
experiences or those considering making a relationship change may report a 
heightened sense of risk (Harding & Helweg-Larsen, 2008). Comparatively, 
actual re-assault (physical, verbal or sexual) is a more quantifiable measurement 
for concrete assessment of reduced or increased safety. The most effective tools 
likely measure all of the above, but research has not yet discovered how risk 
accuracy can be predicted among victims (Cattaneo et al.). 
For the majority of women who are prone to remain in their relationships, 
reports of utilizing safety strategies can shed light on the effectiveness of such 
strategies (Parker & Gielen, 2014) and especially when coupled with reports of 
perceived benefits (Appollis, Lund, de Vries & Mathews, 2015). Some tactics for 
mitigating abuse among those who remain in abusive relationships are: 
“negotiating with the abuser, making the abuse more visible and more likely to be 
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sanctioned, sanctions by family or friends, and/or police arrest leading to court 
sanctions” […] and voluntary counseling” (Dienemman et al., 2002, pg. 223).  
Measuring re-assault as a method for quantifying safety has been 
employed by several sources. Despite the accuracy of this approach, the task 
itself presents logistical problems such as long follow-up periods, relying on 
collateral or retrospective information, and no definitive cut-off point for when it is 
safe to say violence did not reoccur as it could again any time indefinitely into the 
future (Bowen, 2011). Yet, such measurements do tell some of the story of 
participant safety. One study using this approach with South African women 
being tested for HIV in antenatal clinics found that a 20 minute safety planning 
session “contributed to a significant reduction in the level of IPV” with a “mean 
danger assessment score of 6.0 before intervention [falling] significantly to 2.8 
after 3 months” (Matseke et al., 2013, pg. 40). However, such assessments 
require either alterations of measurement tools, given that many tools focus on 
assault in the last year, or longitudinal design (Wagman et al. as cited in 
Kennedy et al., 2015). Nonetheless, it has been shown that reports of safety are 
consistent between two days, and 2, 6 and 12 week follow-up periods, 
suggesting that short-term follow-up may promise the same results as longer-
term follow-up (Kendall et al., 2009). 
Feasibility, Acceptability and Satisfaction 
 The components of feasibility, acceptability and satisfaction were included 
as a means for evaluating the intervention and the implementation process. 
These components are typically included in small preliminary pilot studies. 
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However, this study was more comprehensive than a pilot study and included 
these components for reasons specific to the nature of the study as a Phase II 
trial gathering data necessary to build a Phase III trial. Described in greater detail 
in Chapter Three, this study included these components because A. It is 
recommended that research on sensitive subjects such as IPV evaluate the 
effects of study participation on participants; and B. This study built a new 
approach into an existing program that has already been shown to be effective in 
previous studies. Therefore, this study sought to refine current services and 
monitor the effects of doing so by providing insight into the acceptability, 
feasibility and satisfaction of including an IPV component alongside mobile HCT. 
These evaluation components were reviewed only for the inclusion of the IPV 
component of the protocol (risk assessment and safety planning) as this 
information has already been provided for the HCT component of the protocol in 
past research. Implications from this study will be used to refine standard 
practices that address the HIV-IPV intersection and inform future research on the 
topic. 
A literature review found recommendations for ethically conducting 
research on sensitive subjects such as HIV and IPV. Three themes were 
observed as recommendations for evaluating the effects of participation: studies 
should consider risks, benefits and harm of participation (Appollis et al., 2015). 
These categories were evaluated through questions gauging feasibility, 
satisfaction and acceptability related to the IPV component. 
Measuring Feasibility of the IPV Component 
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One of the main ways the impact of IPV services has been measured is 
through assessment of protocol feasibility. Literature was found on some past 
experiences of implementing both risk assessments and safety plans, and this 
helped to inform appropriate research questions.  
For risk assessment feasibility, past research on the Danger Assessment 
(DA) as a guide for safety planning found no adverse occurrences were 
experienced as a result of study involvement (Bloom et al., 2014). Another study, 
using a safety decision aid similar to the DA, quoted that the aid had helped 
reduce “decisional conflict after only one use in a racially and ethnically diverse 
sample of abused women” (Glass et al., 2010, pg. 959). 
Related to safety planning, feasibility considers the ability for providers to 
implement them, participants reported ability to successfully use techniques from 
the plan (Lewis et al., 2015), and any risks encountered in the process (Appollis 
et al., 2015). Empirical support for implementing safety plans with diverse 
populations was found, with one source reporting successful implementation was 
not impacted by demographic characteristics such as “age, race, income, or 
length of victim–perpetrator relationship” (Kendall et al., 2009, pg. 290). The 
helpfulness of safety planning has been shown to be unaffected of the mode of 
administration (in-person compared to telephonic) and is achievable after only 
brief intervention periods (Bennett, Riger, Schewe, Howard & Wasco, 2004) 
following short training periods for those implementing them (Saunders, Holter, 
Pahl, Tolman & Kenna, 2005). Studies have positively reported on the feasibility 
of using strategies from safety plans; one source reported 75% of women 
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developed an emergency escape strategy during safety planning, and indicated 
that most women successfully “employ components of their safety plan in order 
to become safer” (Goodkind as cited in Parker & Gielen, 2014, pg. 590). 
Thus, the overarching point of assessing the feasibility of an IPV approach 
is two-fold: determining how feasible the techniques are to use and any harms 
experienced as a result of study participation. Questions over the feasibility of 
using strategies or the plan as a whole can be gleaned from the above examples. 
Appropriate ways to measure perceived harm or risk of participation were 
garnered from the Appollis et al. (2015) systematic review and include questions 
over any “negative emotions…unwanted thoughts, distress, bother, or drawback” 
(pg. 11). Finally, a way to measure the risk of using techniques or the plan was 
identified as simply asking about any negative occurrences experienced as a 
result of using the strategies (Bloom et al., 2014).  
Measuring Acceptability of the IPV Component 
Another important way to measure the impact of IPV services is to assess 
reported acceptability among participants. Information from past research on 
acceptability suggests including questions probing the helpfulness of services. 
Lewis et al. (2015) defines acceptability as participants finding the intervention to 
be “agreeable, palatable, or satisfactory” (Lewis et al., 2015, pg. 5), and another 
source explains it considers how participants respond to it (Bowen et al., 2009, 
pg. 3). Past investigation showed women usually describe safety planning as the 
single most helpful factor in reducing IPV (Bloom et al., 2014), with 90% of 
participants finding IPV screening itself to be acceptable (Thackeray et al., 2007). 
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More, studies on sensitive subjects have found that participants with a history of 
abuse are more likely to find study participation beneficial, and this may be 
attributable to the catharsis experienced when discussing relationship difficulties 
to an empathic listener. Yet, most research in this area has failed to ask 
participants about perceived benefits (Decker et al., 2012). Overall, questions 
probing for perceived helpfulness of a protocol as well as the benefits of 
participating in a study over abuse are both important areas to consider when 
assessing acceptability among people with IPV. 
Measuring Satisfaction of the IPV Component 
 The final area to be included when measuring the impact of IPV services 
is participant satisfaction. While there are several ways to measure satisfaction, 
approaches such as conducting risk/benefit comparisons were shown to help 
assess overall satisfaction of study participation. This is different than 
acceptability of the actual components of the protocol because this focuses on 
satisfaction associated with study participation as a whole. Some areas 
considered were general questions about whether or not services were helpful 
overall (Decker et al., 2012) and any regrets of participating in the study or 
talking about the issues at hand during the assessment process (Appollis et al., 
2015).  
In total, literature demonstrates that the effectiveness of safety planning is 
not only measured by the ability to use its techniques and the danger 
experienced while using it, but also it is important to consider any distress or 
difficulties experienced in the process of implementing a risk assessment and 
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safety planning protocol. The culmination of participant responses, for an overall 
evaluation of experience, is necessary for creating a complete risk to benefit 
assessment of study involvement (Appollis et al. 2015). 
 
2.4 Summary 
 This chapter has explored the study’s Independent and Dependent 
Variables. Pertinent concepts have been operationalized, and empirical support 
has been provided from current literature to demonstrate how the protocol was 
developed. Theoretical frameworks have also been included to deconstruct the 
mechanics of the protocol. This chapter has paved the way for the reader to have 
a greater understanding of extant knowledge on the HIV-IPV intersection and the 
rationale behind the best practices incorporated into the protocol. Next, Chapter 
Three will review the study’s methodology and provide further insight into how 













Chapter One outlined the breadth of the HIV-IPV intersection and how it 
has disparately scourged women in South Africa. Chapter Two provided 
theoretical and empirical support for the intervention as well as the rationale for 
measurement methods. Hitherto, the need for effective practices with this 
population as well as more rigorous research in low-resource countries, such as 
South Africa, has been underscored. This study tests a protocol designed to 
address the HIV-IPV intersection and does so by using a risk assessment and 
safety planning protocol to assist women with intimate partner violence (IPV) who 
have tested HIV+ during mobile HIV Counseling and Testing (HCT). Through the 
testing of this protocol, new knowledge has been created on behaviors and 
perceptions after mobile testing as well as the impact of the HIV-IPV intersection 
on linkage to HIV care. 
           This study was a Phase II trial administered to test the effectiveness and 
safety of an HIV-IPV risk and safety protocol as a means to inform a Phase III 
study at a later date. As an experimental study over the novel HIRS protocol, the 
primary aims were to test for protocol effectiveness with study hypotheses 
related to safety and linkage to care. Because the study refined a current 
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evidence-based program, by adding the IPV component, secondary aims sought 
to determine the feasibility, acceptability and effectiveness of the IPV component. 
This chapter explains the study design and methodological procedures employed 
to collect adequate data to answer the study’s research questions. 
            The following research questions were devised to address some of the 
gaps in the literature related to the HIV-IPV intersection.  
  
3.1 Research Questions & Hypotheses 
Primary Research Questions 
Research Question 1A 
What is the difference in participant risk and safety scores between the combined 
Experimental groups and the Standard of Care group?  
Hypothesis: Participants in the combined Experimental group (receiving any level 
of the intervention) will have improved scores on the HIV IPV Risk and Safety 
scale (HIRS) as compared to participants receiving only the standard of care.  
Research Question 1B 
What is the difference in participant risk and safety scores between dosage 
levels of those who received 1. danger indicator score + initial safety plan, and 2. 
danger indicator score + initial safety plan + follow-up safety plan? Analysis was 
done on pre post difference scores. 
Hypothesis: Participants with the highest level of dosage will have the highest  
amount of increased perceived safety as measured by the HIRS. 
Research Question 2 
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What is the difference in participant linkage success between the combined 
Experimental groups and the Standard of Care group? Successful linkage (within 
30 days) and number of days linked were used as indicators. 
Hypothesis: Participants in the combined Experimental groups (receiving any 
level of the intervention) will have increased rates of linkage (more links at a 
faster rate). 
Secondary Research Questions 
Research Question 3A 
What is the difference in participant satisfaction scores between the combined 
Experimental groups and the Standard of Care groups? 
Hypothesis: Participants in the combined Experimental groups (receiving any 
level of the intervention) will have higher satisfaction scores as compared to 
participants receiving only the Standard of Care.  
Research Question 3B 
What is the difference in participant satisfaction, feasibility and acceptability 
scores between dosage levels of those who received 1. danger indicator + initial 
safety plan, and 2. danger indicator + initial safety plan + follow-up safety plan?  
Hypothesis: The possible impact of higher dosage intervention on satisfaction, 
acceptability and feasibility is uncertain.   
 
3.2 Specific Study Aims  
Phase I of Pilot study:  
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1. Refine study instrumentation via focus interviews; improve cultural 
sensitivity of instrument as well as feasibility of use (readability, problems 
with wording, etc.). 
2. Refine program components via focus interviews; improve cultural 
sensitivity of safety plan (phrasing/wording). 
Phase II of Pilot study:  
1. Determine feasibility of safety planning protocol: A). successful 
implementation with 75% of eligible participants 1). participants are 
reachable via call centre; 2). Participants report using safety plan. B). 
successful retention of 75% of participants at one month follow-up. 
2. Determine acceptability of safety planning protocol: A). 80% of participants 
have a positive rating of the intervention. B). Determine if participant 
acceptability varies between dosage levels and between experimental and 
control groups. 
3. Test effectiveness of strategies used to avoid contamination of sample 
between control and experimental groups; successful avoidance of 
contamination determined by low contamination percentage of 10%. 
4. Determine effectiveness of intervention; A). effectiveness with participant 
safety; B). effectiveness with linkage to care. 
 
3.3 Design 
As an Experimental pre-test-post-test control group design, this study 
compares the findings of two intervention groups to those of a control group to 
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test hypotheses (see figure 3.1). Aligned with the purpose of a Phase II clinical 
trial (National Institute of Health, NIH, 2008), the study builds on the work of past 
studies and seeks to further test the effectiveness and safety of an HCT service 
that addresses an IPV component. Because the new IPV component was added 
to an existing evidence-based program, the feasibility of the new component was 
tested. Processes considered were feasibility, acceptability, and satisfaction with 
the overarching study purpose to test protocol effectiveness with linkage to care 
and participant safety. Feasibility components are used to help uncover 
challenges in managing a protocol, needed resources, and needed potency 
(dosage) of an intervention in order to achieve effectiveness (Thabane et al., 
2010). Three groups were involved in this study: one as a Standard of Care 
group, which did not receive risk assessment scores or a safety plan, and two 
sub-groups within the Experimental group, which received different dosage levels 
of the experimental component as a means to test the needed level of 
intervention potency (dosage level 1 and dosage level 2). 
Figure 3.1 Research Design 
R O1   O2 
R O1 X  O2 
R O1 X X O2 
 
3.4 Data Analysis 
Independent sample t tests and Chi square tests were largely employed 
during data analysis. T tests were used specifically to test for condition 
differences on safety scores (between each dosage level) on the HIV IPV Risk 
and Safety (HIRS) scale. Chi Square was most often used to test differences in 
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Satisfaction, Feasibility and Acceptability item responses between the combined 
Experimental group and the Standard of Care group and between the Dosage 
level groups within the Experimental group. Pearson’s Chi-square test was used 
to test group differences in successful linkage to care between the Standard of 
care group and the Experimental group, and pre/post differences for ordinal 
items were analyzed using McNemar’s test. In the cases where there were less 
than 5 responses per cell, Fisher’s exact test results were used to meet analytical 
assumptions (Faul & Lawson, 2012; Rubin & Babbie, 2008). Additionally, results 
for all analyses were reported using two-tailed tests of significance for p values 
as a means for “testing non-directional hypotheses” (Rubin & Babbie, 2008, pg. 
510). Prior to conducting these analyses, reliability and validity testing was 
conducted over the HIRS pre-test scale as well as the Danger Indicator. 
Exploratory Factor Analysis was used for this analysis. 
  
3.5 Operational Definitions 
The Independent Variable was: Intervention with two dosage levels. The 
intervention was twofold: 1). Participant received risk assessment and is 
informed of Danger Indicator score; 2). Participant then developed a 7-domain 
safety plan to address personalized risks uncovered in risk assessment. Those in 
Dosage level 2 received an additional safety plan approximately two weeks after 
the initial intervention.  
This intervention was created with the intention of addressing the HIV-IPV 
intersection among HIV testers, with the ultimate aim of promoting safe and 
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satisfactory linkage to HIV care; hence, this was an HIV intervention that 
addressed IPV as a barrier for linkage to care following mobile testing. This 
protocol did not seek to be an IPV intervention, per se; instead, this intervention 
attempted to impact subjective norms at the individual level as a way to, not only, 
catalyze participants to link to care but to do so in the safest manner, given the 
IPV dynamic. However, the risk assessment and safety-planning component of 
the protocol was built from evidence-based practices found among the IPV 
knowledge base.  
The two Dependent Variables for the primary research question were: 1). 
risk & safety score, and 2). linkage rate. The Risk and Safety score was derived 
from answers to the HIV IPV Risk and Safety (HIRS) scale, which was created 
for this study and was 10 items. The linkage to care rate was operationalized as 
successfully linking to care within 30 days. However, those who took longer to 
link to care, but did so by post-test data collection, are shown separately in the 
Result’s section. 
The three Dependent Variables for the Secondary research question 
were: satisfaction, feasibility and acceptability. Satisfaction was measured using 
three items as separate indicators of satisfaction: 1). Overall, the information you 
received about relationships was helpful, 2). It was helpful to be asked about the 
difficulties in your relationship? and 3). You regret talking about the difficulties in 
your relationship? 
Feasibility was measured in the four domains of 1). Time to reach, 2). 
Length of time to administer intervention, 3). Techniques employed, and 4). Risk. 
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Domain one included the number of attempts it took to reach participants for 
each component of the protocol (pre-test for all groups, follow-up safety plan for 
dosage level 2 only, and post-test for all groups). Domain two calculated the 
amount of minutes it took to administer each component of the intervention (pre-
test for all groups, initial safety plan for both experimental groups, follow-up 
safety plan for dosage level two only, and post-test for all groups). Domain three 
considered the feasibility of using the safety plan or any of the safety strategies 
and included the item 1). Did you use the safety plan? And 2). then considered if 
participants reported having used any of the strategies from the plan. Finally, 
domain four focused on risks associated with study participation as well as use of 
safety strategies and included the following items: 1). If you notified your partner 
of your HIV status, did you experience any type of violence as a result (mental, 
physical or sexual)?, 2). Would it be safe for us to contact you by phone at one 
month, two months or three months? (yes to any= safe to contact again), 3). 
Talking about the difficulties in your relationship placed you at greater danger? 
And 4). The services you received placed you at greater danger?  
Acceptability considered acceptability of the safety plan and any 
discomfort experienced as a result of participating in the study. This section 
included the following items: 1). Did you find the safety plan helpful?; 2). Would 
you recommend the safety plan for a friend?; and 3). Did the respondent use any 
type of safety strategy (not an item directly asked but created from the number of 
respondents reporting use of at least one safety strategy) and 4). It was 
uncomfortable for you to discuss the difficulties in your relationship? 
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Informed by the Appollis et al. (2015) systematic review on conducting 
research on violence and abuse, these items were included to measure 
participant experience of participating in the study as well as utilizing the 
techniques promoted within the intervention. This source highlights the 
importance of using items that probe for perceived feasibility, acceptability and 
satisfaction of any study over the sensitive subject of abuse. By analyzing each 
of these areas as separate indicators of participant experience, a study may 
procure more meaningful data over perceived benefits, harms and risks of 
involvement in research about abuse. This is crucial for all research about abuse 
given that there is the potential for questions to trigger traumatic memories. 
However, Decker et al. (2012) found that respondents who have a history of 
abuse report finding studies about abuse more acceptable (than their 
counterparts who have not endured abuse) and may even find the process 
therapeutic. Further information on these items used as separate indicators may 
be found in Chapter Two as well as Chapter Four. 
 
3.6 Participants 
Mobile HIV testers were invited to participate in this study if they met the 
study inclusion criteria. Foremost, they had to be 1) female and 2) have tested 
HIV+ during mobile HIV Counseling and Testing (HCT) with the chosen NGO in 
Gauteng province, South Africa. They had to 3) give written and verbal consent 
to participate in the study and 4) provide a reachable number for the call centre 
research team to reach them for telephonic study administration. Participants had 
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to 5) currently (or often) be in a romantic relationship, 6) meet IPV eligibility 
(described below in this chapter), 7) be at least 18 years of age (or older), and 8) 
be able to participate in one of the chosen language of English, Sesotho, isiZulu 
or isiXhosa. Those who could not fill these inclusion criteria, or 9) who had 
cognitive impairment that precluded them from giving informed consent, were not 
eligible to participate in the study. 
Recruitment 
This study recruited participants from the NGO, Shout-it-Now (S-N), which 
provides mobile HIV Counseling and Testing (HCT) services in the South African 
province of Gauteng. S-N provides education and screening to 70,000 youth 
each year through this mobile program. Although S-N offers free services to 
those aged ≥12 years, only those participants’ aged ≥18 years were approached 
for study participation. At this phase of the study, individuals were asked to 
participate only if they tested HIV+, were female, and could participate in one of 
the four chosen languages. Those who agreed verbally and in writing to the 
informed consent process were then referred to the study where they were later 
screened by the research team for relationship status, IPV eligibility, access to a 
telephone and cognitive impairment. 
Compensation 
Participants were informed that by participating in the study, those who 
remained in the study throughout its entirety would have their name entered into 
a drawing for an i-pod. All participants received free HIV/TB screenings and 
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counseling as well as a free IPV screen. Those who preferred not to participate 
also received the free HIV/TB screenings and counseling but no IPV screen.  
IPV Eligibility 
            IPV Eligibility was established by answering either ≥2 on the revised Non-
violent Control scale (NVC) or ≥1 on the revised Conflict Tactics Scale 2 (CTS2) 
(see Table 3.1). Once eligibility was established, participants were immediately 
allocated into one of the treatment groups, but all received the remainder of the 
pre-test items. The eligibility items (the NVC and CTS2) in conjunction with the 
remaining pre-test scales (VVS, HIRS and DA) collectively made up the full pre-
test. 
 
3.7 Description of Instruments & Rationale for Use 
Table 3.1: Instruments & Program Components 
Dimension measured Variable or scale name Description Measurement within 
study 
 
Relationship status; Collected 
in eligibility screening 
Relationship 
Eligibility 
2 items; one 
minute or less. 
Dichotomous 
(yes/no) 
Danger related to Intimate 




Composite Score of 
CTS-2 (10 items); NVC 
(6 items); VVS (8 
items); HIRS (10 
items); and DA (11 
items). 
45 items; About 
10-12 minutes 
All, but VVS, 
dichotomous with the 
VVS being a 0-2 
likert scale; Score 
range 0-49. 
Physical and sexual violence; 






& Sugarman, 1996) 














eligibility screening Leone, 2005) 
Violence vulnerability (risk 




(VVS)(Van Zyl, Brown 
& Pahl, 2013) 
8 items 3-point likert scale 
(0,0,1 points 
possible); Scale 
range 0-8 (lacking 
vulnerability-most 
vulnerable). 
Risk and safety related to the 
HIV IPV intersection; Part of 
Pre-test 
*HIV IPV Risk & 
Safety (HIRS) scale 
(created for this study) 
10 items Dichotomous 
(yes/no); Score 
range 0-12 (no risk-
most risk) 
Intimate partner violence 
lethality level; Part of Pre-test 
*Revised Danger 
Assessment (DA) 
(Campbell et al., 2009) 
11 items Dichotomous 
(yes/no); Score 
range 0-13 (limited 
lethality-highest 
lethality) 
Feasibility; Part of Post-test 
for Experimental groups only 
Feasibility: items 
used as separate 
indicators 
5 items  Dichotomous 
(yes/no) 
Acceptability; Part of post-
test for Experimental groups 
only 
Acceptability: items 
used as separate 
indicators 
2 items Dichotomous 
(yes/no) 
Satisfaction level; Part of 
Post-test for All groups 
 
Satisfaction: items 




3 items Dichotomous 
(yes/no) 
Linkage to care; Part of Post-
test for All groups 





Rate (within 30 
days and by post-
test) 
Note. Table 3.1 provides description of each item included in study’s instrumentation. 
 
The Non-violent control scale (NVC) measures psychological 
maltreatment of women and is used to differentiate IPV typology such as 
Situational Couple violence and Intimate Terrorism. This scale was originally part 
of the National Violence Against Women Scale (NVAWS), included 7 items with 
dichotomous (yes/no) responses and had a Cronbach’s alpha of .70 (Johnson 
and Leone, 2005). The scale has not been used in Africa but does have support 
for international use. Findings from this study will contribute to the IPV knowledge 
base by applying Johnson’s theory in an area where it has not yet been applied. 
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This study revised the original NVC by only using 6 items and changing some of 
the wording slightly. 
The original Conflict Tactics Scale 2 (CTS2) measures various dimensions 
of IPV and includes symmetrical responses from both victim and perpetrator. 
Responses are elicited on a 7-point scale with 0 being “this has never 
happened,” 1 being “once in the past year” …and so on, with 6 being (the 
highest) “More than 20 times in the past year” and 7 being “Not in the past year, 
but it did happen before (Straus et al., 1996). Jones et al. (2003) recommends 
this scale for use when jointly working with HIV and IPV. Different versions of this 
scale have been used in sub-Saharan Africa (Hung, Scott, Ricciotti, Johnson & 
Tsai, 2012; Maman et al., 2010; Zacarias, Macassa, Svanstrom, Sores & Antai, 
2012), and it has been specifically used in South African studies (Peltzer, 2013; 
Swart, Seedat, Stevens & Ricardo, 2002). The Physical Aggression dimension of 
the scale has 12 items and has produced a Cronbach’s alpha of .86. The Sexual 
coercion dimension of this scale has 7 items with a Cronbach’s alpha of .87. This 
study revised the original CTS2 so that it included items that measure physical (7 
items) and sexual (3 items) abuse, was only administered to victims, and used 
dichotomous responses to the items (yes/no). Although it had previously been 
translated into isiZulu, items were re-translated for this study because of wording 
changes for this revision. 
The Violence Vulnerability scale (VVS) measures if a romantic relationship 
is vulnerable for IPV to occur. This scale considers if participant’s attitudes and 
beliefs place them at risk for IPV, and the scale was originally part of a study in 
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South Africa regarding young men and women undergoing mobile HIV 
Counseling and Testing (HCT) in Gauteng or Limpopo provinces. Findings over 
this scale have not yet been published. It was originally an 11-item scale with a 
Cronbach’s alpha of .81 and a Corrected Mean total correlation of .45. 
Responses were elicited on a 3-point scale with 1 being “Almost never or never,” 
2 being “Once in a while,” and 3 being “Frequently” (Van Zyl et al., 2013). This 
study revised the original VVS so that it only included 8 items, and points (one 
each) were only assigned to the “Frequently” category. 
The HIV IPV Risk & Safety scale (HIRS) measures perceived risk and 
safety factors associated with help-seeking behaviors for those affected by both 
HIV and IPV. This scale was created for this study and underwent validity and 
reliability testing after data collection. The pre-test and post-test versions have 
slight language variations that allow the pre-test to be seen as perceptions of 
what might occur in future attempts to access HIV care, and the post-test may be 
seen as a tool for reflecting on perceptions of danger for what actually occurred 
in the time between the pre and post-test. The scale elicits dichotomous (yes/no) 
responses and includes 10 items with the last item having 3 points assigned for 
affirmative responses (all other items are only assigned 1 point). 
The Danger Assessment (DA) measures IPV lethality risk. The scale 
contains 20 items with weighted categories and involves the use of a one-year 
calendar to track the frequency of endorsed items. Scores from the scale are 
used to predict respondent’s risk for IPV lethality and include categories (from 
lowest to highest) of variable danger, increased danger, severe danger, and 
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extreme danger. This scale has had a test-retest reliability ranging from .89 to .94 
(Campbell as cited in Campbell et al., 2009, pg. 659). A systematic review found 
that the DA had an Area Under the Curve (AUC) of .618 and a small effect size 
(the AUC is used to assess how predictive a risk assessment is of future re-
assault); however, the systematic review also found that most studies had 
implemented the DA incorrectly. When predicting femicide, the AUC of the DA 
was .916, and .674 “when predicting severe reassault not controlling for 
protective actions taken by the victim, and an AUC of .687 for severe reassault 
when controlling for victim protective actions” (Campbell et al., 2009 & Campbell 
et al., as cited in Messing & Thaller, 2013, pg. 1543). Past studies have found 
convergent construct validity of the DA was supported with moderate to strong 
correlations with other validated scales such as the Conflict Tactics Scale 
(Campbell as cited in Campbell et al., 2009 pg. 659). The DA has been used in 
South Africa in a healthcare study, showing a retention rate of 52.5% (Matseke et 
al., 2013), and a study over the use of orders or protections for IPV (Peltzer, 
Pengpid, McFarlane & Banyini, 2013). One study raised concern over its validity 
in South Africa (Joyner & Mash, 2012) when used merely as a safety planning 
tool and thought it was more accurate to use it as a “danger assessment” that 
should be further evaluated. This study revised the DA so that it only included 10 
items and did not use the calendar to track frequency of endorsed items (given 
the nature of the telephonic version of this study, but see recommendations for 
future studies regarding the calendar use). Minor changes were made to the 
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language of these items and input from the author of the DA was sought and 
honored in the final version of the instrument. 
Rationale for items included on feasibility, acceptability and satisfaction 
are outlined in Chapter Two under Dependent variable. 
Pre-test 
The pre-test was comprised of 45 items total. This included the Non-
violent control scale, which measured the variable of non-violent control or 
psychological abuse related to systemic power and control; revised Conflict 
Tactics Scale 2 (CTS2), which measured the variables 
of physical and sexual abuse; revised Violence Vulnerability Scale (VVS), which 
measures violence vulnerability; the HIV IPV Risk & Safety scale (HIRS), which 
measures risk and safety associated with the HIV-IPV link; and the revised 
Danger Assessment (DA). All 45 items were asked of all participants during 
telephonic contact. 
Post-test 
The post-test was comprised of the HIRS scale and many different items 
that were used as separate indicators of linkage to care and the components 
feasibility, acceptability and satisfaction. Post-tests varied slightly depending on 
group allocation. All participants received the 17 items of the post-test version of 
the HIRS, which included slight verbiage changes, as well as items on 
satisfaction. Only the experimental groups received items regarding feasibility 
and acceptability as these probed for responses to the risk assessment and 
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safety planning component of the protocol. The post-test was also administered 
via telephonic contact. 
 
3.8 Intervention 
Participants in the experimental groups received two main interventions, 
with those in dosage level 2 group receiving more potency of the latter 
intervention. All participants in the experimental groups received both a Danger 
Indicator score and a personalized, 7-domain safety plan. 
1. The Danger Indicator: The Danger Indicator includes all sub-scales in 
the pre-test with points assigned, according to the literature, to create a total 
score that is associated with a danger level. Participants were informed of their 
danger level (0-10, with 5 point increments), which corresponded with their total 
score. This instrument was created for this study and underwent reliability and 
validity testing as well as factor analysis to ensure that it contained one factor for 
which a global score could be assigned as a latent variable. 
2. Safety Planning: Though safety plans are individualistic and a one-size-
fits-all blanketed approach cannot be prescribed word for word, all participants 
received an initial safety plan, which followed a 7-domain format to elicit 
personalized responses for person-tailored plans. Participants in the dosage 
level two experimental group received a second safety plan, or a follow-up safety 
plan, to help participants revise their initial plan if anything had changed in the 
time between pre and post-test. The intent of the safety plan was to increase 
participant’s overall safety, given that violence has been shown to increase after 
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HIV diagnosis, and to help them link more safely to HIV care. Parker & Gielen’s 
(2014) six IPV safety-planning domains were used as a guide during this protocol 
and a 7th-domain was created for this study as a means to help with safe HIV 
help-seeking behaviors. The 7th domain was informed by the NNEDV’s power 
and control wheel, the work of Mkandawire-Valhmu et al. (2013), and insight from 
exploratory studies over women living with HIV and IPV in southern Africa. 
The domains were as follows: 1. Formal network; 2. Informal network; 3. 
Legal; 4. Placating strategies; 5. Resistance Strategies (which are not 
encouraged but, instead, are discussed as a means to dissuade their use given 
that they are shown to increase violence); 6. And general safety planning 
strategies, 7. Accessing HIV care safely. The content for each of these topic 
domains was tailored to address each participant’s unique circumstances 
discussed in the call. 
Goals for safety plan were: 1. Educate participants on the dynamics of IPV 
in their relationship as a means to alter subjective norms about gender-based 
violence, 2. Inform participants of strategies known to increase or decrease 
safety, and 3. Create a plan for ways to safely access medical services for HIV.  
The safety plan was Psychoeducational in nature and not an IPV 
counseling session. The first intervention component informed women that the 
Danger Indicator instrument detected the presence of IPV in their relationship, 
and they were told their level of danger as related to a 10-point scale (with 10 
being the highest level of IPV). They were then asked to reflect on what this 
information meant to them. Next, participants were educated about what types of 
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behaviors were considered abusive from a theoretical level, and they were given 
empirical information about the likelihood of violence increasing after an HIV+ 
diagnosis. Safety strategies were discussed with each strategy followed by 
reflective questions. Participants were also informed of some strategies that have 
been shown to escalate violence. Participants were informed about the existence 
of IPV services in their area and were educated on legal options available as well 
as the process for utilizing legal services such as orders of protections (otherwise 
known as interdicts). Referrals for IPV and legal services were given for those 
who said they wanted them and strategies were discussed for safe places to 
keep the information away from the abusive partner. Participants were asked 
during the safety plan if they planned to leave the relationship, as this information 
was vital to informing the direction of the safety plan given that violence has been 
shown to greatly increase at such a time. However, those who were not planning 
to leave the relationship were supported in their decision and were not 
encouraged to leave. Finally, participants were asked to create a global safety 
plan and particular emphasis was placed on discussing safe ways they could link 
to care, take medicine or notify their partner of their seropositive status if desired. 
They were informed that partner notification of their serostatus was a personal 
decision (UNAIDS, 2000), as they knew what was best for their own lives and 
what was safest in their relationship.  
Those in Dosage level two group received a follow-up safety plan which 
allowed the research team to review the participant’s personal safety plan with 
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them from approximately two weeks before. Participants were asked if anything 
had changed and if they needed any new information or resources.  
 
3.9 Procedure 
All participants underwent mobile HIV Counseling and Testing (HCT) and 
received the same HIV testing services. These services entailed that participants 
watched an edutainment video as a means to encourage testing uptake (Van Zyl 
& Barney, 2014). Individuals, who met the criteria at this stage (had not yet been 
screened for relationship status or IPV eligibility), were invited to participate in the 
study. Written informed consent was obtained at this time in-person, and verbal 
consent was again obtained via the telephonic medium before the study was 
administered. A one-day lag time existed between diagnosis (HIV testing) and 
referral to the study. Therefore, the soonest a potential participant received 
contact from the research team was 24 hours after diagnosis/testing. One month 
after HIV diagnosis/testing, the research team began attempts to reach 
participants for post-tests. 
Phase I of this study went approximately one month and was used to elicit 
feedback over the protocol. Participants referred to the study during Phase I were 
not screened for relationship status or IPV eligibility but were, instead, only asked 
to give feedback over the wording of the instruments, with particular attention 
paid to the cultural appropriateness and shared understanding of the language of 
the instruments. Once this phase was concluded, the feedback was used to 
	   
83 
improve the protocol and phase II commenced. A brief outline of the findings of 
this phase is presented in Chapter Four. 
Phase II followed the same recruitment procedure above; however, once a 
prospective participant had agreed to participate in the study, she then was 
screened for IPV eligibility and relationship status. Both phases were 
administered telephonically. Once an individual had met all the criteria and 
written and verbal consent had been obtained, she was then assigned into a 
study group based on random allocation. The treatment groups and arms are 
described below: 
Standard Of Care  
Immediately following an HIV+ diagnosis, all participants received information 
and referral to local mental health services. Given that WHO (2013) recommends 
that all healthcare workers responding to reported IPV provide at least first-line 
service*, all participants were asked if they would like referral information for IPV 
services before ending the pre-test phone call. Further, all participants were 
contacted again by the NGO’s call centre program and again were offered 
referral for local mental health services if they were in crisis. *A detailed outline of 
first-line support can be found in WHO (2013), but a general description of first-
line support  
refers to the minimum level of (primarily psychological) support and validation 
of their experience that should be received by all women who disclose 
violence to a health-care (or other) provider. It shares many elements with 
what is being called ‘psychological first aid’ in the context of emergency 
	   
84 
situations involving traumatic experiences (WHO, 2013, vii). 
Further, participants in this study group only received a pre-test and a post-test 
but were offered the same interventions as the experimental group after taking 
the post-test. 
Dosage level 1 
Participants received first-line support and were contacted for post-
diagnosis support from the NGO’s call centre. Participants in this study group 
received a score from the Danger Indicator as well as an initial safety plan.  
Dosage level 2 
Participants received the first-line support and were contacted for post-
diagnosis support from the NGO’s call centre. Participants in this study group 
received a score from the Danger Indicator, an initial safety plan, and a follow-up 
safety plan. Attempts to reach for the follow-up safety plan began two weeks 
from the referral date (HIV test date). This safety plan was used to update the 
initial safety plan if anything had changed for the participant in the time between 
the pre and post-tests. 
Power analysis & sample size 
A power analysis showed that each treatment group would need at least 60 
participants in order to have sufficient power for desired analytical methods. This 
breaks down to the following: 
1. Experimental group: until 120 total (includes 75 each at 80% retention 
rate): 
a. Dosage level one (60) 
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b. Dosage level two (60) 
2. Control group: 
a. Standard of care (60) 
Randomization procedure 
The following randomization procedure was followed as a means for 
randomly allocating participants into one of the three group assignments. First a 
list of random numbers with a predetermined maximum (75 x 3 or 225 in this 
case), without duplicates, was generated in Excel. This list was then copied into 
SPSS and three category codes were allocated to the random number 
representing the three conditions. When the study was extended to recruit a 
larger sample size, the same procedure was followed for another 125 
randomized case assignments. 
Data Collection 
            As outlined above, data collection for all participants began as soon as 24 
hours after an individual underwent HCT and received an HIV+ diagnosis. 
Attempts for post-test data collection began at 30 days after the HIV test date. 
Attempts for follow-up safety plans began two weeks after the test date. Even in 
the case where a participant was not immediately reachable for any of these 
collection points, the next stage of the study was attempted at the scheduled time 
with the HIV testing date used to signal data collection times. 
 Three research assistants collected data using paper participant packets 
organized by language and group type. All research assistants administered the 
study with participants from each study group, and assignment to a team 
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member was based on language and availability of research assistant at the time 
the referral came to the team. The research team all worked in one physical 
location to ease utilization of the randomization chart and ensure no group 
allocation was issued twice simultaneously. Once data had been documented on 
the physical participant packets, information was entered into Excel by the 
Research Coordinator and scanned versions of the original document were 
archived for reference. No identifying information was listed anywhere on these 
documents, and participant packets were coded by case ID number (assigned 
chronologically based on when the referral came to the team) with the key to this 
system remaining in the research room and destroyed at study termination. 
Data Management  
Privacy was maintained by all cases receiving a case identification 
number and data being stored electronically by the research team in South Africa 
on a secure server. At the end of the accrual period, the de-identified data file 
was encrypted by the Research Coordinator and forwarded electronically via 
email to the study PI.  The data was provided in Excel format in order to ease 
migration to SPSS for analysis.  The data file received was stored on the PC of 
PI, with access to the computer being password protected, and the PC being 
HIPAA compliant. A copy of original files was saved on a CD and stored in a 
locked cabinet in the PI’s office.  
Staff and training 
            The staff members administering the HCT were already employed by the 
NGO and had previously been trained in administering HCT. However, UofL 
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researchers met remotely with these staff members for a brief IPV training and 
overview. These staff members used a script to ask for study participation and 
were trained in appropriate ways to go over the informed consent document. 
Staff members were offered the chance to receive a bonus for those who 
referred the most participants to the study. Because there were two research 
teams administering HCT, the highest referring staff from each team was offered 
a bonus to reward their recruitment work. 
Research team staff members consisted of one Research Coordinator and 
three Research Assistants and were recruited using two main mechanisms: 1. 
University of Louisville researchers made contacts with Social Work faculty at 
University of Cape Town and University of the Western Cape and asked if they 
could post the positions internally so their students may see the opportunities, 
and 2. The positions were also posted on non-profit advertising sites in South 
Africa commonly used for staffing recruitment by Shout-it-Now (i.e. Gumtree.org, 
NGOpulse.org, etc.). One Research Coordinator was hired to oversee day-to-day 
management of the study, and three Research Assistants were hired. Two 
Research Assistants worked full-time (M-F 8:30am-4:30am) and the other 
Research Assistant worked only two days a week (T & W 8:30-4:30). The part-
time assistant was hired on a part-time basis due to her availability, but she was 
offered full-time work. 
The position announcements advertised that staff must: be comfortable 
discussing content related to HIV status and intimate partner violence; have an 
attitude of gender equality and support women’s ability to make decisions for 
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themselves; be empathetic and show non-judgment when working with 
participants; demonstrate cultural competence; and be people oriented, self-
motivated and able to work independently. The announcement also stated that 
desired staff must be computer literate (Microsoft Office), with particular 
knowledge of Excel. Although there were no degree requirements, all staff 
possessed at least a Bachelor’s degree except for one who was in her final year 
of a Bachelor of Arts in Criminology.  
The Research Coordinator was required to have research and 
management experience. She was Zimbabwean and possessed a Bachelor’s of 
Arts in Education, a Master of Peace and Governance and was working towards 
a PhD in Conflict Transformation and Peace Studies. She was responsible for 
managing day-to-day procedures and supervising the overall study including staff 
performance and data entry. 
All Research Assistants were required to have some type of experience 
comparable to HIV or IPV work and be fluent in English as well as one other 
language (between isiZulu, isiXhosa or Sesotho). All of the Research Assistants 
spoke fluent English, Xhosa and isiZulu with one also speaking Sesotho. All were 
South African nationality, and one had a Bachelor of Arts in Health Science and 
Social Services with a specialization in psychological counseling, and another a 
Bachelor of Social Sciences majoring in Psychology Criminology & Sociology.  
During the interview process, research team staff members were asked 
screening questions about attitudes and beliefs of gender equality in order to 
probe for any attitudes that would not be aligned with the nature of this study. 
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Only staff with attitudes of gender equality were hired for this study, and the 
research team was all female. In order to gain an understanding of changes in 
staff attitude and beliefs of gender equality as well as staff knowledge on IPV & 
HIV, research team staff members were issued a pre/post knowledge test (before 
any training began and after all training had concluded).  There were 20 
questions on this staff knowledge test and results were as follows. For the pre-
test, staff scored a mean of 50% (10 questions correct out of the 20). For the 
post-test, staff scored a mean of 80% (16/20). Results showed a 30% 
improvement from entry-level knowledge. 
Training consisted of four full days with an IPV-experienced Trainer from 
the United States and additional training time to complete CITI ethics training 
(Collaborative Institutional Training Initiative) online with University of Louisville. 
The Research Coordinator received on-going training through daily interaction 
with the main researcher of this study via Skype. Training included information 
sessions with the trainer over IPV, HIV the IPV-HIV link, information on HIV 
services offered by the NGO (presented by the NGO Director), philosophical 
discussions of ways to offer first-line support according to the WHO DV research 
recommendation, and extensive training on the study protocol including item by 
item reviews, discussions of translations, as well as role-play exercises and the 
shadowing of actual phone calls by the main researcher via Skype. All staff 
received a training manual, which was used alongside a power point presentation 
and handouts for training material. 
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Prior to the implementation of the study, the main researcher and chair of 
the dissertation committee visited site locations. The main researcher visited site 
locations during the design stage of study development. First, areas in Gauteng 
province were visited to gain an understanding of the areas where mobile HCT is 
offered. The researcher also visited the study site at the NGO office in Cape 
Town to meet staff that assisted with HCT administration and understand the 
layout of the building for potential study implementation. Additionally, the chair of 
the dissertation committee conducted an onsite visit during the study’s 
administration to address any questions staff may have had and to ensure that 
the facilities were conducive to collecting research data via telephone interviews.  
 
3.10 Ethical considerations 
This study was reviewed by the University of Louisville’s IRB ethics 
committee and has been registered with National Health Research Ethics 
Council also known as the South African Department of Health (SANCTR), per 
the National Health Act, 2003 (Act No. 61 of 2003) and via the South Africa 
Human Research Electronic Application System. Finally, the creation and 
implementation of this study followed the WHO (2013) guidelines for Ethical 
Research on Domestic Violence Against Women and was informed by Jewkes, 
Watts, Abrahams, Penn-Kekana, & Garcia-Moreno (2000) article Ethical and 




Documents were translated into each listed language by translators who 
had their credentials reviewed by University of Louisville’s IRB committee. 
Documents were translated from English to each language and then back-
translated to confirm meaning. Translations were then reviewed with the 
research team to check for colloquial accuracy.  
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More research is needed on effective procedures with women who both 
are HIV+ and experiencing intimate partner violence (IPV); the need is especially 
critical in low resource countries such as South Africa where HIV rates and 
gender based violence are pervasive and those affected by the joint 
phenomenon suffer immensely. This study was designed to address the gaps of 
knowledge surrounding risk assessment and safety planning with women in 
South Africa who have recently tested HIV+ (in mobile HCT) and report IPV. The 
purpose of the study was to develop a valid and reliable psychometric instrument 
that assesses HIV-IPV-specific risk and determine the safety, effectiveness, 
feasibility, acceptability and participant satisfaction of a safety planning protocol 
that focuses on HIV-IPV-related danger levels. In addition to the main purpose of 
this study, a secondary aim was to also gain unknown knowledge regarding 
trends on perceptions and behaviors of those recently mobile-tested who have 
both HIV and IPV; all of which may be used to inform future research and 
practice that attends to the HIV-IPV intersection.  
This study aimed to refine program components, retain all participants, 
avoid contamination, and test effectiveness of the intervention with participants’ 
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perceived safety and linkage to care. To improve the instrumentation and 
program components towards more cultural sensitivity, the study was 
administered in two phases. Phase I employed focus interviews to elicit feedback 
on instrument verbiage, with changes made to documents prior to the full 
protocol being administered. Phase II administered the HIV IPV Risk & Safety 
(HIRS) protocol as a pre post design using randomized allocation into either a 
Standard of Care (SOC) group or one of two Experimental groups (together listed 
as combined Experimental group) which sought to test differences associated 
with protocol dosage level 1 and Dosage level 2). 
Descriptive statistics, including frequencies and indicators of central 
distributions, were run to conduct data screening. Data were then inspected for 
outliers and missingness and subsequently cleaned. Intention-to-treat analysis 
was used for analytical procedures, and analyses over main research questions 
(hypothesis testing) reported two-tailed p values for significance. 
 
4.1 Demographics 
A total of 446 people were recruited to participate in the program. 
Successful recruitment was defined as participants signing a consent form and 
having a reachable number. Of those 446, 191 did not report IPV sufficient for 
eligibility, 255 reported IPV and participated in pre-test data collection, and 249 of 
those were retained for post-test data collection. 99.97% were reachable at post-
test and 97.65% were retained in the study by post-test.  
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255 females participated in the study conducted between the months of 
July-December 1, 2015 (with Phase I conducted in June, 2015). After data 
cleaning and the removal of outliers, 248 participants were included in analysis. 
Of the 248 participants, 97 (39.1%) were considered past testers (testing HIV 
positive previously (ranging from year 1996-2015), and the remainder (151; 
60.9%) were newly diagnosed as HIV positive during mobile HCT. All participants 
had an HIV test (regardless of their tester type (past tester versus newly 
diagnosed) within the time range of July 7, 2015- October 29, 2015. Of those 
past testers, most reported (qualitatively) having accessed mobile HCT services 
to gain their CD4 cell count. Of the 248, 82 (33.1%) were in the standard of care 
group, and 166 were in the experimental group. Of the 166 in the experimental 
group, 83 (33.5%) received dosage level 1, and 83 (33.5%) received dosage 
level 2. Participants all resided in Gauteng province, South Africa, identified as 
black South African, were currently in a relationship, and were of the age range 
18-65 with 33 being the mean age (M= 33.26, SD= 9.89, Mdn= 32) but ages 25, 
26, and 27 accounted for the highest percentages of the sample (18.6%) and age 
25 had the highest frequency (6.9%). Chosen languages for study administration 
were: isiZulu: 176 (69%); isiXhosa: 37 (14.5%); Sesotho: 26 (10.2%); English: 14 
(5.5%) [With 2 respondents having language unknown due to staff failure to 
record these (.8%)]. No other demographic information was collected.  
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Figure 4.1 Participant Age
 
Figure 4.1. Distribution graph for total sample after outliers were removed (n=248). 
 
4.2 Data Cleaning 
A total of 7 outliers were removed from general analyses with one 
removed from the Standard of Care group, 1 from the Experimental Dosage level 
1 group, and 5 from the Experimental Dosage level 2 group. Reasons for 
removal were: cases with uncorrectable entry error from research staff (2 
participants), and cases identified on multiple whisker plots as having issues 
such as exceptional length of time from referral to post-test or exceptional length 
of time from pre-test to post-test (5 participants). For questions relating only to 
post-test (linkage to care, safety, satisfaction) 3 cases were removed from the 
Standard of Care because they were contaminators (reported having accessed 
IPV services elsewhere in the last month, possibly from the first-line support 
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referral). However, these three contaminating cases remained in the analysis for 
the item If you notified your partner of your status, did you experience any type of 
violence as a result? These were included in analyses for this item to consider 
how results of HIV-IPV-specific safety planning may differ from general IPV 
safety planning. Additionally, one person from the Standard of Care group was 
removed only for linkage to care comparisons due to a data entry error that could 
not be reconciled (linkage date was documented as one month before HIV 
testing date). 
Six participants were lost to attrition, and thus were removed for any 
pre/post analysis but were included in pre-test only and descriptive statistics. 
Two of those lost to attrition were unreachable for post-tests and the remaining 
four opted to discontinue study participation. Information on those who dropped 
out was: most were past testers, all were younger than the mean age with a 
range of 24-31 (M= 28.2) and all were in Experimental groups, with most in the 
Dosage level 2 group (67%) and remainder in Dosage Level 1 group. The mean 
Danger Indicator raw score for this group was 8 (M=8, with a range of 7-12) and 
most scored exactly a 7. Of those in Dosage Level 2 group, none received the 
follow-up safety plan, and only 3 of the 6 in the total group received the initial 
safety plan (3 reported it was not needed) and therefore would have only 
received the Danger Indicator score as their intervention. 
Any analyses over post-test data only or analyses comparing pre-test with 
post-test results did not include those 6 participants who were lost to follow-up. 
Therefore, for these analyses, 242 total participants were included with 82 in the 
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Standard of Care group, 81 in Dosage Level 1, and 79 in Dosage Level 2. The 
consort diagram below demonstrates these numbers. 
Figure 4.2 Consort Diagram
Figure 4.2. Consort diagram depicts amount of individuals agreeing to participant and the final 
numbers of those included in analyses. 
 
4.3 Reliability and Validity Testing of Instruments 
Danger Indicator 
The psychometric instrument, the Danger Indicator (DI), was developed 
and tested for validity and reliability. This instrument was tested in pre-test scores 
of 255 participants. The DI consists of the following subscales: 6 items from the 
revised Non-violent control scale, 10 items from the revised Conflict Tactics 
Scale 2 (physical and sexual violence items), 8 items from the revised Violence 
Vulnerability scale, 10 items from the HIV IPV Risk & Safety scale (HIRS), and 
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seen as IPV screening, was established by answering affirmative to ≥2 items on 
the Non-violent control scale and/or ≥1 items on the 10-item revised Conflict 
Tactics scale (physical and sexual violence items) (Straus et al., 1996). Each of 
the subscales of the DI helps measure a component of a global indicator of 
danger.  
Through reliability and validity testing and factor analysis, this DI was 
found to be an appropriate tool for measuring the construct of partner violence 
and particularly physical assault. An Exploratory Factor Analysis (EFA) using a 
Principle Axis Factoring method of the 45 items in the DI was conducted on the 
sample (N=248) (with outliers removed).  
The Danger Indicator is comprised of sub-scales, which were theoretically 
constructed to measure different sub-components of a wider domain. Because 
this study relied on the use of these scales for a global score, a factor analysis 
was done to see if the overall score was sufficiently unidimensional to justify 
using the total score as an indicator of danger. In order to do this, Principle Axis 
Factoring was used in exploratory factor analysis based on one factor to be 
extracted. One factor was extracted, requiring 4 iterations and explained 19% of 
the variance. 
The item with the highest loading was the item “my body was hurt.” This 
item may be seen as describing the core focus of the DI scale. Cronbach’s alpha 
of this scale was .882, which is quite high and indicates reliability sufficient to 
distinguish at the individual level various degrees of safety and danger. However, 
the validity for this scale is less than ideal. The mean of corrected item total 
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correlation was .364. Hence, the validity of the scale shows some limitation and 
future research should refine this instrument.  
 
HIV IPV Risk and Safety (HIRS) scale 
Cronbach alpha’s for the HIRS (10 items) was .824 with a Corrected Item-
Total Correlation mean of .412. Thus, this scale has good reliability and 
approaching sufficient validity. The full scale is listed Appendix D. 
 
4.4 Conceptual Definitions 
To measure Satisfaction, 3 items were used as separate indicators of 
satisfaction: 1. Overall, the information you received about relationships was 
helpful, 2. It was helpful to be asked about the difficulties in your relationship? 
And 3. You regret talking about the difficulties in your relationship? These items 
were created based on the Appollis et al. (2015) systematic review on the ethics 
of conducting research on sensitive research topics (determining risk-benefit 
ratio) and reflect two of the three general categories they used to measure the 
risks, harms and benefits of research about sensitive topics (risks are under the 
Feasibility component, and another harm question is under the Acceptability 
component). The item It was uncomfortable to be asked about the difficulties in 
my relationship could fall into this category as well (under harm) but was 
analyzed within the Acceptability component because discomfort does not 
preclude satisfaction (i.e. someone could experience discomfort while still being 
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satisfied with a product overall, and some discomfort was expected given that the 
topic is inherently uncomfortable). 
 
Feasibility 
The Feasibility component of this study addressed four components of 
domains, with items within each domain being analyzed separately for various 
reasons.  
Domain One measured the time it took to reach participants (number of 
attempts) and included the number of attempts for the pre-test and post-test for 
both groups and the follow-up safety plan for dosage level 2 only. Mean attempts 
were not appropriate for comparison considering that Dosage level 2 had an 
extra contact. 
Domain Two measured the length of intervention administration and 
considered the time to administer the pre-test, initial and follow-up safety plans 
as well as the post-test.  
Domain 3 focused on risks that may prevent implementation and included 
the item Did you use the safety plan? and compared the total number of 
strategies employed (see strategies under the full post-test instrument in 
Appendix I).  Domain 4 measured four different questions related to risk: 1. If you 
notified your partner of your HIV status, did you experience any type of violence 
as a result (mental, physical or sexual)?, 2. Would it be safe for us to contact you 
by phone at one month, two months or three months (yes to any= safe to contact 
again), 3. Talking about the difficulties in your relationship placed you at greater 
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danger? And 4. The services you received placed you at greater danger? All 
were analyzed separately because they measured different aspects of risk, 
mainly falling into the two categories of perceived risk or actual violence.  
For example, the item If you notified your partner of your status, did you 
experience any type of violence as a result measures a behavior or actual 
violence that occurred. Whereas, the other items measured perception of risk 
and varying risk areas. The item Would it be safe for us to contact you again in 
one month, two months or three months asks the respondent to predict what 
would be safe for them in the future, and the items Talking about the difficulties in 
your relationship placed you at greater danger and The services you received 
placed you at greater danger ask the respondent to if they perceived the 
assistance received to have affected their safety levels in general. 
When adding an IPV component to a protocol, it is essential to assess for 
any risks involved in implementation, as this information could be crucial to the 
safety of participants of future studies (Appollis et al., 2015). Reports of risk or 
harm may be a better indicator of overall participant safety because questions 
that measure subjective experience of safety can actually be measuring an 
increase in thoughts about the abuse rather than actual safety, especially among 
those with post-traumatic stress disorder (Cattaneo et al. 2007). However, in 
general, when individuals have a heightened perception that they are at risk, they 
are more likely to adopt protective behaviors to reduce the perceived risk, and 
this may be true for IPV victims as well. Harding & Helweg-Larsen (2008) found 
that “perceptions of risk were associated with intended relationship decisions,” so 
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that women who perceived they were in more danger “exhibited greater intention 
to terminate” the relationship (pg. 9). Hence, heightened perception of risk could 
be indicative of changes in altered subjective norms about abuse or the person’s 
contemplation of the acceptability of abuse in their relationship. 
 
Acceptability  
4 items were analyzed separately as indicators of Acceptability of this 
study and fell into the two categories of acceptability of the safety plan and any 
overall discomfort experienced with the protocol in total (all participants received 
the latter) 1. Did you find the safety plan helpful?; 2. Would you recommend the 
safety plan for a friend?; and 3. Did the respondent use any type of safety 
strategy (not an item directly asked but created from the number of respondents 
reporting use of at least one safety strategy) and 4. It was uncomfortable for you 
to discuss the difficulties in your relationship? The final question was included per 
the Appollis et al. (2015) Systematic review over questions to determine the risk-
benefit ratio of research on relationship violence. Although higher correlation was 
expected between the Acceptability responses in the first category, reliability 
testing revealed there was low correlation among them. The second category 
was included to compare if those who received higher dosage levels experienced 
more discomfort. Crosstabs were run to investigate relationships between the 
items, using the item did you use the safety plan as a primary indicator. This was 
done to try and explain the phenomenon of behavior related to these items. For 
example, some respondents reported that although they did not use a safety 
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strategy they would still recommend a safety plan for a friend. This example 
suggests that just because someone did not use the safety plan they would still 
find it acceptable for someone else. This could be indicative that the respondent 
finds the safety plan acceptable, in general, and that maybe there is another 
reason they personally did not find it helpful for their situation (i.e. their 
perception from the onset was that they did not need a safety plan). Hence, by 
analyzing these items separately and investigating comparisons between them, it 
becomes clear that these items measure different phenomenon or aspects of 
acceptability. The information gleaned from comparing these items will help 
clarify what components of the safety plan were acceptable compared to others.  
Further, because the number of participants who reported poor 
acceptability was low in frequency (only 15/129 reported the safety plan was not 
helpful), acceptability items were analyzed separately to assist with detecting 
differences that would have been more difficult when comparing a score of 
multiple items at once. Additionally, items were compared between dosage levels 
for the same rationale (to detect differences more accurately given the small 
number of individuals who found the protocol not helpful).  
 
4.5 Phase I Findings 
As previously stated, the purpose of Phase I of this study was to elicit 
feedback from participants over the appropriateness of the study instruments so 
that changes could be made prior to implementation. 10 potential participants 
were recruited for Phase I of the study, but only 40% of those were reachable 
	   104 
and participated. Questions asked in Phase I focus interviews were intended to 
1. Clarify meaning of language and vernacular appropriateness, 2. Elicit 
examples to confirm shared meaning of language, and 3. Probe for information 
for enhanced safety planning. None of the four participants interviewed were 
screened for IPV nor asked if they were currently in a relationship, and their 
feedback cannot be assumed to be representative of the population served by 
these instruments. However, it did provide some insight into cultural 
appropriateness and some changes were made to the instruments as a result of 
these interviews.  
Focus interviews did encounter some difficulties that appeared to impede 
the quality of the interviews. Because the research room on-site at the NGO had 
not yet been set up (phones, computers, etc), these interviews had to be held via 
Skype (telephone only). Further, the full research team had not yet been hired, 
and so the interviews were held only in English. The Skype medium posed the 
problems of poor audio quality and the likely confusion of a non-local number 
listing (given the international Skype account used). Further, the Research 
Trainer was responsible for conducting Phase I, and she had an American 
accent that was likely a hindrance, given perceived or actual cultural differences 
assumed by participants due to the observed foreign accent and/or actual 
difficulty understanding one another’s dialect/accent. 
The decision to “confirm” a phrase or word was operationalized as at least 
half of respondents will agree with the language, or no more than 1 will disagree 
(the latter being important in cases where questions were not asked or answered 
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of all participants). If the responses did not meet these criteria, the phrase or 
word was changed. 20 Phrases were confirmed for use through the interviews; 1 
phrase (“partner”) was confirmed but with the notation that it is important to tell 
each participant that the questions reference romantic partners (connecting the 
use of the term “partner” to the first question in Phase II “are you in a 
relationship,” which was not asked of Phase I participants); and 1 phrase was 
changed from “follow-up” to “contact.” 
After these changes to the original instrument, translations were checked 
for accuracy and cultural appropriateness among the research team, who were 
each fluent in English as well as at least one of the other three languages. Minor 
changes were made to improve phrasing to fit better with the original English 
version of the instrument as well as the dialect. This language check was done 
as an effort to increase the research team’s acuity in administering the 
instruments’ reliably and was an important stage in refining the instruments for 
culture appropriateness, given that the focus interviews were only held in 
English. 
 
4.6 Phase II Findings  
Study Aims 
Feasibility  
Aim 1 of Phase II of the study focused on determining the feasibility of the 
protocol with successful implementation operationalized by 75% of eligible 
participants receiving the intervention, and 75% of participants retained at the 
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one month follow-up. 98% received the intervention as assigned, 61.9% reported 
using the safety plan, and 97.65% were retained at the one-month follow-up. 
 
Acceptability 
Aim 2 of Phase II of the study focused on determining the acceptability of 
the protocol as operationalized by 80% of participants reporting a positive rating 
of the intervention, with attention to any variation between dosage levels and 
between combined experimental groups and the Standard of Care group. The 
first two items listed in Table 4.5 were used to determine positive rating. Both 
scores far exceeded the 80% mark, demonstrating the participants 
overwhelmingly reported a positive rating of the protocol. For the item Overall, 
the information you received was helpful, 92.47% of the total sample responded 
yes. 92.41% of those in the Standard of Care group responded yes to this item, 
and 92.5% of participants in the combined Experimental group responded yes. 
For the item It was helpful to be asked about difficulties in your relationship?, 
97.07% of the total sample responded yes. 96.2% of those in the Standard of 
Care group responded yes, and 97.5% of those in the combined Experimental 




Aim 3 of Phase II focused on avoiding contamination as operationalized 
by fewer than 10% of participants in the Standard of Care group report receiving 
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IPV services from another source between pre and post data collection periods. 
The item used to determine contamination of the Standard of Care group was In 
the last month, have you gotten help for relationship abuse from any of the 
following: police, domestic violence hotline or program, counselor, pastor/spiritual 
leader or any where else? Only 4% of the Standard of Care group (3 participants) 
responded yes to this question. Therefore, it can be stated that contamination 
was successfully avoided. However, these 3 contaminating cases were removed 
from analyses in the situations listed above under data cleaning. 
 
4.7 Primary Research Question 1A 
What is the difference in participant risk and safety scores between the combined 
Experimental groups and the Standard of Care group?  
Hypothesis: Participants in the combined Experimental group (receiving any level 
of the intervention) will have improved scores on the HIV IPV Risk and Safety 
scale (HIRS) as compared to participants receiving only the standard of care.  
Prior to analyzing the difference in participant safety scores, scores for the 
group’s pre-est were compared for equivalency in order to determine if the two 
groups were from the same population. An independent sample t-test compared 
the pre-test scores (HIRS with weighted scoring where all count as one point 
except item 10 which an affirmative response counts as 3 points) and results 
were non-significant (t(1,237)= -.540; p= .589), indicating the two groups were 
sufficiently comparable at baseline to proceed with pre-post group difference 
analysis. The pre-test mean for the Standard of Care group was slightly lower 
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than the mean for the combined Experimental group (SOC= M= 2.29, SD= 2.74, 
SE= .31; combined Exp.= M= 2.51, SD= 2.97, SE= .24). Only participants who 
remained in the study for pre and post-tests were included in this analysis. 
Table 4.1 HIRS Pre/Post & Mean Difference Scores I 
Group HIRS Pre-test HIRS Post-test Mean Difference (post-test – pre-test) 
Standard of Care 
M= 2.29 M= 2.17  M= -.13 
 SD= 2.74 SD= 2.07  SD= 3.05 
SEM= .31 SEM= .23 SEM= .34 
Combined Exp. 
 M= 2.51 M= 2.84 M=  .33 
SD= 2.97  SD= 2.17  SD= 3.07 
SEM= .24 SME= .17 SEM= .24 
Note. Table 4.1 depicts HIRS pre-test, post-test and mean difference scores between the 
Standard of Care and the combined Experimental group (N=239). 
 
 
The mean pre-post difference score for the Standard of Care group was 
very similar to the mean pre-post differences score for the combined 
Experimental group (SOC= M= -.13, SD= 3.05, SEM= .34; combined Exp.= M= 
.33, SD= 3.07, SEM= .24). An independent sample t-test showed the pre-post 
difference scores between the Standard of Care and the combined Experimental 
group were non-significant (t(1, 237)= -1.09; p= .278). These results challenge 
the hypothesis that those in the Experimental groups would have a reduced 
mean score on the post-test compared to the Standard of Care group. 
 
4.8 Primary Research Question 1B 
What is the difference in participant risk and safety scores between dosage 
levels of those who receive 1. danger indicator score + initial safety plan, and 2. 
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danger indicator score + initial safety plan + follow-up safety plan? Analysis was 
done on pre post difference scores. 
Hypothesis: Participants with the highest level of dosage will have the highest  
amount of increased perceived safety as measured by the HIRS. 
Table 4.2 HIRS Pre/Post & Mean Difference Scores II 
Group HIRS Pre-test HIRS Post-test Mean Difference (post-test – pre-test) 
Dosage level 1 
M= 2.48 M= 2.84  M= .33 
 SD= 3.02 SD= 2.25  SD= 2.92 
SEM= .34 SEM= .25 SEM= .32 
Dosage level 2 
 M= 2.48 M= 2.84 M=  .33 
SD= 2.87  SD= 2.1  SD= 3.23 
SEM= .33 SME= .24 SEM= .36 
Note. Table 4.2 depicts HIRS pre-test, post-test and mean difference scores between dosage 
levels (N=160) 
 
 An independent sample t-test showed the mean pre-post difference 
scores between the experimental groups of Dosage level 1 and Dosage level 2 
were non-significant (t(1, 158)= .009; p= .993). The two groups had almost 
identical mean difference scores (D1= M= .33, SD= 2.92, SE= .33; D2= M= .33, 
SD= 3.23, SE= .36). These results challenge the hypothesis that participants with 
the highest dosage level will have the highest increase in perceived safety score 
and suggest that the extra dosage has no effect on participant perceived safety. 
Only participants who remained in the study for pre and post-tests were included 
in this analysis. 
  
4.9 Primary Research Question 2 
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What is the difference in participant linkage success between the combined 
Experimental groups and the Standard of Care group? Successful linkage (within 
30 days) and number of days linked were used as indicators. 
Hypothesis: Participants in the combined Experimental groups (receiving any 
level of the intervention) will have increased rates of linkage (more links at a 
faster rate). 
Table 4.3 Linkage to Care  
Group Link to care by post-test Link to care ≤30 days 
Total 109/238 (45.8%) 99/238 (41.6%) 
Standard of Care 32/78 (41.03%) 30/78 (38.5%) 
Combined Experimental 
group 77/160 (48.13%) 69/160 (43.13%) 
Note. Table 4.3 depicts linkage to care comparisons between the Standard of Care and the 
combined Experimental group (N=238). 
 
Figure 4.3 Link to Care by Post-test 
 
Figure 4.3 Percentage of individuals from total sample linked to care by post-test (N=238). 
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Figure 4.4 Link to Care within 30 Days 
 
Figure 4.4 Percentage of individuals linked to care within 30 Days (N= 238). 
 
 
A higher percentage of individuals linked to care, within 30 days, for the 
combined Experimental group compared to the Standard of Care group (SOC= 
38.5%; combined Exp.= 43.13%). Several individuals in each group linked to 
care after the 30 day cut-off (SOC= 2 linked >30days; combined Exp.= 8 linked 
>30days). 
Pearson’s chi-square test was performed to examine the relation between 
receiving the intervention and having a higher rate of linkage to care. Although a 
higher percentage of individuals in the experimental group linked to care, a chi-
square test showed the difference in linkage success (link ≤30 days) between the 
Standard of Care group and the combined Experimental group was non-
significant (X2(1) = .471, p=.493). And the difference remained non-significant 
when comparing group differences in linkage by post-test (X2(1) = 1.07, p=.302). It 
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took slightly fewer days to link for the Standard of Care group compared to the 
combined Experimental group (SOC= M= 11.88, SD=11.45, SEM= 2.02; 
combined Exp.= M= 13.43, SD= 13.1, SEM= 1.5), and the difference was non-
significant (t(1, 107)= -.584; p= .560). The overall mean rate for linkage to care 
by post-test for the entire sample was 13.11 with 50% linking by 11 days 
(M=13.11, SD= 12.62, SEM= 1.20) and only 9% linking after 30 days. 
These results challenge the hypothesis that those in the combined 
Experimental group would significantly link at a faster rate. 
Table 4.4 Linkage to Care by Age Group 
Age group Total sample Standard of Care  combined Exp. group 
≤23 years of age 
14/39 (35.9%)  5/14 (35.7%) 9/25 (36%)  
2>30 days= 16/39 
(41.03%) 
0>30 days= 5/14 
(35.7%) 
2>30 days= 11/25 
total (44%) 
>23 and ≤32 years of 
age  
37/83 (44.6%) 14/30 (46.66%) 
 
2>30 days= 16/30 
(53.33%) 
23/53 (43.4%) 
6>30 days= 43/83 
(51.81%) 
4>30 days= 27/53 
(51%) 
33-43 years of age 
29/75 (38.66%) 4/18 (22.22%) 25/57 (43.86%) 
2>30 days= 31/75 
(41.33%) 
0>30 days= 4/18 
(22.22%) 
2>30 days= 27/57 
(47.4%) 
≥44 years of age 19/41 (46.34%) 7/16 (43.8%) 12/25 (48%) 
Note: Table 4.4 shows linkage to care by age group & compares the Standard of Care to the 
combined Experimental group (N= 238). 
 
 Because literature on linkage to care shows rates vary for different age 
groups, analyses were run to inspect variations in linkage rates among different 
age groups. Chi square tests were conducted to compare differences between 
the combined Experimental group and the Standard of Care among the different 
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age groups for linkage to care within 30 days and by post-test. For those aged 
18-23, link within 30 days, Pearson’s Chi square showed there was no significant 
difference (X2(1) = .043, p=.835), and for the same age group (18-23) link by post-
test, Pearson’s Chi square also found no significant difference (X2(1) = .255, 
p=.614). For those aged 24-32, link within 30 days, Pearson’s Chi square found 
no significant difference (X2(1) = .083, p=.773), and for the same age group (24-
32) link by post-test, Pearson’s Chi square found no significant difference (X2(1) = 
.044, p=.834). For those aged 33-43, link within 30 days, Pearson’s Chi square 
found no significant difference (X2(1) = 2.70, p=.100), and for the same age group 
(33-43), link by post-test, Pearson’s Chi square showed the difference was 
trending towards significant (X2(1) = 3.57, p=.059). For those aged 44+, link within 
30 days, Pearson’s Chi square showed there was no significant difference (X2(1) = 
.007, p=.935), and for those of the same age group (44+) link by post-test, 
Pearson’s Chi square showed there was no significant difference (X2(1) = .071, 
p=.790). 
 
4.10 Secondary Research Question 3A 
What is the difference in participant satisfaction scores between the combined 
Experimental groups and the Standard of Care group? 
Hypothesis: Participants in the combined Experimental group (receiving any level 
of the intervention) will have higher satisfaction scores as compared to 
participants receiving only the Standard of Care.  
Table 4.5 Satisfaction Responses I 






It was helpful to be 
asked about 
difficulties in your 
relationship? 
You regret talking 
about the difficulties in 
your relationship? 
Standard of Care 
(79) 
Yes= 73  
(92.41%) 
Yes= 76  
(96.2%) 





Yes= 148  
(92.5%) 
Yes= 156  
(97.5%) 





was helpful= 221 
(92.47%) 
Yes, it was helpful to 
be asked about 
relationship= 232 
(97.07%) 




Note: Table 4.5 shows satisfaction responses between the Standard of Care group and the 
combined Experimental group (N=239). 
 
Most individuals (about 93%) reported that the overall services they 
received were helpful. Responses were almost equal for the two groups, and a 
Pearson’s Chi square test showed the difference was non-significant (X2(1) = 
.001, p=.979). 
The vast majority of people (about 97%) reported it was helpful to be 
asked about the difficulties in their relationship. A higher percentage of people in 
the combined Experimental group reported it was helpful, but Fisher’s Exact test 
showed the difference was non-significant (X2(1) = .313, p=. 576). 
The vast majority of people (almost 96%) in both groups reported they did 
not regret talking about the difficulties in their relationship, and a Fisher’s Exact 
test showed the difference between the two groups was non-significant (X2(1) = 
.174, p=1.00). 
 
4.11 Secondary Research Question 3B 
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What is the difference in participant satisfaction, feasibility and acceptability 
scores between dosage levels of those who receive 1. danger indicator + initial 
safety plan, and 2. danger indicator + initial safety plan + follow-up safety plan?  
Hypothesis: The possible impact of higher dosage intervention on satisfaction, 
acceptability and feasibility is uncertain.   
 
Satisfaction 






It was helpful to be 
asked about 
difficulties in your 
relationship? 
You regret talking 
about the difficulties 
in your relationship? 
Dosage level 1 (81) Yes= 74 (91.4%) Yes= 79 (97.5%) No= 76 (93.8%) 
Dosage level 2 (79) Yes=74 (93.7%) Yes= 77 (97.5%) No= 76 (96.2%) 
Note: Table 4.6 shows satisfaction responses between Dosage Levels (N=160). 
  
The majority of participants found the information they received to be 
helpful, but more participants reported the information was helpful in Dosage 
level two group. However, a Chi square test showed the difference was non-
significant (X2(1) = .308, p=.579). 
 The vast majority of participants from both groups reported that it was 
helpful to be asked about the difficulties in their relationship, with an equal 
amount giving this positive rating from each group; thus, Fisher’s exact Test 
found the difference was non-significant (X2(1) = .001, p=1.00). 
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 While most participants from both groups reported they did not regret 
talking about the difficulties in their relationship, more individuals in Dosage level 
two reported they had less regret. Fisher’s Exact Test showed the difference was 
non-significant (X2(1) = .475, p=.720). 
 
Acceptability 
Table 4.7 Acceptability Responses 
Group Was safety plan helpful? 
Would you 
recommend it for a 
friend? 
Did you use any of 
the safety 
strategies? 
Dosage level 1  
(81) 




Yes= 77  
(95%)   
No= 4 
(4.9%) 








No= 15  
(19%) 
Yes= 79  
(100%)  
No= 0  
(0%) 
Yes= 65  
(82.3%) 
No= 14   
(17.7%) 
Note: Table 4.7 shows acceptability responses between Dosage Levels (N=160). 
 
There was a slightly higher percentage of people in the Dosage level 2 
group who reported the safety plan was helpful, but Pearson’s Chi square 
showed the difference was non-significant (X2(1) = .100, p=.752). A higher 
percentage of those in Dosage level 2 reported they would recommend the 
safety plan for a friend, but Fisher’s exact test showed the difference was non-
significant (X2(1) = 4.00, p=.120). A higher percentage of those in Dosage level 2 
also reported having used at least one safety strategy, but Fisher’s exact test 
showed the difference was non-significant (X2(1) = .273, p=.690). 
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For the combined experimental group, of those who used at least one 
safety strategy, 114/129 found the safety plan overall helpful (88.4%), and 28/31 
(90.32%) who reported having not used any safety strategies, still found the 
safety plan overall helpful. Chi square showed the difference of the use of the 
safety plan between those who used strategies and did not use strategies was 
significant (X2(1) = 29.17, p=.000). Fisher’s Exact Test showed that significantly 
more people who used at least one safety strategy found the safety plan* to be 
helpful than those who did not use a safety strategy (X2(1) = 8.13, p=.023). 
 Of the 129 who used at least one safety strategy, 127/129 (98.5%) would 
recommend it for a friend. Of those who used at least one safety strategy, 
126/129 (97.7%) reported no violence was experienced if they notified their 
partner of their serostatus. Of those using a safety strategy who did experience 
violence upon partner notification of serostatus, 2 were in Dosage level 1 group, 
and 1 was in Dosage level 2 group. Of those employing 2 or more safety 
strategies, 127/129 (98.5%) reported no violence experienced if they notified 
their partner of their serostatus. Of those 2 reporting violence, both were in 
Dosage level 1, and 0 were in Dosage level 2. Of those who used 3 or more 
strategies, only 1 person reported violence as a result of serostatus notification, 
and this respondent reported experiencing violence despite having used 7 safety 
strategies. Hence, this suggests that with the use of each additional safety 
strategy, coupled with the extra dosage level, participants fair better upon partner 
notification (experienced less violence as a result). 
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For all participants, it was trending towards significant that for those who 
used at least one safety strategy more linked to care by post-test, one-sided (X2(1) 
= 2.46, p=.085). Of those who employed at least one safety strategy, it was 
trending towards significant that more people linked to care (by post-test) in 
Dosage level 1 (38/64) (59.4%) compared to Dosage level 2 (28/65) (43.1%) 
(X2(1) = 3.43, p=.064). Of those who employed 2 or more safety strategies, 
significantly more people linked to care (by post-test) in Dosage level 1 (25/40) 
(62.5%) compared to Dosage level 2 (16/42) (38.1%) (X2(1) = 4.88, p=.046). This 
suggests that with the use of any safety strategy coupled with a higher dosage 
level of safety planning, linkage to care may be delayed. 
 
Feasibility 











Domain 4: Risk 
Dosage 




















Violence upon partner notification:  
No= 77/81 (95.1%) 
Safe to contact again:  
Yes= 78/81 (96.3%) 
Talking placed you in more danger: 
No= 78/81 (96.3%) 
Services placed you in more danger: 
No= 77/81 (95.1%) 
Dosage 





























Violence upon partner notification:  
No= 78/79 (98.7%) 
Safe to contact again:  
Yes= 76/79 (96.2%) 
Talking placed you in more danger: 
No= 79/79 (100%) 
Services placed you in more danger: 
No= 77/79 (97.5%) 
Note: Table 4.8 shows feasibility responses between Dosage Levels (N=160). 
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Domain 1: Time to Reach  
When comparing attempts to reach for post-test only, it took slightly fewer 
attempts to reach those in Dosage level 1 compared to Dosage level 2, but an 
Independent sample t-test showed the difference was non-significant t(1(158) (-
.473), p= .637). 
 
Domain 2: Time to administer  
It took about 2 minutes longer to administer the intervention to those in 
Dosage Level 2, excluding the follow-up safety plan, compared to Dosage Level 
One (D1= M= 24.75, SD= 6.67, SEM= .74; D2= M= 26.81, SD= 7.01, SEM= .79). 
With the follow-up safety plan included, Dosage level 2 had a mean of 31.51 
minutes (M= 31.51, SD= 7.63, SEM= .87), and the follow-up safety plan alone 
took a mean of 4.81 minutes (M= 4.81, SD= 2.02, SEM= .229). 
 
Domain 3: Use of safety techniques 
A similar number of participants in Dosage level 1 and Dosage level 2 
reported having used the safety plan (see table 4.8), and Pearson’s Chi square 
test revealed the difference was non-significant (X2(1) = .100, p=.844).  
Participants in Dosage level 2 reported using more safety strategies than 
those in Dosage level 1 (see table 4.8), but an Independent sample t-test showed 
the difference was non-significant (t(1(158) (-1.04), p= .300). However, a higher 
percentage of those in Dosage level 2 group used slightly more strategies than 
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those in dosage level 1 group (D1: M=1.88, SD= 1.76, SEM= .20; D2: M= 2.18, 
SD= 1.9, SEM= .21), suggesting that the extra dosage level (follow-up safety 
plan) could have contributed to the increased use of strategies.  
The use of any of the consultation strategy was merged into one 
Consultation category. Of all the consultation categories (consulted with medical 
professional, counselor, clergy, IPV provider, family or friend, or legal), 128 
(80%) participants from the combined Experimental group reported having used 
a consultation strategy. The amount of people who used any consultation 
strategy was significantly higher among the combined Experimental group (80%) 
compared to the Standard of Care group (4%) (X2(1) = 127.26, p=.000). 
Additionally, a higher percentage of people in Dosage level 2 group (65/79 or 
82.28%) used at least one consultation strategy than those in Dosage level 1 
group (63/77 or 77.78%).  
 
Figure 4.5 Number of Safety Strategies Used 
 
Figure 4.5 shows the number of safety strategies used by those in the combined Experimental 
group (N= 160). 
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About 19% of the participants reported using no safety strategies at all 
(31/160), and eight people (5%) reported using the Fighting Back technique 
which was counter to that recommended in the safety plan (safety plan informed 
participants that fighting back techniques have been shown to increase violence). 
The complexity of this strategy will be discussed in Chapter Five, as the item 
included several strategies within one per domain categorization by Parker & 
Gielen (2014). 1/8 of those who used this strategy only used this strategy alone, 
and this was coded as a “no” for use of any strategy. Most of the participants who 
used a safety plan used only 1 strategy (29.4%). However, 19.4% used 2 
strategies, 14.4% used 3 strategies, 5.6% used 4 strategies, 5.6% used 5 
strategies, 3% used 6 strategies, 2.5% used 7 strategies, and .6% used 8 
strategies.  
 
Figure 4.6 Frequency of Safety Strategies Used  
 
Figure 4.6 shows the frequency of safety strategies used, by those who used any strategy at all, 
within the combined Experimental group (N= 130). 
 
 
	   122 
Table 4.9 Frequency of Safety Strategies Used 





Care (% out 
of those who 
used strategy) 
% Who Did not 
use strategy but 
linked to care (% 
out of those who did 
not use the strategy) 


























































































Note: Table 4.9 shows the frequency of safety strategies used by those in the combined 
Experimental group and the percentage of individuals within the combined Experimental group 
who used a strategy and linked to care as well as those who did not use a strategy but still linked 
to care (N=160). 
 
As noted above, a trend was observed that more participants using at 
least one safety strategy linked to care. The amount of people in the combined 
Experimental group who used a consultation strategy and linked to care (66/77 or 
85.71%) was higher than those who linked to care but did not use a consultation 
strategy (11/77 or 14.28%). More people who used any consultation strategy also 
linked to care (66/128 or 51.56%)) compared to those who used a consultation 
strategy but did not link to care (62/128 or 48.44%). The difference was trending 
towards significant (X2(1) = 3.03, p=.082). 
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For the combined Experimental group, more participants who used any 
consultation strategy linked to care by post-test than those in the Standard of 
Care group. The difference was trending towards significant (X2(1) = 2.57, 
p=.072).  
For the combined Experimental group, more participants who used any 
consultation strategy reported less violence as a result if they notified their 
partner of their serostatus compared to the Standard of Care group. A Chi square 
test showed the difference was significant (X2(1) = 8.51, p=.005). 
A Pearson’s Chi square showed that those who talked with a friend/family 
member were significantly more likely to link to care than those who did not use 
the strategy (X2(1) = 7.91 p=.005). 
 
Domain 4: Risk level 
For perceived safety to be contacted again (in one month, two months or 
three months, any of the above equaling yes), a Fisher’s exact test showed the 
difference between dosage levels was non-significant (X2(1) = .001 p=1.00).  
For perception that talking about the relationship difficulties placed one at 
greater danger, a Fisher’s exact test showed the difference between dosage 
levels was non-significant (X2(1) = 2.98 p=.245). 
For perception that the services received placed one at greater danger, a 
Chi square test using Fisher’s Exact test showed that the difference between 
dosage levels was non-significant (X2(1) = .642 p=.682). 
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For violence experienced as a result of serostatus notification, a chi 
square test showed the difference between dosage levels was non-significant 
(X2(1) = 1.77 p=.183), but Pearson’s chi square showed the difference between 
the combined Experimental group (5/160 (3.13%)) and the Standard of Care 
group (10/81 (12.35%)) was significant (X2(1) = 7.83, p=.005). Although the 
difference between dosage levels was non-significant, the amount of violence 
reported as a result of serostatus notification was attenuated with more Dosage 
level received as those in dosage level one had 4/81 (4.9%) report violence as a 
result of notification, and those in Dosage level 2 had a lower percentage with 
only 1/79 (1.3%) reporting violence as a result of notification. Only 1/8 people 
who used the fighting back strategy experienced violence as a result of 
serostatus notification. 
 
4.12 Additional Analyses 
Forms of IPV 
Table 4.10 Forms of IPV 


















































Note: Table 4.10 shows the forms of IPV reported by those in the Standard of Care and 
combined Experimental group and also provides a break down of IPV reported among each 
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dosage level group (N=248). The physical or sexual category simply considers how participants 




Figure 4.7 Non-violent Control 
 
Figure 4.7 shows the amount of non-violent control tactics all participants endorsed having 
experienced from a scale of 0-6 tactics (N=248). 
 
 
All participants but two reported having experienced some form of non-
violent control in their current relationship. 6.5% answered affirmative to only one 
item; 26.6% answered affirmative to two items; 29.8% answered affirmative to 
three items; 15.7% answered affirmative to four items; 14.1% answered 
affirmative to five items; and 6.5% answered affirmative to all six non-violent 
control items. 
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The number of participants who reported having experienced at least one 
form of non-violent control was similar to those in the Standard of Care group 
and the combined Experimental group, and Fisher’s exact test showed the 
difference was non-significant (X2(1) = .996, p=1.00). 
Of those who answered no to Your current partner insists on knowing 
where you are all the time, significantly more linked to care in the Experimental 
group (19/29 or 65.52%) than the Standard of Care group (3/15 or 20%). Chi 




Figure 4.8 Physical Abuse 
 
Figure 4.8 shows the amount of physical abuse tactics all participants endorsed having 
experienced from a scale of 0-7 (N=248). 
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150 (60.5%) reported no physical abuse, but the remaining 98 (39.5%) 
answered affirmative to one or more items on physical abuse (in current 
relationship within the last year). 18.1% answered affirmative to 1 item; 8.9% 
answered affirmative to 2 items; 3.6% answered affirmative to 3 items; 3.6% 
answered affirmative to 4 items; 2.8% answered affirmative to 5 items; 1.6% 
answered affirmative to 6 items; 2% answered affirmative to all 7 physical abuse 
items.  
Pearson’s Chi square showed that significantly more people in the 
Experimental group reported experiencing at least one form of physical abuse at 





Figure 4.9 Sexual Abuse 
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Figure 4.9 shows the amount of sexual abuse tactics all participants endorsed having 
experienced from a scale of 0-3 (N=248). 
 
 
132 (53.2%) participants reported having no sexual abuse in their 
relationship, but about 36% answered affirmative to at least one item on sexual 
abuse, and about 11% answered affirmative to at least 2 items on sexual abuse 
(in current relationship within the last year). The item with the highest percentage 
of affirmative answers was In the last year has your partner… “made you have 
sex without a condom,” (110 or 44.4%) followed by “used force to make you have 
sex” (30 or 12.1%) and “used force to make you have anal or oral sex” (13 or 
5.2%). While there were higher percentages of those in the combined 
Experimental group who reported having experienced at least one form of sexual 
abuse, Pearson’s Chi square showed the difference was non-significant (X2(1) = 
.824, p=.364). 
Other sources reporting on IPV occurrence often use the inclusion of any 
physical or sexual assault in the last year, and therefore percentages of those 
with only physical or sexual assault were investigated. Those in the combined 
Experimental group (119/166 or 71.69%) had significantly higher reports of 
having experienced physical or sexual assault in the last year compared to the 
Standard of Care group (48/82 or 58.53%) (X2(1) = 4.32, p=.038), but when the 
amount of assault experienced (number of tactics) was compared between the 
groups, although it remained higher for the combined Experimental group 
(M=1.75; SD=2.12; SEM=.16) than the Standard of Care group (M=1.33; 
SD=1.76; SEM=.19), an Independent sample t test showed the difference was 
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non-significant (t(1, 246)= -1.57; p= .270).  
 
 
Figure 4.10 Danger Indicator Scores 
 
Figure 4.10 shows Danger Indicator scores for the Standard of Care group (SOC) and each 
dosage level (D1 and D2) (N=248). 
 
 
For Danger Indicator scores, Dosage Level 1 had the highest raw scores 
(M= 13.15, SD= 8.65, SEM= .96) followed by Dosage Level 2 (M= 11.95, SD= 
7.16, SEM= .82) and then the Standard of Care group with the lowest scores (M= 
10.52, SD= 6.06, SEM= .69). These scores were out of a possible 0-49 points.  
 
Danger Levels, Re-assault & Partner Notification 
Table 4.11 Danger Score Comparisons 
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M= 2.17  
SD= 2.07 
SEM= .23 
M= 2.63  
SD= 1.91  
SEM= .22 
M= 10.52  










M= 2.88  
SD= 2.00  
SEM= .16 
M= 12.57  
SD= 7.96 
SEM= .63 


























Note: Table 4.11 shows score comparisons between the Standard of Care and combined 
Experimental group as well as a break down of each dosage level in the experimental group for 
pre and post HIRS scores, Danger Assessment scores and Danger Indicator scores. It does not 
include those individuals who were considered contaminating cases in the Standard of Care 
group (N=239). 
 
The DA scores are included to demonstrate that the Combined 
Experimental group also had a slightly higher score on the DA, but an 
Independent sample t-test showed the difference was non-significant (t(237)= -
.916, (p=.361). 
However, an independent sample t-test showed that those in the Standard 
of Care group scored significantly lower than the Combined Experimental group 
on the Danger Indicator at pre-test (t(234)= -2.00, (p=.046). According to this, 
those in the experimental group would be predicted to have a slightly higher 
occurrence of re-assault.  
  When controlling for sexual abuse, it remained that those in the Standard 
of Care group had significantly more people experiencing re-assault, this was 
trending towards significant for both those who reported sexual abuse (X2(1) = 
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4.18 p=.055), but only trending towards significant (one-sided) for those who did 
not have sexual abuse and (X2(1) = 3.9 p=.061). 
However, all participant groups reported an increase in the questions You 
feel safe getting to medical appointments (pre) (236/248 or 95.16%) and You 
have felt safe getting to medical appointments (post) (102/248 or 41.13%). A 
McNemar test showed that the pre-post difference for the total sample was 
significant (X2(1) = .000 p=.000). This indicates that significantly more participants 
experienced a decrease in their perceived safety in getting to medical 
appointments within the first 30 days after testing.  
 
Figure 4.11 Pre-test Perceived Safety in Getting to Medical Appointments 
 
Figure 4.11 shows the amount of participants in the total sample who responded “Yes” to the item 
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Figure 4.12 Post-test Perceived Safety in Getting to Medical Appointments 
 
Figure 4.12 shows the amount of participants in the total sample who responded “Yes” to the item 




Figure 4.13 Tester Status Distribution 
Figure 4.13 demonstrates the unequal distribution between study groups of those who had been 
previously diagnosed as HIV+. Those who had been previously diagnosed are listed as Past 
tester, and those who were newly diagnosed are listed as New tester (N=248). 
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Table 4.12 Tester Status 
Group New Tester (1) Past Tester (2) 
SOC 79 (96.34%) 3 (3.66%) 
Dosage level 1 30 (36.15%) 53 (63.86%) 
Dosage level 2 42 (50.6%) 41 (49.4%) 
Note: Table 4.12 shows the amount of participants in each group, the Standard of Care and each 
dosage level group in the combined Experimental group, who had been previously diagnosed as 
HIV+. Those who had been previously diagnosed are listed as Past tester, and those who were 
newly diagnosed are listed as New tester (N=248). 
 
As mentioned before, not all testers in this sample reportedly were newly 
diagnosed as HIV+, and tester status (New tester/newly diagnosed versus Past 
tester/previously diagnosed) was not evenly distributed among the study groups. 
The total number of Past testers for the whole sample was 97 (39.11%), and the 
dates of original HIV+ tests are listed in table 4.13. 
 
Table 4.13 Past Tester Diagnosis Dates 
Group Frequency 
Within same year (2015) 7 (7.2%) 
 2013-2014 32  (33%) 
2010-2012 26  (26.80%) 
Before 2010 (1996-2009) 32  (33%) 
Note: Table 4.13 shows the date ranges for those previously diagnosed as HIV+, whom are listed 
as past testers (N= 97). 
 
Even among new testers, a greater percentage of participants reported 
violence upon partner notification in the Standard of Care group (6/75 or 8%) 
compared to the combined Experimental group (3/70 or 4%), but the difference 
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was non-significant (X2(1) = .86, p=.496). Among the total group of past testers, 3 
reported violence upon partner notification (1 from the Standard of Care group, 
and 2 from the combined Experimental group). Of the total number of participants 
who reported violence upon partner notification, (3/15) 20% were past testers. 
However, when removing those who had tested longer ago than two years from 
analysis (see table 4.13), Pearson’s Chi square showed that significantly more 
participants in the Standard of Care group (9/79 or 11.4%) compared to the 
combined Experimental group (4/106 or 3.77%) received violence upon partner 
notification (X2(1) = .4.02, p=.045). 
 Additionally, for past testers, the number of participants who reported 
feeling safe getting to medical appointments (96/97 or 98.97%) dropped 
significantly by post-test (35/97 or 36.08%). McNemar showed the difference was 
also significant among this group (X2(1) = .610, p=.000). While the pre-post 
differences remained significant among new testers (pre-test= 140/151 or 
92.72%; post-test= 82/149 or 55.03%); (X2(1) = .01, p=.000)), the most extreme 
change occurred between the pre-test and post-test for the past testers. 
 
Anticipated trouble because of HIV status 
However, other items indicate that past testers also anticipated they would 
experience difficulties because of their status (after this HIV test). For all 
participants responding to the pre-test item, Because of HIV+ status you will be in 
trouble with your partner, a higher percentage (50/160 or 31.3%) of people in the 
combined Experimental group answered yes, compared to those who answered 
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yes in the Standard of Care group (23/78 or 29.49%). Among the combined 
Experimental group, percentages for those answering affirmative to this item 
were slightly higher for new testers (24/70 or 34.29%) than past testers (26/90 or 
28.88%). However, when controlling for the item Because of your HIV status you 
will be in trouble with your partner, the difference between violence upon partner 
notification of serostatus remained significantly higher among those who reported 
they would not be in trouble with their partner in the Standard of Care compared 
to those in the combined Experimental group (X2(1) = 9.95, p=.003). Because the 
number of past testers is not evenly distributed among the research groups (far 
fewer in the standard of Care versus the combined Experimental group), 
numbers for past testers were not sufficiently comparable to test differences in 
linkage between groups. Thus, items that show participants’ anticipated 
difficulties because of their HIV status may be a better indictor for comparing the 
impact of violence upon partner notification. 
Some studies compare the amount of re-assault experienced between 
those who have left the abusive relationship compared to those who remain in 
the abusive relationship. In this study, 11/248 (4.44%) participants had left their 
partners upon pre-test data collection. Of those who had left their partner, 0 
received violence upon partner notification of serostatus, but 2 of those had 
reported they would be in trouble with their partner because of their HIV status. 
 Finally, more people in the combined Experimental group (25/50 or 50%) 
who answered yes to the item You will be in trouble with you partner because of 
your HIV status linked to care than those who answered yes and linked to care in 
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the Standard of Care group (6/23 or 23.2%), and Pearson’s Chi square showed it 












 Thus far, the linked epidemics of HIV and intimate partner violence (IPV) 
have been explored and the impact of the HIV-IPV intersection on South African 
women has been demonstrated. The need for the HIV IPV Risk and Safety 
(HIRS) protocol has been highlighted, as well as its empirical support and 
theoretical underpinnings. The methodology and results of the study have also 
been presented. This final chapter will synthesize the results by comparing 
findings with current literature and postulating their practical significance towards 
research and practice. The majority of this chapter concentrates on interpreting 
the relevance of the results as contextualized within the extant literature and is 
organized by descriptive findings and research questions. The chapter concludes 
by discussing study strengths and limitations, an appraisal of implications for 
practice, recommendations for future research, and a conclusive statement about 
the study’s significance. 
 




Unlike many studies, IPV eligibility for this study included not only 
participants who had experienced physical and sexual abuse but also those who 
had only experienced non-violent control in their relationship. However, 
participants reporting only non-violent control must have reported at least two 
forms of non-violent control for eligibility (compared to those with physical or 
sexual abuse only requiring one form of physical or sexual abuse for eligibility). 
Many studies on IPV only include those with physical or sexual abuse (Abramsky 
et al., 2011; Abramsky et al., 2012). Although comparisons are rendered difficult 
because there is no gold standard for measuring IPV in general (Abramsky et al., 
2011), some comparisons may be firmly drawn. This study found that of the 446 
participants recruited, 191 did not report IPV, but the other 255 (57.18%) did 
report IPV. Of those who reported some form of IPV, 167 (65.49%) had at least 
one form of physical or sexual abuse in the last year. That is an overall 
prevalence of physical or sexual IPV in the last year of 37.44%. Of those who 
met IPV eligibility, 99.19% of the total sample reported having experienced at 
least one form of non-violent control in their relationship within the past year, and 
non-violent control experiences were reportedly very similar between study 
groups. Among the total sample, 40.73% reported having experienced at least 
one form of physical abuse in their relationship in the last year, and percentages 
were significantly higher among the combined Experimental group (45.18%) 
compared to the Standard of Care group (31.71%). Also in the total sample, 
46.77% reported having experienced some form of sexual abuse in their current 
relationship in the past year, and percentages were higher among participants in 
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the combined Experimental group (48.8%) compared to the Standard of Care 
(42.68%). Thus, baseline levels (at pre-test) of IPV were higher for those in the 
combined Experimental group than the Standard of Care group.  
For the overall sample, these prevalence rates are comparable to that 
found in the literature, with some being higher and others being lower. 
Comparisons with household surveys show general IPV prevalence rates to be 
lower than those among women living with HIV. For example, while this study 
found 37% of participants had experienced physical or sexual IPV in the last 
year, Abramsky et al. (2012) report a 27% rate among women in an HIV 
prevalent area in sub-Saharan Africa; another household study of men reporting 
IPV perpetration in the last year showed a prevalence of 29.6% for rape and 
30.7% for physical abuse (Jewkes et al., 2011), and this was similar to another 
South African study reporting 27.5% of men confessed to perpetrating physical 
abuse in their current relationship (Gupta et al. as cited in Peltzer et al., 2013). 
Among those testing HIV+ in South Africa, Dunkle et al. (2004) reported 
an IPV prevalence of 40.2% of physical or sexual assault in the last year among 
a slightly younger age group presenting in an antenatal clinic in the same 
province as this study. Most contrasting with the current finding of 37% was a 
study of young women (aged 16-24 years) in a peri-urban setting in Western 
Cape, South Africa. This study used the WHO violence against women 
instrument and discovered that 86% of the sample had experienced physical or 
sexual IPV in the last year (Zembe, Townsend, Thorson, Silberschmidt & 
Ekstrom, 2015).  
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To compare these rates internationally, Maman et al. (2002) report women 
testing HIV+ during VCT in Tanzania are more than twice as likely to report 
physical or sexual IPV in their current relationship than those testing HIV-, and a 
Ugandan study found 63% of women testing HIV+ had experienced IPV “at some 
point” before HIV testing (Kouyoumdjian et al., 2013, pg. 166). A systematic 
review over literature in the United States, addressing the HIV-IPV link, found up 
to 28% of HIV+ women had experienced physical IPV in their current relationship 
(Gielen et al., 2007). Rates were also higher among women in Tanzania and 
Ethiopia with the latter reporting 54% had experienced physical or sexual 
violence in the last year (Garcia-Moreno, Hansen, Ellsberg, Heise, & Watts, 
2005). 
Rates of emotional abuse, while reported less often, have been cited as 
higher than those of physical and sexual abuse, and this was consistent with the 
current study’s findings. For all 10 countries in the aforementioned multi-country 
study conducted by the World Health Organization, 20-75% of respondents had 
reportedly experienced one or more act of controlling behavior by their partner 
(Garcia-Moreno et al., 2005). Interestingly, one study found only 43.7% of 
women sampled in Gauteng province reported having received emotional abuse, 
but 65.2% of men sampled reported having perpetrated it (Rees, Zweigenthal & 
Joyner, 2014). Because rates of emotional abuse may be underreported in South 
Africa due to cultural complicity of gender inequalities, information procured in 
this study (through safe, confidential and supportive contact) generates new 




Tester Status: previous or new diagnosis 
Of the 248 participants included in this study’s pre-test only analyses, 97 
(39.1%) had previously tested HIV+ and were labeled past testers. It is unknown 
how many times those previously diagnosed had undergone testing before, or 
how many had already notified their partner of a positive serostatus. For those 
previously testing HIV+, dates of initial diagnosis ranged from year 1996-2015 
with 7.2% having been diagnosed the same year as this study (2015), 33% some 
time in the two years before, and almost 60% testing some time between 1996-
2010. The remainder of the sample (151/248 or 60.9%) was newly diagnosed as 
HIV+ (about one day prior to study administration) and was labeled new testers. 
This is a relatively high amount of past testers. Some sources report sample 
percentages of those previously diagnosed, and others fail to notate such 
information. Van Zyl et al. (2015) found 4.1% of their sample had previously 
tested HIV+; Larson et al. (2010) found 6.5%; and Mabuto et al. (2014) found 
2%.  
It is not known exactly why the numbers of those previously diagnosed are 
so high in the current study, but the most viable explanation is that this study 
allowed a more comprehensive inclusion criterion. Results are a likely more 
accurate representation of who was utilizing mobile testing at the time and 
location of study recruitment. Other studies may have excluded this sub-group 
because they were seen as non-representative of the targeted sample for 
research questions. For example, Wagman et al. (2015) allowed this sub-
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population to remain in their study on HIV and IPV in Uganda, but Maman et al. 
(2014) did not allow this sub-population in their study of HIV and IPV in Durban, 
South Africa (as cited in Kennedy et al., 2015). Although including this group 
caused an unequal distribution, muddling group comparisons and obfuscating 
findings, through the participation of this sub-group new information was 
observed about the on-going role of perceived danger related to serostatus for 
those previously diagnosed as HIV+. 
The majority of past testers reportedly sought mobile HCT to obtain their 
CD4 cell counts. This suggests something motivated them to check their CD4 
levels—i.e. changes in physical health or health maintenance in general—but 
likely indicates these individuals were not currently engaged in care elsewhere. 
Because those previously diagnosed as HIV+ were shown at baseline data 
collection to perceive risk levels commensurate to those recently testing HIV+ 
and because greater attention is needed for those who “are not yet eligible for 
ART” (Mugglin et al., 2012, pg. 1509), this sub-group deserves greater attention 
in future studies. Results for each of these groups are discussed and compared 
in greater detail throughout this chapter.  
 
5.2 Demographic Factors 
The mean age of this sample was 33 years, and the median was 32 years. 
These numbers are similar to other studies (Van Zyl et al., 2015) with some 
being slightly lower (Mabuto et al. 2014) and others being slightly higher (Adams 
et al., 2011). Other studies had samples of similar racial make-up to the current 
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study. 100% of this study identified as black South African, consistent with other 
studies in South Africa on voluntary counseling and testing (Kilembe et al., 2015), 
IPV services (Adams et al., 2011) and general HIV prevalence (Kenyon, Buyze, 
& Colebunders, 2013). It is not surprising that a study serving Gauteng residents 
would include such high percentages of black South Africans given the province 
is 77.4% black South African (Statistics South Africa, 2012). Given the 
comparability of this study’s demographics and IPV prevalence, the study’s 
sample resembles the demographic population from which participants were 
recruited.  
 
5.3 Contribution of Psychometric Instruments 
HIV IPV Risk and Safety scale 
The HIV IPV Risk and Safety (HIRS) scale is a 10-item psychometric tool 
developed to uniquely assess for danger associated with HIV testing, HIV 
serostatus, and risks associated with linkage to care and retention in HIV care 
among those already experiencing IPV in their relationship. This tool was shown 
to have good reliability and approaching sufficient validity. Future use of the scale 
should involve minor refinement to improve its validity. 
The creation and use of this instrument allowed trends to be uncovered in 
danger associated with the HIV-IPV intersection. This tool is to be used 
specifically with individuals already testing positive for both HIV and IPV. Given 
the multidirectional nature of HIV and IPV, the purpose of the tool is two-fold: to 
measure how IPV may create a barrier for HIV care and how an HIV+ diagnosis 
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may contribute to further risks for IPV. Results from this tool help compare 
perceptions of danger immediately following an HIV diagnosis to perceptions 30 
days after a diagnosis, as well as between groups receiving the HIRS protocol 
and those only recceing the standard of care. Hale & Vazquez (2011) highlight 
the need for information to be generated on abuse before and after an HIV 
diagnosis, as this information will help explain the nature of violence particular to 
the HIV-IPV intersection. Thus, this tool is a first effort towards filling a significant 
gap in the literature. 
 
Danger Indicator 
The psychometric instrument, the Danger Indicator (DI), is a 45-item scale 
used to measure risk and danger associated with the HIV-IPV intersection. 
Through Exploratory Factor Analysis, this scale was shown to be an appropriate 
indicator of danger levels related to intimate partner violence for those who are 
HIV+; yet, the scale was also shown to need further refinement to be a more 
valid instrument. Although this scale includes measurements of non-violent 
control, physical and sexual violence, vulnerability for any relationship violence, 
safety and risks related to serostatus, and likelihood for femicide, the latent 
variable was physical assault. Hence, danger predictions within this study may 
be more accurate for physical assault rather than sexual or psychological abuse. 
Each of the aforementioned areas were included to create a tool that would 
comprehensively assess risk for IPV reoccurrence, risk for fatality and protective 
factors that may mitigate the IPV (Campbell, 2004), as each of these areas 
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should be considered in order for an IPV assessment tool to provide an accurate 
global assessment. Therefore, future studies should continue to refine the tool so 
that it is a more valid measurement for all the listed areas of abuse. 
 Though the tool was found to be appropriate for assessing danger levels, 
it should be further refined to also consider frequency and severity of past abuse 
as a more accurate predictor of various types of IPV (Hardesty et al., 2015). An 
original version of one sub-scale within the Danger Indicator typically is used with 
a calendar so that the frequency of assaults may be factored into the risk 
equation. This is an important component to predicting future assault and should 
be integrated into the Danger Indicator in future use.  
This tool is an important contribution to the HIV-IPV knowledge base. 
Safety planning for risks relevant to the HIV-IPV intersection relies on an 
accurate assessment of risks that are population-specific. Scores from the 
Danger Indicator were used as a necessary tributary to inform safety planning so 
that the two tools were used as one iterative process for mitigating IPV related to 
serostatus. To date, no tool could be found that measures global scores of 
danger relevant to the HIV-IPV intersection. 
 
5.4 Research Question 1A  
Risk & Safety Scores between Groups 
 For research question 1A, comparing participants’ mean difference scores 
on the HIV IPV Risk and Safety (HIRS) scale, no significant differences were 
found between the Standard of Care group and combined Experimental group. 
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Those in the combined Experimental group had slightly higher mean scores than 
the Standard of Care group at pre-test and post-test. However, differences were 
slight and all non-significant. While this study hypothesized that there would be a 
reduction in mean safety scores (increase in perceived safety) for the combined 
Experimental group, the null hypothesis demonstrates that this protocol did not 
incite more risk among those in the combined Experimental group as indicated 
by participant’s perceived risk levels. There is some debate about the best way to 
measure perceptions of safety among IPV victims (Cattaneo et al., 2007; Harding 
& Helweg-Larsen, 2008), calling to question the validity of self-reports. Some of 
the relevant ways to measure perceptions of safety and their significance are 
explored further throughout this chapter.  
One consideration for the HIRS results is that participants were asked 
about IPV occurrence at pre-test only and before any received psychoeducation 
about IPV. Given the degree of cultural acceptance of violence in South Africa, a 
small increase in risk scores, even if non-significant, could reflect some change 
in awareness of IPV-related issues. Data collection relied on self-report only, and 
sources suggest that when corroborated with other collateral sources, rates may 
be inconsistent if participants are not familiar with recognizing IPV in their 
relationship (Rees et al., 2014). 
Another consideration is this study’s short follow-up period (of only one 
month) may have been too brief to capture the possible reductions in perceived 
risk that could be experienced as a longer-term result of safety plans or safety 
strategizing. While Kendall et al. (2009) found participant safety remained 
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consistent between telephone follow-up periods of 2 days and 2, 6 and 12 
weeks, other examples used longer follow-up periods to uncover increases in 
perceived safety. For example, when Peltzer et al. (2013) conducted a pre-test 
post-test analysis of the effectiveness of orders of protections for victims in South 
Africa, pre-test data were collected immediately following the receipt of an order 
of protection and then post-test data 6 months later. They observed a significant 
reduction in IPV at the 6-month mark and found certain forms of IPV, like 
stalking, played a more active role during the protective order process. This 
indicates there could be an increase in danger or perceived risk at the time of 
employing this legal strategy but reduced danger or perceived risk months after 
doing so. Matseke et al. (2013) also collected data on pre-post Danger 
Assessment scores, after only a 20-minute safety planning session, and found 
significant drops in danger but with a 3-month follow-up period. Thus, a longer 
follow-up period could capture changes only observable farther into the use of a 
strategy and provide further insight into the effectiveness of safety strategies that 
take longer to deploy. Two theoretical models could be applied to understand the 
change process captured in this study, the Transtheoretical Model (TTM) and 
Lempert’s (1996) stages. 
According to the TTM, most behavioral change occurs in longer strides 
than one month, but shifts in cognitive states lead up to such changes. TTM 
posits that behavioral change is contingent upon a series of cognitive shifts such 
as alterations in attitudes and decisions. Therefore, change is hypothesized as 
occurring over time or in stages rather than abruptly or all at once. An Ugandan 
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study, utilizing the TTM with abused women and public health programs, found 
that individuals who are in the precontemplation stage of change do not intend to 
change in the next 6 months, but those who are in contemplation stage do intend 
to change in the next 6 months (Wagman et al., 2013). If the current study 
reached more individuals in the precontemplation stage of change, it is likely that 
behavioral change would be delayed but changes in perception could be 
detected sooner as an individual begins to shift into the contemplation stage. A 
follow-up period of 6 months to one year would show the results of more self-
protective action, rather than shifts in perception occurring earlier on in the 
change process.  
This study worked from the assumption that an HIV+ diagnosis alone 
would not sufficiently lead to changes in behavior (Bundy, 2004), but those 
receiving the experimental components of the protocol would experience an 
accelerated change rate due to alterations in subjective norms around IPV. It is 
not yet known how much the role of IPV impacted the rate of such a change, and 
future studies could include more of the TTM as part of the protocol as well as 
compare change among those receiving HIV diagnoses without IPV to 
understand if psychometric tools such as the HIRS are detecting changes in 
perception—indicative of the change process—or actual increases in risk that 
could occur when a safety strategy is initiated (Matseke et al., 2013).  
The second theoretical model that could apply, and shows the current 
study’s findings challenge that of the Ugandan study, is Lempert’s (1996) theory 
describing the three linear stages a woman goes through in responding to abuse 
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in her relationship. The first stage involves a woman’s attempt to make the abuse 
invisible and essentially cover it up. The second stage involves both the woman 
and the perpetrator acting to “contain the violence and preserve personal 
agency” (Wright, Kiguwa & Potter, 2007, pg. 618). During this stage, a woman 
may engage in placating behaviors or attempt to negotiate for non-violence. 
Strategies used in this stage vary depending on each woman’s meaning making 
of the violence and her available resources. The final stage involves attempts to 
make the violence more visible through consultation with family, friends, legal 
and community resources. At this point, the woman more clearly identifies the 
ramifications of the abuse and the potential to reclaim power by accessing 
available resources. Through these resources, she may be empowered to “re-
establish her own needs, wishes, and eventual departure” [from the relationship] 
(Kirkwood & Lempert as cited in Wright et al., pg. 619).  
Lempert’s theory has been used to describe the experiences of women 
accessing domestic violence shelters in Johannesburg, South Africa. Results 
from a qualitative study were found to be consistent with Lempert’s theory. 
Whereas TTM explains the general process for change-making, Lempert’s theory 
illustrates a linear progression women may go through as they travel along the 
path of an IPV relationship. It is difficult to ascertain where exactly participants of 
this study would have largely been plotted along this theoretical trajectory, but in 
light of the high numbers of those utilizing public (versus private) safety 
strategies (explained under Feasibility), according to this theory it would either be 
assumed that many women were already in the final stage of this three-part 
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stage or that the intervention itself acted as a catalyst, quickening the change 
process and thrusting participants into a state of action (stage 3). 
Given the short follow-up period and limited items asked about readiness 
to change, conclusions about the impact of study participation on the change 
process as well as how the change process impacts participant safety remain 
nebulous. Because this study focused on safely improving HIV outcomes 
(linkage to care) and not IPV outcomes, the most important take-away of these 
results is that those receiving the HIRS protocol did not suffer as a direct result of 
protocol receipt. Rather, those in the experimental group maintained risk levels 
parallel to those in the Standard of Care group, especially considering their pre-
test risk levels were slightly elevated. However, it is hypothesized that a longer 
follow-up period may uncover greater reductions in risks for those receiving the 
protocol, with the 30-day follow-up mark being muddled by women transitioning 
either cognitively or behaviorally into various stages of change. Yet to be 
determined is how exactly these stages of change may typically evolve for 
women impacted by the HIV-IPV link. This study’s working assumption is that 
receipt of the HIRS protocol expedites the change process, as evidenced by the 
significant number of participants in the combined Experimental group who 
accessed public consultation strategies compared to the Standard of Care group. 
Likely, the protocol galvanized participants to take action, thrusting them into a 
different stage of change or Lempert’s stage, the latter being an imperfect theory 
for those experiencing both HIV and IPV. Nonetheless, the amplified results of 
their actions would likely only be observable at a later date. Because this was 
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anticipated to some degree, participants were asked if it would be safe to be 
contacted again at a later date of 1, 2 or 3 months (see Feasibility, domain 4). 
Findings from this question will inform future studies, possibly a Phase II trial, on 
the feasibility of extending the follow-up period.  
 
5.5 Research Question 1B 
Risk and Safety Scores by Dosage Level 
For research question 1B, comparing participant’s mean difference scores 
on the HIV IPV Risk and Safety (HIRS) scale, no significant differences were 
found between Dosage level 1 and Dosage level 2. While it was hypothesized 
that those in Dosage level 2 would report reductions in mean HIRS scores 
(increased safety), the two groups strikingly had the same mean scores for pre-
test and post-test. Thus, the null hypothesis was supported and the extra dosage 
level did not alter perceptions of safety among those in Dosage level 2. It is 
noteworthy that the higher dosage level did not contribute to higher danger 
among participants. 
 
5.6 Research Question 2 
Linkage to Care 
 For research question 2, it was hypothesized that those in the combined 
Experimental group would have a higher number of individuals link to care at a 
faster rate (within 30 days). Although a higher percentage of participants in the 
combined Experimental group linked to care compared to the Standard of Care, 
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the difference was non-significant, and it took slightly longer for those in the 
combined Experimental group to link to care (about 13 days) than those in the 
Standard of Care group (about 12 days).  
The linkage rate of 12-13 days is consistent with van Zyl et al. (2015), but 
the overall percentages of participants linked in this study were lower. Van Zyl et 
al. used the same standard of care as this study but did so in both urban and 
rural settings, with a different recruitment period, using a 31-day linkage mark 
and not controlling for IPV. Their study found higher linkage rates for almost all 
age groups except those aged ≤23 years. The current study found an overall 
linkage rate (for the total sample) of 41.6% within 30 days and 45.8% by post-test 
(with only 9% of those linking after 30 days, M=13.11). Comparatively, van Zyl et 
al. (2015) reported 54% of their female sample linked to care and most did so 
within 14 days. The current study found the highest linkage rate among those 
aged 23-32 years (51.81%), and the lowest linkage rates for those aged ≤23 
years (35.9%). Van Zyl et al. also found the lowest linkage rates among those 
aged <23 years with their urban group (in a similar area as this study) linking only 
32.9% of participants, which was lower than this study’s Standard of Care 
(35.7%) and combined Experimental group (36%). This underscores that those 
aged ≤23 years need greater attention in future research and practice.  
In the current study, those aged 23-32 had very similar linkage rates 
among the Standard of Care, combined Experimental group and those in the van 
Zyl et al. (2015) study. Though differences were negligible, the Standard of Care 
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in this study had the highest rate of 53.33%, followed by 53.1% in van Zyl et al., 
and 51% in the combined Experimental group of the current study.  
The biggest difference in linkage rates, within the current study and 
compared to van Zyl et al. (2015), was found among those aged 33-43 years. In 
the current study, among this age group only about 22% of those in the Standard 
of Care group linked and about 47% of those in the combined Experimental 
group linked. Both of these numbers are lower than the 61.8% found by van Zyl 
et al. among this age group. 
Additionally, for those answering yes to the item Because of your HIV 
status you will you will be in trouble with your partner, significantly more people 
answered in the affirmative but still linked to care among the combined 
Experimental group (50%) compared to those answering in the affirmative but 
still linking to care among the Standard of Care group (23.1%). This could 
suggest that the protocol was more effective in linking those who felt greater risk 
related to their serostatus. 
No other studies could be found reporting on linkage rates for mobile 
testers with IPV. The novelty of this study makes it difficult to compare linkage 
rates with existing studies that do not control for IPV, as other samples naturally 
would have contained participants experiencing IPV (as evidence by the IPV 
prevalence rate among those testing HIV+). Therefore, these findings reveal 
trends previously unknown and mark a significant contribution to the literature on 
linkage to care after mobile HCT.  
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Given that women aged 30-34 have the highest HIV prevalence rate 
(UNAIDS, 2012), the high linkage rates among this age group in the combined 
Experimental group show promise that the protocol can effectively promote 
linkage to care for women in this age group. Further, the salient need for 
interventions addressing the HIV-IPV intersection is highlighted by the 
contrastingly lower linkage rates among those in this age group in the Standard 
of Care, coupled with the volume of participants in the study who were around 
this age (mean was about 33 years old).  
 
5.7 Research Question 3A 
Satisfaction between Groups 
 Research question 3A hypothesized that those in the combined 
Experimental group would have higher satisfaction scores than those in the 
Standard of Care group. Although those in the combined Experimental group did 
have higher percentages of those reporting they were satisfied, the difference 
was non-significant. For the total sample, about 93% of participants reported the 
information they received was helpful; about 97% of participants reported it was 
helpful to be asked about the difficulties in their relationship, and a little over 95% 
reported they did not regret talking about the difficulties in their relationship. For 
both of the first two categories, those in the combined Experimental group 
(92.5%; 97.5%) reported being slightly more satisfied than those in the Standard 
of Care group (92.4%; 96.2%), and only slightly more participants in the 
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combined Experimental group (about 5%) reported feeling regret compared to 
those in the Standard of Care group (about 4%). 
These numbers illustrate that the HIRS protocol was overwhelmingly well-
received by participants regardless of group allocation. This is an important 
finding because it shows that despite having not received the experimental 
components of the study, those in the Standard of Care group were still satisfied 
with the services received and those who received in-depth safety planning were 
not more regretful about discussing their difficulties at such length. Hence, 
participants in either group perceived the benefits of study participation far 
outweighed the regrets.  
 The Appollis et al. (2015) systematic review over harms, benefits & regrets 
experienced while being surveyed about abuse showed the current study’s 
results were standard by comparison. The current study found 5% total reported 
regretting participation, and other studies found anywhere from 4-6% reported 
regret, but some reported about 20% of participants experiencing drawback or 
discomfort (Carter-Visscher as cited in Appollis et al., 2015).  
 The current study operationalized the benefit of study participation as 
affirmative responses to items over the helpfulness of services, but some studies 
operationalize benefit through items directly asking if study participation was 
beneficial. For the current study, only 3% reported services were not beneficial. 
This compares favorably, as one study found 25% did not report a positive 
experience. It is also important to consider that by asking about the helpfulness 
of services overall, participants may have been considering additionally the 
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helpfulness of HCT services and not merely those of study participation. Van Zyl 
& Barney (2014) reported only 1.8% of black participants had been dissatisfied 
with their program, which was used as part of the standard of care for this study. 
Percentages of dissatisfaction were only marginally higher in this study, and 
satisfaction (97%) far outweighed regrets (5%). 
 
5.8 Research Question 3B 
Satisfaction, Acceptability & Feasibility by Dosage Level 
 
Satisfaction 
For research question 3B, the impact of the higher dosage levels on 
participant’s satisfaction scores (which included items over feasibility and 
acceptability) was hypothesized to be unknown. While a higher percentage of 
participants in Dosage level 2 (93.7%) compared to dosage level 1 (91.4%) 
reported that overall they were more satisfied with the services they received, the 
difference was non-significant. Among dosage groups, the same percentage of 
participants (97.5%) reported it was helpful to be asked about the difficulties in 
their relationship, but more participants in Dosage level 2 (96.2%) compared to 
Dosage level 1 (93.8%) reported they did not regret talking about the difficulties 
in their relationship. 
 All of these numbers are practically significant given the dissent among 
researchers about the risk/benefit ratio of involvement in research on abuse. The 
high percentage of satisfaction and low percentage of regret among those in the 
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Standard of Care group demonstrates that individuals currently experiencing IPV 
and recently testing HIV+ find participation in such a protocol (largely amounting 
to IPV screening and continued contact for this group) satisfactory and not 
inducing of psychological distress (although additional probing of baseline 
psychological distress at pre-test would assist with greater certainty).   
 
Acceptability 
 Items related to feasibility and acceptability were given only to the 
Experimental group and targeted the acceptability and feasibility of the protocol—
participants informed of their Danger Indicator results (risk assessment) and the 
creation of a personalized safety plan. Differences in experiences were 
investigated between the dosage levels, and for all three areas assessed, those 
in Dosage level 2 had higher percentages of acceptability. Although a higher 
percentage of participants in Dosage level 2 (81%) compared to Dosage level 1 
(79%) reported they found the safety plan helpful, the difference was non-
significant. Unanimously, those receiving Dosage level 2 (100%) reported they 
would recommend the safety plan for a friend, and most participants in Dosage 
level 1 (95%) also reported they would recommend a safety plan for a friend, but 
the difference was also non-significant. Finally, a higher but non-significant 
number of participants in Dosage level 2 (82.3%) compared to Dosage level 1 
(79%) reported they had used at least one safety strategy. 
 These numbers are practically significant given that no information could 
be found in the current literature on the helpfulness of HIV-IPV specific safety 
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strategies or the perceived helpfulness of HIV-IPV specific safety plans. These 
high percentages suggest that women living with HIV and experiencing IPV find 
safety planning to be helpful and safety strategies acceptable enough for use, 
and they would especially recommend safety plans for friends. 
 Comparisons of perceived safety planning helpfulness and safety strategy 
usage are difficult because only literature on IPV safety planning could be found, 
and literature in this area is not well evolved. Thus, these findings contribute not 
only to the knowledge base on the HIV-IPV intersection but also add to the IPV 
knowledge base by showing perceptions of safety planning helpfulness and 
safety strategy usage. Another caveat to comparing these findings to extant 
knowledge is that most comparison studies present samples of women already 
sheltered (those who have left the abusive partner) and studies reporting on 
strategy usage and perceived helpfulness do so for each safety strategy rather 
than safety plans as whole (Parker & Gielen, 2014). These issues aside, this 
section will compare overall helpfulness of the safety plan to safety strategies, 
and usage percentages for safety strategies are listed below under feasibility. 
 For the total sample in the current study, 81% reported finding the safety 
plan helpful, and 97.5% said they would recommend one for a friend. Parker & 
Gielen (2014) show participants, on average, report informal and formal networks 
(friends and family and medical and health professionals) are more helpful than 
strategies such as legal services. Concurring, Goodman, Dutton, Weinfurt & 
Cook, (2003) reveal the strategy of talking with family or a friend was 
experienced as particularly helpful in their study. This could explain the high level 
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of those who found the safety plan to be helpful in the current study, as legal 
services were infrequently employed versus talking with family/friends, and 
medical and mental health professionals were most often employed. Additionally, 
most studies assessing the helpfulness of a strategy did so using a likert scale 
and not a dichotomous item. Because these studies reported on mean scores for 
those scales, comparisons were incompatible (Parker & Gielen, 2014; Goodman 
et al., 2003). No information could be found from existing literature about whether 
or not other participants would recommend safety planning or certain strategies 
for friends. However, this question could be similar to a question often asked in 
other studies on abuse; generally, participants are asked if they find the topic of 
the study to be important. 
 
Feasibility 
 Assessing feasibility entailed several layers of assessment, so domains 
were created to help demarcate each area. Domain 1 considered the time to 
administer the study (attempts to reach participant by telephonic medium); 
Domain 2 considered the length of the intervention to determine the cost in staff 
time; Domain 3 considered the usefulness of the safety plan as a whole and the 
amount of strategies used; Finally, domain 4 considered any risks experienced 
as a result of receiving services. 
Feasibility: Domain 1 Time to Administer 
For the combined Experimental group, it took an average of almost 4 
attempts to reach participants for the pre-test, and an average of about 6 
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attempts to reach participants for post-test. For those in Dosage level 2, it took 
on average almost 13 attempts to reach participants for follow-up safety plans. 
Given that most participants were reachable not only for pre-tests but also post-
tests and some for follow-up safety plans, participant reachability compares 
extremely favorably with call centre results with a similar population. Van Zyl et 
al., (2015), tracked linkage to care for individuals newly diagnosed as HIV+, and 
used the same Links to Care program as utilized in this study’s standard of care. 
Their study found, of those who did not link to care (N=255), 64.7% in the urban 
setting were not reachable by phone despite many attempts to reach them. This 
dramatic comparison to the current study’s success in reaching participants lends 
only a speculative explanation: participants of this study could have increased 
motivation or need for help given the IPV in their relationships. 
 
Feasibility: Domain 2 Length of Intervention 
For the combined Experimental group, it took an average of about 10 
minutes to administer the pre-test (Danger Indicator) portion of the initial phone 
call; an average of about 9 minutes to conduct the initial safety plan; and an 
average of 6.5 minutes to administer the post-test. For those in Dosage level 2, it 
took an average of 4.8 minutes to conduct the follow-up safety plan. In sum, the 
longest portion of the protocol was the pre-test followed by the initial safety plan, 
with the post-test taking up less time than the pre-test, and the follow-up safety 
plan taking about half as long as the initial safety plan. In light of the increase in 
acceptability and satisfaction found among those in Dosage level 2 in tandem 
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with the small amount of time it took to administer the follow-up safety plan, at 
first appearance the follow-up safety plan appears to be a low-cost component 
relative to operational costs. Conversely, the gross amount of attempts it took to 
reach participants for the follow-up safety plan portends challenges in staff time 
management and, therefore, possible superfluity given the non-significant 
differences between groups. 
The HIRS protocol was intentionally developed to be a short tool that 
could be feasibly used in a high-demand, resource-limited country, as this setting 
poses the most time restrictions. For an HCT service to entertain the use of such 
a protocol, it would have to be brief. The protocol also intentionally narrows its 
focus to strategies relevant to the HIV-IPV intersection and does not attempt to 
tackle general IPV, which would likely require a longer interview time, follow-up 
period and greater community involvement in order to impact greater change. In 
the Goodman et al. (2003) study of the development of the IPV Strategy Index, 
interviews were also held over the phone but each one took an average of 45-60 
minutes. Another study specifically on IPV safety planning, took about one hour 
to administer (Glass et al., 2010). When combining the Danger Indicator 
component of the protocol with the safety plan, the protocol took about 20 
minutes to administer. This highlights the achieved brevity for which the protocol 
was intended.  
Feasibility: Domain 3 Usefulness of Safety Plan & Strategies 
Items for this domain considered if the safety plan was feasible to use 
and, if so, how many of the strategies were used. While a previous item under 
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acceptability uncovered higher percentages of those in the combined 
Experimental group found the safety plan to be helpful, a smaller percentage 
actually reported using the safety plan. A higher percentage of participants in 
Dosage level 2 (63.3%) reported using the safety plan and used more safety 
strategies (M=2.18 strategies used) compared to those in Dosage level 1 (60.5%) 
(M=1.76 strategies used) respectively, but the differences were non-significant. 
 The number of individuals who reported having used a safety plan 
compares well with Glass et al. (2010) who reported 60% of their sample had 
made a safety plan. Further comparisons consider the use of each strategy 
within an overall safety plan and are organized by the most popularly utilized 
strategy category of Consultation strategies & Planning Strategies to the least 
utilized strategy categories of Private Strategies of Resistance & Placation. 
As an overview, the current study found the top four most utilized 
strategies were the Consultation strategies of talking with a medical professional 
(44%), friend/family member (44%), counselor/mental health professional (32%), 
and clergy member (23%). Strategies utilized most after these were the Planning 
strategies of creating a plan to safely take HIV medication (16%) and safely 
access HIV care (15%); and General Safety Planning strategies (thinking ahead 
and doing things like hiding money, keeping important phone numbers with you 
or other behaviors to help prepare for an emergency) (12.5%). Finally, accessing 
formal IPV services (9%) was utilized more than legal services (including police, 
attorneys, orders of protections and both were also considered consultation 
strategies) (7.5%), and Resistance strategies (fighting back, trying to end the 
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relationship, running and hiding when violence occurs) (5%) and Pacification 
strategies (trying to avoid the violence with activities like avoiding partner at 
certain times, doing whatever partner wants you to do, trying to keep things quiet 
or a secret from partner) (4%), also considered private strategies, were utilized 
the least. 
Consultation strategies 
80% of participants in the combined Experimental group reported using 
some type of consultation strategy. If including those in the Standard of Care 
group (who were deemed contaminating cases), 84% of the total sample 
reported using some type of consultation strategy, and usage numbers only 
increased with each dosage level: Dosage level 1 at 77.78% usage and Dosage 
level 2 at 82.28% usage. With 84% of the total sample having accessed some 
type of consultation strategy to mitigate the IPV, the influx of women testing HIV+ 
who could benefit from the integration of HIV and IPV services on a regular basis 
is emphasized. This point is further accentuated by the strategy usage disparity 
between groups; 80% of those in the Experimental group used a consultation 
strategy compared with only 4% in the Standard of Care group. This 
demonstrates that participants were significantly more ready and able to take 
action to protect themselves with receipt of the experimental component of the 
HIRS protocol. Because women who have experienced IPV are more likely to 
access health-related services than formal IPV services, especially in developing 
countries (Chibber & Krishnan, 2011), the potential for assisting many vulnerable 
women with a feasible and appropriate protocol such as the HIRS has been 
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shown. Consultation strategy usage in this study is comparable to usage 
percentages cited in other studies, which range between 87.3% (Coker as cited 
in Parker & Gielen, 2014) and 91% (Glass et al., 2010). Peltzer, Mashego & 
Mabeba (2003) show much lower consultation strategy usage in their study, but 
strategies are separated out into individual groups and so are listed below in 
corresponding areas.  
The percent of participants who used the strategy talking with a medical 
professional was only slightly higher than other (largely North American) studies 
have reported but was equivalent to the strategy of talking with a family or friend. 
The latter informal network, talking with friend or family, is cited as a much more 
common strategy, and the equivalent usage between these strategies in this 
study highlights the significant role of medical professionals to potentially assist 
those with both HIV and IPV. The current study found 44% of participants had 
talked with a medical professional, but other studies reported a range from 22%-
36.4% with less use among individuals in urban areas or among those who 
identified as persons of color (Glass et al., 2010; Shannon as cited in Parker & 
Gielen, 2014). Taking into account the limited services in South Africa (Rees et 
al., 2014), this usage percentage is quite high, particularly considering a South 
African study focusing on IPV only found only 15% of its participants had 
contacted a medical professional (Peltzer et al., 2003). 
The current study’s high percentage of participants consulting with 
medical professionals is consistent with the united message found among 
varying sources—there is an important need for healthcare workers to be trained 
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in IPV response as healthcare sites are accessed by victims more frequently 
than formal IPV services (Lindhorst et al., 2005). Despite this need, some 
healthcare workers have left victims feeling judged (Hale & Vazquez, 2011) or as 
though they must follow their worker’s directive to leave the relationship. One 
study found only 9.7% of doctors in South Africa had been trained in IPV 
response and cites doctors as often holding attitudes of victim blaming while 
reporting they should be involved in IPV response. 
The current study found 44% of participants had talked with family or 
friends. Other studies found 69.1% talked with family, 74.5% talked with friends 
(Cooker as cited in Parker & Gielen, 2014) or 64% talked with a friend, and 49% 
talked with a family member (Glass et al., 2010). As mentioned above, this 
strategy has been shown to be particularly helpful (Goodman et al., 2003). 
Moreover, while this category’s usage frequency is lower in the current study, by 
comparison to studies focusing only on IPV, the high usage frequency within this 
study by comparison to other strategy utilization may explain the high 
percentages of those who perceived the overall safety plan to be helpful. 
IPV is said to not only affect a woman’s physical and emotional self but 
also her spiritual self (Davies & Dryer, 2014). As a country with a high amount of 
religious affiliation—about 2/3 of South Africans identify as Christian—the 
moderate amount of clergy consultation reported in this study is not surprising. 
23% of participants reported utilizing the strategy of talking with clergy, and this 
was very similar to that found in another South African study (priest—25%) 
(Peltzer et al., 2003). Other North American studies cite a range of anywhere 
	   
166 
from 6%-27% of participants using this strategy, with a lower percentage found in 
some rural areas (El-Khoury & Wiist as cited in Parker & Gielen, 2014). Although 
the current study’s numbers hardly show most participants are likely to use this 
strategy, as Peterson (2009) claims, they do provide support for Peterson’s 
assertion that clergy in South Africa should be aware, trained and ready to 
respond to IPV victims. Peterson’s qualitative study uncovered clergy responses 
to IPV in South Africa as running the gamut: some identified IPV as a grave 
problem; others felt ill-equipped to handle it or as though it was not their place to 
respond to IPV; some even displayed burn out from seemingly incessantly needy 
victims and clergy member’s obligatory helping role. Ultimately, Peterson urges 
that there is an exigent need for “sound ministry of healing and compassion” 
within the church not just to respond to victims but also to hold perpetrators 
accountable. The potentially important role clergy members may play in IPV 
response was confirmed by almost a quarter of the current sample seeking help 
through this medium.  
The current study found 32% of participants reported having talked with a 
counselor or mental health professional. Other IPV studies report anywhere from 
29-45.5% of participants had contacted mental health professionals (Coker & El-
Khoury & Parker & Gielen, 2014), and one study separated out various types of 
mental health professionals utilized by South African survivors with 33% 
contacting a social worker before anyone else, followed by a psychologist (7%) 
and traditional healer (5%) (Peltzer et al., 2003). 
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These findings, in-part, support the allegation that IPV survivors in South 
Africa prefer counseling services, but higher rates have been found in other 
studies in South Africa, ranging from 36%-45.8% (Jewkes et al. as cited in Rees 
et al., 2014), and lower percentages in other studies (therapist—12%) (Glass et 
al., 2010). Consultation with a mental health professional was the third most 
popular strategy employed in the current study. Because of its popularity, a brief 
review of perception of IPV among mental health professionals in South Africa 
provides insight into what survivors might experience upon accessing this 
strategy.  
In one exploratory study, the professionals interviewed described IPV 
survivors as either intentionally remaining in abusive relationships or not having 
access to services to assist an escape. According to perception, the survivors 
wanting to remain in abusive relationships allegedly do so “for cultural reasons, 
economic dependence and fear of stigmatization” (pg. 5577). Perception 
continues that from this decision survivors typically end up adopting maladaptive 
coping skills, as a survival mechanism, and ultimately experience impairment in 
mental well-being. These individuals are said to subsequently suffer from 
helplessness, submissiveness, low self-esteem and dependence. Conversely, of 
the many women who want to leave their abusive relationships, many are 
stymied by their lack of knowledge of community services to assist or by the 
actual insufficiency of IPV services in their community. A final perception among 
mental health professionals was the ideology that victims of abuse have a lack of 
survival skills; this idea diverges from the popularly held belief among IPV 
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scholars that survivors are extremely resourceful and persistent in their attempts 
to protect themselves (Goodman et al., 2003). In summation, the authors of the 
above study discuss the need for more community-based services that are 
empowering (Gumani & Mudhovozi, 2013). 
Thus, this depiction of the ideology among mental health professionals, 
while not generalizable, raises concern for how survivors are received upon 
deploying this strategy. First, the perception paints a rather binary view of victim 
experience, one that is bereft of concepts such as love, hope and dreams. 
Although the authors report that the results were in line with Gelles (1987) 
findings, which do discuss hope and the possibility of reform among perpetrators 
(Gumani & Mudhovozi, 2013), results focused more on the cultural reasons 
victims remain in relationships rather than the actual role of love. 
Literature on IPV in South Africa often does not address these concepts 
when attempting to explain why victims remain in abusive relationships, and it 
would enhance cross-cultural understanding for future studies to explore the role 
of these concepts. A qualitative study by Wright et al. (2007) do show their small 
sample addressed the theme of “trust and belief in romantic love” as a reason 
women remain in abusive relationships, but this was coupled with “the sanction 
of marriage used by male partners to keep women in the relationship” (pg. 627). 
However, the intimation that women who do remain eventually transform into 
helpless beings is refuted among IPV scholars (Van Schalkwyk, Boonzaier, & 
Gobodo-Madikizela, 2014), which contradicts Walker’s (1979) theory of learned 
helplessness (for which she eventually recanted herself (Goodman et al., 2003)). 
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Consequently, it may be extrapolated that more robust IPV training for mental 
health professionals is needed if the research-to-practice gap may be bridged. 
Finally, given the discrepancy between IPV ideology among scholars and those 
in the trenches caring for survivors, the potential weakness of safety planning as 
a main intervention component may also be deduced. To some extent, the safety 
plans themselves are only as powerful as the resources within them. This 
underscores the need for greater community-level IPV initiatives and 
interventions to work hand in hand with interventions addressing the HIV-IPV 
intersection. 
Results over utilization of IPV services are the most difficult to compare 
with both domestic and international findings. First, there is a paucity of literature 
on IPV service utilization in South Africa. Second, North American comparisons 
cannot be equitably interpreted given the much higher availability of IPV services 
there, and third, most North American studies include samples of women already 
residing in domestic violence shelters. Strikingly, despite these issues in data 
comparison, the current study found that 9% of the combined Experimental group 
utilized formal IPV services, and a telephonic cross-sectional population-based 
survey in the US found only 10.9% had utilized formal IPV services. As of 2007, 
the idea of sheltering abused women in South Africa was cited as being both a 
relatively new concept and more Western-oriented. Instead, South African culture 
was said to rely more on the support of extended family, and isolation from 
extended family was one of the factors contributing to women utilizing the 
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resource of a shelter (Wright et al., 2007). Differences in shelter milieus between 
Western and African shelters are discussed more thoroughly by Wright et al.  
Although formal IPV services are cited as inadequate or prohibitively 
cumbersome to reach in South Africa (as a vestige of the Group Areas Act) 
(Vetten, 2005), three possible explanations were considered for the comparable 
usage of this strategy. One is that the problem of IPV may be increasingly de-
stigmatized since the country’s adoption of one of the most progressive Domestic 
Violence Acts in the world (Mogale, Burns & Richter, 2012), and connected to 
this could be an increased usage of shelter services among women. An 
important distinction of non-Westernized shelters reviewed by Wright et al. 
(2007) was their openness to women who not only wished to end their 
relationship but also for those who merely wanted a time out or cool down period 
for those who were in danger but did not want to leave for good. This could allow 
IPV victims to more fluidly access services if they are perceived as a less 
dramatic and non-committal option. The final explanation for the high usage of 
IPV services could be related to the effectiveness of the HIRS safety plan, 
specifically in light of the organization of the safety plan. Available domestic 
violence shelters and services were discussed first with participants, and the high 
usage, in accordance with the concept of primacy within memory recall dynamics 
(Kahana & Miller, 2013), could indicate participants recalled this option more 
readily than they would have if otherwise organized. 
For the legal consultation category, 7.5% of participants had used some 
type of legal strategy, but this category assessed for strategy usage by lumping 
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several legal strategies into one item probing for either police or attorney contact 
or taking out an order of protection (restraining order, court order or interdict). 
Peltzer et al. (2013) cite almost 300,000 people applied for an order of protection 
(OOP) in South Africa in 2009/2010, emphasizing the popularity of this approach 
in South Africa. Their study, in the Vhembe district, found OOP’s to be highly 
effective in reducing violence. However, this area varies in many ways from 
areas in the Gauteng province region where the current study’s participants were 
recruited, and Peltzer et al. completed post-test follow-up at the 6 month mark; 
whereas, the current study only waited about 4 weeks for follow-up. It is possible 
that a longer follow-up period may procure different findings for the Gauteng area 
as well. Additionally, because the current study assessed for an aggregate use of 
any legal strategy, it cannot be ascertained how many who used any legal 
strategy actually took out an order of protection versus speaking with a lawyer or 
calling the police. While the number of 7.5% may sound low, another study found 
only 1% of victims had utilized this strategy (Wiist as cited in Parker & Gielen, 
2014) but one study in South Africa cited 27% had contacted the police (Peltzer 
et al., 2003), and one in the U.S. showed 23% had contacted the police (Glass et 
al., 2010). In contradiction with the current study’s findings, Adams et al. (2011) 
reported that seeking help from the police had the strongest correlation with HIV 
testing in their sample, but they did not know if the testing or the help-seeking 
from the police came first. 
Perceived helpfulness of police varies among IPV survivors, with sources 
finding half of participants reporting the police were effective in mitigating the 
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violence, but another 17% reporting they had contributed to worsening the 
violence. Another study from the same systematic review found that 63% of 
participants saw the police helpful but 28% did not (Davies, Block & Campbell as 
cited in Parker & Gielen, 2014). Although these rates portray some of the 
experiences of IPV survivors utilizing the police for assistance, a greater 
depiction of police reception specifically in South Africa is needed to fully 
contextualize this discussion. Bendall (2010) tells that historically police in South 
Africa have been known for neglecting matters related to domestic violence, 
despite the country having one of the most progressive domestic violence acts in 
the world. Police have often been either unaware of the laws around domestic 
violence, responded aggressively to calls, refused to charge men for assault or 
carried similar beliefs and attitudes of gender inequalities as found among IPV 
perpetrators. It is questionable, therefore, if police would be seen as helpful or 
harmful to a victim. Further, women with economic dependence on their abusive 
partner are less likely to contact the police about the abuse (Van Schalkwyk et 
al., 2014), but this study did not assess participant’s economic constitution. 
Planning Strategies 
The category of planning strategies included three areas, which are 
discussed by descending usage popularity. 16% of participants reported using a 
planning strategy to safely take HIV medication, and 15% reported using a 
planning strategy to safely get to medical appointments. To some extent, these 
numbers would be expected as higher due to the number of participants who 
went on to link to care. Nevertheless, it is not surprising that immediately 
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following testing, HIV+ participants may not have been able to accurately assess 
their danger levels, as evidenced by those at pre-test who reported they would 
feel safe getting to medical appointments compared to those who reported at 
post-test that they had not in actuality felt safe getting to medical appointments, 
which increased significantly for all groups.  
Only 12.5% of participants reported using general safety planning 
strategies. Although Goodman et al. (2003) separated out each of the planning 
strategies when assessing for usage and perceived helpfulness and included 
more strategies, usage of planning strategies among their sample ranged from 
29.7-62%. Other studies also separated out many of these strategies with one 
reporting 61% of participants reporting they kept important phone numbers 
hidden and 75% reported they had created an emergency escape plan that 
included hiding money. All the sources reporting higher numbers were procured 
from women who were attending for IPV services such as domestic violence 
agencies or legal aid. 
Private Strategies: Resistance & Placation 
Only 5% of the combined Experimental group reported using Resistance 
strategies. This is significantly lower than that reported in some other studies on 
IPV. One study, having the same sample size as the combined Experimental 
group in the current study but focusing on battered women already in a shelter, 
reported 83% of participants had used this strategy (Van Schalkwyk et al., 2014). 
More aligned with the current study, another source reported 7.5% usage of the 
running and hiding strategy (O’Campo as cited in Parker & Gielen, 2014). One 
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explanation for the low usage numbers of this strategy is the content of the safety 
plan. Participants were informed during safety planning of the correlation 
between fighting back strategies and increases in violence. The low usage of this 
strategy could suggest the effectiveness of this area of the safety plan. 
The final type of strategy discussed during safety planning, which was 
also assessed for in the aggregate, was Placating strategies. The current study 
found that only 4% of participants used the placation strategy, but other studies 
reported 90% of its participants used this type (Goodkind as cited in Parker & 
Gielen, 2014). It is unknown exactly why placation strategies were employed so 
infrequently in this study, but the qualitative study by van Schalkwyk et al. (2014) 
over South African survivors in IPV shelters explains that the women in their 
study, who had already left their abusive partners, reported being much more apt 
to resist abuse and attempt to shift their sense of power away from the abuser 
than they were to acquiesce to the abuse.  
According to Goodman et al. (2003), placating strategies are used to 
change the behavior of a perpetrator without challenging his perception of 
control, and are quite often used in conjunction with resistance strategies before 
the use of public strategies. Thus, the findings of the current study suggest that 
either the participants were responding to escalations in danger, which according 
to Goodman et al. and Lempert’s theory is typically when public strategies are 
employed, or the participants’ safety strategy usage in this study demonstrates 
action unique to the HIV-IPV phenomenon for which women may be charged to 
seek greater consultation after recently testing HIV+, or the HIRS protocol did 
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spur the participants on to more readily take action for the betterment of their 
health. 
 
Interpretation of Strategy Utilization 
In summary of safety strategy and safety plan usage, given that data in 
the current study were procured from individuals undergoing HIV testing services 
and not from individuals seeking IPV specific services, these numbers compare 
favorably. Most comparison data comes from samples of individuals who were 
receiving domestic violence services such as shelters and support groups (Glass 
et al., 2010; Goodman et al., 2003; Parker & Gielen, 2014) or from those who 
specifically sought IPV services (Peltzer et al., 2013). These high numbers 
demonstrate that those testing HIV+ not only are in need of safety planning 
strategies but also are motivated to use them as a means to protect themselves. 
A particularly salient finding from the current study was the popularity of the 
strategies talking with family/friends and medical professionals, which fall into 
informal network strategies as well as public strategies. Goodman et al. (2003) 
explain literature consistently shows women more often begin with private 
techniques such as placating and resistance strategies and then move into more 
public strategies. This may underscore a fundamental difference among those 
who are grappling with the HIV-IPV link versus those who are only navigating the 
nuances of IPV in their relationship. Or this finding could demonstrate the 
effectiveness of informing participants about evidence-based practices known to 




Feasibility: Domain 4  
The final feasibility domain considered risks involved in study participation. 
For the item Would it be safe for us to contact you again in 1, 2 or 3 months, 
there was relatively no difference between dosage levels with 96.3% of those in 
Dosage level 1 answering in the affirmative (any contact again was dichotomized 
post hoc), and 96.2% of those in Dosage level 2 answering affirmative. Although 
it took greater effort to reach Dosage level 2 participants for follow-up safety 
plans and post-tests, these participants seemingly did not mind the extra phone 
calls as evidenced by the parallel response rates to being contacted again. More, 
participants’ willingness and projected ability to safely correspond again about 
their relationship difficulties, suggests that it would be plausible (given the 
resourcing) to extend the follow-up period for a later study. Thus, this finding 
could be a significant contribution to the rationalization of such a methodological 
approach in future research. 
The items Talking about the relationship difficulties placed you at greater 
danger and The services you received placed you in greater danger get to the 
heart of any perceived harm related to study participation. For the item Talking 
about the relationship difficulties placed you at greater danger, a unanimous 
number of participants in Dosage level 2 (100%) reported that talking had not 
placed them in greater danger, and those in Dosage level 1 were similar (96.3%). 
For the item The services you received placed you in greater danger, a similar 
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percentage of participants in Dosage level 1 (95.1%) reported they had not been 
placed in greater danger compared to those in Dosage level 2 (97.5%).  
Although these questions show that participants primarily did not find 
study participation to increase their danger, most studies do not report on 
perception of increased danger as related to study participation. Instead, this is 
often operationalized as discomfort, regret, drawback, etc. These items have 
already been discussed under Acceptability, and response rates in both this 
Feasibility domain and Acceptability compare positively with other studies. From 
such comparisons, it can be concluded that the study is feasible to administer 
without increasing participants’ perceived danger. Albeit the numbers were few, 
future studies should explore how participation and services increased danger 
among those who reported this was the case.   
 
Violence upon Partner Notification of Serostatus 
To further measure risk among study participants, actual violence 
experienced was also assessed but, as an HIV-IPV intervention, it was only in 
relation to partner notification of serostatus. For the item If you notified your 
partner of your HIV status, did you receive any violence as a result, a significantly 
higher number of participants in the Standard of Care group (10/81 or 12.35%) 
compared to the combined Experimental group (5/160 or 3.13%) reported having 
experienced some form of violence upon notifying their partner of their 
serostatus. Although group differences between dosage levels were non-
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significant, the amount of violence received was further attenuated with the 
second dosage level.  
These percentages compare positively with other studies, but the current 
study assessed all forms of violence in one item (physical, sexual or emotional), 
and some studies separated these forms of IPV. One study found 19% of women 
had experienced IPV as a result of their HIV status, and slightly higher rates were 
found in the United States, specifically linking physical violence as a result of a 
woman’s serostatus (Nilo as cited in Hale & Vazquez, 2011, pg. 18). One source 
reviewed literature reporting on violence experienced after partner notification in 
developing countries and found a range between 3.5%-14.6% (Medley et al., 
2004). Another study found 7% of participants had reported experiencing IPV 
before and after serostatus disclosure, 17% had experienced IPV before their 
diagnosis, 18% only after, but 32% reported experiencing any form of abuse 
some time before and after they were HIV+ (Gielen et al., 2000). Maman et al. 
(as cited in Kennedy et al., 2015) found that although violence upon partner 
notification of serostatus was not significantly lower for their intervention group at 
a 16-month follow-up, it was significantly lower by a 35-month follow-up. This 
could indicate that violence related to serostatus disclosure continues to fall, but 
these findings are not generalizable outside of their study among pregnant 
women in an antenatal clinic in Durban, South Africa. 
This finding of the current study could be the herald of significant progress 
towards a protocol that effectively mitigates IPV related to serostatus notification 
among women attending mobile HCT, but results should be contextualized with 
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pre-existing knowledge and other relevant considerations must not be ignored. A 
short review of the history of literature on partner notification assists in 
determining the ways in which this study contributes to the knowledge base. 
There is a substantial amount of literature detailing common experiences 
corollary to partner notification of serostatus. Literature on HIV disclosure spans 
from the early 90’s until recent times, with a large cluster of studies utilizing 
samples in the United States (Chaudoir, Fisher & Simoni, 2011) and some in 
developing countries (Medley et al., 2004). Much of the extant literature does not 
focus on disclosure experiences specific to those with IPV or those that do are in 
the United States (Gielen et al. 2000). Disclosure literature using African samples 
is largely specific to pregnant or postpartum women attending clinics, with the 
goal of reducing mother to child transmission (Medley et al.; Peltzer & Mlambo, 
2013; Tam, Amzel & Phelps, 2015)—populations inherently different than those 
who are not pregnant (though the current study did not ask about pregnancy 
among participants), experiencing acute IPV or those who are undergoing mobile 
testing. 
Other factors contributing to the current study’s findings regarding violence 
upon serostatus notification will be explored and followed by arguments in 
support of the study’s practical significance. First, the results are flagged by the 
unequal distribution of those who had previously known their HIV status. More 
investigation is needed, with a more equally distributed sample set, to confirm 
these findings; the Standard of Care only had 3 (3.66%) individuals who had 
been previously diagnosed, and the combined Experimental group had 94 
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(58.75%) who were past testers. Due to the skewed distribution of the sub-
population, it was not possible to control for tester status because it would have 
violated statistical assumptions. When comparing new testers only, a higher 
percentage of those in the Standard of Care group (6/75 or 8%) compared to the 
Combined Experimental group (3/70 or 4%) experienced violence upon partner 
notification, but this no longer remained significant. It cannot be concluded how 
many of those who had been previously diagnosed went on to inform their 
partner of their serostatus after study participation. 
Second, the current study did not ask how many participants disclosed 
their serostatus to their partner and did not receive violence, and so it is 
impossible to fully contextualize how many people in total notified their partner. 
The item If you notified you partner of your HIV status, did you receive any 
violence as a result was intentionally engineered so participants were not 
pressured to disclose if they had notified their partner of their status. Instead, this 
item along with the item Because of my HIV status I will be in trouble with my 
partner were to be used as indicators of perceived or actual danger related to a 
participant’s serostatus. By not asking participants to disclose if they notified their 
partner, the study upheld an ethical standard in tune with the ethical rules of the 
Health Professions Council of South Africa (Le Roux-Kemp, 2013). Moreover, by 
not asking participants to disclose if they had notified their partners of their 
serostatus, the study also circumvented ethical quandaries related to any 
ensuing HIV criminalization laws given the unfortunate global trend towards 
criminalizing a positive serostatus (Bernard, Cameron, Hows, & Mbewe, 2013).   
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Third, this study did not ask about all violence experienced after study 
participation. A possibly relevant postulation is that the older a woman is, the 
more likely she is to experience physical violence at some point, and therefore 
her “HIV serostatus becomes less relevant as a determinant of violence” (Maman 
et al., 2002, pg. 1334). Because IPV is said to inherently escalate, abuse 
experienced after an HIV+ test may be related to the general cycle of violence 
but interpreted as a repercussion of serostatus. Another South African study, on 
pregnant women with IPV who had undergone HIV testing (but were not 
specifically HIV+) in an antenatal clinic in Mpumalanga province, shows that 
although Danger Assessment scores dropped by a three-month post-test, 9% of 
women experienced an increase in violence and more than 24% reported 
physical assault (Matseke et al., 2013). These results cannot be generalized 
outside of women who are pregnant and clinic-testing in Mpumalanga, but they 
could indicate the general escalation pattern of IPV or the pattern of escalating 
violence endured after any testing regardless of one’s serostatus.  
Conversely, to build a case for how these results do suggest the protocol 
shows practical significance for safe partner notification strategies, several other 
findings are elucidated. First, feeding into the last point about the general cycle of 
violence, Gielen et al. (2000) found that women reported experiencing violence 
“some time” after serostatus disclosure. Gielen et al. frame this finding within the 
natural order of IPV as a typically escalating phenomenon. Consequently, abuse 
experienced after a diagnosis may be not be “instant anger in reaction to the 
news, but rather some time later either in the context of an ongoing or new cycle 
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of violence” (pg. 113). It stands to reason that those who had known their status 
for some time may be in just as much danger for violence relating to their 
serostatus as those newly diagnosed as HIV+. 
Violence, any time after being diagnosed as HIV+, could increase as the 
woman begins to rebuild her sense of agency and bravely attempt to receive 
medical care. Abuse after an HIV diagnosis is said to take on different forms and 
commonly appears as threats of outing the other’s status publically, or 
withholding medication or the ability to access medical care as needed—all as 
means to physically or psychologically harm or isolate a woman or conceal 
abuse (NNEDV, 2014). If IPV is, in fact, escalating, all these tactics specific to 
the HIV-IPV intersection may act as fodder for more novel ways to harm a 
woman or maintain power over her. 
Second, considering significantly more participants in the Experimental 
group employed a consultation strategy to mitigate IPV, it is consistent with the 
literature that this would lead to less general violence. Goodman et al. (2003) 
assert that the use of public safety strategies, such as contacting friends/family or 
medical and mental health professionals, act as stronger forces to prevent 
violence. This is not a perfect comparison as Goodman et al. are comparing 
violence received after the use of these public strategies versus private 
strategies like placation and resistance. However, given the greater usage rate of 
public consultation strategies found among Experimental participants, it could be 
deduced that this played some role in reducing violence, in general, for those in 
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the Experimental group, but it cannot be specifically connected to the violence 
experienced upon partner notification for the aforementioned reasons.  
Third, while it may first be assumptive that those who had previously been 
diagnosed as HIV+ would not experience parallel risks upon partner notification 
or even have the same numbers who had yet to notify their partners, a shocking 
number of participants from all groups reported a sharp increase in fear related to 
getting to medical appointments between pre-test and post-test. For the item, 
You feel safe getting to medical appointments, (236/248 or 95.16%) of the total 
sample reported at pre-test they currently felt safe getting to medical 
appointments, but by post-test this percentage had almost reversed so that only 
(102/248 or 41.13%) answered yes to I have felt safe getting to medical 
appointments. This means that at pre-test only 4.84% anticipated they would feel 
unsafe getting to medical appointments, but within the 30 days after testing 
58.87% reported no longer feeling safe getting to medical appointments. It is a 
considerably alarming finding that perceived risk grew for over half of the sample 
within the first 30 days after testing, independent of tester status. And most 
salient to the present discussion were the significantly diminished percentages of 
those feeling safe getting to medical appointments among past testers (those 
previously diagnosed as HIV+). Among past testers, (96/97 or 98.97%) reported 
they felt safe at pre-test, and only (35/97 or 36.08%) reported feeling safe by 
post-test. Although new testers’ feelings of safety in getting to medical 
appointments also diminished, falling from 140/151 (92.72%) at pre-test to 
(82/149 or 55.03%) at post-test, the most dramatic change occurred among the 
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past testers who had overall 62.89% report a change in feelings of safety 
compared to the new testers at 37.69%. This demonstrates it cannot be assumed 
that the past tester sub-population, those previously diagnosed as HIV+, did not 
also experience grave difficulties getting to medical appointments despite these 
participants having already been aware of their own serostatus. The on-going 
danger associated with HIV serostatus that was observed in this study is 
consistent with the assertion of Medley et al. (2004) that the disclosure process 
(partner notification) is often not immediate but occurs over time with an 
increasing amount of disclosure occurring over time. Further, Wong et al. (2009) 
found that among a general sample of men and women (not specific to IPV) 
those who had already disclosed their serostatus to their sexual partners had 
known their serostatus 7 months longer than those who had not disclosed. 
Although literature consistently finds that most women disclose their serostatus 
to their partner (Gielen et al., 2000) and do so for various reasons (Peltzer & 
Mlambo, 2013), a systematic review showed individuals are more apt to tell 
someone they have a close intimate relationship with (Chaudoir et al., 2011), with 
disclosure among pregnant women being strongest for those who had strong 
partnership with no history of domestic violence (Tam et al., 2015). Thus, it 
cannot be assumed that any of those who had previously been diagnosed had 
disclosed their status to their partner, and even for those with new diagnoses, it 
cannot be assumed how many had disclosed to their partner. 
The fourth reason these results could be practically significant considers 
the potential role of baseline danger scores at pre-test. While no literature could 
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be found on predicting danger associated with the HIV-IPV link, the literature that 
exists on predicting IPV-only risks suggests the best model for predicting IPV is 
use of Campbell’s Danger Assessment (DA) in conjunction with a woman’s 
reported perception of risk (Roehl, O’Sullivan, & Webster, 2005). If the HIRS 
scale measures perception of risk, its use in conjunction with the DA could be the 
strongest indication into actual danger levels for those affected by the HIV-IPV 
link. Although pre-test DA scores for the combined Experimental group were not 
significantly higher than the Standard of Care group, scores for the Danger 
Indicator (whole pre-test, including danger associated with the HIV-IPV 
intersection) showed that those in the Standard of Care group scored 
significantly lower at pre-test than the combined Experimental group. According 
to this, those in the combined Experimental group would be predicted to have a 
slightly higher occurrence of re-assault. Further, those in the Standard of Care 
group reported a significantly lower baseline level of physical and sexual violence 
at pre-test than the combined Experimental group. In general, women who have 
endured IPV report “higher personal-risk ratings for future violence than women 
without such experience” (Helweg-Larsen as cited in Harding & Helweg-Larsen, 
2008, pg. 9). One interpretation of these findings is that because the current 
study did not have baseline equivalence for the two variables of the Danger 
Indicator score and reports of physical and sexual abuse, the intervention was 
possibly more effective than the non-significant results indicate.  
The fifth, and final, reason these results could be practically significant 
builds on the aforementioned reasons and more closely inspects baseline 
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perceptions of danger related to serostatus as a mechanism for including 
women’s perceived risk in tandem with an actuarial score for risk. Results from 
the item You will be in trouble because of your HIV status demonstrate that, 
aside from containing more participants who had been previously diagnosed as 
HIV+, those in the combined Experimental group had greater anticipation at pre-
test that their serostatus could be dangerous in their relationship. About 31% of 
the combined Experimental group answered yes, compared to only 29.4% 
answering yes in the Standard of Care group. For the combined Experimental 
group, percentages were slightly higher for new testers (34.29%) than past 
testers (28.88%). However, when controlling for this item, the difference between 
violence upon partner notification of serostatus remained significantly higher 
among those who reported they would not be in trouble with their partner in the 
Standard of Care compared to those in the combined Experimental group.  
Cattaneo et al. (2007) define situations where individuals predict they are 
low risk for re-abuse but go on to experience re-abuse as false negatives, and 
those who predict they are high risk but then do not experience re-abuse as false 
positives. This source argues there would be qualitative differences between 
false positive and false negative groups with those with more severe violence 
who also “saw themselves at low risk…[being] almost two times more likely to be 
incorrect than correct,” (pg. 438). Unfortunately, this study did not assess for 
severity of physical abuse, and group comparisons on severity cannot be drawn. 
Yet, those in the combined Experimental group had significantly more 
participants reporting any physical abuse at pre-test, and this could suggest they 
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would be more likely to predict re-abuse but went on to experience less re-abuse 
relating to partner notification despite the prediction they would be in trouble with 
their partner because of their serostatus. Hence, this finding is consistent with the 
Harding & Helweg-Larsen (2008) assertion that those who perceive themselves 
to be in greater risk for danger have been shown to have greater intentions of 
making protective changes in their relationship.  
Given that those in the Experimental group had more physical abuse, 
increasing their likelihood to take action to protect themselves, it can be 
hypothesized that receipt of the experimental components of HIRS protocol acted 
as the stimuli inciting participants to make changes by way of first shifting their 
normative beliefs about abuse and then exposing them to available resources. 
One of the central components of the HIRS protocol is the presentation of danger 
levels (from the Danger Indicator) to participants. This is done in the beginning of 
safety planning to inform participants of danger levels in their relationships. It is 
possible that because those in the Standard of Care group were not informed of 
their danger levels they were less aware of the potential risks in their 
relationships and less prepared for re-assault that could ensue upon partner 
notification of serostatus. Another central component of the HIRS protocol—
participants in the experimental group were informed about potential danger with 
partner notification and asked if they wanted to develop a plan to safely notify 
their partners. As a result, the item Because of my HIV status I will be in trouble 
with my partner may be a better indicator of group comparisons rather than tester 
status. As referenced above, this item was also found to be a significant indicator 
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for protocol effectiveness with linkage to care, as more people answering yes to 
the item among the combined Experimental group (50%) linked to care 
compared to those answering yes and linking to care in the Standard of Care 
group (23.1%)—also consistent with the assertion of Harding & Helweg-Larsen 
and ground in Theory of Planned Behavior. 
 
5.9 Strengths 
Though this study had many strengths, six primary areas of strengths are 
enumerated. First, rigorous methodology was maintained while also abiding by 
the ethical standards laid forward by the World Health Organization for Ethical 
and Safety Recommendations for Research on Domestic Violence Against 
Women. Using randomized group allocation, the study assigned participants into 
a Standard of Care group and an Experimental group that contained two 
treatment arms to test variations in outcomes by protocol dosage levels. Sample 
size for group allocation was based on an a priori power analysis and the amount 
needed was exceeded. The Standard of Care group was offered first-line support 
in accordance with ethical standards, and only a small number of those utilized 
resources on their own. These contaminating cases were extracted from 
appropriate analyses as distinguished within Chapter Four.  
Second, almost all participants were retained for post-test data collection. 
This is an extremely high level of retention and shows great evidence for the 
feasibility of the protocol. Of the 255 who participated in pre-test data collection, 
249 (97.65%) of those were retained for post-test data collection, and 99.97% 
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were reachable with only a small amount opting out of post-test collection despite 
being reachable. This is a remarkable retention rate compared to other studies. 
Matseke et al. (2013) found a retention rate in an IPV study in South Africa of 
52.5% with only a slightly longer follow-up period of 3-months; Peltzer et al. 
(2013) used a 6-month follow-up period with IPV survivors and only had a 
retention rate of 44%. If one study’s use of low survey completion rates was 
correctly interpreted to indicate harm experienced by participants (Appollis et al. 
2015), the current study bodes well in feasibly administering a study over a 
sensitive subject with little to no harm as a corollary. 
Third, the study included not only participants who had experienced 
physical and sexual abuse but also those with psychological abuse (non-violent 
control) in their current relationship. Rees et al. (2014) point out that this is often 
not addressed by studies analyzing IPV prevalence, “although it appears to be 
common and has serious mental health implications” (pg. 2). By including those 
with psychological abuse, this form of abuse is upheld as a commensurate threat 
against human rights (as physical and sexual abuse)—allowing those with 
psychological abuse to also reap study benefits, and new knowledge was 
generated on psychological abuse and HIV. 
Fourth, the study addresses a major gap in knowledge on the HIV-IPV 
intersection, having tested and found to be appropriate two new psychometric 
tools. One tool was the HIV IPV Risk and Safety (HIRS) scale. This scale is a 
completely new tool designed specifically to address risk associated with the 
HIV-IPV intersection. The other instrument created and tested within this study 
	   
190 
was the Danger Indicator. This tool includes the HIRS scale within it but is also 
comprised of several other scales with strong empirical support for their validity 
and reliability of use in South Africa. Both were shown to be appropriate 
instruments insofar as the Danger Indicator was sufficiently unidimensional to be 
used as a global score for danger prediction, and the HIRS scale was shown to 
have very good reliability. Although both instruments need some further 
refinement (see Limitations), the preliminary findings on them show they 
represent a significant contribution to measuring perceived risk and safety 
associated with HIV-IPV intersection.  
Not only do the results of this study add to the IPV knowledge base by 
further testing the use of safety strategies among IPV victims—where there is a 
paucity of information—but the results also help establish a 7th domain for IPV 
safety strategies that is specific to those living with both HIV and IPV. The final 
way this study addresses a knowledge gap is by demonstrating what happens 
within the first 30 days after testing HIV+ during mobile testing. Trends in linkage 
to care, immediately following HIV diagnosis, were previously unknown for those 
experiencing IPV. Some information had been gathered on abuse after testing 
but those were for pregnant women, not necessarily testing HIV+, and in a 
different province at an antenatal clinic. This study’s results help gain insight into 
the volume of IPV prevalence among mobile testers in Gauteng province and 
what occurs immediately following diagnosis. Also shown is the heightened 




Fifth, study results contribute substantially to the field of knowledge on the 
HIV-IPV intersection. Items were included in the study to measure not only 
effectiveness of the protocol but also feasibility and acceptability, which are 
integral in determining the risk/benefit ratio—an ethical necessity when 
conducting research on sensitive subjects (Appollis et al., 2015). These findings 
demonstrate how an HIV-IPV protocol can be effective and well received while 
inflicting very little risks, building greater knowledge on the cost/benefit ratio of 
research of the sensitive subject of abuse. Findings also present a protocol 
promising in promoting linkage to care for those aged 33-43 and mitigating 
violence upon partner notification of serostatus. 
The sixth and final strength of this study was its ability to accomplish all 
strengths hitherto listed while employing a protocol shown to be brief in 
administration. The importance of this finding cannot be overemphasized. 
Sources call for more efficient approaches in developing countries (UNAIDS, 
2013a), and adding a needed IPV component cannot become a burden to 
already-existing and vital HCT services. Brevity is key to feasibility given the 
extreme financial and time constraints experienced in such a low resource, high 
prevalence area as Gauteng province, South Africa. Therefore, this protocol 
shows great promise for the feasibility of integrating an IPV protocol into mobile 





As all studies have limitations, and, so too, did this study. Despite the 
randomization process, there was not group equivalency on a few variables. 
Groups differed by portion of physical and sexual abuse reported at baseline as 
well as pre-test scores for Danger Indicator levels. The unequal distribution of 
those newly diagnosed versus previously diagnosed (tester status) was the 
limitation causing the most hindrance to the process of garnering the practical 
significance of study results. While the study exceeded the required sample size 
determined necessary through power analysis, the unequal distribution of those 
previously diagnosed prohibited the use of even elementary analytical methods. 
Although their inclusion helped generate new information about the on-going role 
of perceived danger related to serostatus for those previously diagnosed as 
HIV+, caution should be used in interpreting the finding that the Standard of Care 
group experienced significantly more re-assault upon partner notification of 
serostatus and this research question should be further explored in future studies 
with equally distributed new testers to confirm these results.  
While the vast majority of participants received the protocol within 30 days 
from HIV testing, a small percentage received the intervention slightly over 30 
days. It took some participants longer than others to be reached for each 
component of the study, and this was inherent to the telephonic medium. 
Although it could have been an important confounder if the time to reach 
extended well beyond 30 days, this was not the case in this study. 
The research team administering this study was not blinded to study group 
allocation because the research team had to administer the varying treatments 
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based on group allocation. However, participants were blinded to group 
allocation. Although the randomization process was rigorous, the lack of blinding 
among the research team could be a threat to the validity of the study.  
Limited information was collected on participant demographics. Most other 
studies collect information on participants’ education levels and other data that 
has been shown to be mediate HIV and IPV risk factors. Such information would 
have allowed for stronger contextualization of the data and more robust 
interpretations of the study’s practical significance. Along the same lines, the 
study did not address some of the more common elements found in similar 
studies such as trauma-related co-morbidity among survivors (Appollis et al., 
2015) or the role stigma plays in the HIV-IPV intersection (Zembe et al., 2015). 
As discussed previously, the study did not ask about all abuse endured after 
participation but merely focused on abuse related to partner notification of 
serostatus. All such material could have allowed for stronger contextualization of 
results. Yet, most of these prospective items were jettisoned as an effort to 
maintain brevity, and because there is already a substantial body of information 
in existence on many of the demographic correlates of IPV in areas with high HIV 
prevalence (Abrahams, Mathew, Martin, Lombard & Jewkes, 2012; Abramsky et 
al., 2011; Adams et al., 2011; Dunkle et al., 2004; Jewkes et al., 2002). However, 
it would be advantageous for future studies to include more demographic 
information to draw further parallels with other studies and to uncover any other 
trends that could exist relative to the HIV-IPV intersection, as such information 
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could demonstrate the effectiveness of the current protocol on various 
populations. 
There are other forms of IPV not considered in this study, i.e. IPV in same-
sex relationships, abuse perpetrated by women against men, or IPV in the form 
of financial abuse. These topics should also be explored in research on the HIV-
IPV link. For example, the South African Domestic Violence Act includes all types 
of IPV discussed here but also includes economic abuse, stalking, property 
damage and the act of illegally entering someone’s residence (Peltzer et al., 
2013). While this study did not exclude those in same-sex relationships, it did not 
ask participants about their sexual orientation and operated from the theoretical 
assumption that IPV is largely gender-based and perpetrated by men against 
women. Other studies should include other forms of IPV and allow for the 
inclusion of male victims. 
After the study’s implementation, new information surfaced from personal 
contact with authors of two of the sub-scales used within the study. Personal 
communication (J. Campbell, personal communication, July 29, 2015) with the 
creator of the Danger Assessment led to a slight change in the danger values 
assigned to a few different items within this sub-scale. Changes were made to 
this portion of the Danger Indicator and participants were updated on this 
information at the next contact (some at follow-up safety planning and others 
post-tests). However, this only affected a small portion of the group as this 
change occurred only a few weeks into study recruitment when recruitment was 
at its slowest (due to poor initial buy-in from those administering HCT and 
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responsible for study recruitment). Ultimately, these minor changes only altered 
the overall Danger Indicator score by 1 point, causing it to go from 50 to 49 total 
points, which through inspection was not shown to have changed any 
participant’s overall danger level (in 5 point increments). Hence, the integrity of 
the intervention was not altered due to this change. 
Contact with M.P. Johnson (personal communication, July 23, 2015), one 
of the authors of the non-violent control scale, provided new information relevant 
to the methods used to measure IPV, particularly with the non-violent control 
scale. The dichotomous items used to assess non-violent control were based on 
Johnson & Leone’s (2005) manuscript, but through personal email exchange and 
the sharing of manuscripts unpublished at the time of this study’s 
implementation, a new method was realized. This manuscript by Hardesty et al. 
(2015) was published 1.5 months into this study’s implementation, and thus 
changes were not possible. Hardesty et al. negate the use of measuring IPV by 
merely tallying IPV tactics experienced and explain that, instead, IPV must be 
considered in terms of frequency and severity which can only be obtained 
through asking about the complexity of each tactic used rather than the amount 
of different tactics used. This information is mostly only relevant to the process of 
determining IPV typology among a sample set, which the present study does not 
attempt to do (see recommendations for future research), but this is important 
because the dynamics of the IPV experienced can be drastically different from 
one typology to another (see implications for future practice). Such a 
methodological approach would have enriched the data in the present study, but 
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doing so would have certainly jeopardized the brevity for which the protocol was 
administered.  
 Finally, while the HIRS scale and Danger Indicator both represent 
significant contributions to the HIV-IPV knowledge base, both come with 
limitations. Though the HIRS scale was shown to have strong reliability 
(Cronbach alpha .882), the validity of the scale (the mean of corrected item total 
correlation was .364) was problematic (see recommendations for future studies), 
and, thus, results for the scale should be interpreted with caution. Additionally, 
the Danger Indicator, while shown to be sufficiently unidimensional, had only 
19% of variance accounted for in the final fit during Exploratory Factor Analysis 
(see recommendations for future studies). More, the validity and reliability of 
these psychometric instruments were specific to the validation sample and future 
studies should reassess validation for different populations. 
 
5.11 Implications for future practice 
Literature highlights the urgent need for interventions that address the 
HIV-IPV link; interventions are needed to improve access and retention to 
healthcare services and promote strategies for safe partner notification of 
serostatus. Each component of the HIRS protocol was woven into the protocol 
because it was grounded in the literature as an empirically supported practice in 
the areas of either mobile HCT or intimate partner violence. This study presents 
findings from a first effort in creating a protocol that effectively mitigates IPV as a 
means to promote health and safety after testing HIV+ in mobile HCT. While the 
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results of this study show early promise for an acceptable and feasible protocol 
that has effective strategies to reduce assault upon partner notification of 
serostatus and promote safe linkage to care among those aged 33-43 years, 
further testing and refinement of the HIRS protocol is needed before fully 
implementing the protocol as a standard of care.   
Further testing is required, before implementing the protocol into practice, 
to clarify the current results and strengthen or challenge findings on 
effectiveness. From what is known about the protocol, several challenges may 
emerge with its use as a standard of care. One the one hand, the telephonic 
nature of the protocol would facilitate administration by the NGO’s current links to 
care call centre program. On the other hand, some logistical challenges would 
need to be circumvented. More ad hoc funding would be required so that staff 
time and monies are not detracted from current HCT services. Additionally, all 
staff would need on-going training on the HIV-IPV link and ways to provide 
supportive and empathic services to IPV victims. Social workers are poised as 
the best candidates for such a role, as they are trained to administer clinical 
services from a place of non-judgment and empathy while applying knowledge of 
the person-in-environment. One way to parcel out protocol administration time 
would be to offer the Danger Indicator during HCT but prior to testing uptake. 
Those who meet IPV eligibility would then receive safety planning during their 
contact with the links to care call centre program. However, administration of the 
Danger Indicator prior to testing may have challenges as well; this could reduce 
the numbers of those wanting to test if it took too much of participant’s time, and 
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screening all participants would be costly in either staff time or resources (the 
latter would be the case if the screening were to be administered through 
interactive media). 
Additionally, the protocol itself should be refined to address the varying 
types of IPV, as each IPV typology requires different intervention modalities. 
Whereas the typology of Intimate Terrorism typically includes the use of 
systematic power and control and has been shown to escalate in severity or 
frequency over time, another typology of Situational Couple Violence can present 
with gender parity and is said to not be maintained by power and control but 
instead by maladaptive coping skills employed when the demands of stress 
exceed resources. 
Finally, other populations may benefit from the HIRS protocol. As cited, 
women report experiencing IPV after an HIV+ diagnosis, but some of those have 
not experienced IPV before the diagnosis. Thus, only assisting those who meet 
IPV eligibility may be marginalizing groups of individuals who are vulnerable. 
Consequently, all women may benefit from receipt of the HIRS as a means for 
general safety planning after a diagnosis. More, services should be extended to 
men; they also experience IPV victimization, and there is a great need for 
protocols effective with batterers. Given the ample literature citing the need for 
IPV services with men (Boonzaier & Gordon, 2015; Jewkes et al., 2011), funders 
would likely find such an initiative compelling and grant-worthy.  
 
5.12 Recommendations for future research 
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Despite the call for more evidence-based methods addressing the HIV-
IPV intersection, there is still a paucity of information on effective ways to 
mitigate deleterious health outcomes among women diagnosed as HIV+. Greater 
attention is needed on women already living with HIV to help reduce barriers to 
care and assault related to a seropositive status. HCT has been shown to be a 
prime way to reach women affected by the HIV-IPV link, and more research is 
needed to refine best practices for assisting this population post diagnosis.  
Future studies utilizing similar populations should include some 
components of the HIRS protocol given that it was overwhelmingly well received 
among all participants in this study. Because the experimental components were 
also found to be helpful and safe to administer, future studies could use the 
safety plan in this study but should continue to enhance it with current research 
as such knowledge unfolds. The high retention rate in this study, coupled with the 
number of participants who reported it would be safe to be contacted again at the 
1, 2 and 3-month marks, suggests a future study could also extend the follow-up 
period to gain a more accurate depiction if participant experiences fluctuate 
before and after the first 30 days of a diagnosis or testing.  
Findings from this study will inform future studies in various ways. Namely, 
the HIRS protocol may be refined in a Phase III clinical trial in order to strengthen 
its suitability for practice. Such a study would allow for a larger sample size, 
enabling the covariate of tester status (those previously diagnosed), and more 
administration time to glean richer data over IPV typology, frequency and 
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severity, using continuous variables permitting the use of more sophisticated 
analytical methods and subsequently more robust practical significance.  
Given that the current protocol was found to be safe, acceptable and 
feasible to implement, further effectiveness testing could be done with more rigor 
by implementing an amended HIRS protocol that masks group allocation from 
those administering the instruments. Future studies could do this by changing the 
instruments to be identical so that a designated person would only administer the 
pre and post-test instruments while being blinded to participant group allocation. 
It is recommended that the standard HIRS protocol adopt the second 
dosage level, as outcomes were strengthened by the second dosage. However, 
should financial and time limitations present as insurmountable barriers, 
effectiveness does not appear to hinge on the second dosage level. The extra 
safety plan was found to be beneficial in regards to minor increases in 
acceptability and satisfaction, increases in safety plan and safety strategy usage 
and the attenuation of re-assault related to partner notification of serostatus. The 
follow-up safety plan was, however, found to be cumbersome in administration 
given the excessive amount of attempts it took to reach participants for this 
component. 
Future studies should be designed to more clearly assess for the 
effectiveness of safe partner notification strategies. A systematic review of safe 
partner notification strategies was published after this study began, but it 
contains important recommendations for future research about strategies to 
mitigate violence upon partner notification. Essentially, this source argues that 
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despite the global charge for more interventions addressing safe partner 
disclosure, very limited research has focused on rigorously demonstrating the 
effectiveness of notification strategies (Kennedy et al., 2015). Future studies 
should ask more explicit (but ethically crafted) questions to assess who has 
already disclosed their status to their partners, each type of violence (physical, 
sexual and emotional) should be separately assessed, and study designs should 
include longer follow-up periods to enhance comparability with other studies 
reporting on this topic. The findings of the current study demonstrate the need for 
greater attention to be given to those who are previously diagnosed but remain 
fearful, as they too experienced heightened fear in the 30 days after undergoing 
mobile HCT. A greater understanding of what motivated this group to return for 
CD4 cell testing would assist with more knowledge on this sub-population. For 
those who had already disclosed their serostatus to their partner, important 
information may be gleaned on effective strategies for safe partner notification.  
Other sub-populations should be considered to improve the comparability 
of study findings or to assist those commonly neglected by current research. 
Future studies should assess for all violence experienced between pre and post-
test collection and include group comparisons in linkage rates between those 
with IPV and without IPV. Linkage rate comparisons would be enhanced if 
studies of the HIV-IPV intersection also tracked participants’ CD4 cell counts. 
Fluctuations in CD4 cell counts could demonstrate changes in physical health 
among participants, facilitate comparability with other linkage research given that 
many use CD4 stratum to interpret linkage rate success, and help suss out 
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motivators for linkage to care among those meeting ART eligibility. More 
information is needed on participants aged 33-43 to learn what factors may have 
allowed greater rate of linkage to care among them. Additionally, there is a great 
need to include males in studies on HIV and IPV, with effective batterer 
interventions needed as well as programs shown to be effective with male victims 
of IPV. A greater focus should also be placed on exploring the HIV-IPV 
intersection in same-sex relationships in South Africa.  
To determine if the HIRS protocol is detecting increases in risk or 
heightened awareness of IPV dynamics, future studies should include a means 
for assessing increases in knowledge of IPV. This, in conjunction with assessing 
for all violence experienced between pre and post-test, will shed greater light on 
fluctuations in risk and safety among participants between study groups.  
 Safety strategies in the current study were assessed using combined 
categories. For example, the item on legal strategies lumped together calling the 
police, talking to a lawyer, and taking out an order of protection. Each of these 
could have different implications, and future studies could separate these out to 
better assess which were most utilized and helpful. Further, the helpfulness of 
each strategy should be considered as well as how perceptions of helpfulness 
vary among those with higher danger scores (as found in Goodman et al., 2003), 
and the use of a likert scale would allow for comparison with germane literature 
which report mean scores for helpfulness. 
As united efforts are needed to continue fighting the insidious interlinked 
epidemics of HIV and IPV, there is a great need for cross-cultural exploration of 
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how IPV differs throughout various international contexts. For example, the role 
that concepts such as love, hope and dreams play in IPV relationships among 
people living with HIV should be further explored as these concepts are 
suspiciously omitted from literature on IPV in South Africa, even among 
qualitative findings. 
Greater synergy is needed between those creating protocols such as the 
HIRS and the communities they are administered in so that community-level 
change may happen alongside micro level change. For example, the four most 
popular strategies employed from the safety plans were contact with 
family/friends, medical professionals, mental health professionals and clergy. 
Each of these areas as a sole help line raises concern given that doctors were 
found to be grossly under-trained, mental health professionals may not operate 
from a strength-based or empowerment model, clergy were burned out with their 
role in helping survivors and family and friends likely have adopted similar 
cultural beliefs of normalized gender inequalities. For such a goal, initiatives such 
as the HIRS, targeting the HIV-IPV intersection, will likely need to work more 
closely with IPV-specific programs to create a more substantial break in the 
massive flow of gender inequalities amassed in South African culture. 
  
5.13 Conclusion 
 Eradication of the HIV/AIDS epidemic hinges on the global response to 
interconnected human rights’ issues such as gender-based violence and its all-
too-common manifestation of intimate partner violence. South African women 
	   
204 
have been hit the hardest by both HIV and IPV, and sources have called for more 
rigorously tested approaches that jointly target these phenomena as a means to 
mitigate future assault related to a seropositive status and reduce barriers to HIV 
care. Findings from the study Mitigating Intimate Partner Violence to Promote 
Safe Linkage to Care Among South African Women Testing HIV+ During Mobile 
Counseling and Testing show positive results of a promising protocol developed 
to mitigate violence related to the HIV-IPV intersection while promoting safe HIV 
outcomes.  
 The study furthers the HIV-IPV knowledge base by testing two new 
psychometric instruments and showing the feasibility and acceptability of a new 
HIV-IPV protocol. The psychometric instruments of the Danger Indicator and the 
HIV IPV Risk and Safety (HIRS) scale were shown to be suitable for use with the 
HIRS having good reliability and the Danger Indicator having the latent variable 
of physical assault. However, both instruments will need some refinement to 
improve their validity in future studies. All of the study’s aims were achieved: The 
HIV IPV Risk and Safety (HIRS) protocol was found to be feasible to implement, 
as evidenced by extremely high retention, brevity in administration, and high 
rates of safety strategy usage with minimal risks experienced as a result of 
participation. Participants reported high levels of satisfaction, as evidenced by an 
overwhelming number of positive ratings, and the Standard of Care group 
contained minimal contamination with very few participants in this group 
receiving services elsewhere.  
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The HIRS protocol was shown to be effective with regards to mitigating 
violence upon partner notification of serostatus and promoting greater linkage to 
care for those in the experimental group but significantly more so among those 
aged 33-43 years. Moreover, the protocol achieved effectiveness in these areas 
while also demonstrating that the perceived benefit of study participation far 
outweighed reported harms or risks. 
New trends were uncovered in how South African women enduring IPV 
experience difficulties related to a seropositive status and the various strategies 
utilized for self-protection. This study evinces the experiences of women with IPV 
in the first 30 days following an HIV+ diagnosis: across all groups, significantly 
more people reported decreased safety in getting to medical appointments, 
indicating danger associated with getting to medical appointments increases 
within the first 30 days after a diagnosis. More, a surprisingly large number of 
women previously diagnosed as HIV+ reported being fearful their serostatus 
would cause them to be in trouble in their relationship, showing that danger 
associated with serostatus remains a concern for women and may also be worse 
some time after diagnosis.  
Women who received the HIRS protocol were shown to be self-determined to 
take action for self-protection while suffering significantly less re-assault upon 
partner notification than those who did not receive the protocol. Most of the 
experimental group deployed at least one safety strategy, and consistent with the 
literature, the most popularly utilized strategies (consulting with a friend/family 
member or medical professional) have been shown to reduce the likelihood of re-
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assault. Conversely, the least utilized strategies (placation and resistance) have 
been shown in the literature to increase the likelihood of re-assault. The large 
number of participants deploying safety strategies to effectively protect 
themselves reveals the influx of individuals undergoing HCT daily who could 
benefit from the integration of IPV assistance into mobile HCT; this is especially 
true considering significantly fewer participants in the Standard Of Care group 
consulted with someone about IPV compared to those in the Experimental group. 
The number of participants utilizing public safety strategies shows the 
effectiveness of a brief psychoeducational intervention in galvanizing South 
African women to take action to protect themselves from IPV through the 
reclaiming of power rather than acts of placation or complicity. 
 Overall, most of the linkage rates for all groups and ages were lower than 
those found in extant literature, especially among those aged >23 years; thus, 
the need for greater efforts in mitigating IPV as a barrier to HIV care is 
demonstrated. The HIRS protocol was shown to be safe, feasible, acceptable 
and effective. Its effectiveness in facilitating safe partner notification of serostatus 
could be a significant contribution to the knowledge base, but more research is 
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  work	  you	  are	  already	  doing	  and	  takes	  the	  work	  of	  the	  call	  centre	  one	  step	  further.	  We	  know	  young	  women	  have	  the	  worst	  rates	  for	  linking	  to	  HIV	  care	  after	  their	  diagnosis.	  We	  also	  know	  that	  one	  major	  barrier	  for	  women	  to	  receive	  HIV	  treatment	  is	  domestic	  violence.	  We	  want	  to	  find	  out	  which	  of	  our	  clients,	  who	  have	  just	  tested	  HIV+,	  are	  experiencing	  domestic	  violence	  and	  offer	  them	  extra	  support.	  This	  extra	  support	  will	  help	  them	  safely	  link	  to	  HIV	  treatment	  after	  their	  diagnosis.	  	  
Ø On	  average,	  about	  20-­‐55%	  of	  women	  in	  South	  Africa	  are	  experiencing	  some	  type	  of	  domestic	  violence.	  In	  fact,	  South	  Africa	  has	  the	  highest	  rate	  of	  women	  killed	  by	  their	  partners	  in	  the	  world.	  Many	  of	  the	  women	  you	  have	  served	  in	  the	  past	  or	  even	  this	  week	  or	  today	  could	  be	  in	  grave	  danger,	  or	  at	  the	  very	  least,	  never	  receive	  the	  HIV	  treatment	  they	  need.	  	  
Ø This	  study	  has	  been	  created	  so	  that	  women	  with	  HIV	  can	  receive	  the	  treatment	  they	  need.	  I	  am	  asking	  for	  your	  help	  in	  reaching	  the	  vulnerable	  young	  women	  who	  test	  HIV+	  with	  Shout-­‐it-­‐Now.	  	  
Ø Once	  a	  woman	  has	  tested	  HIV+	  and	  you	  have	  had	  some	  time	  to	  do	  counseling	  with	  her	  during	  this	  very	  difficult	  time,	  please	  introduce	  this	  important	  study	  and	  ask	  for	  her	  participation.	  	  


















Appendix	  C	  	  
Informed	  Consent	  English	  	  	  
 
Subject Informed Consent Document 
 
HIV Screening and Intimate Partner Violence Safety Study 
 
Sponsor(s) name & address: University of Louisville, Louisville, KY and Shout-it-
Now, Cape Town, SA 
Investigator(s) name & address: Primary Investigator Michiel A. van Zyl and Co-
investigator Leslie Lauren Brown: 2217 South Third St. Louisville, KY 40292, 
USA. 
Site(s) where study is to be conducted: Gauteng province and telephone calls will 
be made from Cape Town, South Africa.  
Phone number for subjects to call for questions: 021 7134414 
 
Introduction and Background Information 
 
You are invited to participate in a research study.  The study is being conducted 
by Dr. Riaan van Zyl, PhD; Lauren Brown, LCSW, PhD Candidate and Shout-it-
Now.  The study is sponsored by the University of Louisville, Department of Kent 
School of Social Work. The study will take place at all mobile HIV Counseling 
and Testing locations in Gauteng province that S-N visits within the timeframe of 
this study. Contact for this study will occur by phone, through the Shout-it-
Now call centre, which is located in Tokai, Western Cape. Approximately 225 
subjects will be invited to participate.   
 
Purpose 
The purpose of this study is to see if women benefit from knowing their 
relationship safety score when screened for HIV and having a safety plan after 




In this study, you will be contacted by phone the day after receiving services with 
Shout-it-Now. Participation may occur in one of two phases. 
If you are a participant in Phase I of this study, the phone interview or focus 
group you receive will only be used to help improve the study survey or 
intervention (content for phone discussion). We will contact you to get your 
opinion about survey questions and the phone discussion content. We want to 
know if you think the questions will be helpful, are beneficial, make you 
uncomfortable or if any changes are needed so people can better understand the 
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questions or discussion and feel most satisfied with this process. Some or all of 
the questions from Phase II may be asked of you during this phase. These 
interviews or groups will not be audio recorded but, instead, your feedback will be 
written down by hand or typed into a computer. 
If you are a participant in Phase II of this study, you will be asked questions in 
order to help determine how safe your relationship is from violence. Some 
questions were developed just for this study, and other questions are similar to 
questions routinely asked in different parts of the world to determine safety in 
relationships. Some questions relate to physical and sexual intimate partner 
violence and others emotional safety. There are also a few questions about 
experiences you may have had in the past with violent partners and your 
attitudes towards violence in a relationship. You will be contacted 2-3 times for 
this study and asked these questions during the first contact and the last contact. 
The first questions, in total, should take about 8-20 minutes to answer. There are 
46 short questions in the first contact and 18-30 short questions in the final 
contact. Should any of the questions make you feel uncomfortable, you may 
choose to not answer them. You will continue to receive S-N services even if you 
do not answer all or any of the questions. 
Participants in Phase II of this study will be randomized into different study 




This study does have some possible risks, but most risks occur in HIV testing, in 
general, and HIV testing with those already affected by intimate partner violence 
(with or without a study). Some risks occurring with HIV testing, in general, are 
fears of someone finding out you have received an HIV test and/or feeling upset 
during the testing process, which can increase when someone is diagnosed as 
having HIV. When persons are diagnosed with HIV, they may feel fear of or 
actual isolation or judgment from their family and community. You may be at-risk 
of worse violence if there is already a history of partner violence in your 
relationship and because partner violence may increase when someone is either 
diagnosed with HIV or attempting to receive HIV treatment. Risks specific to this 
study are the possibility of feeling slightly uncomfortable when answering difficult 
questions about personal or sexual experiences; answering these questions may 
cause you to recall upsetting situations from the past. If this happens, you will be 
given information for a local agency that may assist you. Another potential risk, 
specific to this study, is that Shout-it-Now will use the telephone to make contact 
with you. This could be dangerous if your partner is aware that you have received 
this phone call. Do not answer the phone if it is not safe to do so. You may 
contact the call centre when it is safe or we will try to reach you at another time. 
Shout-in-Now has been using this call back approach for some time and no 
negative experiences have been reported. Also, research has shown that the use 
of telephone check-ins can help increase safety with women who have been 
harmed in their relationship. Therefore, the benefits of this study appear to be 






This study has many potential benefits. You may experience the feeling of being 
more supported or having more resources as a result of participating in this 
study. You may find that the questions help you to think about your relationship 
and seek out help from your family or community so that you are safer. For 
participants diagnosed with HIV, it is the hope that they will be able to get HIV 
treatment more safely than if they had not participated in this study. In general, 
the hope is that participants will experience feeling safer as a result of 
participating in this study. Research shows that some women, who participate in 
studies about partner violence, say they found the study to be beneficial to them. 
Additionally, information from this study will be used to help other women get HIV 
services in a safer manner. By getting HIV services more safely, women may feel 
more satisfied with their life as well experience increased healthiness or longer 
life. Ultimately, these experiences could lead to less people infecting others with 
HIV as well as less people dying from HIV-related death. Although information in 
this study may not benefit you directly, the information learned in this study may 
be helpful to others. 
 
Compensation  
If you participate in this study, and remain in the study throughout the entire 
course of the study, your name will be entered into a drawing for a free i-pod. 
Additionally, by participating in any part of this study, you will receive a free 
HIV/TB screening and counseling as well as a free intimate partner violence 
assessment. If you prefer not to participate in this study, you will still receive a 




Total privacy cannot be guaranteed.  Your privacy will be protected to the extent 
permitted by law.  If the results from this study are published, your name will not 
be made public.  While unlikely, the following may look at the study records: 
The University of Louisville Institutional Review Board, Human Subjects 
Protection Program Office, and Privacy Office.  
Office for Human Research Protections (OHRP)  
 
Each case will receive a case identification number so that your name is 
not used to identify your information. Data (or information from this study) will be 
stored electronically by the research team in South Africa on a secure server. 
Once the study has been completed, study information, (data) in the form of case 
identification numbers and not names, will be sent by email to the primary 
investigator of this study. The study information (data) to be provided will be 
stored on the computer of the primary investigator. Access to the computer will 
be password protected, and the computer will be HIPAA compliant (follow privacy 
guidelines of the Health Insurance Portability and Accountability Act). A copy of 
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original files will be saved on a CD and be stored in a locked cabinet in the 




Taking part in this study is voluntary. You may choose not to take part at all. If 
you decide to be in this study you may stop taking part at any time. If you decide 
not to be in this study or if you stop taking part at any time, you will not lose any 
benefits for which you may qualify.   
 
Research Subject’s Rights, Questions, Concerns, and Complaints 
 
If you have any concerns or complaints about the study or the study staff, you 
have three options.  
        
 You may contact the principal investigator at 502-852-2430 (USA). 
 
If you have any questions about your rights as a study subject, questions, 
concerns or complaints, you may call the Human Subjects Protection 
Program Office (HSPPO) (502) 852-5188.  You may discuss any 
questions about your rights as a subject, in secret, with a member of the 
Institutional Review Board (IRB) or the HSPPO staff.  The IRB is an 
independent committee composed of members of the University 
community, staff of the institutions, as well as lay members of the 
community not connected with these institutions.  The IRB has reviewed 
this study. 
 
If you want to speak to a person outside the University, you may call 1-
877-852-1167. You will be given the chance to talk about any questions, 
concerns or complaints in secret. This is a 24 hour hot line answered by 
people who do not work at the University of Louisville.   
__________           
   
 
This paper tells you what will happen during the study if you choose to take part.  
Your signature means that this study has been discussed with you, that your 
questions have been answered, and that you will take part in the study.  This 
informed consent document is not a contract.  You are not giving up any legal 
rights by signing this informed consent document.   
 
____________________________________ 









Signature of Subject/Legal Representative   Date Signed 
 
___________________________________________ _____________________ 
Signature of Person Explaining the Consent Form  Date Signed 
(if other than the Investigator) 
__________________________________________ _____________________ 
Signature of Investigator      Date Signed 
 
LIST OF INVESTIGATORS  PHONE NUMBERS 
 
Michiel A. van Zyl, PhD   1-502-852-2430 
Lauren Brown, LCSW, PhD Candidate 1-502-852-2430  
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Appendix	  D	  	  
Pre-­‐test:	  Danger	  Indicator	  English	  	  	  
Pre-­‐test	  English	  SOC	  &	  Exp	  Groups	  
Script:	  “Hi,	  this	  is	  ____________with	  Shout-­‐it-­‐Now.	  I	  was	  given	  
your	  information	  from	  my	  shout-­‐it-­‐now	  teammate	  because	  
you	  agreed	  to	  participate	  in	  a	  brief	  study	  with	  us.	  This	  will	  
take	  about	  20	  minutes	  or	  more.	  Are	  you	  still	  willing	  to	  
participate	  in	  this	  study?	  Great.	  Is	  this	  a	  safe	  time	  to	  talk?	  
Okay,	  I	  am	  going	  to	  ask	  you	  some	  questions	  now.”	  	  
Pre-­‐test	  	  	  	  	  	  	  	  Date	  __________	  	  	  	  	  	  	  	  	  	  	  	  	  Time	  of	  call:	  __________	  
1.	  RS	  1.	  You	  are	  currently	  in	  a	  romantic	  relationship?	   Yes	   No	  2.	  (if	  yes	  to	  1,	  skip	  2):	  You	  often	  find	  yourself	  in	  romantic	  relationships	   Yes	   No	  No	  Total	  for	  RS	  (does	  not	  count	  towards	  total)	  but	  is	  used	  for	  eligibility)	  
2.	  NVC	  (put	  an	  X	  in	  each	  chosen	  block)	  
Would	  you	  say	  your	  current	  partner…	  1.	  tries	  to	  limit	  your	  contact	  with	  family	  and	  friends?	  	  	   Yes	  (1)	   No	  2.	  is	  jealous	  or	  possessive?	  	   Yes	  (1)	   No	  3.	  insists	  on	  knowing	  who	  you	  are	  with	  at	  all	  times?	  	   Yes	  (1)	   No	  4.	  calls	  you	  names	  or	  puts	  you	  down	  in	  front	  of	  others?	  	   Yes	  (1)	   No	  5.	  makes	  you	  feel	  worthless	  or	  useless?	   Yes	  (1)	   No	  6.	  yells	  or	  swears	  at	  you?	  	   Yes	  (1)	   No	  7.	  Has	  hurt	  your	  body	  in	  the	  last	  year?	   Yes	  (1)	   No	  
	  
Total	  Yes	  points:	  ________	  	  
3.	  CTS-­‐2	  (put	  an	  X	  in	  each	  chosen	  block)	  
In	  the	  last	  year	  your	  partner…	  1.	  Hit	  you	   Yes	  	  (1)	   No	  
	   
247 
2.	  Hit	  you	  with	  something	   Yes	  	  (1)	   No	  3.	  Choked	  you	   Yes	  	  (1)	   No	  4.	  Beat	  you	  up	   Yes	  	  (1)	   No	  5.	  Threatened	  you	  with	  a	  weapon	   Yes	  	  (1)	   No	  6.	  Used	  a	  weapon	  on	  you	   Yes	  	  (1)	   No	  7.	  Made	  you	  have	  sex	  without	  a	  condom	   Yes	  	  (1)	   No	  8.	  Used	  force	  to	  make	  you	  have	  sex	   Yes	  	  	  (1)	   No	  9.	  Used	  force	  to	  make	  you	  have	  oral	  or	  anal	  sex	   Yes	  	  	  (1)	   No	  
	  
Total	  Yes	  points:	  ________	  
To	  be	  IPV	  eligible:	  Must	  score	  2	  or	  higher	  on	  NVC	  or	  score	  1	  or	  higher	  in	  CTS-­‐
2	  
NVC:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  CTS-­‐2:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total:	  
IPV	  eligible	  	  	  	  	  	  _______Yes	  	  	  	  ________No	  
If	  yes,	  complete	  remainder	  of	  scales	  
	  
For	  those	  not	  IPV	  eligible:	  “Thank	  you	  very	  much	  for	  answering	  these	  
questions.	  We	  will	  not	  be	  in	  contact	  with	  you	  any	  further.	  Before	  I	  go,	  do	  you	  
mind	  if	  I	  quickly	  just	  ask	  what	  your	  age	  and	  race	  are	  for	  research	  purposes?	  
Age	  _________________	  Race	  __________________	  
Thank	  you.”	  
4.	  VVS	  (Put	  an	  X	  in	  each	  chosen	  block)	  How	  frequent	  do	  the	  following	  happen:	  	  
Almost	  never	  or	  never	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Once	  in	  a	  while	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Frequently	  
1.	  Your	  partner	  seems	  to	  view	  your	  words	  or	  actions	  more	  
negatively	  than	  you	  mean	  them	  to	  be.	  	   0	   0	   1	  
2.	  When	  you	  all	  have	  a	  problem	  to	  solve,	  it	  is	  like	  you	  are	  on	  
opposite	  teams.	  	   0	   0	   1	  
3.	  You	  feel	  lonely	  in	  the	  relationship.	  	   0	   0	   1	  
4.	  When	  you	  argue,	  one	  of	  you	  withdraws	  .	  .	  .	  that	  is,	  does	  not	  
want	  to	  talk	  about	  it	  anymore	  or	  leaves	  the	  scene.	  	   0	   0	   1	  
5.	  You	  are	  afraid	  of	  your	  partner.	   0	   0	   1	  
6.	  You	  feel	  like	  your	  opinions	  or	  emotions	  do	  not	  matter	  in	  your	  
relationship.	   0	   0	   1	  
7.	  When	  you	  argue,	  your	  partner	  always	  has	  to	  "win"	  the	  
argument	  and	  will	  not	  really	  listen	  to	  your	  side	  of	  the	  story.	   0	   0	   1	  
8.	  You	  have	  been	  nervous	  or	  afraid	  to	  refuse	  your	  partner's	  
sexual	  advances.	   0	   0	   1	  
	  
Total	  “Frequently”	  points:	  ______	  
5.	  HIRS	  (put	  an	  X	  in	  each	  chosen	  box)	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Do	  you	  agree	  with	  the	  following	  statements?	  
Because	  of	  your	  HIV+	  status…	  1.	  You	  will	  be	  in	  trouble	  with	  your	  partner	   Yes	  (1)	   No	  2.	  Your	  partner	  will	  be	  a	  support	  to	  you	   No	  (1)	   Yes	  (0)	  3.	  Your	  relationship	  with	  your	  partner	  will	  worsen	   Yes	  (1)	   No	  4.	  Receiving	  treatment	  will	  be	  dangerous	  because	  of	  your	  partner	   Yes	  (1)	   No	  5.	  You	  will	  feel	  unsafe	  in	  your	  relationship	   Yes	  (1)	   No	  6.	  Others	  will	  help	  you	  if	  you	  feel	  unsafe	  in	  your	  relationship	   No	  (1)	   Yes	  (0)	  7.	  It	  is	  not	  safe	  to	  discuss	  HIV	  testing	  with	  your	  partner	   Yes	  (1)	   No	  8.	  It	  is	  not	  safe	  to	  discuss	  your	  HIV	  status	  with	  your	  partner	   Yes	  (1)	   No	  9.	  You	  feel	  safe	  getting	  to	  medical	  appointments	   No	  (1)	   Yes	  (0)	  10.	  You	  fear	  your	  partner	  will	  try	  to	  kill	  you	   Yes	  (3)	   No	  
Total	  points:	  _________	  (remember	  question	  10	  is	  worth	  3	  points	  and	  2,6	  &	  9	  
are	  reverse	  scoring)	  
6.	  DA	  (put	  an	  X	  in	  each	  chosen	  block)	  
In	  the	  last	  year…	  1.	  Has	  the	  violence	  in	  your	  relationship	  gotten	  worse?	   Yes	  	  	  (1)	   No	  2.	  Does	  your	  partner	  own	  a	  gun?	   Yes	  	  	  (2)	   No	  3.	  Have	  you	  left	  or	  broken	  up	  with	  your	  partner?	   Yes	  	  	  (2)	   No	  (0)	  4.	  Does	  your	  partner	  threaten	  to	  kill	  you?	   Yes	  	  	  (2)	   No	  5.	  Does	  your	  partner	  use	  illegal	  drugs	  such	  as	  (e.g.	  tik,	  crack/cocaine,	  sniff	  glue,	  etc.)	  or	  mix	  dagga	  with	  other	  drugs?	   Yes	  	  (1)	   No	  6.	  Is	  your	  partner	  an	  alcoholic	  or	  problem	  drinker?	   Yes	  	  (1)	   No	  7.	  Has	  your	  partner	  ever	  threatened	  to	  commit	  suicide?	   Yes	  	  (2)	   No	  8.	  Does	  your	  partner	  follow	  or	  spy	  on	  you	  or	  leave	  threatening	  notes	  or	  messages?	   Yes	  	  (.5)	  half	   No	  9.	  Has	  your	  partner	  destroyed	  your	  property?	   Yes	  	  (.5)	  half	   No	  10.	  Have	  you	  ever	  threatened	  or	  tried	  to	  commit	  suicide?	   Yes	  	  (0)	   No	  (0)	  11.	  Do	  you	  have	  a	  child	  that	  is	  not	  by	  your	  current	  partner?	   Yes	  (1)	   No	  (0)	  
Total	  points	  __________	  (remembering	  that	  questions	  2,3,4,	  &	  7	  count	  2	  points	  
each):	  	  	  
Time	  of	  End	  of	  Pre-­‐test	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Appendix	  E	  	  Initial	  Safety	  Plan	  	  
Safety	  Plan	  Protocol:	  (Script):	   Time	  Safety	  plan	  begins:	  ___________	  	  Based	  on	  your	  answers	  to	  questions	  that	  tell	  us	  how	  safe	  you	  are	  and	  feel	  in	  your	  relationship	  you	  have	  a	  score	  of	  __________	  out	  of	  10	  points	  where	  10	  means	  extremely	  high	  danger.	  How	  do	  you	  feel	  hearing	  this	  information?	  (2)____________________________________________________________________________________________________	  Your	  HIV	  diagnosis	  is	  new	  and	  you	  have	  not	  had	  much	  time	  to	  think	  about	  it.	  It	  may	  be	  difficult	  to	  think	  about	  much	  else	  right	  now,	  but	  it	  is	  important	  to	  start	  thinking	  about	  how	  you	  will	  stay	  safe	  in	  your	  relationship	  with	  this	  diagnosis.	  I	  have	  some	  important	  information	  for	  you.	  Women	  experience	  violence	  in	  their	  relationships	  in	  three	  main	  ways:	  emotionally,	  physically	  and	  sexually.	  All	  of	  these	  types	  of	  abuse	  may	  increase	  after	  an	  HIV	  diagnosis.	  Examples	  of	  emotional	  abuse	  are	  name-­‐calling,	  putting	  you	  down	  or	  trying	  to	  control	  you.	  Examples	  of	  physical	  abuse	  are	  hitting	  you,	  kicking	  you,	  or	  slapping	  you.	  Examples	  of	  sexual	  abuse	  are	  forcing	  you	  to	  have	  sex	  or	  forcing	  you	  to	  have	  sex	  without	  a	  condom.	  Women,	  who	  are	  in	  a	  relationship	  where	  there	  is	  abuse	  or	  violence,	  are	  at	  an	  increased	  risk	  for	  more	  violence	  after	  they	  receive	  an	  HIV	  diagnosis.	  Some	  women	  experience	  more	  danger	  when	  they	  disclose	  their	  HIV	  status	  to	  their	  partner	  or	  when	  they	  attempt	  to	  get	  medical	  care	  or	  medication	  for	  HIV.	  Abusive	  partners	  may	  try	  to	  prevent	  them	  from	  accessing	  treatment	  or	  from	  taking	  medication.	  Although	  it	  can	  be	  a	  dangerous	  time	  in	  your	  relationship,	  many	  women	  prefer	  to	  tell	  their	  partner	  about	  their	  status	  so	  that	  their	  partner	  may	  also	  get	  tested	  or	  get	  treatment.	  If	  you	  decide	  to	  tell	  your	  partner,	  it	  is	  important	  to	  come	  up	  with	  a	  plan	  for	  the	  safest	  way	  to	  do	  so.	  It	  is	  your	  decision	  if	  you	  decide	  you	  want	  to	  tell	  your	  partner	  about	  your	  HIV	  status.	  Is	  it	  okay	  if	  we	  briefly	  talk	  about	  some	  ways	  to	  stay	  safe	  in	  your	  relationship?	  	  1. There	  are	  many	  people	  in	  your	  life	  and	  community	  that	  can	  help	  you	  if	  you	  feel	  you	  are	  in	  danger	  in	  your	  relationship.	  This	  could	  include	  your	  doctor,	  nurse,	  counselor,	  clergy	  or	  spiritual	  leader	  or	  a	  service	  specifically	  for	  relationship	  abuse.	  
Ø There	  are	  free	  and	  confidential	  hotlines	  you	  can	  call	  if	  you	  need	  someone	  to	  talk	  to	  or	  emergency	  shelter.	  One	  number	  is:	  0800-­‐150-­‐150.	  It	  is	  important	  to	  write	  this	  in	  a	  safe	  place	  so	  that	  your	  partner	  cannot	  find	  it.	  Where	  are	  some	  safe	  places	  you	  could	  put	  this?	  (ex:	  work	  or	  in	  your	  phone	  as	  a	  different	  listing).	  (3)______________________________________________________________________________________	  2. Some	  people	  prefer	  to	  talk	  with	  or	  get	  help	  from	  people	  they	  know.	  This	  may	  mean	  talking	  with	  your	  family	  or	  friends	  or	  someone	  in	  your	  community.	  Talking	  with	  a	  family	  member	  or	  friend	  can	  help	  you	  if	  an	  emergency	  occurs.	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Ø Think	  about	  which	  of	  your	  family	  members	  or	  friends	  are	  safe	  (will	  not	  relay	  information	  to	  your	  partner).	  You	  may	  call	  this	  person	  if	  there	  is	  an	  emergency	  (and	  use	  a	  code	  word	  to	  signal	  for	  help).	  	  3. There	  is	  also	  legal	  help	  for	  partner	  violence.	  Some	  examples	  are	  calling	  the	  police,	  contacting	  a	  lawyer	  or	  filing	  for	  an	  order	  of	  protection.	  
Ø Basically,	  an	  order	  of	  protection	  will	  prevent	  your	  partner	  from	  entering	  your	  home	  or	  your	  work,	  or	  from	  having	  contact	  with	  your	  children.	  Also,	  these	  orders	  help	  prevent	  further	  abusive	  acts.	  Would	  you	  like	  the	  number	  to	  access	  information	  about	  an	  order	  of	  protection?	  (must	  be	  completed	  via	  application	  or	  affidavit	  with	  local	  police	  department)	  or	  through	  head	  office	  (in	  Pretoria)	  at	  +27	  (0)	  12	  393	  1000.	  
Ø Keep	  this	  in	  a	  safe	  place	  (family	  member’s	  house,	  on	  you	  at	  home	  or	  in	  your	  purse	  in	  a	  secret	  place	  like	  inside	  tube	  of	  lipstick	  or	  write	  the	  name	  of	  a	  different	  service	  next	  to	  it	  (hair	  salon,	  take	  out	  food,	  etc)	  4. Some	  people	  try	  to	  do	  things	  to	  avoid	  abuse	  during	  dangerous	  times.	  When	  fighting	  occurs,	  some	  people	  attempt	  to	  calm	  their	  partner	  down,	  but	  remember	  his/her	  behavior	  is	  not	  your	  fault	  or	  responsibility.	  
Ø Are	  there	  any	  particular	  times	  you	  can	  think	  of	  you	  might	  want	  to	  stay	  clear	  because	  it	  is	  most	  dangerous?	  (4)	  _____________________________________________________	  5. Some	  people	  try	  to	  resist	  the	  abuse	  when	  it	  occurs.	  Examples	  of	  this	  are	  fighting	  back,	  hiding	  a	  gun	  where	  only	  you	  know	  where	  it	  is,	  trying	  to	  leave	  or	  end	  the	  relationship,	  or	  running	  and	  hiding	  during	  episodes.	  Research	  has	  shown	  that	  resisting	  the	  abuse	  can	  be	  more	  dangerous	  and	  increase	  the	  violence.	  
Ø Are	  you	  considering	  leaving	  your	  relationship?	  (5)	  Yes	  No	  If	  so,	  it	  is	  good	  to	  create	  a	  plan	  because	  this	  is	  the	  most	  dangerous	  time	  in	  a	  violent	  relationship.	  (6)	  Plan	  is	  ___________________________________________________________________________________________	  6. Other	  strategies	  include	  preparing	  for	  an	  emergency	  and	  hiding	  money,	  important	  phone	  numbers	  and	  personal	  items	  in	  case	  you	  need	  to	  leave	  in	  a	  hurry.	  It	  is	  also	  good	  to	  plan	  in	  advance	  where	  you	  could	  go	  in	  your	  house	  if	  a	  fight	  occurs	  (go	  to	  a	  safe	  room	  where	  there	  are	  no	  weapons	  or	  sharp	  objects)	  	  In	  closing	  this	  call,	  I	  would	  like	  to	  help	  you	  make	  a	  plan	  for	  how	  you	  may	  safely	  take	  care	  of	  yourself,	  given	  this	  new	  diagnosis	  and	  the	  danger	  in	  your	  relationship.	  	  If	  you	  decide	  to	  tell	  your	  partner	  about	  your	  status,	  now	  or	  sometime	  later,	  what	  are	  some	  ways	  you	  can	  protect	  yourself?	  (7)________________________________________________________________________________________________________	  If	  you	  suspect	  your	  partner	  is	  having	  a	  sexual	  relationship	  with	  someone	  else,	  it	  is	  important	  to	  know	  that	  confronting	  your	  partner	  about	  this	  may	  lead	  to	  more	  violence.	  Using	  condoms,	  after	  getting	  an	  HIV	  diagnosis,	  has	  been	  shown	  to	  reduce	  re-­‐infection	  but	  asking	  your	  partner	  to	  use	  condoms	  has	  also	  been	  shown	  to	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increase	  violence.	  If	  you’re	  going	  to	  begin	  using	  condoms,	  consider	  the	  safest	  way	  to	  talk	  to	  your	  partner	  about	  this.	  It	  is	  best	  after	  a	  diagnosis	  to	  immediately	  go	  to	  a	  clinic	  to	  get	  medical	  care.	  Until	  you	  decide	  if	  you	  want	  to	  tell	  your	  partner	  about	  the	  diagnosis,	  how	  can	  you	  safely	  get	  medical	  services?	  Do	  you	  need	  to	  plan	  to	  tell	  your	  partner	  you	  are	  going	  somewhere	  else?	  What	  could	  you	  say?	  (8)	  _____________________________________________________________________________________________	  If	  your	  CD4	  cell	  count	  is	  low	  (less	  than	  500),	  it	  will	  be	  recommended	  that	  you	  begin	  antiretroviral	  therapy	  medication.	  A	  common	  safety	  strategy	  is	  to	  hide	  these	  medications	  from	  an	  abusive	  partner.	  What	  are	  some	  ways	  you	  could	  do	  this	  if	  needed?	  (for	  example,	  putting	  pills	  into	  a	  Tylenol	  bottle	  and/or	  keeping	  it	  with	  you).	  What	  can	  you	  do?	  (9)	  ____________________________________________________________________________________________________________	  	  	   Is	  there	  anything	  else	  we	  can	  help	  you	  with	  today	  so	  that	  you	  can	  safely	  get	  the	  medical	  attention	  you	  need	  and	  take	  care	  of	  yourself	  physically	  and	  emotionally?	  (10)	  ____________________________________________________________________________________________________________	  	  






Initial	  safety	  plan	  for	  past	  testers	  
	  
Safety	  Plan	  Protocol	  Past	  Testers:	  (Script):	  Time	  Safety	  plan	  begins:	  __________	  	  Based	  on	  your	  answers	  to	  questions	  that	  tell	  us	  how	  safe	  you	  are	  and	  feel	  in	  your	  relationship	  you	  have	  a	  score	  of	  __________	  out	  of	  10	  points	  where	  10	  means	  extremely	  high	  danger.	  How	  do	  you	  feel	  hearing	  this	  information?	  (2)____________________________________________________________________________________________________	  Given	  that	  you	  have	  known	  about	  your	  HIV	  status	  for	  some	  time,	  can	  you	  tell	  us	  what	  caused	  you	  to	  return	  to	  Shout-­‐it-­‐Now	  recently	  to	  be	  retested?	  3)	  ________________	  ________________________________________________________________________________________________.	  Although	  you	  have	  had	  some	  time	  to	  adjust	  to	  this	  diagnosis,	  your	  relationship	  may	  be	  affected	  by	  your	  HIV	  status	  or	  your	  need	  to	  get	  treatment.	  I	  have	  some	  important	  information	  for	  you.	  Women	  experience	  violence	  in	  their	  relationships	  in	  three	  main	  ways:	  emotionally,	  physically	  and	  sexually.	  All	  of	  these	  types	  of	  abuse	  may	  increase	  after	  an	  HIV	  diagnosis.	  Examples	  of	  emotional	  abuse	  are	  name-­‐calling,	  putting	  you	  down	  or	  trying	  to	  control	  you.	  Examples	  of	  physical	  abuse	  are	  hitting	  you,	  kicking	  you,	  or	  slapping	  you.	  Examples	  of	  sexual	  abuse	  are	  forcing	  you	  to	  have	  sex	  or	  forcing	  you	  to	  have	  sex	  without	  a	  condom.	  Women,	  who	  are	  in	  a	  relationship	  where	  there	  is	  abuse	  or	  violence,	  are	  at	  an	  increased	  risk	  for	  more	  violence	  once	  they	  are	  diagnosed	  with	  HIV.	  Some	  women	  experience	  more	  danger	  when	  they	  disclose	  their	  HIV	  status	  to	  their	  partner	  or	  when	  they	  attempt	  to	  get	  medical	  care	  or	  medication	  for	  HIV.	  Abusive	  partners	  may	  try	  to	  prevent	  them	  from	  accessing	  treatment	  or	  from	  taking	  medication.	  Have	  you	  experienced	  any	  difficulties	  getting	  to	  your	  HIV	  appointments	  or	  being	  able	  to	  safely	  take	  your	  medication	  because	  of	  your	  relationship?	  4)	  A)	  No	  (B)Yes:	  explain:________________________________________________________________________________________	  
	  
A)	  No:	  If	  you	  have	  not	  experienced	  danger	  in	  your	  relationship	  related	  to	  getting	  to	  medical	  appointments	  or	  taking	  HIV	  medication,	  can	  you	  talk	  about	  how	  you	  approached	  this	  with	  your	  partner	  that	  allowed	  these	  activities	  to	  be	  safe?	  	  ________________________________________________________________________________________________	  Thank	  you.	  Do	  you	  mind	  if	  I	  tell	  you	  about	  some	  other	  general	  strategies	  for	  staying	  safe	  when	  there	  is	  violence	  in	  your	  relationship	  and	  you	  must	  take	  care	  of	  your	  health?	  (follow	  with	  safety	  plan	  below)	  	  	  
B)	  Yes:	  Can	  we	  discuss	  a	  plan	  for	  you	  to	  do	  these	  things	  safely?	  (follow	  with	  
safety	  plan	  below)	  7. There	  are	  many	  people	  in	  your	  life	  and	  community	  that	  can	  help	  you	  if	  you	  feel	  you	  are	  in	  danger	  in	  your	  relationship.	  This	  could	  include	  your	  doctor,	  nurse,	  counselor,	  clergy	  or	  spiritual	  leader	  or	  a	  service	  specifically	  for	  relationship	  abuse.	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Ø There	  are	  free	  and	  confidential	  hotlines	  you	  can	  call	  if	  you	  need	  someone	  to	  talk	  to	  or	  emergency	  shelter.	  One	  number	  is:	  0800-­‐150-­‐150.	  It	  is	  important	  to	  write	  this	  in	  a	  safe	  place	  so	  that	  your	  partner	  cannot	  find	  it.	  Where	  are	  some	  safe	  places	  you	  could	  put	  this?	  (ex:	  work	  or	  in	  your	  phone	  as	  a	  different	  listing).	  (5)_____________________________________________________________________________	  8. Some	  people	  prefer	  to	  talk	  with	  or	  get	  help	  from	  people	  they	  know.	  This	  may	  mean	  talking	  with	  your	  family	  or	  friends	  or	  someone	  in	  your	  community.	  Talking	  with	  a	  family	  member	  or	  friend	  can	  help	  you	  if	  an	  emergency	  occurs.	  	  
Ø Think	  about	  which	  of	  your	  family	  members	  or	  friends	  are	  safe	  (will	  not	  relay	  information	  to	  your	  partner).	  You	  may	  call	  this	  person	  if	  there	  is	  an	  emergency	  (and	  use	  a	  code	  word	  to	  signal	  for	  help).	  	  9. There	  is	  also	  legal	  help	  for	  partner	  violence.	  Some	  examples	  are	  calling	  the	  police,	  contacting	  a	  lawyer	  or	  filing	  for	  an	  order	  of	  protection.	  
Ø Basically,	  an	  order	  of	  protection	  will	  prevent	  your	  partner	  from	  entering	  your	  home	  or	  your	  work,	  or	  from	  having	  contact	  with	  your	  children.	  Also,	  these	  orders	  help	  prevent	  further	  abusive	  acts.	  Would	  you	  like	  the	  number	  to	  access	  information	  about	  an	  order	  of	  protection?	  (must	  be	  completed	  via	  application	  or	  affidavit	  with	  local	  police	  department)	  or	  through	  head	  office	  (in	  Pretoria)	  at	  +27	  (0)	  12	  393	  1000.	  
Ø Keep	  this	  in	  a	  safe	  place	  (family	  member’s	  house,	  on	  you	  at	  home	  or	  in	  your	  purse	  in	  a	  secret	  place	  like	  inside	  tube	  of	  lipstick	  or	  write	  the	  name	  of	  a	  different	  service	  next	  to	  it	  (hair	  salon,	  take	  out	  food,	  etc)	  10. Some	  people	  try	  to	  do	  things	  to	  avoid	  abuse	  during	  dangerous	  times.	  When	  fighting	  occurs,	  some	  people	  attempt	  to	  calm	  their	  partner	  down,	  but	  remember	  his/her	  behavior	  is	  not	  your	  fault	  or	  responsibility.	  
Ø Are	  there	  any	  particular	  times	  you	  can	  think	  of	  you	  might	  want	  to	  stay	  clear	  because	  it	  is	  most	  dangerous?	  (6)	  _____________________________________________________	  11. Some	  people	  try	  to	  resist	  the	  abuse	  when	  it	  occurs.	  Examples	  of	  this	  are	  fighting	  back,	  hiding	  a	  gun	  where	  only	  you	  know	  where	  it	  is,	  trying	  to	  leave	  or	  end	  the	  relationship,	  or	  running	  and	  hiding	  during	  episodes.	  Research	  has	  shown	  that	  resisting	  the	  abuse	  can	  be	  more	  dangerous	  and	  increase	  the	  violence.	  
Ø Are	  you	  considering	  leaving	  your	  relationship?	  (7)	  Yes	  No	  If	  so,	  it	  is	  good	  to	  create	  a	  plan	  because	  this	  is	  the	  most	  dangerous	  time	  in	  a	  violent	  relationship.	  (8)	  Plan	  is	  ________________________________________________________________________________	  12. Other	  strategies	  include	  preparing	  for	  an	  emergency	  and	  hiding	  money,	  important	  phone	  numbers	  and	  personal	  items	  in	  case	  you	  need	  to	  leave	  in	  a	  hurry.	  It	  is	  also	  good	  to	  plan	  in	  advance	  where	  you	  could	  go	  in	  your	  house	  if	  a	  fight	  occurs	  (go	  to	  a	  safe	  room	  where	  there	  are	  no	  weapons	  or	  sharp	  objects)	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Follow-­‐up	  Safety	  plan	  
Follow-­‐up	  safety	  plan:	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Appendix	  H	  	  
Standard	  of	  Care	  Post-­‐test	  	  
Post-­‐test	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Time	  call	  begins:	  _______________	  
1.	  HIRS	  	  	  	  	  	  	  Since	  receiving	  your	  HIV+	  diagnosis…	  	  	  	  	  	  	  	  	  	  	  	  Do	  you	  agree	  with	  the	  following	  statements?	  1.	  You	  have	  been	  in	  trouble	  with	  your	  partner	   Yes	   No	  2.	  You	  partner	  has	  been	  a	  support	  to	  you	   Yes	   No	  3.	  Your	  relationship	  with	  your	  partner	  has	  worsened	   Yes	   No	  4.	  Receiving	  treatment	  has	  been	  dangerous	  because	  of	  your	  partner	   Yes	   No	  5.	  You	  have	  felt	  unsafe	  in	  your	  relationship	   Yes	   No	  6.	  Others	  have	  been	  available	  to	  help	  you	  if	  you	  feel	  unsafe	  in	  your	  relationship	   Yes	   No	  7.	  It	  has	  not	  been	  safe	  to	  discuss	  HIV	  testing	  with	  your	  partner	   Yes	   No	  8.	  It	  has	  not	  been	  safe	  to	  discuss	  your	  HIV	  status	  with	  your	  partner	   Yes	   No	  9.	  You	  have	  felt	  safe	  getting	  to	  medical	  appointments	   Yes	   No	  10.	  You	  have	  feared	  your	  partner	  will	  try	  to	  kill	  you	   Yes	   No	  
2.	  SS	  Do	  you	  agree	  with	  the	  following	  statements:	  1.	  Overall,	  the	  information	  you	  received	  about	  relationships	  was	  helpful	   Yes	   No	  2.	  It	  was	  helpful	  to	  be	  asked	  about	  the	  difficulties	  in	  your	  relationship	   Yes	   No	  3.	  You	  wish	  you	  could	  have	  discussed	  the	  difficulties	  in	  your	  relationship	  more	   Yes	   No	  4.	  It	  was	  uncomfortable	  for	  you	  to	  discuss	  the	  difficulties	  in	  your	  relationship	   Yes	   No	  5.	  You	  regret	  talking	  about	  the	  difficulties	  in	  your	  relationship	   Yes	   No	  6.	  Talking	  about	  the	  difficulties	  in	  your	  relationship	  placed	  you	  at	  greater	  danger	   Yes	   No	  7.	  The	  services	  you	  received	  placed	  you	  at	  greater	  danger	   Yes	   No	  8.	  Would	  it	  be	  safe	  for	  us	  to	  contact	  you	  by	  phone	  at…	   One	  month	   Two	  months	   Three	  months	  9.	  Since	  learning	  your	  HIV	  status,	  have	  you	  been	  to	  a	  clinic	  or	  gotten	  any	  medical	  care	  (to	  get	  your	  CD4	  count	  results,	  talk	  with	  a	  counselor	  about	  treatment	  options)?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐If	  so,	  when	  did	  you	  go	  (exact	  date):	  
Yes	   No	  
10.	  If	  you	  notified	  your	  partner	  of	  your	  status,	  did	  you	  experience	  any	  type	  of	  violence	  as	  a	  result?	  (physical,	  mental	  or	  sexual)?	   Yes	   No	  11.	  In	  the	  last	  month,	  have	  you	  gotten	  help	  for	  relationship	  abuse	  from	  any	  of	  the	  following:	  police,	  domestic	  violence	  hotline	  or	  program,	  counselor,	  pastor/spiritual	  leader	  or	  anywhere	  else?	   Yes	   No	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Appendix	  I	  	  
Experimental	  Post-­‐test	  	  
Post-­‐test	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Time	  call	  begins:	  ___________	  
1.	  HIRS	  
Since	  receiving	  your	  HIV+	  diagnosis…	  	  	  	  	  	  	  	  	  	  Do	  you	  agree	  with	  the	  following	  statements?	  1.	  You	  have	  been	  in	  trouble	  with	  your	  partner	   Yes	   No	  2.	  Your	  partner	  has	  been	  a	  support	  to	  you	   Yes	   No	  3.	  Your	  relationship	  with	  your	  partner	  has	  worsened	   Yes	   No	  4.	  Receiving	  treatment	  has	  been	  dangerous	  because	  of	  your	  partner	   Yes	   No	  5.	  You	  have	  felt	  unsafe	  in	  your	  relationship	   Yes	   No	  6.	  Others	  have	  been	  available	  to	  help	  you	  if	  you	  feel	  unsafe	  in	  your	  relationship	   Yes	   No	  7.	  It	  has	  not	  been	  safe	  to	  discuss	  HIV	  testing	  with	  your	  partner	   Yes	   No	  8.	  It	  has	  not	  been	  safe	  to	  discuss	  your	  HIV	  status	  with	  your	  partner	   Yes	   No	  9.	  You	  have	  felt	  safe	  getting	  to	  medical	  appointments	   Yes	   No	  10.	  You	  have	  feared	  your	  partner	  will	  try	  to	  kill	  you	   Yes	   No	  
	  2.	  SS	  
Do	  you	  agree	  with	  the	  following:	  1.	  Overall,	  the	  information	  you	  received	  about	  relationships	  was	  helpful	  	   Yes	   No	  2.	  It	  was	  helpful	  to	  be	  asked	  about	  the	  difficulties	  in	  your	  relationship	   Yes	   No	  3.	  You	  wish	  you	  could	  have	  discussed	  the	  difficulties	  in	  your	  relationship	  more	   Yes	   No	  4.	  It	  was	  uncomfortable	  for	  you	  to	  discuss	  the	  difficulties	  in	  your	  relationship	   Yes	   No	  5.	  You	  regret	  talking	  about	  the	  difficulties	  in	  your	  relationship	   Yes	   No	  6.	  Talking	  about	  the	  difficulties	  in	  your	  relationship	  placed	  you	  at	  greater	  danger	   Yes	   No	  7.	  The	  services	  you	  received	  placed	  you	  at	  greater	  danger	   Yes	   No	  
3.	  FAS	  1.	  Did	  you	  use	  the	  safety	  plan?	   Yes	   No	  2.	  Did	  you	  find	  the	  safety	  plan	  helpful?	   Yes	   No	  3.	  Which	  of	  the	  following	  strategies	  did	  you	  mostly	  use?	  	  A.	  Talking	  to	  doctor,	  nurse	  or	  other	  health	  professional	   Yes	   No	  B.	  Talking	  to	  counselor	   Yes	   No	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C.	  Talking	  to	  a	  pastor,	  spiritual	  leader	  or	  someone	  at	  church	   Yes	   No	  D.	  Seeking	  help	  with	  a	  domestic	  violence	  service	  (in-­‐person	  or	  by	  phone;	  individual	  or	  group)	   Yes	   No	  E.	  Talking	  to	  Family	  or	  friends	   Yes	   No	  F.	  Contacting	  police,	  attorney	  or	  getting	  an	  order	  of	  protection/restraining	  order,	  court	  order	  or	  interdict	   Yes	   No	  G.	  Trying	  to	  avoid	  the	  violence	  (activities	  like	  avoiding	  partner	  at	  certain	  times,	  doing	  whatever	  partner	  wants	  you	  to	  do,	  trying	  to	  keep	  things	  quiet	  or	  a	  secret	  from	  partner)	   Yes	   No	  H.	  Fighting	  back,	  trying	  to	  end	  the	  relationship,	  running	  and	  hiding	  when	  violence	  occurs	   Yes	   No	  I.	  Thinking	  ahead	  and	  doing	  things	  like	  hiding	  money,	  keeping	  important	  phone	  numbers	  with	  you	  or	  other	  behaviors	  to	  help	  prepare	  for	  an	  emergency	   Yes	   No	  J.	  Creating	  a	  plan	  around	  the	  safest	  way	  to	  get	  to	  a	  clinic	  or	  medical	  care	  for	  HIV	  treatment	  	   Yes	   No	  K.	  Creating	  a	  plan	  around	  the	  safest	  way	  to	  get	  medication	  or	  safely	  take	  medication	  regularly.	   Yes	   No	  
	  4.	  Would	  you	  recommend	  a	  safety	  plan	  for	  friends	  in	  similar	  situations?	   Yes	   No	  5.	  Would	  it	  be	  safe	  for	  us	  to	  contact	  you	  by	  phone	  at…	   One	  month	   Two	  months	   Three	  months	   	  6.	  Since	  learning	  your	  HIV	  status,	  have	  you	  been	  to	  a	  clinic	  or	  gotten	  any	  medical	  care	  (to	  get	  your	  CD4	  count	  results,	  talk	  with	  a	  counselor	  about	  treatment	  options)?	  If	  so,	  when	  did	  you	  go	  (exact	  date):	  
Yes	   No	  












Informed	  Consent	  isiXhosa	  
 
UXwebhu lokuNikezelwa kwemVume ngoLwazi 
 
UkuHlolwa kwe-HIV noPhononongo koKhuseleko lobuNdlobongela 
lweQabane eliseNyongweni 
 
Igama nedilesi yom/abaXhasi: IYunivesithi yaseLouisville, eLouisville, KY kunye 
ne-Shout-it-Now, eKapa, eMzantsi Afrika 
Igama nedilesi yom/abaphandi: Umphandi oyiNtloko uMichiel A. van Zyl noGxa 
wakhe okwangumphandi uLeslie Lauren Brown: 2217 South Third St. Louisville, 
KY 40292, eUSA. 
I/iindawo oluza kuqhutywa kuzo uphononongo: Kwiphondo laseGauteng yaye 
iminxeba iza kwenziwa eKapa, eMzantsi Afrika.  
Iinombolo zeminxeba abafanele batsalele kuzo abalingwa xa benemibuzo: 021 
7134414 
 
InTshayelelo nenkCazelo engentSusa 
 
Uyamenwa ukuba ube nenxaxheba kuphononongo lophando.  Olu phononongo 
luqhutywa nguGqr. uRiaan van Zyl, PhD; uLauren Brown, LCSW, ogaqele iPhD 
kunye ne-Shout-it-Now.  Olu phononongo luxhaswa yiYunivesithi yaseLouisville, 
iSebe leSikolo iKent sezeNtlalo-ntle. Olu phononongo luza kuqhutywa kuzo 
zonke iindawo ezingoomahamba-ehlala zeengCebiso nezokuHlola i-HIV 
kwiphondo laseGauteng ezityelelwa yi-S-N ngexesha lokuqhutywa kolu 
phononongo. Uqhagamshelwano malunga nolu phononongo luza 
kuqhutywa ngomnxeba, kwiziko leminxeba le-Shout-it-Now, eliseTokai, 
eNtshona Koloni. Ngabalingwa abamalunga nama-225 abaza kumenywa ukuba 
babe nenxaxheba.   
 
Injongo 
Injongo yolu phononongo kukubona enobana abantu basetyhini bayaxhamla na 
ngokwazi amanqaku angokhuseleko kwabo bancuma nabo xa behlolelwa i-HIV 




Kolu phononongo, uza kunxityelelwana nawe ngomnxeba emva kosuku ufumene 




Ukuba uza kuthatha inxaxheba kwisiGaba I solu phononongo, udliwano-ndlebe 
lomnxeba okanye kwiqela elithile luya kusetyenziselwa ukuphucula uphando 
lophononongo okanye ungenelelo kuphela (umba wencoko yomnxeba). Siza 
kuqhagamshelana nawe ukuze sive uluvo lwakho ngemibuzo yophando olo 
kunye nomba wencoko yomnxeba. Sifuna ukwazi enobana ucinga ukuba imibuzo 
iluncedo na, enobana ikhona na into onokuyivuna kuyo, ikwenza ukhululeke 
okanye enobana kufuneke kwenziwe iinguqu ezithile na ukuze abantu bayiqonde 
imibuzo okanye ingxoxo baze bazive bexolile yile nkqubo. Eminye okanye yonke 
imibuzo ekwisiGaba II usenokuyibuzwa kwesi sigaba. Olu dliwano-ndlebe 
okanye amagqela akazokurekhodwa, kunoko, ingxelo yakho iya kubhalwa 
ngesandla okanye ichwethezwe ekhompyutheni. 
Ukuba uza kuthatha inxaxheba kwisiGaba II solu phononongo, uza kubuzwa 
imibuzo ngenjongo yokufumanisa ukuba ubudlelwane bakho bukhuseleke 
kangakanani kubundlobongela. Eminye yemibuzo yenzelwe olu phononongo, ize 
eminye imibuzo ifane naleyo idla ngokubuzwa kwiindawo ngeendawo zehlabathi 
ngenjongo yokufumanisa ukhuseleko kubudlelwane. Eminye imibuzo ihlobene 
nobundlobongela ngokwasemzimbeni nangokwesondo besinqanda-mathe sakho 
kwaye eminye ihlobene nokhuseleko ngokwasengqondweni. Kukwakho 
nemibuzo embalwa engamava osenokuba wawukhe wanawo ngamaqabane 
anobundlobongela kwanendlela ocinga ngayo ngokumayela nobundlobongela 
kubudlelwane. Kuya kuqhagamshelwana nawe izihlandlo ezi-2 ukuya kwezi-3 
kolu phononongo uze ubuze le mibuzo kunxibelelwano lokuqala nolokugqibela. 
Imibuzo yokuqala, iyonke, ifanele ithathe imizuzu esi-8 ukuya kwengama-20 
ukuyiphendula. Kukho imibuzo emifutshane engama-46 kunxibelelwano lokuqala 
nemibuzo emifutshane eli-18 ukuya kwengama-30 kunxibelelwano lokugqibela. 
Xa kunokwenzeka ukuba nayiphi na imibuzo ikwenze ungakhululeki, 
usengakhetha ukungayiphenduli. Uya kuqhubeka ufumana iinkonzo ze-S-N 
kwanokuba akuyiphenduli yonke okanye eminye yale mibuzo. 
Abathathi-nxaxheba besiGaba II solu phononongo baya kufakwa kumaqela 





Olu phononongo ngokunokwalo alunamingcipheko ekhoyo, kodwa inkoliso 
yemingcipheko yenzeka xa kuhlolwa i-HIV ngokubanzi, naxa kuhlolwa i-HIV 
kwabo bachatshazelwa lugonyamelo lwezinqanda-mathe zabo (abakolu 
phononongo okanye abangekho kulo). Eminye imingcipheko eyenzekayo xa 
kuhlolwa i-HIV ngokubanzi, luloyiko lokuba omnye umntu usenokufumanisa 
ukuba uhlolwe i-HIV kunye/okanye nokukhathazeka xa uhlolwa, yaye kungade 
kuthi chatha xa umntu kufunyaniswe ukuba une-HIV, usenokoyika ukubukulwa 
okanye ukugxekwa lusapho lwakhe naluluntu. Usenokuba semngciphekweni 
wobundlobongela obumasikizi xa ngaba iqabane lakho belikhe 
lanobundlobongela kubudlelwane benu yaye ngenxa yokuba ubundlobongela 
beqabane busenokuthi chatha xa omnye efunyaniswe ene-HIV okanye ezama 
ukufumana unyango lwe-HIV. Imingcipheko yolu phononongo kukuziva 
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unendawana engakhululekanga xa uphendula imibuzo enzima engamava obuqu 
okanye ezesondo; ukuphendula le mibuzo kungakuvuselela iinkumbulo 
ezingamnandanga ezadlulayo. Ukuba kwenzeka loo nto, uya kunikwa inkcazelo 
emalunga ne-arhente yasekuhlaleni engakunceda. Omnye umngcipheko okhoyo 
wolu phononongo ngowokuba i-Shout-it-Now iya kuqhagamshelana nawe 
ngomnxeba. Le nto ingayingozi xa iqabane lakho lisazi ukuba ufumene lo 
mnxeba. Ungawuphenduli umnxeba ukuba akukhuselekanga ukuwuphendula. 
Ungaqhagamshelana neziko leminxeba xa kukhuselekile ukwenjenjalo okanye 
siya kuzama ukuqhagamshelana nawe ngelinye ixesha. I-Shout-in-Now sele 
inexesha isebenzisa le ndlela yokutsala umnxeba yaye akukho mava mabi athe 
axelwa. Kwakhona, uphando lubonise ukuba ukusetyenziswa komnxeba 
kunokunceda ekwandiseni ukhuseleko kubantu basetyhini abathe bonzakala 





Olu phononongo luneenzuzo ezininzi. Unganemvakalelo yokuziva uxhaswa 
ngakumbi okanye unemithombo yoncedo engakumbi ngenxa yokuthatha 
inxaxheba kolu phononongo. Usengafumanisa ukuba le mibuzo ikunceda ucinge 
ngobudlelwane okubo uze ufune uncedo losapho lwakho okanye loluntu ukuze 
ukhuseleke ngakumbi. Kubathathi-nxaxheba abafunyaniswe bene-HIV, 
kuthenjwa ukuba baya kufumana unyango lwe-HIV ngokukhuseleke ngakumbi 
kunaxa bebengayi kuthatha inxaxheba kolu phononongo. Ngokubanzi, kuthenjwa 
ukuba abathathi-nxaxheba baya kuziva bekhuseleke ngakumbi ngenxa 
yokuthatha inxaxheba kolu phononongo. Uphando lubonisa ukuba abanye 
abantu basetyhini abathatha inxaxheba kolu phononongo malunga nogonyamelo 
lwamaqabane abo, bathi bafumanise olu phononongo luluncedo kubo. 
Ukongezelela koko, inkcazelo yolu phononongo iya kusetyenziselwa ukunceda 
abanye abantu basetyhini ekufumaneni iinkonzo ze-HIV ngokukhuselekileyo. Xa 
befumana iinkonzo ze-HIV ngokukhuseleke ngakumbi, abasetyhini bayoneliseka 
ngakumbi ngobomi babo baze babe sempilweni ngakumbi babe nobomi obude. 
Ekugqibeleni, la mava angabangela abantu bangosulelani kangako nge-HIV 
yaye babe mbalwa nabantu ababulawa yi-HIV. Nangona inkcazelo ekolu 
phononongo isenokungabi yinzuzo kuwe ngokuthe ngqo, inkcazelo efumaneke 
kolu phononongo ingabanceda abanye. 
 
Imbuyekezo  
Ukuba uthatha inxaxheba kolu phononongo, uze uhlale kolu phononongo de 
luphele, igama lakho liya kuluhlu lwamagama aza kutsalelwa ukufumana i-i-pod 
yasimahla. Ukongezelela, ngokuthatha inxaxheba kulo naliphi na icandelo lolu 
phononongo, uya kuhlolelwa i-HIV/TB nokufumana iingcebiso simahla kunye 
nokuphononongelwa ubundlobongela beqabane lakho simahla. Ukuba ukhetha 
ukungathathi inxaxheba kolu phononongo, usaya kuqhubeka ufumana ukuhlolwa 
i-HIV/TB nokufumana iingcebiso simahla kodwa ungaphononongelwa 






Asinakukwazi ukuqinisekisa ukuba izinto ziya kuba yindaba yakwamkhozi 
ngokupheleleyo.  Izinto zakho ziya kukhuselwa kangangoko kwamkelekileyo 
ngokwasemthethweni.  Ukuba iziphumo zolu phononongo ziyapapashwa, igama 
lakho aliyi kuthiwa pahaha.  Ngeli lixa kungenakufane kwenzeke, la maziko 
alandelayo asenokuzijonga iingxelo zophononongo: 
IBhodi yokuHlola yeZiko leYunivesithi yaseLouisville, i-Ofisi yenkQubo 
yokuKhuselwa kwabaLingwa abangabaNtu, kwane-Ofisi yeemFihlo.  
I-Ofisi yokuKhuselwa koPhando lwabaNtu (OHRP)  
 
Imeko nganye iya kufumana inombolo eyahlulayo ukuze igama lakho 
lingasetyenziselwa ukwahlula inkcazelo yakho. Iingcombolo (okanye inkcazelo 
yolu phononongo) ziya kugcinwa ekhompyutheni liqela lophando eMzantsi Afrika 
kwiseva ekhuselekileyo. Lusakube lugqityiwe uphononongo, inkcazelo 
yophononongo, (iingcombolo) ebhalwe iinombolo hayi amagama, iya 
kuthunyelwa nge-imeyili kumphandi oyintloko wolu phononongo. Inkcazelo 
yophononongo (iingcombolo) eza kunikezelwa iya kugcinwa ekhompyutheni 
yomphandi oyintloko. Umntu ungena ngephasiwedi kuloo khompyutha, yaye loo 
khompyutha ilungiselelwe ihambisana ne-HIPAA (imigaqo yeemfihlo yoMthetho 
we-Inshorensi wokuPhatha nokuPhendulisa ngezeMpilo). Ikopi yeefayile 
zokuqala ziya kugcinwa kwi-CD zize zifakwe kwikhabhathi etshixwayo kwi-ofisi 
yomphandi oyintloko.   
 
UkuThatha iNxaxheba ngokuziThandela 
 
Uthatha inxaxheba kolu phononongo ngokuzithandela. Usenokukhetha 
ukungathathi inxaxheba kwaphela. Ukuba ukhetha ukuba kolu phononongo 
usenokuyeka ukuthatha inxaxheba nanini na. Ukuba ukhetha ukungabi 
nanxaxheba kolu phononongo okanye ukuba uyayeka nangaliphi na ixesha, soze 
uphulukane neenzuzo onokuzifumana.   
 
AmaLungelo, imiBuzo, amaXhala, kwaneziKhalazo zabaLingwa boPhando 
 
Ukuba unawo nawaphi na amaxhala okanye izikhalazo ngolu phononongo 
okanye ngabasebenzi bophononongo, ungakhetha kwezi zinto zintathu.  
        
 Ungaqhagamshelana nomphandi oyintloko kule nombolo 502-852-2430 
(eUSA). 
 
Ukuba unayo nayiphi na imibuzo ngamalungelo akho njengomlingwa 
wophononongo, ngemibuzo, ngamaxhala okanye izikhalazo onazo, 
ungatsalela umnxeba kwi-Ofisi yenkQubo yokuKhuselwa koPhando 
lwabaNtu (HSPPO) (502) 852-5188.  Ungaxoxa ngayo nayiphi na imibuzo 
engamalungelo akho njengomlingwa emfihlekweni, kunye nelungu leBhodi 
	   
263 
yokuHlola yeZiko (IRB) okanye umsebenzi we-HSPPO.  I-IRB yikomiti 
ezimeleyo eyilwe ngamalungu ekomiti yeYunivesithi, abasebenzi 
bamaziko lawo, kunye namalungu oluntu angenanto yakwenza nala 
maziko.  I-IRB iye yaluhlola olu phononongo. 
 
Ukuba ufuna ukuthetha nomntu ongengoweYunivesithi, ungatsalela 
umnxeba apha 1-877-852-1167. Uya kunikwa ithuba lokuthetha ngayo 
nayiphi na imibuzo, amaxhala okanye izikhalazo onazo emfihlekweni. Lo 
ngumnxeba oxakekileyo weeyure ezingama-24 ophendulwa ngabantu 
abangasebenzeli iYunivesithi yaseLouisville.   
__________           
   
 
Eli phepha likuxelela into eya kwenzeka ebudeni bophononongo ukuba ukhetha 
ukuthatha inxaxheba.  Utyikityo lwakho luthetha ukuthi olu phononongo luye 
lwaxoxwa nawe, nokuthi imibuzo yakho iphendulwe, nokuthi uza kuthatha 
inxaxheba kolu phononongo.  Olu xwebhu lokunika imvume unolwazi 
alusosivumelwano.  Awunikezeli ngalo naliphi na ilungelo lakho elisemthethweni 




Igama eliprintiweyo lomlingwa    Language preference: 
        isiZulu _________ Xhosa 
___________ 
____________________________________  Sesotho ________
 English __________ 
 
Inombolo yomnxeba yomlingwa: 
 
________________________________________________________________ 
Utyikityo lomLingwa/uMmeli osemThethweni   Umhla wokutyikitya 
 
___________________________________________ _____________________ 
Utyikityo lomNtu obeCacisa iFomu yemVume  Umhla wokutyikitya 
(ukuba asinguye umPhandi) 
__________________________________________ _____________________ 
Utyikityo lomPhandi      Umhla wokutyikitya 
 
ULUHLU LWABAPHANDI  IINOMBOLO ZEMINXEBA 
 
UMichiel A. van Zyl, PhD   1-502-852-2430 







Pre-­‐test:	  Danger	  Indicator	  isiXhosa	  
Xhosa	  Pre-­‐test	  Exp	  &	  SOC	  Groups	  
Uvavanyo	  lokuQala	  	  	  	  Date	  __________	  Time	  of	  call	  
________	  
1.	  RS	  1.	  Ingaba	  uyathandana	  sithethanje?	   Ewe	   Hayi	  2.	  (ukuba	  uthi	  Ewe	  ku-­‐1,	  tsiba	  2):	  Usoloko	  uzifumana	  uthandana	   Ewe	   Hayi	  No	  Total	  for	  RS	  (does	  not	  count	  towards	  total)	  but	  is	  used	  for	  eligibility)	  
2.	  NVC	  (beka	  u-­‐X	  kwibhloko	  nganye	  oyikhethileyo)	  
Ungatsho	  na	  ukuba	  iqabane	  lakho	  onalo	  ngoku…	  1.	  lizama	  ukunciphisa	  unxibelelwano	  lwakho	  nosapho	  lwakho	  kwanabahlobo?	  	  	   Ewe	  (1)	   Hayi	  2.	  linesikhwele	  okanye	  liyalinda?	  	   Ewe	  (1)	   Hayi	  3.	  lisoloko	  lifuna	  ukwazi	  ukuba	  uhleli	  nabani	  ngawo	  onke	  amaxesha?	  	   Ewe	  (1)	   Hayi	  4.	  likubiza	  ngento	  yonke	  okanye	  likuthob’	  isidima	  phambi	  kwabanye?	  	   Ewe	  (1)	   Hayi	  5.	  likwenza	  uzive	  ungento	  yanto?	   Ewe	  (1)	   Hayi	  6.	  liyakungxolisa	  okanye	  likuthuke?	  	   Ewe	  (1)	   Hayi	  7.	  Likwenzakalisile	  emzimbeni	   Ewe	  (1)	   Hayi	  
Zizonke:	  	  
3.	  CTS-­‐2	  (beka	  u-­‐X	  kwibhloko	  nganye	  oyikhethileyo)	  
Kunyaka	  ophelileyo	  iqabane	  lakho…	  1.	  Lakubetha	   Ewe	  (1)	   Hayi	  2.	  Lakubetha	  ngento	   Ewe	   Hayi	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(1)	  3.	  Lakukrwitsha	   Ewe	  (1)	  	  	   Hayi	  4.	  Lakubetha	  kakhulu	   Ewe	  (1)	   Hayi	  5.	  Lakugrogrisa	  ngesixhobo	   Ewe	  (1)	  	   Hayi	  6.	  Lasebenzisa	  isixhobo	  kuwe	   Ewe	  (1)	  	   Hayi	  7.	  Lakwenza	  wabelana	  ngesondo	  ngaphandle	  kwekhondom	   Ewe	  (1)	   Hayi	  8.	  Lasebenzisa	  amandla	  ukukwenza	  wabelane	  ngesondo	  nalo	   Ewe	  (1)	  	  	   Hayi	  9.	  lasebenzisa	  amandla	  ukwabelana	  ngesondo	  ngendlela	  ezohlukeneyo	   Ewe	  (1)	   Hayi	  
	  
Zizonke	  “Yes”	  points:	  _________	  
To	  be	  IPV	  eligible:	  Must	  score	  2	  or	  higher	  on	  NVC	  or	  score	  1	  or	  higher	  in	  CTS-­‐
2	  
NVC:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  CTS-­‐2:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total:	  
IPV	  eligible	  	  	  	  	  	  _______Yes	  	  	  	  ________No	  
If	  yes,	  complete	  remainder	  of	  scales	  
For	  those	  not	  IPV	  eligible:	  “Thank	  you	  very	  much	  for	  answering	  these	  
questions.	  We	  will	  not	  be	  in	  contact	  with	  you	  any	  further.	  Before	  I	  go,	  do	  you	  
mind	  if	  I	  quickly	  just	  ask	  what	  your	  age	  and	  race	  are	  for	  research	  purposes?	  
Age	  _________________	  Race	  __________________	  
Thank	  you.”	  
4.	  VVS	  (beka	  u-­‐X	  kwibhloko	  nganye	  oyikhethileyo)	  Le	  nto	  elandelayo	  yenzeka	  rhoqo	  kangakanani:	  	  
0=Phantse	  ayizange	  okanye	  zange	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0=Kanye	  emva	  kwexesha	  elide	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1=Rhoqo	  
1.	  Iqabane	  lakho	  libonakala	  liwabona	  amazwi	  akho	  okanye	  izenzo	  
zakho	  kakubi	  kunokuba	  wenza	  ubucinga.	  	   0	   0	   1	  
2.	  Xa	  ninengxaki	  enifanele	  niyisombulule,	  iba	  ngathi	  nidlalela	  
amaqela	  achaseneyo.	  	   0	   0	   1	  
3.	  Uziva	  ulilolo	  kolu	  thando.	  	   0	   0	   1	  
4.	  Xa	  nixambulisana,	  omnye	  wenu	  uyarhoxa	  .	  .	  .	  into	  ethetha	  
ukuthi,	  akafuni	  ukuthetha	  ngayo	  kwakhona	  okanye	  uvela	  ahambe.	  	   0	   0	   1	  
5.	  Uyaloyika	  iqabane	  lakho.	   0	   0	   1	  
6.	  Uziva	  ngathi	  iimbono	  zakho	  okanye	  iimvakalelo	  zakho	  
azibalulekanga	  kolu	  thando	  lwenu.	   0	   0	   1	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7.	  Xa	  nixambulisana,	  iqabane	  lakho	  lisoloko	  lifuna	  “ukuphumelela”	  
yaye	  elifuni	  ukumamela	  ukuba	  wena	  uthini.	   0	   0	   1	  
8.	  Unoloyiko	  lokwalela	  iqabane	  lakho	  isondo.	   0	   0	   1	  
	  	  
Zizonke	  “Rhogo”	  points:__________	  
5.	  HIRS	  (beka	  u-­‐X	  kwibhloko	  nganye	  oyikhethileyo)	  Ingaba	  uyavumelana	  nala	  mazwi	  alandelayo?	  
Ngenxa	  yobume	  bakho	  bokuba	  ne-­‐HIV+…	  1.	  Uza	  kuyibeka	  apha	  kwiqabane	  lakho	   Ewe	  (1)	   Hayi	  2.	  Iqabane	  lakho	  liza	  kukuxhasa	   Hayi	  
(1)	  
Ewe	  (0)	  3.	  Uthando	  lwenu	  luza	  lubi	  nangakumbi	   Ewe	  (1)	   Hayi	  4.	  Ukufumana	  unyango	  kuza	  kuba	  yingozi	  ngenxa	  yeqabane	  lakho	   Ewe	  (1)	   Hayi	  5.	  Uza	  kuziva	  ungakhuselekanga	  kuthando	  lwenu	   Ewe	  (1)	   Hayi	  6.	  Abanye	  baza	  kukunceda	  ukuba	  uziva	  ungakhuselekanga	  eluthandweni	  lwenu	   Hayi	  (1)	   Ewe	  (0)	  7.	  Akukhuselekanga	  ukuxoxa	  ngokuhlola	  i-­‐HIV	  neqabane	  lakho	   Ewe	  (1)	   Hayi	  8.	  Akukhuselekanga	  ukuxoxa	  ngobume	  bakho	  be-­‐HIV	  neqabane	  lakho	   Ewe	  (1)	   Hayi	  9.	  Uziva	  ukhuselekile	  ukuya	  kumadinga	  ezonyango	   Hayi	  
(1)	  




Zizonke:	  _________	  (remember	  question	  10	  is	  worth	  3	  points	  and	  2,6	  &	  9	  are	  
reverse	  scoring)	  
6.	  DA	  (beka	  u-­‐X	  kwibhloko	  nganye	  oyikhethileyo)	  
Kunyaka	  ophelileyo…	  1.	  Ingaba	  ubundlobongela	  buye	  bathi	  chatha	  kubudlelwane	  benu?	   Ewe	  (1)	   Hayi	  2.	  Ingaba	  iqabane	  lakho	  linompu?	   Ewe	  (2)	   Hayi	  3.	  Have	  you	  left	  or	  broken	  up	  with	  your	  partner?	   Ewe	  (2)	   Hayi	  4.	  Ingaba	  iqabane	  lakho	  likugrogrisa	  ngokukubulala?	   Ewe	  (2)	   Hayi	  5.	  Ingaba	  iqabane	  lakho	  lisebenzisa	  iziyobisi	  ezingekho	  mthethweni	  ezifana	  (umz.,	  i-­‐tik,	  i-­‐crack/cocaine,	  lifunxa	  i-­‐glu,	  njl.)	  okanye	  lixuba	  intsangu	  notywala	  okanye	  nezinye	  iziyobisi?	   Ewe	  (1)	   Hayi	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or	  mix	  dagga	  with	  other	  drugs?	  6.	  Ingaba	  iqabane	  lakho	  likhoboka	  lotywala	  okanye	  liyindla-­‐manzi?	   Ewe	  (1)	   Hayi	  7.	  Ingaba	  iqabane	  lakho	  lakha	  lagrogrisa	  ngokuzibulala?	   Ewe	  (2)	   Hayi	  8.	  Ingaba	  iqabane	  lakho	  liyakulandela	  okanye	  lisoloko	  likubeke	  elisweni	  okanye	  likushiyele	  imiyalezo	  egrogrisayo?	   Ewe	  (.5)	  half	   Hayi	  9.	  Ingaba	  iqabane	  lakho	  liyazitshabalalisa	  izinto	  zakho?	   Ewe	  
(.5)	  half	   Hayi	  10.	  Ingaba	  wakha	  wagrogrisa	  ngokuzibulala	  okanye	  wazama	  ukuzibulala?	   Ewe	  (0)	   Hayi	  11.	  Do	  you	  have	  a	  child	  that	  is	  not	  by	  your	  current	  partner?	   Ewe	  (1)	   Hayi	  
	  Zizonke	  points	  __________	  (remembering	  that	  questions	  2,3,4,	  and	  7	  count	  2	  
points	  each):	  	  	  
Time	  of	  End	  of	  Pre-­‐test	  
Thank	  you	  for	  answering	  those	  questions.	  Do	  you	  mind	  if	  I	  ask	  what	  your	  age	  
and	  race	  are?	  	  
Uhlanga:	  __________________________	  Iminyaka:	  ________________________	  For	  Standard	  of	  Care	  group,	  state:	  	  
Script:	  Thank	  you	  so	  much	  for	  participating.	  We	  will	  contact	  you	  again	  in	  one	  month.”	  For	  Experimental	  groups,	  tally	  their	  scores	  and	  begin	  Safety	  plan.	  
	  
Totals:	  NVC:	  CTS-­‐2:	  VVS:	  HIRS:	  DA:	  
ONLY	  THOSE	  IN	  EXPERIMENTAL	  GROUP	  RECEIVE	  
THEIR	  SCORE!	  
Total	  Score:	  _____________	  
Meaning	  of	  Score	  
1	   	   0-­‐5	   	   	   	   6	   	   26-­‐30	  
2	   	   6-­‐10	   	   	   	   7	   	   31-­‐35	  
3	   	   11-­‐15	  	   	   	   8	   	   36-­‐40	  
4	   	   16-­‐20	  	   	   	   9	   	   41-­‐45	  










Initial	  Safety	  Plan	  isiXhosa	  
	  
	  
Initial	  Safety	  Plan	  
IsiCwangciso	  senkQubo	  yoKhuseleko:	  (Umbhalo):	  	  Ngokweempendulo	  zakho	  kwimibuzo	  esixelela	  ngendlela	  okhuseleke	  ngayo	  noziva	  ngayo	  ngomntu	  wakho	  ufumene	  __________	  kwi-­‐10	  apho	  i-­‐10	  libonisa	  ukuba	  usengozini	  enkulu.	  Uziva	  njani	  ngokuva	  le	  nkcazelo?	  (2)_________________________________	  Ubume	  bakho	  be-­‐HIV	  busebutsha	  yaye	  awukhange	  ufumane	  ixesha	  elaneleyo	  lokucinga	  ngayo.	  Kusenganzima	  ukucinga	  into	  eninzi	  ngokwangoku,	  kodwa	  kubalulekile	  ukucinga	  ngendlela	  oya	  kuhlala	  ukhuseleke	  ngayo	  kumntu	  wakho	  ekubeni	  unezi	  ziphumo.	  Ndikuphathele	  inkcazelo	  ebalulekileyo.	  Abantu	  basetyhini	  bafumana	  ubundlobongela	  ngeendlela	  ezintathu	  eziphambili:	  ngokwasengqondweni,	  emzimbeni	  nangokwesondo.	  Zonke	  ezi	  ntlobo	  zokuxhatshazwa	  zinokuthi	  chatha	  emva	  kokufunyaniswa	  kwe-­‐HIV.	  Imizekelo	  yokuxhatshazwa	  ngokwasengqondweni	  kukubizwa	  ngento	  yonke,	  ukuthob’	  isidima	  okanye	  ukuzama	  ukukulawula.	  Imizekelo	  yokuxhatshazwa	  emzimbeni	  kukubethwa,	  ukukhatywa,	  okanye	  ukukuqhwaba	  ngempama.	  Imizekelo	  yokuxhatshazwa	  kwezesondo	  kukukunyanzela	  wabelane	  ngesondo	  naye	  okanye	  wabelane	  ngesondo	  ngaphandle	  kwekhondom.	  Abasetyhini	  abaxhatshazwayo	  okanye	  abanamaqabane	  anobundlobongela,	  baba	  semngciphekweni	  othe	  chatha	  wokufumana	  ubundlobongela	  obungakumbi	  emveni	  kokufunyaniswa	  bene-­‐HIV.	  Abanye	  abantu	  basetyhini	  baba	  kwingozi	  enkulu	  xa	  bexelela	  amaqabane	  abo	  ngobume	  babo	  be-­‐HIV	  okanye	  xa	  bezama	  ukufumana	  unyango	  lwezamayeza	  okanye	  unyango	  lwe-­‐HIV.	  Amaqabane	  axhaphazayo	  anokuzama	  ukubathintela	  ekufumaneni	  unyango	  okanye	  xa	  besiya	  kuthatha	  amayeza.	  Nangona	  isenokuba	  lixesha	  eliyingozi	  kwezothando	  lwakho,	  abasetyhini	  abaninzi	  bakhetha	  ukuwaxelela	  amaqabane	  abo	  ngobume	  babo	  ukuze	  nawo	  ahlolwe	  okanye	  afumane	  unyango.	  Ukuba	  ugqiba	  ekubeni	  ulixelele	  iqabane	  lakho,	  kubalulekile	  ukuvela	  nesicwangciso	  seyona	  ndlela	  ikhuselekileyo	  ongakwenza	  ngayo	  oko.	  Sisigqibo	  sakho	  ukuba	  ugqiba	  ekubeni	  ulixelele	  iqabane	  lakho	  ngobume	  bakho	  be-­‐HIV.	  Ingaba	  kulungile	  xa	  sisithi	  gqaba-­‐gqaba	  nje	  ngezinye	  zeendlela	  onokuhlala	  ukhuselekile	  ngazo	  kumntu	  wakho?	  	  13. Kukho	  abantu	  abaninzi	  ebomini	  bakho	  naseluntwini	  abanokukunceda	  ukuba	  uziva	  usengozini	  emntwini	  wakho.	  Baquka	  ugqirha	  wakho,	  umongikazi,	  umcebisi,	  umfundisi	  okanye	  umthandazeli	  okanye	  inkonzo	  ejongene	  nabantu	  abaxhatshazwayo.	  
Ø Kukho	  iminxeba	  exakekileyo	  esimahla	  neyimfihlo	  onokuyitsalela	  xa	  udinga	  umntu	  onokuthetha	  naye	  okanye	  indawo	  kaxakeka.	  Enye	  yile	  nombolo:	  0800-­‐150-­‐150.	  Kubalulekile	  ukuba	  uyibhale	  kwindawo	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ekhuselekileyo	  ukuze	  iqabane	  lakho	  lingayiboni.	  Zeziphi	  ezinye	  zeendawo	  onokuyibeka	  kuzo?	  (umz.:	  emsebenzini	  okanye	  emnxebeni	  wakho	  qha	  uyinike	  igama	  elahlukileyo).	  (3)___________________	  14. Abanye	  abantu	  bakhetha	  ukuthetha	  okanye	  ukufuna	  uncedo	  kubantu	  ababaziyo.	  Oku	  kusenokuquka	  ukuthetha	  nosapho	  lwakho	  okanye	  abahlobo	  okanye	  umntu	  wasekuhlaleni.	  Ukuthetha	  nelungu	  losapho	  okanye	  umhlobo	  kungakunceda	  xa	  ngexesha	  likaxakeka.	  	  
Ø Cinga	  ukuba	  leliphi	  kumalungu	  osapho	  okanye	  kubahlobo	  ekukhuselekileyo	  ukuthetha	  naye	  (ongasayi	  kulixelela	  iqabane	  lakho).	  Ungambiza	  lo	  mntu	  ngexesha	  likaxakeka	  (unokusebenzisa	  igama	  elithile	  elaziwa	  nini	  nobabini	  xa	  uchaza	  ukuba	  ufuna	  uncedo).	  	  15. Kukwakho	  noncedo	  olusemthethweni	  xa	  iqabane	  linobundlobongela.	  Eminye	  imizekelo	  kukubiza	  amapolisa,	  ukunxibelelana	  negqwetha	  okanye	  ukufaka	  umyalelo	  wokhuseleko.	  
Ø Ngokusiseko,	  umyalelo	  wokhuseleko	  uya	  kulithintela	  iqabane	  lakho	  ekungeneni	  kwikhaya	  lakho	  okanye	  emsebenzini	  wakho,	  okanye	  ekunxibelelaneni	  nabantwana	  bakho.	  Kwakhona,	  le	  miyalelo	  inceda	  ekuthinteleni	  izenzo	  ezingakumbi	  zokuxhaphaza.	  Ingaba	  ungathanda	  ukufumana	  inombolo	  ongafumana	  kuyo	  inkcazelo	  malunga	  nomyalelo	  wokhuseleko?	  (ifanele	  igcwaliswe	  njengesicelo	  okanye	  ingxelo	  efungelweyo	  kwisebe	  lamapolisa	  asekuhlaleni)	  okanye	  kwi-­‐ofisi	  elikomkhulu	  (ePitoli)	  apha	  +27	  (0)	  12	  393	  1000.	  
Ø Yigcine	  kwindawo	  ekhuselekileyo	  (kwindlu	  yelungu	  losapho,	  kwikhaya	  lakho	  okanye	  kwipesi	  yakho	  kwindawo	  efihlakeleyo	  njengakwityhubhu	  ye-­‐lipstick	  okanye	  ubhale	  igama	  lenkonzo	  eyahlukileyo	  kuyo	  (isalon	  yeenwele,	  indawo	  ethengisa	  ukutya,	  njl)	  16. Abanye	  abantu	  bazama	  ukwenza	  izinto	  ngenjongo	  yokuphepha	  ukuxhatshazwa	  ngamaxesha	  ayingozi.	  Xa	  kuvuka	  umlo,	  abanye	  abantu	  bazama	  ukuwathomalalisa	  umsindo	  amaqabane	  abo,	  kodwa	  khumbula	  ukuba	  indlela	  eliziphatha	  ngayo	  asilotyala	  lakho	  okanye	  uxanduva	  lwakho.	  
Ø Ingaba	  akho	  amaxesha	  athile	  ocinga	  ukuba	  kungakuhle	  ukuba	  uhlalele	  kude	  engozini?	  (4)	  ________________________	  17. Abanye	  abantu	  bazama	  ukuxhathisa	  ukuxhatshazwa	  xa	  kuvela.	  Imizekelo	  yoku	  kukuzilwela,	  ukufihla	  umpu	  kwindawo	  eyaziwa	  nguwe	  wedwa,	  ukuzama	  ukuhamba	  okanye	  ukuphelisa	  into	  ebenihlangene	  ngayo,	  okanye	  ukubaleka	  okanye	  ukuzimela	  xa	  kuvela	  ingxaki.	  Uphando	  lubonise	  ukuba	  ukuxhathisa	  ukuxhatshazwa	  kunokuba	  yingozi	  enkulu	  yaye	  kungabenza	  buthi	  chatha	  ubundlobongela.	  
Ø Ingaba	  ucinga	  ngokumshiya	  umntu	  wakho?	  (5)	  Ewe	  Hayi	  Ukuba	  kunjalo,	  Kuhle	  ukwenza	  isicwangciso	  kuba	  eli	  lixesha	  eliyingozi	  kakhulu	  kwezothando	  ezinobundlobongela.	  (6)	  Isicwangciso	  sesi	  ________________________________	  18. Ezinye	  izicwangciso	  ziquka	  ukulungiselela	  imini	  kaxakeka	  nokufihla	  imali,	  iinombolo	  ezibalulekileyo	  nezinto	  zobuqu	  xa	  kunokufuneka	  umke	  buphuthuphuthu.	  Kukwakuhle	  ukuceba	  kwangaphambili	  	  ukuba	  uza	  kuya	  phi	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xa	  kuvuka	  umlo	  endlwini	  yakho	  (uye	  kwigumbi	  elikhuselekileyo	  apho	  kungekho	  zixhobo	  okanye	  izinto	  ezibukhali)	  	  Ekuqukumbeleni	  lo	  mnxeba,	  ndingathanda	  ukukunceda	  wenze	  isicwangciso	  ngendlela	  onokuzikhathalela	  ngayo	  ngokukhuselekileyo,	  ekubeni	  kukho	  ezi	  ziphumo	  zintsha	  kunye	  nengozi	  yeqabane	  lakho.	  	  Ukuba	  ugqiba	  ekubeni	  uxelele	  iqabane	  lakho	  ngobume	  bakho,	  ngoku	  okanye	  ngelinye	  ixesha,	  zeziphi	  ezinye	  zeendlela	  onokuzikhusela	  ngazo?	  (7)______________________________________	  Ukuba	  ukrokrela	  ukuba	  iqabane	  lakho	  lilala	  nomnye	  umntu,	  kubalulekileyo	  ukwazi	  ukuba	  ukuxambulisana	  neqabane	  lakho	  ngaloo	  nto	  kungabangela	  ubundlobongela	  obungakumbi.	  Ukusebenzisa	  iikhondom,	  emveni	  kokufumana	  iziphumo	  ze-­‐HIV	  kuye	  kwabonisa	  ukuba	  kuyanceda	  ekosuleleni	  abanye	  abantu	  kodwa	  ukucela	  iqabane	  lakho	  lisebenzise	  iikhondom	  kuye	  kwabonisa	  ukuba	  kuye	  kwakho	  ubundlobongela	  obuthe	  chatha.	  Ukuba	  uza	  kuqalisa	  ukusebenzisa	  iikhondom,	  cinga	  ngeyona	  ndlela	  ekhuselekileyo	  yokuthetha	  neqabane	  lakho	  ngaloo	  nto.	   Kuhle	  kakhulu	  ukuba	  emveni	  kweziphumo	  uye	  ngoko	  nangoko	  ekliniki	  ukuya	  kufumana	  unyango	  lwezamayeza.	  Ude	  ube	  ugqiba	  ekubeni	  ulixelele	  iqabane	  lakho	  ngeziphumo,	  ungazifumana	  njani	  ngokukhuselekileyo	  iinkonzo	  zamayeza?	  Ingaba	  kufuneka	  wenze	  icebo	  lokuxelela	  iqabane	  lakho	  ukuba	  uya	  kwenye	  indawo?	  Uza	  kuthini?	  (8)	  _____________________	  Ukuba	  umlinganiselo	  we-­‐CD4	  uphansi	  (ungaphantsi	  kwama-­‐500),	  kuya	  kucetyiswa	  ukuba	  uqalise	  unyango	  lwee-­‐antiretroviral.	  Icebo	  elixhaphakileyo	  kukuwafihla	  la	  machiza	  kwiqabane	  elixhaphazayo.	  Zeziphi	  ezinye	  iindlela	  ongakwenza	  ngazo	  oku	  ukuba	  kuyimfuneko?	  (ngokomzekelo,	  ukufaka	  iipilisi	  kwibhotile	  ye-­‐Tylenol	  kunye/okanye	  nokuzigcina	  kuwe).	  Uza	  kwenza	  njani	  wena?	  (9)	  __________________	  	  	   Ingaba	  ikho	  enye	  into	  esingakunceda	  ngayo	  namhlanje	  ukuze	  ufumane	  unyango	  oludingayo	  lwezamayeza	  ngokukhuselekileyo	  ukuze	  uzikhathalele	  ngokwasemzimbeni	  nangokwasengqondweni?	  (10)	  _________________________________________________________________________________________________	  	  
Time	  safety	  plan	  ends	  ______________	  
	  Qualitative	  answers	  from	  Safety	  Plan:	  	  1.	  Level	  of	  danger	  is:	  	  	  2.	  Feelings	  after	  hearing	  level	  of	  danger:	  	  	  3.	  If	  accepted	  free	  hotline	  number,	  where	  is	  safe	  place	  to	  keep	  number:	  	  	  4.	  Times/situations	  need	  to	  stay	  away	  from	  partner:	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Ukususela	  ekufunyanisweni	  kwakho	  ukuba	  une-­‐HIV…	  	  	  	  	  	  	  	  	  	  Ingaba	  uyavumelana	  nala	  mazwi	  alandelayo?	  1.	  Usenkathazweni	  kwiqabane	  lakho	   Ewe	   Hayi	  2.	  Iqabane	  lakho	  liyakuxhasa	   Ewe	   Hayi	  3.	  Uthando	  lwenu	  lusengxakini	  enkulu	   Ewe	   Hayi	  4.	  Ukufumana	  unyango	  bekuyingozi	  ngenxa	  yeqabane	  lakho	   Ewe	   Hayi	  5.	  Uziva	  ungakhuselekanga	  kolu	  thando	  lwenu	   Ewe	   Hayi	  6.	  Abanye	  bebekhona	  ukuze	  bakuncede	  xa	  uziva	  ungakhuselekanga	  kumntu	  wakho	   Ewe	   Hayi	  7.	  Bekungakhuselekanga	  ukuxoxa	  ngokuhlola	  i-­‐HIV	  neqabane	  lakho	   Ewe	   Hayi	  8.	  Bekungakhuselekanga	  ukuxoxa	  ngobume	  bakho	  be-­‐HIV	  neqabane	  lakho	   Ewe	   Hayi	  9.	  Ubuziva	  ukhuselekile	  ukuya	  kumadinga	  ezonyango	   Ewe	   Hayi	  10.	  Ubunoloyiko	  lokuba	  iqabane	  lakho	  liza	  kuzama	  ukukubulala	   Ewe	   Hayi	  
	  2.	  SS	  
Ingaba	  uyavumelana	  nezi	  zinto	  zilandelayo:	  1.	  Iyonke	  inkcazelo	  othe	  wayifumana	  ngezothando	  ibe	  luncedo	  	   Ewe	   Hayi	  2.	  Bekuluncedo	  ukubuzwa	  ngeenzingo	  kwezothando	   Ewe	   Hayi	  3.	  Unqwenela	  ukuba	  akwaba	  ubunokuxoxa	  ngakumbi	  ngeenzingo	  kwezothando	   Ewe	   Hayi	  4.	  Ubungakhululekanga	  ukuxoxa	  ngeenzingo	  zothando	   Ewe	   Hayi	  5.	  Uyazisola	  ngokuthetha	  ngeenzingo	  zothando	  lwakho	   Ewe	   Hayi	  6.	  Ukuthetha	  ngeenzingo	  zothando	  lwam	  kundibeke	  kwenkulu	  ingozi	   Ewe	   Hayi	  7.	  Linkonzo	  ozifumeneyo	  zikubeke	  kwenkulu	  ingozi	   Ewe	   Hayi	  
3.	  FAS	  1.	  Ingaba	  usisebenzisile	  isicwangciso	   Ewe	   Hayi	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sokhuseleko?	  2.	  Ingaba	  usifumanise	  siluncedo	  isicwangciso	  sokhuseleko?	   Ewe	   Hayi	  3.	  Zeziphi	  kwezi	  zicwangciso	  zilandelayo	  ozisebenzise	  kakhulu?	  	  A.	  Ukuthetha	  nogqirha,	  umongikazi	  okanye	  enye	  ingcali	  yezempilo	   Ewe	   Hayi	  B.	  Ukuthetha	  nomcebisi	   Ewe	   Hayi	  C.	  Ukuthetha	  nomfundisi	  okanye	  umthandazeli	   Ewe	   Hayi	  D.	  Ukufuna	  uncedo	  kwiinkonzo	  zobundlobongela	  zasekhaya	  (ngokuya	  buqu	  okanye	  ngomnxeba;	  kumntu	  omnye	  okanye	  eqeleni)	   Ewe	   Hayi	  E.	  Ukuthetha	  noSapho	  ukanye	  abahlobo	   Ewe	   Hayi	  F.	  Ukunxibelelana	  namapolisa,	  igqwetha	  okanye	  ukufumana	  umyalelo	  wokhuseleko/wokumthintela	   Ewe	   Hayi	  G.	  Ukuzama	  ukuphepha	  ubundlobongela	  (izinto	  ezifana	  nokuphepha	  iqabane	  ngamaxesha	  athile,	  ukwenza	  nantoni	  iqabane	  lakho	  elifuna	  uyenze,	  ukuzama	  kubekho	  inzolo	  okanye	  ungalixeleli	  imfihlo	  iqabane	  lakho)	  
Ewe	   Hayi	  
H.	  Ukuzilwela,	  ukuzama	  ukuphelisa	  into	  ebenihlangene	  ngayo,	  ukubaleka	  nokuzmela	  xa	  kuvuka	  ubundlobongela	   Ewe	   Hayi	  I.	  Ukucinga	  kwangoko	  nokwenza	  izinto	  ezifana	  nokufihla	  imali,	  ukugcina	  iinombolo	  ezibalulekileyo	  zeminxeba	  kuwe,	  okanye	  imikhwa	  ethile	  ngelokuzilungiselela	  imini	  kaxakeka	   Ewe	   Hayi	  J.	  Ukwenza	  isicwangciso	  esikhuselekileyo	  sokuya	  kufika	  ekliniki	  okanye	  kunyango	  lwezamayeza	  lwe-­‐HIV	  	   Ewe	   Hayi	  K.	  Ukwenza	  isicwangciso	  esikhuselekileyo	  sokufumana	  amayeza	  okanye	  ukuya	  kuthatha	  amayeza	  ngokukhuselekileyo	  rhoqo.	   Ewe	   Hayi	  
	  4.	  Ingaba	  ubungacebisa	  	  kwa	  isicwangciso	  esifanayo	  	  kubahlobo	  bakho	  abakwimeko	  enje	  ngale	  yakho	   Ewe	   Hayi	  5.	  Ingaba	  kukhuselekile	  ukuba	  sinxibelelane	  nawe	  ngomnxeba…	   Kwinyanga	  eNye	   Kwiinyanga	  ezimBini	   Kwiinyanga	  ezinTathu	   	  6.	  Ukususela	  ekuveni	  kwakho	  ngobumo	  bakho	  be-­‐HIV,	  ukhe	  waya	  ekliniki	  okanye	  wafumana	  unyango	  lwezamayeza	  (ukuya	  kufumana	  iziphumo	  zakho	  ze-­‐CD4	  kwiiseli,	  ukuya	  kuthetha	  nomcebisi	  ngonyango	  olukhoyo)?	  
Ukuba	  kunjalo,	  uye	  waya	  phi	  (umhla	  othe	  
ngqo):	  
Ewe	   Hayi	  
7.	  Ukuba	  uye	  walazisa	  iqabane	  lakho	  ngobume	  bakho,	  ingaba	  liye	  lanobundlobongela	  balo	  naluphi	  na	  uhlobo	  ngenxa	  yaloo	  nto?	  (emzimbeni,	  engqondweni	  okanye	  kwezesondo)?	  
Ewe	   Hayi	  






Post-­‐test	  Standard	  of	  Care	  isiXhosa	  	  
Uvavanyo	  lwaMva	  	  	  Date	  ________	  Time	  call	  begins	  
_______	  
1.	  HIRS	  
Ukususela	  ekufunyanisweni	  kwakho	  ukuba	  une-­‐HIV…	  	  	  	  	  	  	  	  	  	  Ingaba	  uyavumelana	  nala	  mazwi	  alandelayo?	  1.	  Usenkathazweni	  kwiqabane	  lakho	   Ewe	   Hayi	  2.	  Iqabane	  lakho	  liyakuxhasa	   Ewe	   Hayi	  3.	  Uthando	  lwenu	  lusengxakini	  enkulu	   Ewe	   Hayi	  4.	  Ukufumana	  unyango	  bekuyingozi	  ngenxa	  yeqabane	  lakho	   Ewe	   Hayi	  5.	  Uziva	  ungakhuselekanga	  kolu	  thando	  lwenu	   Ewe	   Hayi	  6.	  Abanye	  bebekhona	  ukuze	  bakuncede	  xa	  uziva	  ungakhuselekanga	  kumntu	  wakho	   Ewe	   Hayi	  7.	  Bekungakhuselekanga	  ukuxoxa	  ngokuhlola	  i-­‐HIV	  neqabane	  lakho	   Ewe	   Hayi	  8.	  Bekungakhuselekanga	  ukuxoxa	  ngobume	  bakho	  be-­‐HIV	  neqabane	  lakho	   Ewe	   Hayi	  9.	  Ubuziva	  ukhuselekile	  ukuya	  kumadinga	  ezonyango	   Ewe	   Hayi	  10.	  Ubunoloyiko	  lokuba	  iqabane	  lakho	  liza	  kuzama	  ukukubulala	   Ewe	   Hayi	  
	  2.	  SS	  
Ingaba	  uyavumelana	  nezi	  zinto	  zilandelayo:	  1.	  Iyonke	  inkcazelo	  othe	  wayifumana	  ngezothando	  ibe	  luncedo	  	   Ewe	   Hayi	  2.	  Bekuluncedo	  ukubuzwa	  ngeenzingo	  kwezothando	   Ewe	   Hayi	  3.	  Unqwenela	  ukuba	  akwaba	  ubunokuxoxa	  ngakumbi	  ngeenzingo	  kwezothando	   Ewe	   Hayi	  4.	  Ubungakhululekanga	  ukuxoxa	  ngeenzingo	  zothando	   Ewe	   Hayi	  5.	  Uyazisola	  ngokuthetha	  ngeenzingo	  zothando	  lwakho	   Ewe	   Hayi	  6.	  Ukuthetha	  ngeenzingo	  zothando	  lwam	  kundibeke	  kwenkulu	   Ew Hayi	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ingozi	   e	  7.	  Linkonzo	  ozifumeneyo	  zikubeke	  kwenkulu	  ingozi	   Ewe	   Hayi	  8.	  Ingaba	  kukhuselekile	  ukuba	  sinxibelelane	  nawe	  ngomnxeba…	   Kwinyanga	  eNye	   Kwiinyanga	  ezimBini	  
Kwiinyanga	  ezinTathu	  
9.	  Ukususela	  ekuveni	  kwakho	  ngobumo	  bakho	  be-­‐HIV,	  ukhe	  waya	  ekliniki	  okanye	  wafumana	  unyango	  lwezamayeza	  (ukuya	  kufumana	  iziphumo	  zakho	  ze-­‐CD4	  kwiiseli,	  ukuya	  kuthetha	  nomcebisi	  ngonyango	  olukhoyo)?	  Ukuba	  kunjalo,	  uye	  waya	  phi	  (umhla	  othe	  ngqo):	  
Ewe	   Hayi	  
10.	  Ukuba	  uye	  walazisa	  iqabane	  lakho	  ngobume	  bakho,	  ingaba	  liye	  lanobundlobongela	  balo	  naluphi	  na	  uhlobo	  ngenxa	  yaloo	  nto?	  (emzimbeni,	  engqondweni	  okanye	  kwezesondo)?	  
Ewe	   Hayi	  
11.	  Kwinyanga	  ephelileyo,	  ingaba	  ukhe	  wafumana	  uncedo	  ngenxa	  yokuxhatshazwa	  kwezothando	  kuyo	  nayiphi	  na	  yale	  mithombo	  elandelayo:	  emapoliseni,	  umnxeba	  oxakekileyo	  okanye	  inkqubo	  yobundlobongela	  basekhaya,	  umcebisi,	  umfundisi/okanye	  umthandazeli	  okanye	  naphi	  na?	  

































Subject Informed Consent Document 
 
HIV Screening and Intimate Partner Violence Safety Study 
 
Sponsor(s) name & address:University of Louisville, Louisville, KY and Shout-it-
Now, Cape Town, SA 
Investigator(s) name & address: Primary Investigator Michiel A. van Zyl and Co-
investigator Leslie Lauren Brown: 2217 South Third St. Louisville, KY 40292, 
USA. 
Site(s) where study is to be conducted: Gauteng province and telephone calls will 
be made from Cape Town, South Africa.  
Phone number for subjects to call for questions:021 7134414 
 
Introduction and Background Information 
 
Umenyiwe uzoxhasa uchwaningo. Ucwaningo luholwa uDr. Riaan van Zyl, 
PhD;Lauren Brown, LCSW, PhD Candidate and Shout-it-Now.  Lolucwaningo 
luxhaswe yiuniese yase  Louisville, nomyaga we Kent School of Social Work. 
Lolucwaingo lozothathela kuwownke ahambayo umeluleki wenculaza nokuhlolwa 
emalokishini aseGoli we S-N loluhambo luzokwenzala esikhathi esihleliwe. 
Ukuthintana kwalocwaningo kuzovela ngocingo, ngaphansi kwe Shout-it-Now, 





Isizathu salolucwaningo ukubona ukuthi abantu besimame baunani uma bazi 





Kolocwaningo, uzothintwa ngocingo ngakusasa emva kokuthola usizo nababe 
Shout-it-Now. 
Ukuxhasana kungavela ngedlela ezimbili.  
 
Uma uvela kwisombe sokuqaba, ukuhlolwa kwakho ngocingo kuzo bakana 
nokuxhasa ucwaningo kabanzi. Sizokuthinta ukuze sithole umbono wakho 
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ngololucwaningo nemibuzo. Sifuna ukwazi ukuthi ucabanga ukhuthi lemibuzo 
inosizo. Eminye imibuzo yasesombeni sesibili ingabuzwa esomboni sokuqala. 
Lama intavu nyeke enkodiwe kodwa kozo bhalwa phansi nase komputheni. 
Uma ungenxanye yesombe sesibili kwalolucwaningo, uzobuzwa imibuzo 
ezokusiza ukuthi sibone ukuthi ubudlelwane bakho buphephile yini. Eminye 
imibuzo ikhandelwe lolucwaningo. Eminye imibuzo ejwayelekile ukubuzwa 
umhlaba wonke jikele. Eminye imibuzo ibheke kwabantu abazwanayo 
ngokwenganekwane ngokozimba nangokwecansi udlame nokunye okomoyo 
ukuphepha. Ikhona eminye imibuzo mayelana nokwazi kwakho okwayenzeka 
kudala nomlingani wakho onodlame nemizwa yakho mayelana nodlame 
ebudlelwaneni. Ungathinwa 2-3 isikhathi mayelana locwaningo okokuqala 
ubuzwe imibuzo kanti nasekugcineni. Imibuzo yokuqala ingathatha imizuzu eqala 
ku 8 kuya ewu 20  ukuze uphendule. Kunemibuzo engu 46 emifishane uma 
besaqala ukukuthinta kanti egugcineni iba ngu 18-30 emifishane. Uma eminye 
imibuzo ingakuphathi khahle, ungakhetha ukungayiphenduli. Uzoqhubeka uthole 
usizo luka S-N noma ungaphendulanga yonke imibuzo. Amalungu esombeni 





Lolucwaningo alunalo ubugozi obutize, kodwa ubungozi kuvela uma kuhlolwa 
inculaza, nokuhlolwa kwabantu abanaba lingani abanodlame. Ubungozi obuvela 
uma kuhlolwa ukuthuka kokuthi umuntu okwaziyo ekubone, lokukungenyuka 
uma usuthola ukuthi unesifo senculaza. Uma umuntu esethola ukuthi uneculaza 
uzizwa ngathi uyagxekwa umdeni wakhe nomphakathi. Ungagena engozini 
kakhulu uma ele ebudlelaleni wakho kunodlame vele. Ubungozi kahle kahle 
kololucwaningo ukuzizwa ungaphathekile kahle uma uphendula imibuzo enzima 
engawe noma ezinocansi kakhulu, ukuphendula lemibuzo kungenza ucabange 
izino ezenzeka kudala ezibuhlungu. Uma lokhu kwenzeka uzonikezwa 
imimimigwane yomuntu ongakusiza oseduze. Obunye ubungozi ukuthi I Shout-it 
Now izosebenzisa ucingo ukuxhumana nawe. Lokhu kungaba ngozi uma 
umlingani wakhe ethola. Ungayiphenduli ucingo uma kungaphephile. Kubonakala 




Lolucwaningo linemipumela emihle eminingi. Ungazizwa uxhaswa kancono 
nezinto zenzeka kalula. Uzothola ukuthi lemibuzo ikwenze ucabanga kancono 
ngobudlelwane bako futhi ikwenze ufune usizo emundeni nasemphakathini 
ukuze uzizwe uphephile. Kukho konke locwaningo linethemba lokuthuthu abantu 
bathole usizo futhi bazizwe bephephile ucwaningo lukhombisa ukuthi abantu 
besifazane ababeyinxhenye yaloluhlelo bathole usizo. Futhi ulwazi lulana 
kulolucwaningo kuzokwenza abanye abantu besimame bethole usizo nedlela 
zokutho imithi yenculaza. Ngokutho imithi yabo abantu besimame bazoziwa 
bephephile, bezizwe becqusekile futhi begomqemane bephila impilo ezinde. 
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Lemiphumela enganza kwehle ukuthelelana kwenculaza nabantu bengasafi 





Uma uwungenela lolucwaningo, uhlale lizo liyophela, igama lakho lizongena 
kumncitiswano uzothola i-pod yamahala. Futhi uzotho ukuhlolwa kwamahala kwi  
HIV/TB kanye umeluleki wamahala. Uma ungafuni ukuba yinxenye yocwaningo 




Imfihlo egcelwe nyeke uyethembise. Imfihlo zakho zizo ikelwa umthetho. Uma 
imiphumela yalolucwaningo iezwa igama lakho nyeke ivezwe, kodwa laba 
bazokwaz: The University of Louisville Institutional Review Board, Human 
Subjects Protection Program Office, and Privacy Office. 
Office for Human Research Protections (OHRP) 
 
Icala necala lizothola inobolo yayo ukuze igama lakho alaziwa emuninigwano 
yakho. Umninigwano igcineka kahle iqhembu lase Ningizimu Afika. Uma 
umninigwane isiqediwe lonke ulwazi selizovela kodwa hayi amagamo inombolo 
zamacala, bese zithunyelwa komseshi oqavile. Ukungena kuwu lamakomputha 
akukho lula noba ku khona igama lemfihlo elivalile nekomputha ine-HIPPA 
(follow privacy guidelines of the Health Insurance Portability and Accountability 
Act). Eminye imininingwano izogcineka kwi CD bese ivalelwa kukabin 
kwamaseshi oqaile emahoisini wakhe. 




Ukungenela kulento uyazinkela. Ungakhetha ukunga ngeneli. Uma ungenile 
ungakhetha ukushiya phansi noma yinini, nyeke uphuthelwe yilutho. 
 
Research Subject’s Rights, Questions, Concerns, and Complaints 
 
Uma unenkinga noma ikhalazo ngocwaningo ngabasebenzi, unezinto eziwu 3 
ongazenza.Ungaxhumana noNhlokomseshi ku 502-852-2430 (Emelika). 
 
Uma unemibuzo mayelana namalungelo wakho ngocwaningo, imibuzo, ikhalazo 
noma inking, ungashayela Human Subjects Protection Program Office (HSPPO) 
(502) 852-5188.  
 
Ungaxoxisana uma unemibuzo ngama lungelo wakho ngemfihlo, nelungu le 
Institutional Review Board (IRB) noma  HSPPO isebenzi sakhona.  I IRB ilungu 
elizimele lecomidi elihlanganiswe amalungu eyuniesi yomphakathi, amalungu 
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noma isebenzi zenhlagano, kanye namalungu omphakathi abangahlangene 
nalenhlangano I-IRB iyawabukisisa lolucwaniningo.  
 
Uma ufuna ukukhuluma nomuntu ngaphandle kwenivesi ungathinta 1-877-852-
1167. Uzonikezwa ithuba lokukhuluma nanoma umuphi umbuzo, ikhalazo noma 
inking ngemfihlo. Lolucingo lusebenza amahora angu 24, kodwa labantu 
abasebenzi euniesi yase Louisville. 
__________           
   
 
Leliphepha lizokutshela ukuthi kuzokwezalani uma ukhetha ukuba inxenye 
yalolucwaningo. Ukusiyina kwakho kuchaza ukuthi yonkinto ikhulunyiwe nawe, 
yonke imibuzo iphenduliwe futhi uzoba yinxenye yocwaningo. Leliphepha 
akusikona ikotlaki Amalungelo wakho awayi ndawo uyawagcine ngokusiyina 










____________________________________  Language preference:  
Igama elibhaliwe isikhonzi     isiZulu _______ Xhosa 
_______ 
        Sesotho _____
 English ______ 
____________________________________ 
 
Inombolo yocingo yesikhozi: 
 
________________________________________________________________ 
Isayini yesikhozi/Omele Obomthetho   Usuku Lokusayina 
 
___________________________________________ _____________________ 
Isayini yomuntu ochazayo leliformi                        Usuku Lokusayina  
(uma ngaphandle komhloli) 
__________________________________________ _____________________ 
Isayini yoseshi                 Usuku Lokusayina  
 
AMAGAMA WABASESHI              INOMBOLO 
 
Michiel A. van Zyl, PhD   1-502-852-2430 







Pre-­‐test:	  Danger	  Indicator	  isiZulu	  
	  
Pre-­‐test	  Zulu	  SOC	  &	  Exp	  Groups	  
Script:	  “Hi,	  this	  is	  ____________with	  Shout-­‐it-­‐Now.	  I	  was	  given	  your	  information	  from	  my	  shout-­‐it-­‐now	  teammate	  because	  you	  agreed	  to	  participate	  in	  a	  brief	  study	  with	  us.	  This	  will	  take	  about	  20	  minutes	  or	  more.	  Are	  you	  still	  willing	  to	  participate	  in	  this	  study?	  Great.	  Is	  this	  a	  safe	  time	  to	  talk?	  Okay,	  I	  am	  going	  to	  ask	  you	  some	  questions	  now.”	  
	  
Pre-­‐test	  	  	  	  	  	  	  	  	  	  	  	  Time	  of	  Call________	  
1.	  RS	  1.	  Unomuntu	  ozwana	  naye	  njengamanje?	   Yebo	   Cha	  2.	  (Uma	  uyebo	  ku	  1,	  ndula	  u2):	  Uzithola	  uthandana	  esikhathini	  esiningi	   Yebo	   Cha	  No	  Total	  for	  RS	  (does	  not	  count	  towards	  total)	  but	  is	  used	  for	  eligibility)	  
2.	  NVC	  (Put	  an	  X	  in	  each	  chosen	  block)	  
Ungathi	  umlingani	  wakho	  manje	  uya…	  1.	  Uzama	  ukunciphisa	  ubudlelwane	  bakho	  nabangani	  nomndeni	  wakho?	  	  	   Yebo	  (1)	   Cha	  2.	  Unesikhwele	  noma	  unesiphano?	  	   Yebo	  (1)	   Cha	  3.	  Ufuna	  ukwazi	  ukuthi	  ukuphi	  ngaso	  sonke	  isikhathi?	   Yebo	  (1)	   Cha	  4.	  Ukubiza	  amagama	  noma	  ukuwisa	  umoya	  uma	  ninabanye	  abanthu?	   Yebo	  (1)	   Cha	  5.	  Ukwenza	  uzizwe	  ngathi	  awulutho	  noma	  awunamusebenzi?	   Yebo	  (1)	   Cha	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6.	  Uyakwethuka	  noma	  akuthethise?	  	   Yebo	  (1)	   Cha	  7.	  Ulimaze	  umzimba	  wakho	   Yebo	  (1)	   Cha	  
	  
Total	  “Yebo”	  points:	  ___________	  
3.	  CTS-­‐2	  (Put	  an	  X	  in	  each	  chosen	  block)	  
Onyakeni	  ondlule	  umlingani	  wakho…	  1.	  Ukushayile	   Yebo	  (1)	   Cha	  2.	  Ukushaye	  ngokutize	   Yebo	  (1)	   Cha	  3.	  Ukuklinyile	   Yebo	  (1)	   Cha	  4.	  Uku	  shayile	  kakhulu	   Yebo	  (1)	   Cha	  5.	  Songela	  ngesikhali	   Yebo	  (1)	   Cha	  6.	  Wasebenzisa	  isikhali	  kuwe	   Yebo	  (1)	   Cha	  7.	  Wakwenza	  ukuthi	  niyecansini	  nigaliqokile	  ijazi	  lomkhwenyane	   Yebo	  (1)	   Cha	  8.	  Wasebenzisa	  udlame	  ukuze	  niye	  ocansini	   Yebo	  (1)	   Cha	  9.	  Wasebenzisa	  udlame	  ukuze	  niye	  ocansini	  ngendlela	  ezahlukile	  	   Yebo	  (1)	   Cha	  
Total	  “Yebo”	  points:	  ______________	  
To	  be	  IPV	  eligible:	  Must	  score	  2	  or	  higher	  on	  NVC	  or	  score	  1	  or	  higher	  in	  CTS-­‐
2	  
NVC:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  CTS-­‐2:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total:	  
IPV	  eligible	  	  	  	  	  	  _______Yes	  	  	  	  ________No	  
If	  yes,	  complete	  remainder	  of	  scales	  
	  
For	  those	  not	  IPV	  eligible:	  “Thank	  you	  very	  much	  for	  answering	  these	  
questions.	  We	  will	  not	  be	  in	  contact	  with	  you	  any	  further.	  Before	  I	  go,	  do	  you	  
mind	  if	  I	  quickly	  just	  ask	  what	  your	  age	  and	  race	  are	  for	  research	  purposes?	  
Age	  _________________	  Race	  __________________	  
Thank	  you.”	  
	  
4.	  VVS	  (put	  an	  X	  in	  each	  chosen	  block)	  Lokhu	  okulandelayo	  kujwayele	  ukwenza	  kayingaki:	  




1.	  Umlingani	  wakho	  uthatha	  izinto	  ozisho	  nozenzayo	  kabi	  noma	  
kunga	  fanele.	  	   0	   0	   1	  
2.	  Uma	  kukhona	  inkinga	  efuna	  ukhuthi	  niyixazulule,	  kuyashintsha	  
niqhudelane.	  	   0	   0	   1	  
3.	  Uzizwa	  uwedwa	  kulobu	  budlelwane.	  	   0	   0	   1	  
4.	  Uma	  nixabana,	  oyedwa	  wenu	  aphonse	  ithawula…makwenzeka,	  
akasafuni	  ukukhuluma	  ngenxabano	  noma	  evele	  ehambe.	   0	   0	   1	  
5.	  Uyamusaba	  umlingani	  wakho	   0	   0	   1	  
6.	  Uzizwa	  ngathi	  imizwa	  nemibono	  yakho	  ayibalulekile	  kolobu	  
budlelwane.	   0	   0	   1	  
7.	  Uma	  nixabana,	  umlingani	  wakho	  kufanele	  ephumelele	  futhi	  
akali	  laleli	  icala	  lakho.	   0	   0	   1	  
8.	  Ukewaba	  novalo	  nehloni	  ukwala	  izinto	  zo	  cansi	  zomlingani	  
wakho	   0	   0	   1	  
Total	  “Njalo”	  or	  Frequently	  points:	  ________	  
5.	  HIRS	  (put	  an	  X	  in	  each	  chosen	  block)	  Uyavumelana	  nalezizistetimende	  ezilandelayo?	  






Total	  points:	  _________	  (remember	  question	  10	  is	  worth	  3	  points	  and	  2,6	  &	  9	  
are	  reverse	  scoring)	  
6.	  DA	  (put	  an	  X	  in	  each	  chosen	  block)	  
Onyakeni	  ondlule…	  1.	  Udlame	  ebudlewanini	  bakho	  bandile	  yini?	   Yebo	  (1)	   Cha	  2.	  Umlingani	  wakho	  unaso	  isibhamu?	   Yebo	  (2)	   Cha	  3.	  Have	  you	  left	  or	  broken	  up	  with	  your	  partner?	   Yebo	  (2)	   Cha	  4.	  Umlingani	  wakho	  uyakwethusa	  ngokukabulala?	   Yebo	  (2)	   Cha	  5.	  Umlingani	  wakho	  uyazisebenzisa	  izidagamizwa	  nje	  nge	  (e.g.	  tik,	  crack/cocaine,	  sniff	  glue,	  etc.)	  or	  mix	  dagga	  with	  
other	  drugs?	   Yebo	  (1)	   Cha	  6.	  Umlingani	  wakho	  unayo	  inkinga	  yoku	  phuza	  noma	  uphuza	  kwakhe	  ku	  yikinga	  ?	   Yebo	  (1)	   Cha	  7.	  Umlingani	  wakho	  wake	  wasabisa	  ngokuzibulala?	   Yebo	  (2)	   Cha	  8.	  Umlingani	  wakho	  uyakulandela	  noma	  ekuhlole	  ungazi	  noma	  eshiye	  imiyalezo?	   Yebo	  (.5)	  half	   Cha	  9.	  Umlingani	  wakho	  uyazimosha	  izinto	  zenu	  endlini?	   Yebo	  (.5)	  half	   Cha	  10.	  Wake	  wazama	  noma	  wathusela	  ngokuzibulala?	   Yebo	  (0)	   Cha	  11.	  Do	  you	  have	  a	  child	  that	  is	  not	  by	  your	  current	  
partner?	   Yebo	  (1)	   Cha	  
	  Total	  points	  __________	  (remembering	  that	  questions	  2,3,4,	  and	  7	  count	  2	  
points	  each):	  	  	  
Time	  of	  end	  of	  Pre	  test	  _____________	  
	  
Thank	  you	  for	  answering	  those	  questions.	  Do	  you	  mind	  if	  I	  ask	  what	  your	  age	  
and	  race	  are?	  	  
Race:	  __________________________	  Age:	  ________________________	  
	  
Time	  of	  end	  of	  call:	  ______________	  For	  Standard	  of	  Care	  group,	  state:	  	  
Script:	  Thank	  you	  so	  much	  for	  participating.	  We	  will	  contact	  you	  again	  in	  one	  month.”	  For	  Experimental	  groups,	  tally	  their	  scores	  and	  begin	  Safety	  plan.	  
	  
Totals:	  NVC:	  CTS-­‐2:	  VVS:	  HIRS:	  DA:	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ONLY	  THOSE	  IN	  EXPERIMENTAL	  GROUP	  RECEIVE	  
THEIR	  SCORE!	  
Total	  Score:	  _____________	  
	  
Meaning	  of	  Score:	   	   1	   	   0-­‐5	   	   6	   	   26-­‐30	  
2	   	   6-­‐10	   	   7	   	   31-­‐35	  
3	   	   11-­‐15	  	   8	   	   36-­‐40	  
4	   	   16-­‐20	  	   9	   	   41-­‐45	  










































Safety	  Plans	  isiZulu	  
	  	  
Ngokwendlela	  ophendule	  ngayo	  imibuzo	  esitshelayo	  ngendlela	  ophephe	  ngayo	  
ebudlelwaneni	  onabo,	  umphumela	  wakno	  ungu	  __________	  kokungu	  10.	  Lapho	  	  u	  10	  
asho	  ukuthi	  ubungozi	  buphezulu	  kakhulu.Uzizwa	  njani	  ngokuzwa	  lezindaba?	  (2)_____________________________________________________________________________________________ Ulwazi	  lakho	  ngenculaza	  lusha	  futhi	  awukakabi	  nesikhathi	  esiningi	  sokucabanga.	  Kunga	  bandzima	  ukucabanga	  ukhuthi	  uzophepha	  kanjani	  ebudlelwaneni	  bakho	  njoba	  usuthole	  ulwazi.	  Nginolwazi	  olubalulekile.	  Abantu	  besimame	  bahlukunyezwa	  ngezindle	  ezintathu	  ebudlelwaneni:	  ngokomoya,	  ngokomzimba	  na	  ngokocansi.	  Konke	  lokuhlukunyezwa	  kungenyuka	  emva	  kokuthola	  ngesifiso	  senculaza.	  Izibonelo	  zokuhlukunyezwa	  ngokomoya	  ,ukubiza	  ngamagama	  amabi	  ,ukucikela	  phansi,	  ukuzama	  ukulawula	  .Izibonelo	  zokuhlukuyezwa	  ngokomomzimba	  ukushawa,	  ukhahlelwa	  noma	  ushayiwa	  ngempama.	  Izibonelo	  zokuhlukunyezwa	  ngokwecansi	  ukuphoqwa	  ukuya	  ecansini	  noma	  ukuphoqwa	  ukuthi	  ningali	  sebenzisi	  ijazi	  linkamkhwenyana	  .	  Abantu	  besimame	  abazithola	  ebudlelwaneni	  lapho	  kunodlame	  noku	  hlukumezeka,	  basencuphelweni	  enkulu	  uma	  sebethole	  ulwazi	  ngesimo	  sabo	  ngesifo	  sengculaza.	  Abanye	  abantu	  besifazane	  bazithola	  engozi	  enkulu	  uma	  beveza	  izimo	  zabo	  noma	  sebelanda	  imithi	  yesifo	  sengculazi.	  Abalingani	  babo	  bangazama	  ukubanqanda	  ukuthi	  bangawutholi	  umuthi	  noma	  bawuphuze	  .Abesimame	  	  abaningi	  bakhetha	  ukubatshela	  abalingani	  babo	  ukuzee	  nabo	  behlolwe	  futhi	  bewuthole	  umuthi.	  Uma	  ukhetha	  ukumtshela	  umlingani	  wakho,	  kuncono	  uthole	  icebo	  lokumtshela	  eliphephile.Yisinqumo	  sakho	  uma	  ufuna	  ukumshela	  umlingani	  wakho	  ngolwazi	  ngesifo	  sengculazi	  	  Kulungile	  yini	  uma	  singakhuluma	  ngedlela	  zokuhlala	  uphephile	  ebudlelwaneni	  bakho?	  	  19. Baninigi	  abantu	  empilweni	  yakho	  nasemphakathini	  abangakusiza	  uma	  uzizwa	  ngathi	  usengozini.	  Singabala	  udokotela	  wakho	  onesi,	  umeluleki,	  umfundisi.	  
Ø LUkhona	  ucingo	  lamahala	  elinezimfihlo	  uma	  ufuna	  umuntu	  ozokhuluma	  naye	  noma	  	  udinga	  indawo	  yakulala.	  Inombolo	  eyodwa	  ithi:	  0800-­‐150-­‐150.	  Kubalulekile	  ukubhala	  lokhu	  endaweni	  ephephile	  ukuze	  umlingani	  wakho	  angazukuyibona.	  Zikuphi	  izindawo	  eziphephile?	  (Isb:	  emsebenzini	  noma	  ocingweni	  lakho	  kodwa	  ubhale	  ngegama	  elinye).	  	  (3)___________________	  20. Abanye	  abantu	  babona	  kugcono	  ukukhuluma	  noma	  besizwe	  abantu	  ababaziyo.	  Lokhu	  kuchaza	  ukuthi	  uzokhulumo	  nelungu	  lomndeni,	  umngani	  noma	  ilungu	  lomphakhathi.	  Ukukhuluma	  nomdeni	  noma	  nomgani	  kusiza	  uma	  kunesimo	  esiphuthumayo	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Ø Cabanga	  	  ukuthi	  ubani	  emundenini	  noma	  kubangani	  ophephile	  (ongeke	  edlulise	  ulwazi	  kumlingani	  wakho).	  Ungamamuthinta	  lomuntu	  uma	  kunisimo	  esiphuthumayo	  (usebenzise	  igama	  noma	  isibonelo).	  21. Lukhona	  nosizo	  olusemthethweni	  uma	  umlingani	  wakho	  enodlame.	  Ezinye	  izibonelo	  ukushayela	  amaphoyisa,	  ukuthinta	  umeli	  noma	  uhlelo	  lokuvimba	  ngomthetho	  (protection	  order).	  
Ø Kahle	  kahle,	  uhlelo	  lokuvimba	  ngomthetho	  kuzovimbela	  umlingani	  wakho	  ukuze	  angangeni	  endlini	  yakho	  noma	  emusebenzini	  wakho,	  noma	  ukuthintana	  izingane	  zakho.	  Kanti	  futhi,	  loluhlelo	  lusiza	  ukuthintela	  okunye	  ukuhlukumezeka	  	  okungenzeka	  .	  Ungathanda	  ukwazi	  inombolo	  zokuthola	  ulwazi	  ngohlelo	  lokuvimba	  ngomthetho?	  (Kufanele	  ugcwalise	  amaphepha	  noma	  isitatimende	  esifugelwayo	  namaphoyisa	  asendaweni)	  noma	  ehovisi	  eliphezulu	  (ePetoli)	  shayela	  +	  27	  (0)	  12	  393	  1000.	  
Ø Gcina	  lokhu	  endaweni	  ephephile	  (ilungu	  lomndeni,	  kuwe	  endlini	  noma	  esikhwameni	  sakho	  noma	  phakathi	  kwerooge	  bese	  ubhala	  igama	  elihlukile	  eduze	  kwayo	  (ukudla,	  inkantini)	  	  4. Abanye	  abantu	  bazama	  izinto	  ukuze	  benqande	  ukuhlukunyezwa	  ngeykhathi	  eziyingozi.	  Uma	  kuliwa,	  abanye	  abantu	  bazama	  ukupholisa	  abalingani	  babo,	  kodwa	  khumbula	  ukuthi	  ukuziphatha	  kwakhe	  akusikona	  icala	  lakho.	  
Ø Zikhona	  izikhathi	  ongazicabanga	  ukuthi	  ungaqhelelana	  nazo	  ngoba	  ziyingozi	  khakhulu	  ?(4)	  ________________________	  5. Abanye	  abantu	  bazama	  ukusinqaba	  isimo	  sokuhlukumezeka	  umasehla.	  Izibonelo	  zalokho	  ukuzilwelwa,	  ukufihla	  isibamu	  lapho	  kwazi	  wena	  wedwa,	  ukuzama	  ukuhamba	  noma	  uqede	  ubudlelwane,	  ukubaleka	  noma	  uzifihle	  ezikhathini.	  Uphenyo	  lukhobisa	  ukuthi	  ukunqanda	  ukuhlukunyezwa	  kunengozi	  futhi	  kwandisa	  udlame.	  
Ø Ucabanga	  ukushiya	  ubudlelwane	  bakho?	  (5)	  Yebo	  Cha	  Uma	  kunjalo,	  kungcono	  uzame	  icebo	  ngoba	  manje	  isikhathi	  esiyingozi	  kakhulu	  ebudlelwaneni	  obunodlame.	  (6)	  Cebo	  lithi	  ________________________________	  6. Amanye	  amasu	  ukugcina	  imali	  mhla	  kuvela	  isimo	  esiphuthumayo	  ,	  inobolo	  ezibalulekile	  nezinto	  ongazidinga	  uma	  uhamba	  usushesha.	  Ekuvaleliseni,	  ngingathanda	  ukukusiza	  wenze	  icebo	  ukuze	  uzizwe	  uphephile	  futhi	  uzinakekele,	  njoba	  uphethe	  ulwazi	  olusha	  ngobungozi	  bobudlelwane	  bakho.	  Uma	  usutshela	  umlingani	  wakho	  ngesimo	  sakho,	  iziphi	  izindlela	  ongazi	  phephela	  ngazo?(7)______________________________________	  Uma	  usola	  ukuthi	  kukhona	  okudla	  izithende,	  kubalulekile	  ukwazi	  ukuthi	  ukumbuza	  kunga	  letha	  olunye	  udlame,	  ukusebenzisa	  ijazi	  lomkhwenyana	  ngemuva	  kokuthola	  ulwazi	  ngesimo	  sakho	  kuyanciphisa	  uzalo	  lenculaza,	  kodwa	  ukucela	  umlingani	  wakho	  ukuthi	  esebenzise	  ijazi	  kunyusa	  udlame.	  Uma	  usaqala	  ukusebenzisa	  ijazi	  thola	  indlela	  ephephili	  yokumtshela.	  Kulungekakhuku	  emva	  kokuthola	  ulwazi	  ngesimo	  sakho	  ushone	  komtholampilo.	  Waze	  wanquma	  ukuthi	  ufuna	  ukutshela	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umlingani	  wakho	  ngesimo	  sakho,	  iyiphi	  indlela	  ephephile	  yokuthola	  imithi?	  Kufanele	  yini	  ukuthi	  umazise	  umlingani	  wakho	  uma	  uzophuma?	  Ungathini?	  8)	  _____________________	  Uma	  uCD4	  cell	  count	  yakho	  iphansi	  (ngaphansi	  kwa	  500),	  kuzofanela	  ukuthi	  uqale	  i	  antiretroviral	  theraphy	  medication.	  Indlela	  ephephile	  ejwayelekile	  ukufihla	  lemithi	  uma	  umlingani	  wakho	  enodlame.	  Eziphi	  ezinye	  izindlela	  zokwenza	  lokhu	  makudingeka?	  (Isibonelo,	  ukufaka	  amaphilisi	  ebhodleleni	  le-­‐tylenol	  (	  panado)/	  noma	  uwagcine	  nawe).	  Ungenzani?	  	  (9)	  __________________	  Akukho	  okunye	  esingakusiza	  ngakho	  namhlanje	  ukuze	  uzizwe	  uphephile	  uthole	  imithi	  noma	  ukuze	  uphatheke	  kahle	  ngokomzimba	  nangokomoya?	  	  	  	  	  	  	  	  	  	  (10)	  _______________________________________________________________	  
	  	  
Time	  safety	  plan	  ends	  ______________	  	  Qualitative	  answers	  from	  Safety	  Plan:	  	  1.	  Level	  of	  danger	  is:	  	  	  2.	  Feelings	  after	  hearing	  level	  of	  danger:	  	  	  3.	  If	  accepted	  free	  hotline	  number,	  where	  is	  safe	  place	  to	  keep	  number:	  	  	  4.	  Times/situations	  need	  to	  stay	  away	  from	  partner:	  	  	  5.	  Yes	  or	  No	  (to	  leaving	  relationship)	  	  6.	  Plan	  for	  leaving	  is:	  	  	  	  	  	  7.	  Ways	  to	  protect	  self	  if	  discloses	  to	  partner:	  	  	  	  8.	  Plan	  to	  safely	  get	  to	  HIV	  medical	  care	  or	  clinic:	  	  	  	  9.	  	  Plan	  to	  keep	  HIV	  medication	  safe	  (if	  applicable):	  	  	  	  10.	  Anything	  else	  we	  can	  help	  with	  to	  keep	  physically	  and	  emotionally	  safe:	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Appendix	  R	  	  
Post-­‐test	  Experimental	  group	  isiZulu	  	  
Experimental	  
Post-­‐test	  	  	  	  	  	  	  	  	  	  Time	  call	  begins	  ______________	  
1.	  HIRS	  
Sukela	  uthola	  ulwazi	  ngesifo	  sengculaza	  ngawe…	  Uyavumelana	  nalezistetimente	  ezilandelayo?	  1.	  Uke	  wangena	  enkingeni	  nomlingani	  wakho	   Yebo	   Cha	  2.	  Umlingani	  wakho	  uyakuxhasa	   Yebo	   Cha	  3.	  Ubudlelwane	  nomlingane	  wakho	  bubebucayi	   Yebo	   Cha	  4.	  Ukuthola	  imithi	  kube	  nengozi	  ngexa	  yomlingani	  wakho	   Yebo	   Cha	  5.	  Uzizwa	  ungaphephile	  ebudlelwaneni	  bakho	   Yebo	   Cha	  6.	  Abantu	  bakhona	  abakusizayo	  uma	  uzizwa	  ungaphephile	   Yebo	   Cha	  7.	  Akuphephile	  ukuxoxa	  ngokuhlolwa	  kwengculaza	  nomlingani	  wakho	  	   Yebo	   Cha	  8.	  Akuphephile	  ukuxoxa	  ngesimo	  senculaza	  nomlingano	  wakho	   Yebo	   Cha	  9.	  Uzizwa	  uphephile	  uma	  uthola	  amalanga	  akhethiwe	  ukuze	  uthole	  imithi	   Yebo	   Cha	  10.	  Unokwethuka	  ukuthi	  umlingani	  wakho	  engazama	  ukwebulala	   Yebo	   Cha	  
	  2.	  SS	  
Uyavumela	  nalokhu	  okulandelayo:	  1.	  Kukokonke,	  ulwazi	  olutholile	  libenosizo	  kakhulu	   Yebo	   Cha	  2.	  Kube	  nosizo	  kakhulu	  ukubuzwa	  ngezinkinga	  zobudlelwane	  bami	   Yebo	   Cha	  3.	  Ufisa	  ngathi	  ngabe	  nixoxe	  kabanzi	  ngezinkinga	  zobudlelwane	  bami	   Yebo	   Cha	  4.	  Bekungangihlalisi	  kahle	  ukuxoxa	  ngezinkinga	  zami	   Yebo	   Cha	  5.	  Uyazisola	  ngokukhuluma	  ngekinga	  zobudlwane	  bami	   Yebo	   Cha	  6.	  Ukukhuluma	  ngekinga	  zama	  kungi	  beke	  ebungozini	  obukhulu	   Yebo	   Cha	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7.	  Usizo	  olutholile	  lokubeke	  ebungozini	  obukhulu	   Yebo	   Cha	  
3.	  FAS	  1.	  Ulisebenzisile	  icebo	  lokuphepha?	   Yebo	   Cha	  2.	  Lelicebo	  ulithole	  linosizo	  olukhulu?	   Yebo	   Cha	  3.	  Iliphi	  uso	  olusebenzise	  kakhulu?	  	  A.	  Ukukhuluma	  nodokotela,	  unesi	  nomunye	  umuntu	  osebenza	  kwamtholampilo	   Yebo	   Cha	  B.	  Ukukhuluma	  nomululeki	   Yebo	   Cha	  C.	  Ukukhuluma	  	  noclergy,	  nomfundisi/spiritual	  leader	   Yebo	   Cha	  D.	  Ukubeka	  usizo	  nabo	  bedlame	  lwasendlini	  (ngocingo,uyele,	  ibandla)	   Yebo	   Cha	  E.Ukukhuluma	  nomndeni	  noma	  umngani	   Yebo	   Cha	  F.	  Thintana	  namaphoyisa,	  umeli	  noma	  uthola	  uhlelo	  lokuvimba	  ngomthetho	  	   Yebo	   Cha	  G.	  Uzama	  ukubalekela	  udlame	  (ngenye	  iynkathi	  ngamboni	  umlingani,	  wenze	  lokhu	  umlingani	  whakho	  ethi	  kwenze)	   Yebo	   Cha	  H.	  Ukuzilwela,	  uqede	  ubudlelwane,	  ukubaleka	  ucashe	  uma	  udlame	  luqala	   Yebo	   Cha	  I.	  Ukucababgela	  phambili	  njengokufihla	  imali,	  ukugcina	  izinombolo	  ezibalulekile	   Yebo	   Cha	  J.	  Ukuthola	  amasu	  okuya	  komtholamphilo	  utho	  yenculaza	   Yebo	   Cha	  K.	  Ukuthola	  indlela	  ephephile	  yokuthola	  imithi	  njalo	  nje	   Yebo	   Cha	  
	  4.	  Ungaphakamisa	  icebo	  lokuphepha	  abanganini	  bakho	  abanekinga	  efana	  neyakho?	   Yebo	   Cha	  5.	  Kungaphepha	  uma	  singakulandela	  ngocingo	  emva	  kwe…	   Nyanga	  1	   Nyanga	  2	   Nyanga	  3	   	  6.	  Sukela	  uthola	  ngesifo	  senculaza,	  usuke	  waya	  kwomatholampilo	  wathola	  usizo	  (uthole	  imiphumela	  ye	  CD4	  cell,	  wakhuluma	  nomemuleki)?	  -­‐If	  so,	  when	  did	  you	  go	  (exact	  date):	  
Yebo	   Cha	  
7.	  Uma	  usumazisile	  umlingani	  wakho	  ngesimo	  sakho,	  ubone	  udlame	  (ngokomoyo,	  ngokomzimba	  noma	  ngokwecansi)?	   Yebo	   Cha	  	  	  	  










Post-­‐test	  Standard	  of	  Care	  isiZulu	  
	  
	  
Post-­‐test	  	  	  	  	  	  	  	  	  Time	  call	  begins	  ____________	  
1.	  HIRS	  
Kumuva	  kokuthola	  ulwazi	  ngawe	  nesifo	  senculaza	  …Uyavumelana	  nalezistetimente	  ezilandelayo?	  1.	  Ukewaba	  nekinga	  nomlingani	  wakho	   Yebo	   Cha	  2.	  Umlingani	  wakho	  uyakuxhasa	   Yebo	   Cha	  3.	  Ubudlelwane	  benu	  buele	  bababucayi	   Yebo	   Cha	  4.	  Ukuthola	  ukulapheka	  kobe	  nokungozi	  ngenxa	  yomlingani	  wakho	   Yebo	   Cha	  5.	  Uzizwa	  ungakhoselekile	  ebudlwelwane	  benu	   Yebo	   Cha	  6.	  Abanthu	  bakhona	  abakusekelayo	  uma	  uzizwa	  ungakhoselekile	  ebudlelwaneni	  bakho	   Yebo	   Cha	  7.	  Akuphephile	  yini	  uma	  ukhuluma	  ngokuhlolwa	  isifo	  senculaza	  nomlingani	  wakho	   Yebo	   Cha	  8.	  Akuphephile	  uma	  nixoxa	  ngesimo	  sakho	  mayelana	  nesifo	  senculaza	  nomlingani	  wakho	   Yebo	   Cha	  9.	  Uzizwa	  uphephile	  uma	  unqumelwa	  usuku	  lokuya	  kotholampilo	   Yebo	   Cha	  10.	  Uzizwa	  unoalo	  ukhuthi	  umlingani	  wakho	  engakubulala	   Yebo	   Cha	  
2.	  SS	  
Uyavumelana	  nalezistetimente	  ezilandelayo:	  1.	  Kukokonke,	  ulwazi	  olutholile	  ngobudlwelwane	  libonosizo	   Yebo	   Cha	  2.	  Kubenosizo	  ukubuzwa	  ngobunzima	  abutholakala	  ebuhlobeni	   Yebo	   Cha	  3.	  Ufisa	  ngathi	  uxoxisane	  kabanzi	  ngobunzima	  ebuhlobeni	  bakho	   Yebo	   Cha	  4.	  Bekumgangi	  phathi	  khahle	  uma	  ukhuluma	  ngekinga	  ebuhlobeni	  bakho	   Yebo	   Cha	  5.	  Uyazisola	  ngokuxoxa	  ngezikinga	  zobudlelwane	  bakho	   Yebo	   Cha	  6.	  Ukuxoxa	  ngekinga	  zabudlewano	  bakho	  beke	  wena	  engozini	   Yebo	   Cha	  7.	  Usizo	  olitholile	  likubeke	  engozini	  enkulu	   Yebo	   Cha	  8.	  Kungaba	  ncono	  uma	  sikuthinte	  ngomakhalekhukhwini…	   Inyanga	  1	   Inyanga	  2	   Inyanga	  3	  9.	  Usuwaya	  yini	  etholampilo	  uyothola	  imithi	  ngemva	  kokuthola	  ulwazi	  ngawe	  ngesifo	  senculaza	  (imphumela	  ye	  CD4	  cell,	  ukukhuluma	  nomeluleki	  ngamakhambi	  athize)?	  -­‐If	  so,	  when	  did	  you	  go	  (exact	  date):	  
Yebo	   Cha	  
10.	  Uma	  usumtshelile	  umlingani	  wakho	  ngesimo	  sakho,	  ubone	   Yebo	   Cha	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ushintso	  ebudlelwaneni	  benu?	  (ngokomzimba,	  ngokomqondo	  noma	  ngokocansi)?	  11.	  Enyangeni	  endlule,	  ukewathola	  usizo	  mayelana	  nokuhlukumezeka	  ebudlelwane	  bakho	  kulezi	  ndawo:	  emphoyiseni,	  ucingo	  lokuhlukumezeka	  endlini	  noma	  uhlelo	  umeluleki,	  umfundisi	  noma	  ezinye	  izindawo	  

















































Subject Informed Consent Document 
 
HIV Screening and Intimate Partner Violence Safety Study 
 
Sponsor(s) name & address:University of Louisville, Louisville, KY and Shout-it-
Now, Cape Town, SA 
Investigator(s) name & address: Primary Investigator Michiel A. van Zyl and Co-
investigator Leslie Lauren Brown: 2217 South Third St. Louisville, KY 40292, 
USA. 
Site(s) where study is to be conducted: Gauteng province and telephone calls will 
be made from Cape Town, South Africa.  
Phone number for subjects to call for questions:021 7134414 
 
Introduction and Background Information 
 
O memelwa ho nka karolo diphuputsong. Dr. Riaan van Zyl, PhD;Lauren Brown, 
LCSW, PhD Candidate YA Shout-it-Now.  Diphuputso di patallwa ke University of 
Louisville, lefapheng la Kent School of Social Work. Thupelo etla nka sebaka di 
dibakeng tsohle tsa bohlabolli le diteko tsa  HIV proincing ya Gauteng ka nako ya 
thupelo tsena. Diphuputso di tla nka sebaka ka nako ya thupelo. Dipuisano di tla 
etswa ka mohala ka Shout-it-Now call centre e sebakeng sa Tokai, Western 




Sepheo thutong ena ke ho bona hore basadi ba kgola ho tseba hore lerato la 
bona le lehlakoreng la polokeho ho hlahiswa ha HIV  kapa hoba le leqheka le 





Mo thutlong ena otla hoka hangwa ka mohala letsatsi kamora ho bona 
tshebediso ka pitso ya hona jwale. Honka karolo e ka etsahala ka seka sele seng 
kanako tse kabang pedi. 
 
Haole monka karalo ya seka sa pele sa thuto, teko ya mohala kappa mokgahlo. 
Oo  shebileng otla o boning otla sebediswa feela ho thusa ho lokafatsa tlholo ya 
thuto kappa hokenella (dikahare tsa puisano ya mohala). Retla holahana le wena 
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ho bona tshwaelo ya hao ka dipotso tsa tokafatso le diteng tsa puisano ya 
mohala. Re batla ho tseba hore o nahana hore dipotso tsena ditla re tswela 
masola ho inwela, ho o etsa oseka wa dudiseha kapa ho hlolehala ho fetola hore 
batho ba utlwisise haholo dipotso kapa dipuisano  le ho ikutwa ba kgotsofaditswe 
ke tsamaiso tse ding tsa dipotso kapa dipuisana le ho ikutwa ba kgotsofaditswe 
ke tsamaiso tse ding tsa dipotso kapa dipotso kaofela hotswa ho seka seo. 
Tlhodiso ena kapa mokgahlo eka sehatiswe empa mo boemong dipatlisiso tsa 
hao ditla ngolwa fatshe ka letshoho kapa e hatiswe ka mochini wa botaki haole 
monka karolo moo sekeng sena sa bobedi sa thuto o tla botswa ho thusa ho 
bontsha thireletso ya hao setwalleng sa dikamano. Dipotso tse ding di fela hore 
ruta le dipotso tse ding di tswella ho botsiswa moo dikarolong tse di fapanang tsa 
lefatshe ho batlisisa tshireletso ya setswalle. Dipotso tse ding di amana le 
popeho kapa bongwe ba kgolahano le molekana le tse ding tsa tshireletso ya 
maikutlo hona le dipotso hape tse mmalwa ka maitemohelo ao o ka bang o a 
bone moo nakong e fetileng ka moratuwa oo utlwisang bohloko. O tla hoka 
hangwa ha bedi kapa ha raro ka thuto le ho botswa dipotso ka nako ya 
hokahanyo ya pele le ya hoqetela. Dipotso tsa pele ka kakaretso di tshwanetse 
ho tsamaya metsotso e 8-20 hore di arabuwe. Hone le dipotso tse 
kgutsafaditsweng dile 46 tsa kgokahano ya pele le dipotso tse kgutsofaditsweng 
dile 18-30 tsa kgolahano ya hoqetela. Ha ho kaba le dipotso tseodi o etsang o 
seke wa dudiseha oka kgetha ho se diarabe. O ka tswella ho amohela 
tshebediso ya S-N le ha o sa araba tse ding kapa dipotso kaofela. Banka karolo 
ba seka sa bobedi sa thuto e ba tsweletsa ho thuta ho mekgatlo efapaneng hore 
seka ban ka karolo bohle ba amohela tshebediso tse tshwanang.  
 
Kotsi e bohlokwa 
 
Thutong ena e na le karolo ya tse ding tsa boiteko bo bongata a hlahellang moo 
ho itlatlhobong	   HIV  le bao ba setseng ba tshwaeditswe ke baratuwa ba bona ba 
setseng ba tshwaeditswe ke baratuwa ba bona ba ba utlwisang bohloko (ka thuto 
kapa eseng ka thuto) . diteko tse ding tsee din ka karolo ka diteko tsa HIV  kapa 
o ikutlwa o utlwile bohloko ka nako ya teko ya HIV e ka oketsehang ha motho a 
bolellwa hore ona le HIV baka ikutlwa ba tshohile kapa ba ikgatholla kapa ba a 
hlolwa le leloko le setjhaba o ka ba kotsing e feteletseng ya ho utlwiswa bohloko 
haho setse hona le le mong le moratuwa o ho utlwisang bohloko moo leratong la 
lona. Ka hoba kutlwiso bohloko ke moratuwa moo leratong eka oketseha ha 
omong a fihletswe a le HIV  kapa leka holo amohela kalafi ya HIV . 
 
Bokotsi ba thuto ena ke kgonahalo ya ho ikutlwa osa phutholoha hao araba 
dipotso tse thatha ka bowena, hona ho ikekellwa ha thobalana ho araba dipotso 
tsena hoka o bakela ho hoopla di ketsahalo otla fuwa tsebiso ya mosebetsi ya 
haufi yaka o thusang. Khotsi engwe e bohlokwa ka thuto ena ke ho o eletsa jwale 
o ka sebedisa mohala ho ikopanya le wena. Sena se kaba kotsi ha moratuwa wa 
hao a ka lemoha hore o amohetse mohala oo. O seke wa araba mohala ha ho sa 
loka, o seke wa etsa jwalo. O ka ikopanya le lefapha la mehala ha ho loketse ho 
etsa jwalo, hobane re tlo leka ho o fihlella ka nako e ngwe, ho letsa homa jwaele 
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etsa e etse ka mokgwa o mong wa ho letsa ha morao, ebile ke matsapa a feng a 
beilweng. 
Ditlhatlhobo di behilwe hore tshebediso ya basadi ba ntshwang kotsi mo leratong 
ya basadi ba ntshwang kotsi mo leratong la bona. Hahole jwalo ditholwana tsa 




 Thuto ena le dikgolo tse bohlokwa. O ka itemohela maikutlo eya theilweng ka ho 
feteletseng kapa ho ba le disebediswa e le ditla morao tsa ho nka karolo moo 
thutong ena. O ka fihlela hore dipotso tse dika o thusa ho nahana ka kamahano 
ya hao leho batla thuso lelokong kapa setjhabang hore o sireletsehe. Ba nka 
karolo ba fihletsweng bana le HIV ke tshepo ya hore batla kgona ho bona kalafo 
ya  HIV e sireletsehileng. Kaho fitisisa ho fitisa baneng ba sa nke karalo thutong 
ena. Dipatiisiso di bontsha hore basadi ba bang ba nka karolo dithutong ka 
baratuwa ba bona bao utlwisang bohloko bare ba fihletse thuto ena. Ba oketsa 
tsebo ya bona ka tsebiso ya hotswa ho thuto etla etswa ho thusa basadi ba bang 
ho fihlele tshebediso ya HIV ka mokgwa o sireletsehileng. Ho fihlella tshebediso 
ya HIV tshireletso ho basadi  ba ka ikutwa ba kgotsofetse hofitisisa ka maphelo a 
bona hape le ka maitemohelo a eketsehileng a tsa maphelo kapa ho phela nako 
etelele. Qetellong maitemohelo a ka ke hore palo ya batho ba ba tshwaetsang ba 
bang HIV hape palo ena emyame ya batho ba shwa ka baka la HIV .Tsebo ena 
ya thuto eka se ho kgole re ithutile hore thuto ena eka thusa ba bang. . 
 
Papiso  
Hao nka karolo thutong ena, hape o sala ka hara thato ena kaofela, lebitso la 
hao letla Kenya tlhodisanong ya kgalo ya i-pod ya mahala. Kemyeletso ya ba 
nkileng karalo thutong otla amohela HIV /TB tlhatlhobo le kemoso le thoso ya ho 
hlahlobelwa moratuwa wa hao mahala. Hao sa battle ho nka karolo thutong, otla 
amohela tlhatlhobo ya HIV/TB le kemoso empa ho kenyeletswe moratuwa wa 




Sephiri seka se tshepuwe. Sehiri sa hao setla bolokeha ho fihlela tumellanong sa 
molao. Haeba sepheto sa thuto se phatlaladitswe, lebitso la hao leka se 
phatlalatswe. Haho se jwalo, ba latelang batla lekola rekota ya thuto. Setheo sa 
thuto ekgolo sa Louisille sa lekala la tlhatlhobiso kantoro le kantoro e ikgathileng 
The University of Louisville Institutional Review Board, Human Subjects 
Protection Program Office, and Privacy Office. 
Office for Human Research Protections (OHRP) 
 
Taba ka ngwe etla amohela nomoro hore lebitso la hao le se sebediswe ho 
hlalosa ho tsejwa ha hao data (kapa tsebo hotswa thutong) etla behwa ke ba 
hlahlobi ba lekgotla la Africa Borwa. Hang ha thuto e qetilwe, tsebo ya thuto 
(data) o hlodilwe hotsha dinomorong eseng mabitsong. Etla romelwa ka email 
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hoba hlahlubi ba tsa thuto ena. Tlhebo ka computa etlaba HIPAA ka botlalo (ho 
latela lefapha la tsa Health Insurance Portability and Accountability Act). Defile 
otla dithola ka cabineteng e notletsweng ya primary officer.	  	  
Baithaupi 
 
Honka karolo thutong ena ya baithaupi. O ka kgetha ho senke karalo hohong. 
Hao nka qeto ya hoba thutong ena oka emisa monka karolo nako efe kapa efe 
hao emisa honka karalo nako engwe le engwe, o ka se lahlehlwe ke dikqolo tsa 
seo tshwanetseng. 
 
Patlisiso ya tsa Dilokelo, Dipotso, Tumelano le Ditlotlebo 
 
Patlisiso ya tsa dilokelo, dipotso, tumelano le ditletlebo. 
 
Hao na le seo osa se utlwisising kapa seo o tletlebang ka sona ka thato ena 
kapa disebediswa tsa thuto ema le dikgetho tse tharo. 
 
O ka hokahana ka mohala le Mosuwe hloho ya dipatlisiso ho 502-852-2430 
(USA). 
 
Haeba ona le dipotso ka ditokela tsa hao ka ha thuto, dipotso, le hoba kgahlano, 
kapa hotletleba o ka hoka hana le ba kantoro ya Human Subjects Protection 
Program Office (HSPPO) (502) 852-5188. O ka bua ka dipotso kaha ditokelo tsa 
hao ka hara sephiri, le setho sa setheo sa thuto e kgalo kapa kantoro ya 
Institutional Review Board (IRB) kapa ba  HSPPO. IRB e hlahisitswe thusong 
ena 
 
Haiba o batla ho bua le motho kantle ho lefapha la thutelo, oka hokahana le 1-
87-852-1167. O ka fuwa monyetla wa ho bua ka dipotso, kgahlano kapa tletlebo 
sephiring. Sena ke 24  1-87-852-1167. O ka fuwa monyetla wa ho bua ka 
dipotso, kgahlano kapa tletlebo sephiring. Sena ke 24 a dihora ya mohala o 
arajwang ke batho basa sebetseng lefaphang University of Louisville. 
 
   
__________           
   
 
Pampiri ena yao bolella hore ho etsahalang nakong eo o kgethang honka karalo. 
Ho tekema ho bolela hore thuto ena ho buisana le wena hore dipotso tsa hao di 
arabilwe, hape o tla nka karalo thutong ena. Sena hase tumellano. Hao nehelane 
ka ditikelo tsa molao ka ho tekema lengolo lena o tla fuwa pampiri ya bopaki hoe 
beya ele bopaki. 
 
____________________________________  Language Preference: 
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Gatisa lebitso la motho     isiZulu ______ Xhosa 
______ 
        Sesotho ______
 English ______ 
____________________________________ 
 
Nomoro ya mogala watho: 
 
________________________________________________________________ 
Tekeno ya moemedi wa Moloa                         Kekeno ya letsatsi 
 
___________________________________________ _____________________ 
Motho ya Hlalosang Lemgolo la Kumellano            Kekeno ya letsatsi  
(if other than the Investigator) 
__________________________________________ _____________________ 
Tekenoya Mmatiisisi     Kekano ya letsasi 
 
LENANE LA BABATIISISI              NOMORO YA MOGALA 
 
Michiel A. van Zyl, PhD   1-502-852-2430 




























Appendix	  U	  	  
Sesotho	  Pre-­‐test	  
Script:	  “Hi,	  this	  is	  ____________with	  Shout-­‐it-­‐Now.	  I	  was	  given	  
your	  information	  from	  my	  shout-­‐it-­‐now	  teammate	  because	  
you	  agreed	  to	  participate	  in	  a	  brief	  study	  with	  us.	  This	  will	  
take	  about	  20	  minutes	  or	  more.	  Are	  you	  still	  willing	  to	  
participate	  in	  this	  study?	  Great.	  Is	  this	  a	  safe	  time	  to	  talk?	  
Okay,	  I	  am	  going	  to	  ask	  you	  some	  questions	  now.”	  
Pre-­‐test	  
1.	  RS	  1.	  Anai	  o	  maratong	   Nnete	   Tjhee	  2.	  (Ha	  hole	  jwalo,	  se	  arebe	  potso	  ya	  bobedi):	  Ha	  ngata	  o	  ithola	  
ole	  maratong	   Nnete	   Tjhee	  No	  Total	  for	  RS	  (does	  not	  count	  towards	  total)	  but	  is	  used	  for	  eligibility)	  
2.	  NVC	  (put	  an	  X	  in	  each	  chosen	  block)	  
O	  kare	  ho	  moratuwa	  wa	  hao…	  1.	  Leka	  ho	  fokotsha	  kamano	  ya	  leloko	  la	  hao	  le	  metswalle?	  	  	   Nnete	  (1)	   Tjhee	  2.	  Ke	  mona	  kapa	  ho	  o	  laola?	  	   Nnete	  (1)	   Tjhee	  3.	  O	  phehella	  ho	  tseba	  hore	  ona	  lemang	  ka	  nako	  tsohle?	   Nnete	  (1)	   Tjhee	  4.	  O	  o	  bitsa	  ka	  mabitso	  kappa	  oo	  nkela	  fatshe	  pela	  ba	  bang?	   Nnete	  (1)	   Tjhee	  5.	  O	  etsa	  hore	  o	  ikutlwe	  o	  sena	  loleng	  kapa	  mosola?	   Nnete	  (1)	   Tjhee	  6.	  Wao	  halefela	  kappa	  ho	  ho	  hlapaola?	  	   Nnete	  (1)	   Tjhee	  7.	  O	  utlwisitse	  mmele	  wa	  hao	  bohloko?	   Nnete	  (1)	   Tjhee	  
Totala	  “Nnete”	  (or	  Yes)	  points:	  __________	  
3.	  CTS-­‐2	  (put	  an	  X	  in	  each	  chosen	  block)	  
Ka	  selemo	  sefitileng	  moratuwa	  wa	  hao…	  1.	  O	  o	  shapile?	   Nnete	  (1)	   Tjhee	  2.	  O	  o	  shapile	  ka	  hohong?	   Nnete	  (1)	   Tjhee	  3.	  O	  o	  kgamme?	   Nnete	  (1)	   Tjhee	  4.	  Oho	  shapile	  haholo? Nnete	  (1)	   Tjhee	  5.	  O	  o	  tshoseditse	  ka	  sebetsa?	   Nnete	  (1)	   Tjhee	  
	   
298 
6.	  O	  sebedisetse	  sebetsa	  ho	  wena?	   Nnete	  (1)	   Tjhee	  7.	  O	  entse	  hore	  le	  etse	  thobalano	  ntle	  le	  tshireletso	   Nnete	  (1)	   Tjhee	  8.	  O	  o	  hatelletse	  hore	  le	  etse	  thobalano?	   Nnete	  (1)	   Tjhee	  9.	  O	  hatelletse	  hore	  le	  etse	  thobalano	  ya	  pele	  kapa	  ya	  ka	  morao	   Nnete	  (1)	   Tjhee	  
Totala	  “Nnete”	  (or	  Yes)	  points:	  ____________	  
To	  be	  IPV	  eligible:	  Must	  score	  2	  or	  higher	  on	  NVC	  or	  score	  1	  or	  higher	  in	  CTS-­‐
2	  
NVC:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  CTS-­‐2:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total:	  
IPV	  eligible	  	  	  	  	  	  _______Yes	  	  	  	  ________No	  
If	  yes,	  complete	  remainder	  of	  scales	  
4.	  VVS	  (put	  an	  X	  in	  each	  chosen	  block)	  O	  kare	  tsena	  dietsehala	  kgafetsa	  hakakang?	  
Ha	  ho	  kgonahale,	  ka	  haho	  etsahale	  	  	  	  	  	  	  	  	  	  	  	  Ha	  ngwe	  ka	  mora	  nako	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Kgafetsa	  
1.	  Moratuwa	  wa	  hao	  o	  hlahisa	  mantswe	  a	  hao	  kapa	  diketso	  ka	  
mokgwa	  o	  sa	  nepahalang	  ho	  feta	  ka	  moo	  o	  di	  bolelang.	  	   0	   0	   1	  
2.	  Ha	  lena	  le	  mathata	  ho	  o	  rarolla,	  o	  kare	  lo	  mokgahlo	  o	  
fapaneng.	  	   0	   0	   1	  
3.	  O	  ikutlwa	  ole	  mong	  se	  tswalleng	  sa	  hao	   0	   0	   1	  
4.	  Hale	  ngangisana,	  o	  mong	  o	  tshe-­‐tshella	  morao,	  ka	  seo,	  ha	  a	  
sabatla	  ho	  bua	  ka	  sona	  kapa	  o	  tlohele	  taba	  ele	  jwalo.	   0	   0	   1	  
5.	  O	  tshaba	  moratuwa	  wa	  hao	  .	   0	   0	   1	  
6.	  O	  oikutlwa	  ekareng	  tlhahiso	  kapa	  maikutlo	  a	  hao	  ha	  a	  nataba	  
setwalleng	  sa	  hao?	   0	   0	   1	  
7.	  Hale	  ngangisano	  moratuwa	  wa	  hao	  o	  tlameha	  ho	  hlola	  
ngangisaho	  hape	  aka	  se	  mamele	  lehlakore	  la	  taba	  ya	  hao.	   0	   0	   1	  
8.	  8	  o	  ba	  le	  ho	  tshoha	  kapa	  ho	  tshaba	  ho	  hana	  ha	  morutuwa	  oa	  
hao	  aleka	  hore	  le	  etse	  thobalano.	   0	   0	   1	  
Totala	  “Kgafetsa”	  (or	  Frequently)	  points:	  __________	  
5.	  HIRS	  (Put	  an	  X	  in	  each	  chosen	  block)	  O	  dumellana	  le	  sebolewang	  ?	  
Ka	  baka	  la	  boemo	  ba	  ha	  obo	  kwaysi	  ya	  bosalla	  tlhapi	  HIV	  …	  1.	  O	  tlaba	  ka	  hara	  mathata	  le	  moratuwa	  wa	  hao	   Nnete	  (1)	   Tjhee	  2.	  Moratuwa	  wa	  hao	  e	  tlaba	  tshebetso	  ho	  wena	   Tjhee	  (1)	   Nnete(0)	  3.	  Setswale	  sa	  hao	  le	  moratuwa	  wa	  hao	  setlaba	  ma	  emong	  a	  hlobaetsang	  haholo	  na?	   Nnete	   Tjhee	  4.	  Ho	  fumana	  pheko	  ho	  thlaba	  kotsi	  ka	  baka	  la	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  5.	  O	  tla	  ikutlwa	  osa	  bolokeha	  ka	  hara	  setswale	  la	  lona	   Nnete	   Tjhee	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6.	  Babang	  batla	  o	  thusa	  ha	  o	  ikutlwa	  osa	  tshirelletseha	  se	  tswaleng	  sahao	   Tjhee	  (1)	   Nnete(0)	  7.	  Ha	  wa	  bolokeha	  hao	  bua	  ka	  boemo	  bo	  hao	  ba	  kwatsi	  ya	  bosolla	  tlhapi	  HIV	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  8.	  Ha	  hao	  bolokeha	  ho	  bua	  ka	  boemo	  ba	  hao	  ba	  kwatsi	  ya	  bosolla	  tlhapi	  HIV	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  9.	  O	  i	  kutlwile	  o	  bolokehile	  hao	  kena	  ho	  tsa	  hlophiso	  ya	  maphelo?	   Tjhee	  (1)	   Nnete(0)	  10.	  O	  tshaba	  moratuwa	  wa	  hao	  otla	  leka	  hoo	  bolaya	   Nnete	  
(3)	  
Tjhee	  
Totala	  points:	  ___________	  (remember	  question	  10	  is	  worth	  3	  points	  and	  2,6,	  &	  
9	  are	  reverse	  scoring)	  
6.	  DA	  (put	  an	  X	  in	  each	  chosen	  block)	  
Ka	  selemo	  sa	  ho	  se	  fitileng	  …	  1.	  Moferefere	  setswaleng	  saho	  oile	  wafitisisa	   Nnete	  (2)	   Tjhee	  2.	  Moratuwa	  wa	  hao	  ona	  le	  sethuya?	   Nnete	  (1)	   Tjhee	  3.	  O	  mmoho	  le	  moratuwa	  wa	  hao?	   Nnete	  (1)	   Tjhee	  4.	  Moratuwa	  wa	  hao	  o	  tshosetsa	  ho	  o	  bolaya?	   Nnete	  (2)	   Tjhee	  5.	  Moratuwa	  wa	  hao	  o	  sebedisa	  di	  thitefatsi	  tse	  seng	  molaong	  jwaloka	  (e.g.	  tik,	  crack/cocaine,	  sniff	  glue,	  etc.)kappa	  ho	  kopanya	  matekwane	  mmoho	  le	  bojwala	  kappa	  tse	  ding	  tsa	  dithethefatsi?	  
Nnete	  (1)	   Tjhee	  
6.	  A	  na	  moratuwa	  wa	  hao	  ke	  letawa	  kappa	  onale	  bothata	  ba	  honwa	   Nnete	  (1)	   Tjhee	  7.	  Ebe	  moratuwa	  wa	  hao	  oile	  a	  tshosetsa	  ho	  I	  polaya.	   Nnete	  (2)	   Tjhee	  8.	  Moratuwa	  wa	  hao	  o	  waho	  latela	  kapa	  ahonyonyobele	  kapa	  a	  siye	  melaetsa	  etshosetsang	   Nnete	  (1)	   Tjhee	  9.	  Moratuwa	  wa	  hao	  oile	  a	  senya	  thapa	  ya	  hao?	   Nnete	  (1)	   Tjhee	  10.	  O	  kile	  wa	  tshosetsa	  kapa	  ho	  leka	  ho	  ipolaya?	   Nnete	  (2)	   Tjhee	  
	  
Total	  points	  __________	  (remembering	  that	  questions	  1,4,7	  and	  10	  count	  2	  
points	  each):	  	  	  	  
Thank	  you	  for	  answering	  those	  questions.	  Do	  you	  mind	  if	  I	  ask	  what	  your	  age	  
and	  race	  are?	  	  
Race:	  __________________________	  Age:	  ________________________	  For	  Standard	  of	  Care	  group,	  state:	  	  
Script:	  Thank	  you	  so	  much	  for	  participating.	  We	  will	  contact	  you	  again	  in	  one	  month.”	  For	  Experimental	  groups,	  tally	  their	  scores	  and	  begin	  Safety	  plan.	  
	  
Totals:	  NVC:	  CTS-­‐2:	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VVS:	  HIRS:	  DA:	  
ONLY	  THOSE	  IN	  EXPERIMENTAL	  GROUP	  RECEIVE	  
THEIR	  SCORE!	  
Total	  Score:	  _____________	  
	  
Meaning	  of	  Score	  
1	   	   0-­‐5	  
2	   	   6-­‐10	  
3	   	   11-­‐15	  
4	   	   16-­‐20	  
5	   	   21-­‐25	  
6	   	   26-­‐30	  
7	   	   31-­‐35	  
8	   	   36-­‐40	  
9	   	   41-­‐45	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Appendix	  V	  	  Sesotho	  Safety	  Plan	  	  
Moloo	  o	  ngotsweng	  wa	  Tshireletso:	  	  
Ho	  ea	  ka	  dikarabo	  tseo	  ore	  nehileng	  tsona,tse	  re	  bolellang	  hore	  o	  tshereletsehile	  ha	  
kakang	  setswaleng	  sena	  sa	  hao.O	  fomane	  	  dintlha	  tse_____________	  ho	  tse	  10.mo	  
leshume	  (10)	  le	  bolellang	  hore	  okotsing	  e	  hodimo	  haholo.	  e	  kaba	  oe	  kutlwa	  joang	  ka	  
tsebo	  e? Kemeho	  ya	  hao	  ya	  kwatsi	  ya	  bosolla	  tlhapi	  entjha	  ha	  waka	  wa	  fumana	  nako	  e	  ngata	  ho	  nahana	  ka	  yona.	  Ho	  kaba	  boima	  ho	  nahana	  ka	  yona	  haholo	  hona	  jwale,	  empa	  ho	  bohlokwa	  ho	  qala	  ho	  nahana	  kaha	  hore	  otla	  ikuklwa	  o	  bolokehile	  le	  ratong	  la	  lona	  ka	  kameho	  ena.	  Kena	  le	  tsebiso	  e	  bohlokwa	  bakeng	  sa	  hao.	  Basadi	  bana	  le	  ho	  bona	  tlhekefetso	  ka	  ditsela	  tse	  tharo:	  maikutlong,	  mmeleng	  le	  ka	  thobalano.	  Kaofela	  mefuta	  ena	  ya	  tlhekefetso	  e	  phahama	  kamora	  kameho	  ya	  HIV.	  Mehlala	  ya	  tlhekefetso	  ya	  maikutlo	  ao	  bitsa,	  baya	  fatshe	  kappa	  o	  leka	  ho	  itaola.	  Mehlala	  ya	  tlhekefetso	  ya	  mmele	  ya	  o	  hlola,	  yao	  raha,	  kappa	  ho	  o	  shapa.	  Mehlala	  ya	  tlhekefetso	  ya	  thobalano	  eo	  hatella	  ho	  robalana	  kappa	  ho	  o	  hatella	  ho	  etsa	  thobalano	  eo	  hatella	  ho	  robalana	  kappa	  ho	  o	  hatella	  ho	  etsa	  thobalano	  ntle	  le	  tshireletso.	  Basadi	  ba	  kahara	  lerato	  hona	  le	  tlhekefetso	  kappa	  moruso,monyetla	  o	  moholo	  wa	  tlhekefetso	  haba	  qeta	  ho	  amohela	  sepheto	  sa	  HIV.	  Basadi	  ba	  bang	  ba	  tseba	  kotsi	  haba	  qeta	  ho	  thola	  kaha	  maemo	  a	  bona	  ho	  baratuwa	  ba	  bona	  kappa	  ba	  thola	  tsa	  tlhokomelo	  ka	  kalafo	  ya	  HIV.Motho	  ya	  hlekefetsa	  baka	  leka	  ho	  itshereletsa	  tekong	  ya	  tlhatlhobo	  kappa	  honka	  kalafo.	  Hole	  jwalo	  ekaba	  nako	  e	  kotsi	  leratong	  la	  hao,	  basadi	  ba	  bangata	  ba	  tshepa	  ho	  bolella	  baratuwa	  ba	  bona	  ka	  maemo	  a	  bona	  hore	  baratuwa	  ba	  bona	  le	  bona	  ba	  hlahlojwe	  kappa	  bat	  hole	  kalafo.	  Habeba	  ban	  ka	  qeto	  ya	  ho	  bolella	  baratuwa	  ba	  bona.	  Ho	  bohlokwa	  hotla	  ka	  leano	  ho	  tshepahala	  ha	  seo	  ose	  etsang.	  Ke	  qeto	  ya	  hao,	  hao	  batla	  ho	  bolella	  moratuwa	  wa	  hao	  ka	  boemo	  ba	  hao	  ba	  HIV.	  	  Ho	  lokile	  haeba	  o	  bolela	  hanyane	  ka	  ditsela	  tsa	  ho	  dula	  o	  bolokehile	  kahara	  lerato	  la	  hao?	  	  22. Batho	  ba	  bangata	  bophelong	  ba	  hao	  le	  setjhabeng	  baka	  o	  thusang	  hao	  iketla	  ole	  kotsing	  ka	  hara	  lerato	  la	  hao.	  Sena	  seka	  konyeletsa	  ngaka	  ya	  hao,	  mooki,	  molemosi,	  baeteledi	  pele,	  baeteledi	  pele	  ba	  semoya	  kapa	  tshebeletso	  e	  itseng	  ya	  tlhekefetso	  ya	  thobalano.	  
Ø Hona	  le	  maholale	  ditokomane	  tse	  itseng	  eo	  o	  ka	  e	  letsetsang	  hao	  hloka	  motho	  oo	  oka	  le	  yena	  kappa	  ya	  potlako.	  Nomoro	  ele	  new	  ke	  :	  0800-­‐150-­‐150.	  Ho	  bohlokwa	  ho	  ngola	  sena	  moo	  ho	  bolokehileng	  oka	  behang	  tsena?	  (mosebetsing	  wa	  hao	  kappa	  mohaleng	  wa	  hao	  omang	  le	  mabitso	  a	  fapaneng).	  (3)___________________	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23. Batho	  ba	  bang	  ba	  thabela	  ho	  bua	  le	  kapa	  ba	  thole	  thuso	  bathong	  baba	  tsebang.	  Sena	  seka	  bolela	  ho	  bua	  le	  ba	  leloko	  la	  hao	  kapa	  metswalle	  e	  ka	  o	  thusa	  ha	  etsahala	  ho	  itseng	  .	  	  
Ø Nahana	  ka	  omong	  wa	  leloko	  kappa	  motswalle	  ba	  bolokehileng	  (yaka	  se	  hlahise	  sena	  ho	  moratuwa	  wa	  hao).	  O	  ka	  letsetsa	  motho	  eo	  ha	  fela	  hona	  leho	  potlakileng	  (sebedisa	  nomoro	  ya	  kgokahane	  bakeng	  sa	  thuso).	  24. Hona	  le	  thuso	  ya	  molao	  bakeng	  sa	  moratuwa	  ya	  hlelefetsang.	  Mehlala,	  letsetsa	  maponesa,	  letsetsa	  mmuelli	  kappa	  otlatse	  diforomo	  tsa	  tshireletso.	  
Ø Ho	  itshetlehile	  ,	  hore	  foromo	  ya	  tshireletso	  etla	  thibela	  moratuwa	  wa	  hao	  kema	  ntlong	  ya	  hao	  kappa	  mosebetsing	  wa	  hao	  kappa	  hoba	  le	  kgokahano	  le	  bana	  ba	  hao.	  Tsena	  di	  thusa	  ho	  thibela	  diketso	  tsa	  tlhekefetso.	  O	  ka	  thabela	  dinomoro	  tse	  ka	  o	  thusang	  tsebang	  kaha	  tshireletso?	  (Di	  tshwanetse	  di	  phethahale	  hoya	  ka	  bopaki	  ba	  lefapha	  la	  seponesa)	  le	  hahole	  jwale	  kamtoro	  e	  kgolo	  (ko	  Petoria)ko+27	  (0)	  12	  393	  1000.	  
Ø Boloka	  sena	  sebakang	  sa	  polokehe	  (ntlong	  yaw	  a	  leloko	  ho	  wena	  ntlong	  kappa	  sepatjheng	  tulong	  e	  kahare	  ka	  hara	  setlotsa	  molomo	  kappa	  ngola	  lebitso	  ka	  tshebetso	  e	  fapaneng	  haufi	  le	  yona	  (tokisong	  ya	  moriri,moo	  hontshwang	  dijo)	  25. Batho	  ba	  bang	  ba	  leka	  ho	  qoba	  nakong	  ya	  kotsi	  ya	  tlhekefetso.	  Ha	  ntwa	  e	  bat	  eng	  batho	  ba	  bang	  ba	  leka	  ho	  kokobetsa	  ba	  ratuwa	  ba	  bona.	  Empa	  hoopla	  hore	  boitshwaro	  hase	  molato	  kappa	  boikarabelo.	  
Ø Hona	  le	  ka	  dinako	  tse	  ding	  moo	  oka	  nahanang	  hore	  o	  batla	  ho	  ema	  o	  hlwekile	  ka	  baka	  la	  bo	  ngata	  ba	  dikotsi?	  (4)	  ________________________	  26. Batho	  ba	  bang	  ba	  leka	  ho	  balehela	  tlhekefetso	  ha	  e	  tsahala.	  Mohlala,	  ho	  leka	  ho	  ipuseletsa	  ho	  pata	  sethunya	  mo	  ho	  tsebang	  wena	  hore	  se	  kae	  ho	  leka	  ho	  tsamaya	  kappa	  ho	  fedisa	  lerato	  kappa	  hobaleya,	  hoipata	  nakong	  ya	  ketsahalo.	  Di	  patlisiso	  di	  bontshitse	  hore	  ho	  balehela	  tlhekefetso	  ho	  kotsi	  haholo	  ho	  eketsa	  le	  ntwa	  kappa	  moferefere.	  
Ø O	  nahana	  ho	  tswa	  leratong?	  (5)	  Nnete	  tjhee,	  ha	  hole	  jwalo,	  ho	  lokile	  ho	  lohale	  qheka	  hobane	  ke	  nako	  e	  hlokolosi	  haholo	  nakong	  ya	  lerato	  lemoferefere.	  (6)	  Leqheka	  ke	  ________________________________	  27. Mekgahlelo	  emeng	  e	  kenyeletsa	  ho	  lokisetsa	  botlako	  le	  ho	  pata	  tjhelete,	  ho	  bohlokwa	  ho	  letsetsa	  dinomoro	  le	  batho	  haeba	  o	  hloka	  ho	  tsamaya	  ka	  potloko.	  Hape	  ho	  holokile	  ho	  ba	  leleqheka	  pele,	  o	  kaya	  ntlong	  ya	  hao	  ha	  ntwa	  eka	  etsahala	  (eya	  kamoreng	  e	  bolokehileng	  moo	  ho	  semang	  dibetsa	  kapa	  dintho	  tse	  bohale)	  Hare	  kwala	  pitso	  ena,	  re	  lakatsa	  ho	  o	  thusa	  ho	  etsa	  leqheka	  hore	  otla	  itlhokomela	  ka	  bowena,	  o	  fane	  ka	  botjha	  ba	  kameho	  le	  kotsi	  leratong.	  Hao	  nka	  qeto	  ya	  ho	  bolella	  moratuwa	  wa	  hao	  ka	  boemo	  ba	  hao,	  hona	  jwale	  kappa	  pele	  letsatsi	  le	  dikela,	  ke	  ditsela	  tse	  feng	  tseo	  oka	  itshereletsang	  ka	  tsona?	  (7)______________________________________	  
	   	  	  	  	  	  	   	  
303 
Hao	  belaela	  hore	  moratuwa	  wa	  hao	  o	  etsa	  thobalano	  le	  motho	  omong,	  ho	  bohlokwa	  ho	  tseba	  hoo,	  o	  mo	  bolelle	  kaha	  sona.	  Sena	  seka	  hohela	  moferefere	  o	  moholo.	  Ho	  sebedisa	  tshireletso	  ka	  mora	  hoba	  o	  thole	  tshwaetso	  ya	  HIV,	  ho	  eketsa	  bontshitse	  ho	  eketseha	  ha	  tshwaetso	  empa	  ho	  kopa	  moratuwa	  wa	  hao	  ho	  sebedisa	  tshireletso	  hoka	  bontsha	  ho	  eketsa	  moferefere.	  Empa	  hao	  qla	  ho	  sebedisa	  tshireletso,	  nahana	  tsela	  ya	  polokeho	  ya	  ho	  bua	  le	  moratuwa	  wa	  hao	  ka	  yona.	  Hotlang	  pele	  ka	  mora	  kameho	  hanghang	  eya	  kalafong	  ho	  thola	  pheko	  ya	  meriana.	  	  Ho	  fihlela	  onka	  qeto	  hore	  o	  batla	  ho	  bolella	  moratuwa	  wa	  hao	  ka	  kameho,	  o	  tla	  thola	  jwang	  tshebeletso	  ya	  pheko.	  Ohloka	  honka	  qeto	  ya	  ho	  bolella	  moratuwa	  wa	  hao	  hore	  hona	  le	  koo	  oyang	  teng?	  O	  tlareng(8)	  _____________________	  Haeba	  CD4	  cell	  count	  (ele	  tlase	  )e	  tla	  totobatswa	  hore	  o	  qale	  ka	  ho	  nka	  kalafi	  e	  tshwanetseng.	  Mokga	  o	  bolokehileng	  o	  tlwaelehileng	  ke	  ho	  pata	  di	  kalafo	  tsa	  hao	  ho	  moratuwa	  wa	  hao	  ya	  o	  hlekefetsang.	  Ke	  ditsela	  tse	  feng	  tseo	  o	  ka	  di	  etsang	  (mohlala,	  ho	  Kenya	  dipidisi	  ka	  hara	  lebotlolo	  la	  polasitiki	  kappa	  le	  boloke	  le	  wena).	  O	  ka	  etsang?(9)	  __________________	  Hona	  le	  seo	  reka	  ka	  o	  thusang	  ka	  sona	  kajeno	  hotleo	  bolokehe	  ho	  fumana	  pheko	  eo	  oe	  hlokang	  hape	  itlhokomele	  mmeleng	  le	  moyeng?	  	  (10)	  _______________________________________________________________	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   Appendix	  W	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1.	  HIRS	  
Ha	  esale	  o	  a	  amohela	  sepheto	  sakwatsi	  ea	  bosolla	  tlhapi	  ...ekaba	  o	  dumellana	  le	  se	  bolelwang?	  1.	  O	  bile	  ka	  hara	  mathata	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  2.	  Moratuwa	  wa	  hao	  o	  bile	  tshehetso	  ho	  wena	   Nnete	   Tjhee	  3.	  Setswalle	  sa	  lona	  setlaba	  matateng	  hofitisisa	   Nnete	   Tjhee	  4.	  Ho	  thola	  kalafo	  hobi	  le	  kotsi	  ka	  baka	  la	  moratuwa	  wa	  wahao	   Nnete	   Tjhee	  5.	  O	  ikutlwa	  osa	  bolokeha	  setswalleng	  la	  lona	   Nnete	   Tjhee	  6.	  Ba	  bang	  ba	  tholahala	  hoo	  thusa	  hao	  ikutlwa	  osa	  bolokeha	  setswalleng	  la	  lona	   Nnete	   Tjhee	  7.	  Hone	  hosa	  bolokeha	  ho	  bua	  ka	  teko	  ya	  kwatsi	  ya	  bosolla	  tlhapI	  {HIV}	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  8.	  Hone	  hosa	  bolokeha	  ho	  bua	  ka	  boemo	  ba	  hao	  ba	  HIV	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  9.	  O	  ikutlwile	  o	  bolokehile	  ho	  kena	  hara	  hlophiso	  ya	  maphelo	   Nnete	   Tjhee	  10.	  oile	  waikutlwa	  otsoha	  hore	  molekane	  ao	  hao	  aka	  leka	  ho	  o	  bolaya	   Nnete	   Tjhee	  
	  2.	  SS	  
O	  dumellana	  le	  sebolelwang:	  1.	  Kaofela	  thuso	  ena	  eo	  oye	  fumaneng	  ka	  tsa	  setswalle	  ebile	  molemo	   Nnete	   Tjhee	  2.	  Ho	  bile	  thata	  ho	  botswa	  katsa	  marato	  a	  hao	   Nnete	   Tjhee	  3.	  O	  lakatsa	  hore	  nkabe	  o	  buile	  ka	  mathatha	  a	  hao	  a	  setswalle	  hofeta	   Nnete	   Tjhee	  4.	  O	  ne	  osa	  phothuloha	  hao	  ne	  o	  bua	  ka	  mathato	  a	  tsa	  setswalle	  sa	  hao	   Nnete	   Tjhee	  5.	  Wa	  itshola	  ho	  bua	  ka	  mathata	  a	  setswalle	  sa	  hao	   Nnete	   Tjhee	  6.	  Ho	  bua	  ka	  mathata	  setswalleng	  la	  hao	  ho	  o	  beile	  mongetleng	  o	  moholo	  wa	  kotsi	   Nnete	   Tjhee	  7.	  Tshebeletso	  eo	  o	  efumanang	  eo	  beile	  mnyetleng	  o	  moholo	  wa	  kotsi	   Nnete	   Tjhee	  
3.	  FAS	  1.	  O	  sebedisitse	  leqheka	  le	  bolokehileng?	   Nnete	   Tjhee	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2.	  ofumane	  thuso	  ka	  leqeka	  lebolokehileng	  ele	  molemo	  na	   Nnete	   Tjhee	  3.	  Ke	  mokga	  ofe	  o	  owusebedisitseng	  sebedisitseng	  ?	  	  A.	  Ho	  bua	  le	  ngaka,	  mooki	  kappa	  babang	  ba	  ditsebitsa	  maphelo	   Nnete	   Tjhee	  B.	  Ho	  bua	  le	  molemosi	   Nnete	   Tjhee	  C.	  Ho	  bua	  le	  moruti,	  moetelli	  pele	  wa	  tumelo	  e	  itseng	   Nnete	   Tjhee	  D.	  Ho	  batla	  thuso	  katsa	  thlekefetso	  ya	  tshebetso	  ya	  ka	  hae	  (ka	  bo	  wena	  kappa	  ka	  mohala	  ka	  bonngwe	  kappa	  mokgahlo)	   Nnete	   Tjhee	  E.	  Ho	  bua	  le	  baleloko	  kappa	  metswale	   Nnete	   Tjhee	  F.	  Ho	  hoka	  hana	  le	  maponesa,	  tsa	  molao	  kappa	  ho	  thola	  forome	  ya	  tshireletso	   Nnete	   Tjhee	  G.	  Ho	  leka	  ho	  qoba	  moferefere	  (ho	  etsa	  dintho	  ho	  leka	  ho	  qoba	  moratuwa	  wa	  hao	  ka	  nako	  tse	  ding	  ho	  etsa	  eng	  kappa	  eng	  batlang	  hore	  oe	  etse,	  ho	  leka	  ho	  thola	  kappa	  ho	  etsa	  dintho	  ka	  sephiri	  ho	  moratuwa	  wa	  hao)	   Nnete	   Tjhee	  H.	  Ho	  e	  phetetsa	  ho	  lwana,	  ho	  leka	  ho	  fedisa	  setswalle,	  ho	  baleha	  kappa	  ho	  ipata	  ha	  moferefere	  o	  etsahala	   Nnete	   Tjhee	  I.	  Ho	  nahanela	  pele	  kappa	  hoetsa	  dintho	  tsa	  ho	  pata	  tjhelete	  ho	  boloka	  dinomoro	  tse	  bohlokwa	  ho	  wena	  kappa	  boitshwaro	  bo	  ka	  o	  thusong	  ho	  itukusetsa	  ketsahalo	  yaka	  pele	   Nnete	   Tjhee	  J.	  Ho	  loha	  leqheka	  ka	  tsela	  ebolokehileng	  ho	  thola	  pheko	  ho	  nka	  pheko	  kgafhetsa	   Nnete	   Tjhee	  K.	  Ho	  loha	  leqheka	  ka	  tsela	  ebolokehileng	  ho	  thola	  ho	  nka	  ditlhare	  kgafetsa.	   Nnete	   Tjhee	  
	  4.	  O	  ka	  rata	  ho	  hlahisa	  leqheka	  le	  bolokehileng	  bakeng	  sa	  metswalle	  ka	  hara	  boemo	  bo	  tshwanang	  le	  bona?	   Nnete	   Tjhee	  5.	  Ho	  tla	  bolokeha	  hare	  ohlola	  ka	  mohalo	  ka…	   Kwedi	  ele	  ngwe	  
Kgwedi	  tse	  pedi	   Kgwedi	  tse	  tharo	   	  6.	  Haesale	  o	  I	  ithutile	  ka	  boemo	  ba	  HIV	  oile	  waya	  kalafong	  kappa	  pheko	  (o	  thola	  CD4	  cell	  boemo,	  ho	  bua	  le	  molemosi	  kaha	  kgetho	  ya	  kalafo)?	  hahole	  joalo,	  oile	  neng?	  (kekopa	  onehe	  letstsi	  le	  nepahetseng)	  
Nnete	   Tjhee	  
7.	  ha	  eba	  ola	  tsebisa	  moratuwa	  wa	  hao	  ka	  boemo	  ba	  hao	  ,ekaba	  o	  eile	  wa	  efumana	  oleka	  hara	  afe	  maemo	  athlekefetso?	  (mmele,	  monahano	  kappa	  thobalano)	   Nnete	   Tjhee	  	  	  
 
Time of test end __________ 





Post-­‐test	  Standard	  of	  Care	  Sesotho	  
	  
Post-­‐test	  	  	  	  	  Date	  __________	  	  Time	  of	  test	  __________	  
1.	  HIRS	  
Ha	  esale	  o	  a	  amohela	  sepheto	  sakwatsi	  ea	  bosolla	  tlhapi	  ...ekaba	  o	  dumellana	  le	  se	  bolelwang?	  1.	  O	  bile	  ka	  hara	  mathata	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  2.	  Moratuwa	  wa	  hao	  o	  bile	  tshehetso	  ho	  wena	   Nnete	   Tjhee	  3.	  Setswalle	  sa	  lona	  setlaba	  matateng	  hofitisisa	   Nnete	   Tjhee	  4.	  Ho	  thola	  kalafo	  hobi	  le	  kotsi	  ka	  baka	  la	  moratuwa	  wa	  wahao	   Nnete	   Tjhee	  5.	  O	  ikutlwa	  osa	  bolokeha	  setswalleng	  la	  lona	   Nnete	   Tjhee	  6.	  Ba	  bang	  ba	  tholahala	  hoo	  thusa	  hao	  ikutlwa	  osa	  bolokeha	  setswalleng	  la	  lona	   Nnete	   Tjhee	  7.	  Hone	  hosa	  bolokeha	  ho	  bua	  ka	  teko	  ya	  kwatsi	  ya	  bosolla	  tlhapI	  {HIV}	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  8.	  Hone	  hosa	  bolokeha	  ho	  bua	  ka	  boemo	  ba	  hao	  ba	  HIV	  le	  moratuwa	  wa	  hao	   Nnete	   Tjhee	  9.	  O	  ikutlwile	  o	  bolokehile	  ho	  kena	  hara	  hlophiso	  ya	  maphelo	   Nnete	   Tjhee	  10.	  oile	  waikutlwa	  otsoha	  hore	  molekane	  ao	  hao	  aka	  leka	  ho	  o	  bolaya	   Nnete	   Tjhee	  
	  2.	  SS	  
O	  dumellana	  le	  sebolelwang:	  1.	  Kaofela	  thuso	  ena	  eo	  oye	  fumaneng	  ka	  tsa	  setswalle	  ebile	  molemo	   Nnete	   Tjhee	  2.	  Ho	  bile	  thata	  ho	  botswa	  katsa	  marato	  a	  hao	   Nnete	   Tjhee	  3.	  O	  lakatsa	  hore	  nkabe	  o	  buile	  ka	  mathatha	  a	  hao	  a	  setswalle	  hofeta	   Nnete	   Tjhee	  4.	  O	  ne	  osa	  phothuloha	  hao	  ne	  o	  bua	  ka	  mathato	  a	  tsa	  setswalle	  sa	  hao	   Nnete	   Tjhee	  5.	  Wa	  itshola	  ho	  bua	  ka	  mathata	  a	  setswalle	  sa	  hao	   Nnete	   Tjhee	  6.	  Ho	  bua	  ka	  mathata	  setswalleng	  la	  hao	  ho	  o	  beile	  mongetleng	  o	  moholo	  wa	  kotsi	   Nnete	   Tjhee	  7.	  Tshebeletso	  eo	  o	  efumanang	  eo	  beile	  mnyetleng	  o	  moholo	  wa	  kotsi	   Nnete	   Tjhee	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8.	  Ho	  tla	  bolokeha	  hare	  ohlola	  ka	  mohalo	  ka…	   Kwedi	  ele	  ngwe	   Kgwedi	  tse	  pedi	   Kgwedi	  tse	  tharo	   	  9.	  Haesale	  o	  I	  ithutile	  ka	  boemo	  ba	  HIV	  oile	  waya	  kalafong	  kappa	  pheko	  (o	  thola	  CD4	  cell	  boemo,	  ho	  bua	  le	  molemosi	  kaha	  kgetho	  ya	  kalafo)?	  hahole	  joalo,	  oile	  neng?	  (kekopa	  onehe	  letstsi	  le	  nepahetseng)	  
Nnete	   Tjhee	  
10.	  ha	  eba	  ola	  tsebisa	  moratuwa	  wa	  hao	  ka	  boemo	  ba	  hao	  ,ekaba	  o	  eile	  wa	  efumana	  oleka	  hara	  afe	  maemo	  athlekefetso?	  (mmele,	  monahano	  kappa	  thobalano)	  
Nnete	   Tjhee	  
11.	  kgweding	  efitileng,	  ekaba	  oile	  wa	  thola	  thuso	  bakeng	  sa	  thlekefetso	  setswalleng,hotsena	  tselatelang:	  molemosi,	  moetapele	  watsa	  batho	  kapa	  ho	  hong?	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PhD     University of Louisville 
     Kent School of Social Work 
     Expected May 2016 
 
LCSW     Board of Health, Tennessee 
     2012-present 
 
MSSW    University of Tennessee, Nashville 
     School of Social Work   
     Clinical Track 
     August 2008 
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Title: Mitigating Intimate Partner Violence to Promote Safe Linkage to Care for 
South African Women who test HIV+ During Mobile HIV Counseling and Testing 
 
Committee: Michiel “Riaan” van Zyl (Chair), Bibhuti Sar, Anita Barbee, Marie 
Antoinette Sossou, & Emma Sterrett-Hong 
 
• Phase II trial study using an experimental pre post design, with two tests 
groups of standard of care and experimental and two treatment arms 
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within experimental, to test effectiveness and safety of HIV-IPV risk and 
safety protocol 
• Creation of a reliable psychometric instrument (Cronbach’s alpha 
coefficient .882) measuring risk and safety relative to the HIV-IPV 
intersection 
• Chi-square and Independent sample t tests were conducted to tests for 
condition differences on safety scores, linkage to care rates, and post-test 





• Intimate Partner Violence 
• Trauma 
• HIV/AIDS 
• HIV and IPV link 
• International Social Work and Global Health 
• Social Work Epistemology 
• Forensic Social Work 
• Older Adults 






• Direct Social Work Practice 
• Psychopathology 
• International Social Work 
• Macro Practice 
• Anti-Oppressive Social Work 
• Research Methods 
 
 
GRANTS & ASSISTANTSHIPS 
 
2015  $800   Commission on Diversity and Racial  
     Equality (CODRE) Research Grant                          
School of Interdisciplinary and Graduate
 Studies Diversity Research  
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2015   $3000   Dissertation Research Grant   
            Kent School of Social Work 
 
2015  $3000   Dissertation funding by committee member 
     Kent School of Social Work 
 
2015  $1000   Dissertation funding by Assistant Dean of 
     Research 
     Kent School of Social Work 
 
2013  Admission  IDEA festival scholarship   
     Louisville, KY   
             
2013  $600   6th annual SAAIDS conference scholarship 
    SAAIDS, Durban, South Africa  
 
2013  $2000   Dean’s Office Award for Conference Travel 
     Kent School of Social Work        
 
2012-2014 $38,000  Doctoral Student Assistantship 
     University of Louisville  
 
Other Grant Experiences 
 
2014  submitted,  National Institute of Health RO1 
  not funded  University of Louisville, University of California 
     Los Angeles, Shout-it-Now 
Assisted with development of application




Peer-reviewed journal articles 
 
1. Norton, L., Woods, G., Brown, L. (2014). Secondary Trauma in Forensic 
Settings: Effects on Court Personnel, Jurists, Jurors, and Correctional 
Officers. International Journal of Trauma Research and Practice, 1(1), 28-
33. 
 
2. Van Zyl, A.M., Brown, L.L. Pahl, K. (2015). Using a Call Center to Expand 
Mobile HCT and Link HIV positive Individuals to Care. AIDS Care. Print 
information forthcoming. (2014 Impact Factor 2.095) 
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3. Brown, L.L. (under review). HIV IPV Risk & Safety Protocol for Young South 




1. Brown, L.L., van Zyl, A.M., Pahl, K. Attitudes of Gender Inequalities among 
Mobile HIV Testers (in preparation). 
 
2. Held, M.L., Brown, L.L. (in preparation). Effects of Intimate Partner Violence on 
the Well-Being of Hispanic Women and their Children. 
 
3. Cooper, R.L., Brown, L., Cummings, S. (in preparation). Outcomes of a pilot 
study of a combined MI & CBT intervention for older adult public housing 
residents. 
 
4. Brown, L., Winter, G. (in preparation). Social Work & Capital Punishment: A 
call to action in Tennessee 
 
5. Brown, L. Boamah, D., Thompson, J., van Zyl, A. The Practice of Social Work 




Van Zyl, M.A., Pahl, K, Brown, L.L. (2013). Youth attitudes, perceptions and 
behaviors around gender norms and gender based violence in South 
Africa. Report submitted to Swedish International Development 





Brown, L.L. & Lawson, J. (2015).  Active Teaching to Promote Collaborative 
Engagement in Online Learning Communities. Break out presentation at 
Council on Social Work Education annual conference in Denver, CO, 
October, 2015. 
 
Cooper, R.L., Cummings, S., Brown, L.L. (2014). Substance Abuse and Mental 
Health Among Older Adults in Public Housing. Paper presentation at 
Council on Social Work Education, annual conference in Tampa, FL, 
October 2014. 
 
Faul, A.C., Gordon, B., D'Ambrosio, J.G., Ferrell, G., Tucker, M., Schapmire, 
T.J., Fields, M., Thompson, J., Rhema, S., Miller, J.D., Boamah, D.A., 
Brown, L., Boes, R.C., Zheng, Y., Lawson, T.R. (2013). Academia and the 
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Aging Network. 38th Annual N4A Conference and Tradeshow, Louisville, 
KY, July 27-31. 
 
Faul, A.C., Lawson, T. R., D’Ambrosio, J.G., Boamah, D.A., Cotton, S., Alkohaiz, 
M., Smith, L.D., Lewis, S.N., & Brown, L. (2014). Collaborative 
Teaching and Learning as a Tool to Ignite the Spark in students. 2014 
Celebration of Teaching and Learning, University of Louisville, Delphi 
Center for Teaching & Learning, Louisville, KY, February 7. 
 
Faul, A.C., Lawson, T. R., D’Ambrosio, J.G., Boamah, D.A., Brown, L., Fields, M. 
(2014). Collaborative Teaching and Learning as a Tool to Ignite 
the Spark in students. 2014 Kentucky Association of Social Work 
Educators. Western Kentucky University, Bowling Green, KY, April 10. 
 
Faul, A.C., Gordon, T.R. Lawson, Boamah, D.A., Boes, R.C., Brown, L.L., J.G., 
Fields, M., Thompson, J., Zheng, Y., (2013). Lower Income, Vulnerable 
Adults: Effects of Nutritional Programs on Aging in Place. Summer Series 
on Aging, Louisville, KY June. 
 
Van Zyl, R.M., Pahl, K., Brown, L.L. (2013) Innovations in Links to Care for 
Community-based HCT Programmes, SAAIDS Conference, Durban, 
South Africa, June 2013 
 
Brown, L.L. Domestic Violence Resources and Emotional Safety Planning. 
Nashville Coalition Against Domestic Violence (NCADV) Annual Training. 
Nashville, TN, 2011. 
 
Brown, L.L., Kennedy, B. Domestic Violence Shelter Rules: Rising to the 
Changes in our Movement: advocating without power and control. 
Tennessee Coalition Against Domestic and Sexual Violence (TCADSV) 
Annual Conference. Franklin, TN, 2009. 
 
Brown, L.L. Butler, A. Domestic Violence through the Lens of Family Systems 
Theory. Tennessee Coalition Against Domestic and Sexual Violence 





2015  Research Assistant, Qualitative Coder 
  Principal Investigator: Mary Lehman Held 
  University of Tennessee 
  Hired as researcher, with knowledge of Latin American culture, to 
  assist with coding qualitative component of mixed methods  
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  dissertation study over remunerations with immigrant populations. 
  Created themes and codes over focus groups and interviews  
  and then discussed themes and codes with other coder to enhance 
  the study’s validity and reliability. 
 
2015  Co-Investigator, Fragile Families  
  Principal Investigator: Mary Lehman Held 
  University of Louisville & University of Tennessee 
 Used secondary data from the Fragile Families data set to build
 knowledge on the effects of Intimate Partner Violence (IPV) on
 Hispanic/Latina women and their children. Applied logistic 
 regression to analyze how the differences between country nativity
 and contextualized intimate partner violence (IPV) affect mental
 and physical well-being of women and their children. Conducted
 literature review, assisted with manuscript composition and variable
 coding. 
 
2014-  Co-Investigator, Tennesseans for Alternatives to the Death 
present  penalty   
Principal Investigator: Michiel van Zyl 
  Nashville, TN 
  Collaborated with community organization to analyze secondary 
  data over three years of student conference evaluations. Used 
  basic descriptive statistics to analyze demographic information of 
  student attendees. Conducted literature review, composed  
  manuscript, analyzed results, and collaborated with MSSW student 
  intern.  
 
2014-  Co-Investigator, The Family Center  
present Nashville, TN 
  Principal Investigator: Anita Barbee 
  Collaborated with community organization to analyze secondary 
  data over 12 months of pre/post surveys used to measure the 
  efficacy of parenting classes administered in prisons, community 
  centers and drug and alcohol programs. Will use Hierarchal Linear 
  Modeling to analyze efficacy of programs given the various site 
  locations. Used Confirmatory Factor Analysis (CFA) to test validity 
  and reliability of psychometric tool (Adult Adolescent Parenting 
  Inventory version-2).  
 
2014  Graduate Student Researcher, Kent School of Social Work 
Principal Investigator: Michiel van Zyl 
University of Louisville 
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Analyzed results from Kent School of Social Work’s students’
 pre/post responses on the California Critical Thinking Survey, and
 assisted in the development of discipline-specific survey for social
 work. Built on previous cohort’s social work critical thinking survey
 and used Classical Test Theory and Item Response Theory to test
 old and new items to replace those with unacceptable reliability and
 validity. 
 
2013-2014 Graduate Student Researcher, Shout-it-Now 
Principal Investigator: Michiel van Zyl 
University of Louisville and Gauteng & Limpopo provinces, South
 Africa 
Under a grant from the Swedish government, conducted study to
 determine link between gender inequalities and HIV in youth in
 South African provinces of Gauteng and Limpopo. Used principle
 component analysis (PCA) for scale development of psychometric
 tool created to measure violence vulnerability of participants. After
 PCA, Cronbach alpha of created subscale was .807 with a
 Corrected Mean Total Correlation of .45. 
 
2013-  Graduate Student Researcher, Center for Women and Families 
present  Principal Investigator: Anita Barbee 
University of Louisville and Louisville, KY 
Collaborated with community agency for chart review (secondary
 data analysis) to help organization conduct program evaluation.
 Acted as consultant to organization in their transition to a trauma
 informed center or program of No Rules. 
 
2013-2015 Graduate Student Researcher, Shout-it-Now 
Principal Investigator: Michiel van Zyl 
University of Louisville & Gauteng and Limpopo provinces, South
 Africa 
Secondary data analysis over data collected by agency’s call
 centre. Use of Chi Square Automatic Interaction Detection (CHAID)
 analysis to determine success of links-to-care program. Conducted
 literature review, prepared manuscript, submitted and was
 approved by IRB, submitted to journal and was published. 
 
2012-2014  Graduate Student Researcher, Kentuckiana Regional Planning & 
  Development Agency (KIPDA) 
 Principal Investigators Anna Faul and Tom Lawson 
 University of Louisville 
  Conducted collaborative study between Kent school of social work 
  doctoral program and KIPDA to help determine efficacy of three 
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  different KIPDA programs on older adults aging in place. Presented 
  results and won poster award at Summer Series on Aging.  
   
2011-  Project Coordinator, Metropolitan Development & Housing  
  Agency 2014 (MDHA) 
  Principal Investigator: Robert Cooper 
  Oversaw and administered pilot research study done in  
  collaboration between MDHA and University of Tennessee.  
  Administered study as clinician, oversaw grant reporting and later 
  assisted with data analysis. Used Fischer’s exact test and paired 





Fall, 2014  Instructor  
& 2015 Advanced Social Work Practice II (SW 640 Distance Education) 
University of Louisville, Louisville, KY  
This is an online course that utilizes Blackboard, Softchalk, Tegrity 
and Collaborate for virtual meetings. This course teaches advanced 
problem-solving practice models and critical thinking skills to assist 
social workers in preparation for clinical roles or supervision of 
direct service providers. Practice models taught are crisis 
intervention theory, solution-focused therapy, motivational 
interviewing, and cognitive-behavioral therapy. The course requires 
integration of Advanced Research Course material related to: 
evidence-based practice, evaluation, critical thinking, problem 
solving, and planned intervention.            
Spring, 2015 Instructor 
  Advanced Social Work Practice III (SW 677 Distance   
  Education) 
  University of Louisville, Louisville, KY 
This course provides special attention to complex practice 
situations encountered by social workers in social welfare 
organizations, schools, health and mental health care facilities, and 
in the community. Students learn intervention strategies and 
practice skills to promote change at multiple levels of social 
systems using a case based learning approach. The first half of the 
course explores trauma and trauma-focused care, and the latter 
half focuses on the theory and application of Anti-Oppressive social 
work practice on multi-systemic levels. The course helps students 
bridge clinical and macro-level social work and seeks to inspire 
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them to practice and respond to oppression on multi-levels as they 
commit to lifelong learning. 
 
Spring, 2015 Course Designer 
  Advanced Social Work Practice III (SW 677) Distance Education 
  Designed online course for entire online course sequence and was 
  asked by Associate Dean to do so as the course had never been 
  taught online. Created modules for weekly sessions using Softchalk 
  and designed assignments to fit online medium. 
   
Fall, 2014 Course Designer 
  Advanced Social Work Practice III (SW 677) Distance Education 
Designed online course for entire online course sequence and was 
 asked by Associate Dean for Academic Affairs to do so as the 
 course had never been taught online. Created modules for weekly 
 sessions using Softchalk and designed assignments to fit online
 medium. 
 
Spring, 2014 Instructor 
  Advanced Social Work Practice III (SW 677) 
  University of Louisville, Louisville, KY 
  This is the same course as listed above but is taught face-to-face 
  within a traditional classroom setting. 
 
Fall, 2013 Graduate Instructor 
  Advanced Social Work Practice II (SW 640) 
  University of Louisville, Louisville, KY 
  This is the same course as listed above but is taught   
  face-to-face within a traditional classroom setting. 
 
Jan., 2009- Instructor 
Dec. 2011 Social Work Interviewing Skills (SW 220)    
  Nashville State Community College 
  Nashville, TN       
  This course teaches basic social work interviewing skills focusing 
  on engagement, assessment, the helping phase, evaluation and 
  termination. Students learn basic principles of ethical decision- 
  making and how to use an ethics hierarchy to resolve ethical  
  dilemmas. Basic practice skills are also taught.           
 
 
SOCIAL WORK PRACTICE EXPERIENCE 
 
Mar., 2015- Mitigation Expert 
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Present Contract consultation 
Provide social work mitigation for homicide cases with public  
 defender’s office 
 
Jan., 2014- Mitigation Expert 
Present Center for Trauma Therapy 
  Chronologist for capital homicide cases   
 
Sep., 2012- Psychotherapist  
Present Symmetry Counseling        
Focusing on trauma (sexual assault, etc.), transgender issues, &
 self harm. Work with teens, young adults, adults, couples &
 families. Use of EMDR, Cognitive Behavioral Therapy, Motivational
 Interviewing and Acceptance and Commitment therapy 
 
Sep. 2011- HeLP Project Coordinator   
Apr., 2014 Metropolitan Development & Housing Agency (MDHA)          
            Administered research study using Motivational Interviewing and 
  Cognitive Behavioral therapy for older adults with substance  
  misuse, mental health or dual diagnosis; Managed grant and  
  implemented pilot study. 
 
Sep., 2007- Program Coordinator 
Sep. 2011 YWCA Domestic Violence Center   
 Supervised full-time and part-time crisis counselors, case  
  managers, childcare workers and interns in residential and hotline 
  setting 
 
Oct., 2008- Therapist 
Sep., 2011  YWCA Domestic Violence Center             
Conducted individual and group therapy using Cognitive Behavioral
 Therapy and Motivational Interviewing 
 
Aug., 2007- MSSW Field Practicum 
Jul., 2008 Nashville Cares, HIV/AIDS        
 Individual and group therapy with adults infected and affected with 
  HIV/AIDS who either had mental health issues or substance abuse  
Worked in Intensive Outpatient treatment 
 
Aug., 2006- MSSW Foundation Field Practicum   
May, 2007 YW Newstart Program, TN Prison for Women,         
Individual and group therapy for incarcerated women in minimum 
security 
 
	   	  	  	  	  	  	   	  
318 
Mar., 2005- Children’s Counselor 
Sep., 2007 YWCA Domestic Violence Center 
Individual, family and group sessions in-shelter and in community
 with DeDe Wallace, Oasis center and Monroe Harding 
Conducted Parenting group in-shelter and TN Prison for Women 
Child Abuse Review Team with Child Protective Services 
 
Mar., 2004- Women’s Advocate        
March, 2005 YWCA Domestic Violence Center 
Answered hotline, conducted intakes, worked in residential setting 
 
 
CERTIFICATES & SKILLS 
 
2012-  CITI and HIPPA certified  
present        
 
2012-  Licensed Clinical Social Worker                   
present 
 
2011/2012 EMDR Level II trained                  
       
2008  Phi Alpha Honor Society Iota Epsilon Chapter, 4.0 GPA 
University of Tennessee 
 
2009-2011 Spanish courses, Nashville State Community College              
          
2012-2014 Spanish courses, Tennessee Foreign Language Institute  
   Conversational Spanish and extensive travel in Latin America: 
  Colombia, Dominican Republic, Puerto Rico, Argentina, Uruguay, 
  Paraguay, Peru, Bolivia, Brazil, Mexico, Costa Rica, Panama, 




SERVICE SOCIAL WORK PROFESSION 
 
Fall, 2015 Peer Reviewer for AIDS Care 
Invited personally by editors of UK-based Taylor & Frances journal, 
with impact factor of 2.095, for specific article as an expert on HIV 
services in South Africa 
 
Feb. 2009-  Board of Directors 
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Present Tennesseans for Alternatives to the Death Penalty 
Lobby for death penalty repeal; fundraise for agency operation; 
organize and manage annual benefit; oversee organization; 
mobilize community towards abolition 
 
Apr., 2013 Capstone Judge 
BSW Capstone poster presentations 
         
Oct. 2009- Board of Directors 
Oct. 2012 South Nashville Action People 
Organize neighborhood events such as monthly meeting, Creek
 clean up and holiday gift drive; help re-write organization mission
 and by laws; worked on grants to move from volunteer-based
 organization to one with two paid staff; oversaw budget of
 organization as well as organization-owned affordable housing
 units; oversaw renovation of housing units and assisted with money
 appropriation of housing revenue. 
      
2009-2012 Board of Directors, Chair 2009-2010, Co-Chair 2011-2012 
Nashville Coalition Against Domestic Violence, 
Conducted monthly meetings, organized events such as Meet Us at 
the Bridge, NCADV annual legal training and NCADV annual 
benefit; synergized with domestic violence service providers in 
Nashville to provide cohesive and unified response to domestic 
violence in Davidson county; wrote and received a grant to provide 
financial assistance to community victims of domestic violence and 
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Professor & Doctoral Program Director 
Kent School of Social Work 
Patterson Hall 






Professor, Associate Dean for Academic Affairs 
Kent School of Social Work 
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Houston, TX 77098 
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